data_2it8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2it8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.5 t -94.53 118.19 66.94 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.22 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.19 150.95 54.29 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.59 2.86 . . . . 0.0 113.232 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -77.89 17.92 0.53 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.122 1.369 . . . . 0.0 114.226 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.0 pt -79.12 159.71 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.983 1.713 . . . . 0.0 112.341 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.4 tp -105.56 87.55 2.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.676 1.191 . . . . 0.0 108.935 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -107.95 127.08 53.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.259 1.424 . . . . 0.0 110.704 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -70.59 159.13 34.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.25 0.932 . . . . 0.0 112.744 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.3 p -159.51 153.18 22.8 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -96.25 -30.01 13.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.24 1.816 . . . . 0.0 110.837 169.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.2 ptm85 -169.21 173.23 6.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.327 2.651 . . . . 0.0 110.67 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.81 -26.81 66.06 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.314 1.046 . . . . 0.0 113.252 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 m -62.99 -18.59 63.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.083 1.353 . . . . 0.0 114.049 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -86.47 -10.55 53.95 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.169 0.988 . . . . 0.0 112.923 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.3 m -101.87 136.34 19.54 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.825 1.25 . . . . 0.0 113.265 -171.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -88.73 155.08 6.17 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.428 2.752 . . . . 0.0 112.559 -169.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.72 -123.14 30.99 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.86 5.89 50.2 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.526 1.13 . . . . 0.0 113.883 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.9 m -64.0 144.9 56.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.408 1.004 . . . . 0.0 112.228 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.3 pt -120.06 155.69 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.42 1.888 . . . . 0.0 109.8 171.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.4 t -79.64 126.27 30.69 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.348 -0.845 . . . . 0.0 110.674 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -97.94 168.26 10.4 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.801 1.24 . . . . 0.0 111.756 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.45 -17.62 66.71 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 124.585 1.088 . . . . 0.0 115.218 -171.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -77.49 -7.84 56.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.714 1.206 . . . . 0.0 114.21 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.0 19.06 52.64 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.123 1.344 . . . . 0.0 114.263 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -129.98 156.22 44.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.323 1.449 . . . . 0.0 112.35 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.5 m -73.08 138.29 45.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.009 1.723 . . . . 0.0 112.203 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.95 0 C-N-CA 125.042 1.306 . . . . 0.0 113.556 177.305 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.8 t -90.48 117.33 67.91 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.104 172.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -62.11 160.57 29.73 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.149 2.566 . . . . 0.0 112.721 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -77.36 32.04 0.15 Allowed 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.263 1.425 . . . . 0.0 113.65 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 pp -80.33 174.05 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.353 1.861 . . . . 0.0 112.853 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.8 tp -136.48 86.75 2.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.292 1.437 . . . . 0.0 108.325 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -109.4 133.03 53.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.511 1.524 . . . . 0.0 110.287 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -70.98 160.01 33.68 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.329 0.968 . . . . 0.0 111.221 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.6 p -160.32 152.27 20.18 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -94.42 -34.59 12.69 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.198 1.799 . . . . 0.0 110.433 169.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -166.77 178.06 6.12 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.233 2.613 . . . . 0.0 110.449 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -61.1 -26.9 67.98 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.1 p -69.64 -13.15 62.16 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -82.08 -18.43 43.1 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.018 0.826 . . . . 0.0 112.593 170.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.6 m -91.66 139.9 25.05 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.697 1.199 . . . . 0.0 113.766 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -85.7 150.13 9.97 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.439 2.759 . . . . 0.0 112.437 -169.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.56 -123.52 32.18 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.35 9.83 42.17 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.646 1.178 . . . . 0.0 113.832 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 91.2 m -61.62 145.71 51.29 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.071 -1.018 . . . . 0.0 112.31 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.2 pt -120.43 154.57 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.398 1.879 . . . . 0.0 110.006 174.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.9 t -80.68 123.87 28.54 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.385 -0.822 . . . . 0.0 110.626 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -95.76 169.97 9.64 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.891 1.277 . . . . 0.0 111.734 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.47 -17.88 67.05 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.574 1.083 . . . . 0.0 115.224 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -78.25 -6.09 53.91 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.839 1.256 . . . . 0.0 114.212 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.0 15.75 60.56 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.082 1.325 . . . . 0.0 114.281 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -127.33 156.53 41.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.975 1.31 . . . . 0.0 113.099 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.2 m -74.02 137.3 43.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.753 1.621 . . . . 0.0 112.466 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 C-N-CA 125.225 1.393 . . . . 0.0 113.366 177.162 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.5 t -90.59 116.16 65.79 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.182 173.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.1 154.46 72.45 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.947 2.432 . . . . 0.0 111.735 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -83.25 14.97 3.15 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -169.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.2 pt -79.18 151.73 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.5 1.52 . . . . 0.0 112.279 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.4 tp -89.47 89.38 7.83 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.322 1.049 . . . . 0.0 109.249 174.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -109.71 122.5 47.62 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.704 1.601 . . . . 0.0 109.61 -173.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -73.14 160.09 32.53 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.169 -0.957 . . . . 0.0 112.095 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.5 p -161.78 153.49 18.94 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -96.31 -32.95 12.14 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.993 1.717 . . . . 0.0 110.34 169.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.7 ptt-85 -165.85 177.32 7.24 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 128.417 2.687 . . . . 0.0 110.437 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -59.33 -27.29 65.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.334 1.054 . . . . 0.0 113.496 -172.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.7 m -60.01 -22.4 62.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.094 1.358 . . . . 0.0 114.067 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -88.56 -10.32 49.21 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.196 0.998 . . . . 0.0 113.085 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.2 m -93.79 140.14 22.93 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -84.43 147.47 11.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.548 2.832 . . . . 0.0 112.317 -169.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.88 -122.03 28.44 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.903 -0.498 . . . . 0.0 111.916 177.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.54 6.0 50.09 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.746 1.218 . . . . 0.0 114.03 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.0 m -63.76 149.62 46.38 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.173 -0.954 . . . . 0.0 113.109 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.9 pt -117.4 157.1 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.605 1.962 . . . . 0.0 110.107 169.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.8 t -84.18 119.93 25.59 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.439 -0.788 . . . . 0.0 110.911 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -88.28 168.09 13.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.651 1.18 . . . . 0.0 111.519 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -16.72 66.04 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.587 1.089 . . . . 0.0 115.297 -172.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -78.06 -7.07 56.47 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 172.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.82 16.94 57.45 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.851 1.215 . . . . 0.0 114.225 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -129.88 156.52 44.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.049 1.34 . . . . 0.0 112.763 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.9 m -76.43 144.0 40.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.164 1.386 . . . . 0.0 113.016 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.917 0 C-N-CA 125.158 1.361 . . . . 0.0 113.444 177.06 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.4 t -92.57 116.03 65.8 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.261 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 147.2 63.78 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.666 2.244 . . . . 0.0 111.101 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -80.92 17.64 1.16 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.869 1.268 . . . . 0.0 114.379 -171.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.9 pt -75.79 152.91 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.532 1.533 . . . . 0.0 112.231 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.2 tp -88.14 87.35 7.29 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.303 1.041 . . . . 0.0 109.506 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -109.56 121.03 44.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.76 1.624 . . . . 0.0 109.527 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -73.56 159.21 33.47 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.208 -0.932 . . . . 0.0 112.289 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.1 p -161.54 156.21 23.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.18 -32.5 9.11 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.572 1.949 . . . . 0.0 109.686 168.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -159.62 177.1 11.24 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.232 2.213 . . . . 0.0 111.295 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -60.67 -26.78 67.34 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.455 1.102 . . . . 0.0 113.496 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.8 m -60.02 -21.16 61.0 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.02 1.328 . . . . 0.0 113.928 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -86.65 -13.84 44.41 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.237 1.015 . . . . 0.0 113.097 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.1 m -92.35 140.13 24.18 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.46 147.48 11.19 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.573 2.848 . . . . 0.0 112.301 -169.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.96 -121.59 27.05 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.76 5.85 50.34 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.697 1.199 . . . . 0.0 113.964 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.1 m -63.77 150.32 44.85 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.108 -0.995 . . . . 0.0 113.134 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.0 155.68 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.636 1.974 . . . . 0.0 109.941 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.6 t -78.8 131.99 36.71 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.18 -0.95 . . . . 0.0 110.642 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -104.25 167.64 9.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.596 1.158 . . . . 0.0 111.765 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.74 -16.89 66.48 Favored Glycine 0 N--CA 1.477 1.403 0 C-N-CA 124.712 1.149 . . . . 0.0 115.362 -170.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -76.83 -8.06 56.63 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 171.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.4 15.98 56.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.09 1.329 . . . . 0.0 114.2 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -130.98 157.44 42.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.03 1.332 . . . . 0.0 112.631 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.9 m -76.02 141.47 42.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.201 1.4 . . . . 0.0 112.89 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.994 0 C-N-CA 125.417 1.484 . . . . 0.0 113.437 176.357 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.6 t -93.65 116.72 66.85 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.176 173.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.21 150.11 71.2 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.785 2.324 . . . . 0.0 111.591 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -77.29 13.43 1.17 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -171.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 pt -78.21 151.59 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.539 1.536 . . . . 0.0 112.301 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.4 tp -89.3 88.45 7.5 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.384 1.074 . . . . 0.0 109.407 175.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -109.66 121.97 46.42 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.783 1.633 . . . . 0.0 109.562 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -73.6 159.33 33.25 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.131 -0.98 . . . . 0.0 112.312 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.2 p -163.74 161.86 23.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -112.99 -32.29 6.41 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.505 1.922 . . . . 0.0 110.299 168.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -155.33 175.36 13.96 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.141 1.776 . . . . 0.0 111.057 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -61.97 -26.88 68.47 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.165 1.386 . . . . 0.0 113.439 -169.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.2 m -63.36 -18.79 64.04 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.758 1.223 . . . . 0.0 113.499 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -84.67 -13.83 50.32 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.284 1.034 . . . . 0.0 112.901 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.6 m -95.17 141.54 23.38 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.701 1.201 . . . . 0.0 114.18 -169.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -84.39 146.35 10.97 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.585 2.856 . . . . 0.0 112.262 -169.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.84 -122.69 30.53 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.84 5.97 50.34 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.793 1.237 . . . . 0.0 113.986 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.4 m -62.99 149.03 45.91 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.227 -0.921 . . . . 0.0 113.04 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.6 pt -117.86 155.97 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.458 1.903 . . . . 0.0 110.338 170.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 t -82.97 122.71 28.64 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.374 -0.829 . . . . 0.0 111.021 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -93.46 168.13 11.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.7 1.2 . . . . 0.0 111.74 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.7 -17.22 66.8 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.631 1.11 . . . . 0.0 115.294 -171.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -77.7 -7.39 56.42 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 172.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.18 16.99 56.75 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.982 1.277 . . . . 0.0 114.221 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -130.63 157.16 43.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.974 1.309 . . . . 0.0 112.632 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.5 m -76.08 143.51 41.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.185 1.394 . . . . 0.0 112.849 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.998 0 C-N-CA 125.127 1.346 . . . . 0.0 113.422 177.908 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.4 t -89.41 118.38 69.04 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.209 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -58.8 161.25 15.66 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.472 2.782 . . . . 0.0 113.467 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -78.58 17.91 0.63 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.865 1.266 . . . . 0.0 113.355 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 tp -76.1 148.59 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 126.124 1.77 . . . . 0.0 112.076 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.1 tp -106.2 86.55 2.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.763 1.225 . . . . 0.0 108.101 169.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -107.15 131.63 53.93 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.123 1.369 . . . . 0.0 110.442 -176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -70.56 160.76 31.9 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.059 0.845 . . . . 0.0 111.089 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -160.21 150.76 18.61 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -93.3 -35.67 12.95 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.406 1.882 . . . . 0.0 110.428 169.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -165.04 -179.85 5.96 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.399 2.68 . . . . 0.0 110.198 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -59.72 -26.03 65.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.318 1.047 . . . . 0.0 113.645 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 m -59.46 -22.76 62.01 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.375 1.47 . . . . 0.0 114.176 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -84.47 -17.3 39.57 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.896 0.878 . . . . 0.0 113.004 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.6 m -91.21 138.09 25.94 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -169.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -87.15 151.53 8.15 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.406 2.737 . . . . 0.0 112.441 -169.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.56 -125.07 36.27 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.57 9.36 41.73 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.578 1.151 . . . . 0.0 113.862 174.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.2 m -62.35 146.93 49.91 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.104 -0.997 . . . . 0.0 112.256 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.94 154.53 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.442 1.897 . . . . 0.0 109.823 172.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -78.38 129.86 35.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.336 -0.852 . . . . 0.0 110.525 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -103.29 169.81 8.33 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.644 1.178 . . . . 0.0 111.854 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.52 -17.71 66.96 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.695 1.14 . . . . 0.0 115.297 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -77.28 -6.7 54.12 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.751 1.22 . . . . 0.0 114.131 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.11 15.77 60.34 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.19 1.376 . . . . 0.0 114.201 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -127.95 156.86 42.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.074 1.35 . . . . 0.0 113.098 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.4 m -73.8 136.21 43.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.711 1.605 . . . . 0.0 112.468 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.96 0 C-N-CA 125.332 1.444 . . . . 0.0 113.452 176.785 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 48.7 t -84.11 117.77 69.55 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.337 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.88 175.58 10.18 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.517 2.811 . . . . 0.0 112.337 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -76.44 35.26 0.14 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.026 1.731 . . . . 0.0 113.635 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.3 pt -80.35 170.82 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.459 1.904 . . . . 0.0 112.185 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.4 tp -143.86 91.03 2.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.969 1.308 . . . . 0.0 109.372 173.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -112.33 136.85 51.27 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.672 1.589 . . . . 0.0 111.041 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -63.94 155.72 29.99 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 118.844 0.747 . . . . 0.0 111.597 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.0 p -159.83 155.15 25.28 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -98.46 -36.19 10.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.443 1.897 . . . . 0.0 110.485 169.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -163.16 175.53 10.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.937 2.495 . . . . 0.0 109.442 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -60.6 -26.4 66.96 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.397 1.479 . . . . 0.0 113.523 -169.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.5 m -62.54 -20.44 64.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.867 1.267 . . . . 0.0 113.781 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -83.07 -14.25 54.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.723 0.809 . . . . 0.0 113.023 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.3 m -99.03 137.38 20.46 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.046 1.338 . . . . 0.0 113.014 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -86.65 150.93 8.79 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.834 2.356 . . . . 0.0 112.015 -170.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.56 -123.3 32.46 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.34 0.495 . . . . 0.0 112.168 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.17 1.83 56.97 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.689 1.196 . . . . 0.0 114.085 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.8 m -64.2 143.42 57.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.375 0.989 . . . . 0.0 112.376 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.6 pt -120.76 155.86 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.34 1.856 . . . . 0.0 110.132 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.0 t -83.1 116.27 22.25 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.505 -0.747 . . . . 0.0 110.886 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -86.88 169.2 12.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.935 1.294 . . . . 0.0 111.777 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.48 -17.26 66.35 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 124.565 1.079 . . . . 0.0 115.21 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -77.64 -6.6 54.39 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.777 1.231 . . . . 0.0 114.2 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.39 20.46 54.58 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.867 1.223 . . . . 0.0 114.17 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -131.93 157.99 42.59 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.003 1.321 . . . . 0.0 112.865 177.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 75.3 m -73.6 136.77 43.96 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.595 1.558 . . . . 0.0 112.514 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.933 0 C-N-CA 125.257 1.408 . . . . 0.0 113.366 177.816 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.9 t -90.59 117.86 68.28 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.322 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.32 146.06 52.71 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.875 3.05 . . . . 0.0 113.286 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -78.41 10.49 3.07 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -170.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.4 pt -79.45 154.05 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.333 1.453 . . . . 0.0 112.114 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.34 93.6 6.59 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.508 1.123 . . . . 0.0 108.805 171.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -108.22 133.63 52.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.3 1.44 . . . . 0.0 111.196 -175.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -62.24 153.74 29.66 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.946 0.794 . . . . 0.0 112.269 171.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -160.42 167.02 28.23 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -128.02 -9.94 5.39 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.242 1.417 . . . . 0.0 112.922 169.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 ptm85 -167.01 166.16 15.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.085 2.154 . . . . 0.0 111.987 173.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -61.37 -30.47 70.55 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.565 1.146 . . . . 0.0 112.85 -171.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 m -62.72 -19.14 63.63 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.098 1.359 . . . . 0.0 113.617 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -95.57 -2.57 48.15 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.288 1.435 . . . . 0.0 112.904 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.3 m -97.64 140.42 21.97 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.063 1.345 . . . . 0.0 112.947 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -83.39 148.52 12.93 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.422 2.748 . . . . 0.0 112.559 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.28 -123.55 33.3 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.669 -0.573 . . . . 0.0 111.669 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.93 8.61 43.18 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.703 1.201 . . . . 0.0 113.917 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.2 m -62.38 145.71 53.23 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.439 1.018 . . . . 0.0 112.151 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.8 pt -115.32 154.75 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.198 1.799 . . . . 0.0 110.198 172.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.0 t -82.65 123.54 29.35 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.457 -0.777 . . . . 0.0 110.635 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.44 167.07 11.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.737 1.215 . . . . 0.0 111.761 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.23 66.6 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 124.572 1.082 . . . . 0.0 115.269 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -77.7 -6.41 53.83 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 171.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.44 22.64 46.71 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.872 1.225 . . . . 0.0 113.978 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -132.77 156.36 47.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.216 1.406 . . . . 0.0 112.747 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.8 m -73.82 140.67 45.96 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 112.363 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.015 0 C-N-CA 125.194 1.378 . . . . 0.0 113.395 176.766 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.9 t -90.03 114.0 59.24 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 118.177 -0.916 . . . . 0.0 109.985 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.95 160.89 47.94 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.942 2.428 . . . . 0.0 111.872 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -79.62 18.58 0.73 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.082 1.353 . . . . 0.0 114.246 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.4 mt -79.01 138.15 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.709 1.604 . . . . 0.0 109.921 -176.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.5 tp -84.07 84.83 7.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.16 0.984 . . . . 0.0 108.701 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -107.01 123.42 48.17 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.906 1.682 . . . . 0.0 109.484 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -72.22 159.28 34.36 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.075 -1.016 . . . . 0.0 111.982 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.2 p -162.27 158.46 24.31 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -112.37 -26.71 8.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.265 1.826 . . . . 0.0 110.658 168.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.3 175.97 12.73 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.91 2.084 . . . . 0.0 111.37 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -60.91 -27.19 68.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.966 0.907 . . . . 0.0 113.265 -171.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -62.86 -18.06 62.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.178 1.391 . . . . 0.0 113.881 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.7 -14.2 46.13 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.349 1.059 . . . . 0.0 112.881 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.7 m -93.43 141.36 23.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -83.81 146.35 11.74 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.442 2.762 . . . . 0.0 112.129 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.8 -121.8 27.73 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.79 7.33 46.84 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.792 1.237 . . . . 0.0 113.907 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.2 m -63.19 150.88 41.87 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.127 -0.983 . . . . 0.0 113.023 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.2 pt -119.35 154.76 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.542 1.937 . . . . 0.0 110.162 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.9 t -79.1 132.53 36.62 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.145 -0.972 . . . . 0.0 110.849 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -105.26 167.12 9.94 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.624 1.169 . . . . 0.0 111.798 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.03 -16.51 66.58 Favored Glycine 0 N--CA 1.478 1.478 0 C-N-CA 124.649 1.119 . . . . 0.0 115.433 -170.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -76.8 -6.97 54.47 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.21 58.98 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.043 1.306 . . . . 0.0 114.154 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -130.38 157.49 42.45 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.99 1.316 . . . . 0.0 112.741 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.0 m -76.48 141.51 41.27 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.265 1.426 . . . . 0.0 112.729 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.922 0 C-N-CA 125.637 1.589 . . . . 0.0 113.375 176.071 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.2 t -92.75 115.94 65.69 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.33 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.68 145.94 59.16 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.691 2.261 . . . . 0.0 110.975 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -80.82 18.06 1.06 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.825 1.25 . . . . 0.0 114.254 -171.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 pt -75.02 153.38 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.591 1.556 . . . . 0.0 112.235 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.7 tp -87.71 86.66 7.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.279 1.032 . . . . 0.0 109.586 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -109.16 120.41 42.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.843 1.657 . . . . 0.0 109.454 -175.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -72.75 159.29 34.04 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.23 -0.919 . . . . 0.0 112.284 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.4 p -162.37 156.22 21.06 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.93 -31.85 9.05 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.546 1.938 . . . . 0.0 109.726 168.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 ptm85 -161.06 174.65 13.42 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.285 2.234 . . . . 0.0 111.428 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -60.97 -26.6 67.67 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.461 1.104 . . . . 0.0 113.93 -169.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 t -66.03 -14.85 62.4 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -86.16 -14.41 44.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.041 0.937 . . . . 0.0 112.836 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -92.74 140.62 23.79 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.41 147.3 11.21 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.619 2.88 . . . . 0.0 112.314 -169.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.01 -121.56 26.92 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.62 5.77 50.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.691 1.196 . . . . 0.0 114.005 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.3 m -63.91 150.34 45.22 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.19 -0.944 . . . . 0.0 113.146 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.2 pt -119.48 155.9 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.704 2.002 . . . . 0.0 109.913 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.5 t -78.97 132.23 36.61 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.986 -1.071 . . . . 0.0 110.68 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -104.35 167.26 9.86 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.645 1.178 . . . . 0.0 111.775 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -16.77 66.41 Favored Glycine 0 N--CA 1.477 1.393 0 C-N-CA 124.713 1.149 . . . . 0.0 115.4 -170.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -76.69 -8.1 56.62 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.5 16.16 55.65 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.133 1.349 . . . . 0.0 114.13 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -131.4 157.23 43.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.918 1.287 . . . . 0.0 112.679 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.7 m -75.82 141.65 42.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.278 1.431 . . . . 0.0 112.808 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.938 0 C-N-CA 125.375 1.464 . . . . 0.0 113.394 176.317 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.8 t -87.4 115.91 64.35 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 118.15 -0.929 . . . . 0.0 109.984 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.45 151.34 80.25 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.69 2.26 . . . . 0.0 111.609 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -75.77 12.62 1.01 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -170.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.1 pt -79.35 148.52 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.397 1.479 . . . . 0.0 111.885 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 tp -95.11 93.47 7.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.394 1.078 . . . . 0.0 109.299 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -109.32 130.01 55.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.216 1.406 . . . . 0.0 110.835 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -70.3 158.0 36.7 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.237 0.926 . . . . 0.0 112.749 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.9 p -159.97 162.63 34.41 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.581 1.153 . . . . 0.0 113.705 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -113.49 -19.11 11.79 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.406 1.482 . . . . 0.0 112.474 168.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -167.87 169.0 11.84 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 127.105 2.162 . . . . 0.0 111.881 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -60.8 -30.9 70.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.628 1.171 . . . . 0.0 112.987 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -62.86 -18.51 63.01 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.999 1.32 . . . . 0.0 113.667 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -97.62 -0.44 45.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.409 1.484 . . . . 0.0 112.79 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.9 m -97.54 142.59 24.79 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.065 1.346 . . . . 0.0 113.018 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -83.56 146.36 12.06 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.619 2.88 . . . . 0.0 112.587 -169.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.91 -120.8 24.38 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.73 7.76 45.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.757 1.223 . . . . 0.0 114.007 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.9 m -62.54 146.73 51.06 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.155 -0.966 . . . . 0.0 112.458 177.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.7 pt -116.63 153.49 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.302 1.841 . . . . 0.0 110.195 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -82.32 121.93 27.31 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.481 -0.762 . . . . 0.0 110.43 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -93.89 168.47 10.96 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.852 1.261 . . . . 0.0 111.895 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -17.92 67.5 Favored Glycine 0 N--CA 1.477 1.398 0 C-N-CA 124.683 1.135 . . . . 0.0 115.169 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -77.59 -6.86 55.21 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.669 1.188 . . . . 0.0 114.111 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.64 16.07 58.99 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.076 1.322 . . . . 0.0 114.416 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -126.92 157.5 39.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.475 1.51 . . . . 0.0 112.253 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.3 m -74.7 139.85 43.75 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.049 1.74 . . . . 0.0 112.22 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.926 0 C-N-CA 125.171 1.367 . . . . 0.0 113.465 177.31 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.8 t -85.63 120.5 73.0 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.387 173.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.05 170.72 19.12 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.44 2.76 . . . . 0.0 112.122 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.62 36.64 0.21 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.752 1.621 . . . . 0.0 113.693 -175.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.0 pt -78.4 161.46 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.937 1.695 . . . . 0.0 112.327 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.3 tp -123.21 83.26 2.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 108.567 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -112.1 124.03 51.55 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.98 1.712 . . . . 0.0 109.594 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.5 153.1 36.62 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.344 -0.847 . . . . 0.0 112.819 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -160.38 161.7 33.15 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -113.62 -32.09 6.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.726 2.01 . . . . 0.0 110.349 168.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.05 174.43 15.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.797 1.639 . . . . 0.0 111.354 175.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -62.42 -25.8 68.15 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.322 1.449 . . . . 0.0 113.756 -169.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 p -65.31 -16.26 63.39 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.206 1.402 . . . . 0.0 113.852 174.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -83.34 -14.47 52.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.232 1.013 . . . . 0.0 112.838 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -100.76 138.9 20.19 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.942 1.297 . . . . 0.0 113.448 -169.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.22 147.87 9.0 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.149 2.566 . . . . 0.0 111.988 -169.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.17 -122.71 30.8 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.41 0.528 . . . . 0.0 112.415 175.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.29 -0.37 57.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.747 1.219 . . . . 0.0 114.204 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 79.7 m -64.75 144.68 57.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.374 0.988 . . . . 0.0 112.962 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.8 pt -119.18 156.79 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.676 1.99 . . . . 0.0 110.122 172.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.8 t -83.24 119.12 24.16 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.321 -0.862 . . . . 0.0 111.13 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -89.74 167.34 12.96 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.791 1.236 . . . . 0.0 111.743 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.44 -17.0 65.97 Favored Glycine 0 N--CA 1.477 1.408 0 C-N-CA 124.634 1.111 . . . . 0.0 115.295 -172.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -76.83 -8.93 58.25 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 171.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.58 23.48 36.34 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.821 1.2 . . . . 0.0 114.077 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -136.5 157.57 46.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.97 1.308 . . . . 0.0 112.546 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.6 m -73.62 139.19 45.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.463 1.505 . . . . 0.0 112.681 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.986 0 C-N-CA 125.247 1.403 . . . . 0.0 113.33 178.705 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.7 t -89.6 117.42 68.14 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.3 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.99 169.63 21.72 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.143 2.562 . . . . 0.0 112.243 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -73.3 26.82 0.06 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.271 1.829 . . . . 0.0 115.3 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.3 pt -75.03 168.24 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.282 1.833 . . . . 0.0 112.752 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.2 tp -132.5 86.48 2.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.273 1.429 . . . . 0.0 108.603 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.26 131.19 54.95 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.506 1.523 . . . . 0.0 110.647 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.54 153.02 37.0 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.895 0.771 . . . . 0.0 112.128 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -160.69 160.59 31.67 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -117.68 -17.44 9.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.893 1.677 . . . . 0.0 111.339 167.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -163.16 168.69 20.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.928 2.091 . . . . 0.0 112.065 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -62.31 -26.15 68.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.943 0.897 . . . . 0.0 113.134 -171.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -63.49 -18.04 63.38 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.962 1.305 . . . . 0.0 113.964 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -79.3 -22.51 44.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.834 0.854 . . . . 0.0 112.494 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.0 m -93.55 134.14 27.08 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.957 1.303 . . . . 0.0 113.788 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -88.29 159.04 6.86 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.374 2.716 . . . . 0.0 112.14 -171.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.11 -123.68 31.88 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.46 6.7 46.99 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.462 1.105 . . . . 0.0 113.787 174.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.2 m -64.23 145.95 55.13 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.144 -0.972 . . . . 0.0 112.451 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.3 pt -122.59 156.12 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.791 2.036 . . . . 0.0 109.737 173.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -77.61 130.57 37.05 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.191 -0.943 . . . . 0.0 110.781 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -104.09 166.98 10.06 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.814 1.245 . . . . 0.0 111.798 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.73 -16.74 66.24 Favored Glycine 0 N--CA 1.477 1.372 0 C-N-CA 124.665 1.126 . . . . 0.0 115.348 -171.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -76.7 -7.52 55.49 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.718 1.207 . . . . 0.0 114.179 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.9 22.11 43.77 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.93 1.253 . . . . 0.0 114.016 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -135.43 157.61 46.46 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.086 1.355 . . . . 0.0 112.736 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.8 m -72.85 137.86 45.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.602 1.561 . . . . 0.0 112.307 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.914 0 C-N-CA 125.255 1.407 . . . . 0.0 113.494 176.383 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.8 t -89.03 114.1 58.8 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.098 173.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.04 153.49 67.57 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.642 2.228 . . . . 0.0 110.92 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -78.88 25.16 0.28 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.861 1.264 . . . . 0.0 114.148 -171.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.3 mt -79.5 136.17 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.845 1.658 . . . . 0.0 109.381 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.7 tp -89.4 88.62 7.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.385 1.074 . . . . 0.0 109.043 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -108.15 130.52 55.12 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.296 1.439 . . . . 0.0 110.579 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -71.68 159.36 34.53 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.026 0.83 . . . . 0.0 111.411 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.4 p -161.67 157.36 24.38 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -108.75 -25.71 10.68 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.495 1.918 . . . . 0.0 110.511 168.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -161.91 172.98 15.15 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.766 2.026 . . . . 0.0 112.142 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.84 -27.36 68.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.238 1.015 . . . . 0.0 112.97 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 m -62.42 -18.66 62.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.312 1.445 . . . . 0.0 113.952 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.47 -20.15 34.54 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.176 0.99 . . . . 0.0 112.683 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.5 m -90.11 141.63 28.0 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -168.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -84.88 147.6 10.63 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.575 2.85 . . . . 0.0 112.32 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.63 -121.51 26.82 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.41 7.89 45.65 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.681 1.192 . . . . 0.0 113.95 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.4 m -62.54 147.03 50.25 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.07 -1.019 . . . . 0.0 112.339 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.2 pt -120.62 154.11 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.496 1.918 . . . . 0.0 110.09 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -79.07 125.82 29.9 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.341 -0.849 . . . . 0.0 110.616 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -99.06 168.71 9.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.754 1.222 . . . . 0.0 111.89 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.87 -17.43 67.42 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 124.628 1.108 . . . . 0.0 115.241 -172.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -77.35 -6.68 54.19 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.663 1.185 . . . . 0.0 114.116 171.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.95 15.4 59.4 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.157 1.36 . . . . 0.0 114.3 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -128.34 156.65 42.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.914 1.286 . . . . 0.0 113.019 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.8 m -73.23 138.52 45.63 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.536 1.534 . . . . 0.0 112.298 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.952 0 C-N-CA 125.144 1.354 . . . . 0.0 113.398 177.376 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.94 115.46 63.99 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 118.308 -0.854 . . . . 0.0 109.831 171.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.74 170.32 18.97 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.837 2.358 . . . . 0.0 111.832 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -76.71 33.43 0.14 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.765 1.626 . . . . 0.0 113.785 -174.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -79.72 173.73 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.296 1.839 . . . . 0.0 112.649 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 tp -141.97 88.48 2.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.171 1.389 . . . . 0.0 108.398 169.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -110.23 134.67 52.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.568 1.547 . . . . 0.0 110.04 -177.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -68.35 160.87 28.66 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.476 1.035 . . . . 0.0 110.794 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -157.01 150.9 24.69 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -94.2 -28.87 15.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.282 1.433 . . . . 0.0 111.431 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.0 ptm85 -173.51 174.17 3.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.666 2.787 . . . . 0.0 110.728 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -59.19 -31.04 68.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.508 1.123 . . . . 0.0 113.141 -173.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -63.87 -17.64 63.38 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.943 1.297 . . . . 0.0 113.836 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -92.0 -9.39 43.08 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.132 1.373 . . . . 0.0 112.398 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.8 m -92.18 140.74 24.55 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.008 1.323 . . . . 0.0 113.399 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.92 149.95 12.47 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.374 2.716 . . . . 0.0 112.404 -169.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.88 -122.72 29.59 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.72 10.84 40.65 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.583 1.153 . . . . 0.0 113.706 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -61.27 146.74 46.86 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.119 -0.988 . . . . 0.0 112.579 176.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.4 pt -118.89 152.94 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.417 1.887 . . . . 0.0 110.227 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -82.21 121.39 26.56 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.418 -0.801 . . . . 0.0 110.531 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.06 169.71 10.07 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.928 1.291 . . . . 0.0 111.817 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.99 67.49 Favored Glycine 0 N--CA 1.477 1.396 0 C-N-CA 124.6 1.095 . . . . 0.0 115.14 -172.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -78.33 -5.59 52.61 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.824 1.25 . . . . 0.0 114.197 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.09 13.84 63.48 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.182 1.373 . . . . 0.0 114.409 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -124.85 156.67 37.49 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.064 1.345 . . . . 0.0 113.373 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.5 m -73.97 137.49 43.57 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.87 1.668 . . . . 0.0 112.447 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.909 0 C-N-CA 125.329 1.442 . . . . 0.0 113.267 176.996 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.6 t -96.84 117.73 65.62 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.637 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -53.96 142.87 63.31 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.257 3.305 . . . . 0.0 113.276 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.55 13.57 6.73 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.4 pt -79.13 154.4 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.496 1.518 . . . . 0.0 112.347 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.0 tp -87.82 88.45 7.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.37 1.068 . . . . 0.0 109.299 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -109.3 121.88 46.13 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.82 1.648 . . . . 0.0 109.675 -174.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -73.51 159.66 32.85 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.148 -0.97 . . . . 0.0 112.311 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -162.44 159.49 25.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -175.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -109.98 -29.68 8.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.321 1.848 . . . . 0.0 110.503 168.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -158.98 177.58 10.98 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.542 1.937 . . . . 0.0 111.965 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.21 -27.31 68.89 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -169.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.0 p -69.87 -12.38 61.58 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -83.85 -14.05 52.16 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.029 0.932 . . . . 0.0 112.558 171.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.3 m -96.0 140.53 22.31 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.924 1.29 . . . . 0.0 113.984 -169.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -84.25 147.91 11.57 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.459 2.772 . . . . 0.0 112.206 -169.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.22 -125.1 37.88 Favored Glycine 0 CA--C 1.532 1.102 0 O-C-N 121.84 -0.538 . . . . 0.0 111.911 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.2 6.62 47.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.92 1.288 . . . . 0.0 114.1 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.3 m -62.52 147.5 48.72 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.055 -1.028 . . . . 0.0 112.813 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.7 pt -115.5 156.99 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.507 1.923 . . . . 0.0 110.228 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.3 t -83.5 118.11 23.55 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.47 -0.769 . . . . 0.0 110.797 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.5 mmm-85 -86.85 167.46 14.33 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.635 1.174 . . . . 0.0 111.609 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.66 -16.76 66.12 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 124.601 1.096 . . . . 0.0 115.322 -172.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -77.73 -7.5 56.62 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.687 1.195 . . . . 0.0 114.186 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.23 17.41 55.68 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.885 1.231 . . . . 0.0 114.264 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -130.49 156.29 45.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.85 1.26 . . . . 0.0 112.71 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.9 m -75.26 143.47 43.02 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.133 1.373 . . . . 0.0 112.857 -175.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.95 0 C-N-CA 124.943 1.259 . . . . 0.0 113.494 177.493 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.0 t -91.56 117.42 67.78 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.233 173.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.81 149.66 86.54 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.829 2.353 . . . . 0.0 111.336 176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -81.82 18.24 1.33 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -169.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.6 pt -74.57 150.98 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.412 1.485 . . . . 0.0 111.993 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 tp -94.33 86.39 4.88 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.265 1.026 . . . . 0.0 109.18 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -107.73 124.73 50.46 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.391 1.477 . . . . 0.0 110.699 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -70.89 158.57 36.19 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.18 -0.95 . . . . 0.0 113.106 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.1 p -159.17 154.72 25.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -174.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -100.57 -31.85 11.05 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.259 1.423 . . . . 0.0 110.721 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.72 177.32 9.45 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.083 2.153 . . . . 0.0 111.155 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -60.8 -25.52 66.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -63.39 -19.46 64.69 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.933 1.293 . . . . 0.0 113.993 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.8 -17.67 52.79 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.064 0.946 . . . . 0.0 112.798 173.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.8 m -98.83 137.11 20.5 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.803 1.241 . . . . 0.0 113.837 -169.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -88.76 154.55 6.14 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.752 2.968 . . . . 0.0 112.446 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -121.5 26.55 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.28 5.04 51.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.449 1.1 . . . . 0.0 113.933 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.8 m -64.91 145.4 56.35 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.458 1.026 . . . . 0.0 112.217 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.5 pt -120.42 156.29 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.572 1.949 . . . . 0.0 109.755 171.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.8 t -79.65 125.86 30.18 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.315 -0.866 . . . . 0.0 110.62 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -97.47 168.36 10.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.732 1.213 . . . . 0.0 111.819 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.58 -17.62 67.0 Favored Glycine 0 N--CA 1.476 1.354 0 C-N-CA 124.631 1.11 . . . . 0.0 115.273 -171.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -77.31 -8.18 57.22 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.673 1.189 . . . . 0.0 114.181 171.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.32 18.51 52.8 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.09 1.329 . . . . 0.0 114.346 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -129.8 156.6 44.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.414 1.486 . . . . 0.0 112.238 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 82.4 m -72.91 139.21 46.66 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.979 1.711 . . . . 0.0 112.376 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 C-N-CA 124.977 1.275 . . . . 0.0 113.514 177.321 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.7 t -79.33 119.9 78.61 Favored Pre-proline 0 CA--C 1.551 0.984 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.217 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.26 173.25 11.69 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.625 2.884 . . . . 0.0 112.845 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -75.32 33.02 0.1 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.262 1.825 . . . . 0.0 114.048 -174.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.8 pt -78.37 168.93 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.027 1.731 . . . . 0.0 112.169 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 tp -137.85 83.44 1.98 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.844 1.257 . . . . 0.0 108.847 170.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -106.75 126.51 52.38 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.484 1.514 . . . . 0.0 110.108 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -70.28 156.67 38.95 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.32 0.964 . . . . 0.0 112.804 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.1 p -160.0 156.98 27.94 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -106.96 -25.44 11.63 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.575 1.95 . . . . 0.0 110.607 168.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -163.11 171.87 15.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.461 1.904 . . . . 0.0 112.143 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -61.32 -27.11 68.25 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 113.058 -172.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -62.7 -18.46 62.51 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.145 1.378 . . . . 0.0 113.856 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -81.16 -22.03 39.28 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.083 0.953 . . . . 0.0 112.417 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.1 m -92.69 135.95 25.69 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.886 1.274 . . . . 0.0 113.244 -169.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.72 148.14 9.67 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.965 2.444 . . . . 0.0 111.918 -170.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.27 -122.73 30.82 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.437 0.542 . . . . 0.0 112.378 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.58 -2.56 58.7 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.81 1.244 . . . . 0.0 114.313 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -65.74 146.3 54.95 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.325 0.966 . . . . 0.0 112.844 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.9 pt -125.1 155.39 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.859 2.064 . . . . 0.0 109.632 174.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.79 131.29 37.54 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.146 -0.971 . . . . 0.0 110.712 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -105.95 168.15 9.32 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.649 1.18 . . . . 0.0 111.79 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.82 -17.11 66.93 Favored Glycine 0 N--CA 1.477 1.394 0 C-N-CA 124.632 1.11 . . . . 0.0 115.255 -171.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -76.52 -7.99 56.27 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.701 1.2 . . . . 0.0 114.095 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.17 17.79 54.97 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.079 1.323 . . . . 0.0 114.266 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -130.77 157.97 41.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.341 1.456 . . . . 0.0 112.306 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.1 m -73.81 135.21 43.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.086 1.754 . . . . 0.0 112.057 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.009 0 C-N-CA 125.398 1.475 . . . . 0.0 113.315 177.82 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.6 t -89.23 117.33 68.12 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.925 171.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -61.6 163.26 18.73 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.194 2.596 . . . . 0.0 113.153 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -76.01 28.29 0.11 Allowed 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.598 1.559 . . . . 0.0 113.871 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.09 174.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.531 1.932 . . . . 0.0 112.939 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.8 tp -138.88 88.05 2.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.391 1.476 . . . . 0.0 108.226 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -109.29 133.07 53.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.503 1.521 . . . . 0.0 110.439 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -69.05 158.9 33.88 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.246 0.93 . . . . 0.0 111.06 176.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.8 p -160.95 157.87 27.14 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -176.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -111.03 -24.38 10.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.619 1.968 . . . . 0.0 110.615 168.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -161.91 173.29 14.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.835 2.054 . . . . 0.0 111.977 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.68 -26.68 67.28 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.232 1.013 . . . . 0.0 113.024 -173.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 m -60.98 -20.16 62.02 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.548 1.539 . . . . 0.0 113.968 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -82.79 -20.78 35.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.247 1.019 . . . . 0.0 112.697 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.8 m -90.87 138.98 25.98 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 124.933 1.293 . . . . 0.0 114.312 -168.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -86.27 151.38 9.32 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.417 2.745 . . . . 0.0 112.301 -170.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.4 -124.03 33.76 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.73 10.51 41.0 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.639 1.176 . . . . 0.0 113.765 173.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 80.6 m -61.8 147.05 47.65 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.157 -0.964 . . . . 0.0 112.082 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.31 153.23 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.42 1.888 . . . . 0.0 110.029 175.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -77.47 130.01 36.45 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.357 -0.839 . . . . 0.0 110.629 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -104.91 168.64 8.92 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.716 1.207 . . . . 0.0 111.866 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -17.18 66.93 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 124.743 1.163 . . . . 0.0 115.247 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -76.95 -6.41 52.43 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.795 1.238 . . . . 0.0 114.109 171.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.22 16.72 58.7 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.125 1.345 . . . . 0.0 114.13 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -129.81 156.65 43.99 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.97 1.308 . . . . 0.0 113.25 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 82.9 m -73.67 134.12 43.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.773 1.629 . . . . 0.0 112.084 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.008 0 C-N-CA 125.428 1.489 . . . . 0.0 113.382 176.628 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.2 t -83.78 117.99 70.17 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.161 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.42 172.29 14.49 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.388 2.725 . . . . 0.0 112.245 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.01 34.57 0.13 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.928 1.691 . . . . 0.0 113.914 -175.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.0 pt -79.05 168.22 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.135 1.774 . . . . 0.0 112.112 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.4 tp -136.49 86.41 2.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.961 1.304 . . . . 0.0 108.597 169.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -108.04 134.78 50.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.757 1.623 . . . . 0.0 110.635 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.34 154.95 22.56 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.413 1.006 . . . . 0.0 111.974 171.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.1 p -153.6 151.04 29.28 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.605 1.705 . . . . 0.0 115.605 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -96.51 -25.43 15.65 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.697 1.999 . . . . 0.0 113.246 169.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -174.89 173.69 2.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 128.01 2.524 . . . . 0.0 111.257 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -60.2 -33.43 72.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.329 1.052 . . . . 0.0 112.871 -175.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -64.38 -16.58 62.55 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.942 1.297 . . . . 0.0 113.474 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -93.34 -8.26 42.47 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.635 1.574 . . . . 0.0 112.516 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.8 m -94.71 138.95 22.09 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.534 1.534 . . . . 0.0 112.629 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -84.02 149.79 12.29 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.107 2.538 . . . . 0.0 112.2 -169.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -123.72 33.14 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.297 0.475 . . . . 0.0 111.985 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.59 3.5 55.41 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.603 1.161 . . . . 0.0 114.015 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.6 m -63.61 145.97 54.66 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.159 -0.963 . . . . 0.0 112.683 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.2 pt -119.88 154.77 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.74 2.016 . . . . 0.0 110.039 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.9 t -83.51 123.16 29.46 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.39 -0.819 . . . . 0.0 110.531 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -95.28 169.36 10.13 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.732 1.213 . . . . 0.0 111.796 -176.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.48 -17.92 67.13 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.653 1.121 . . . . 0.0 115.157 -172.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -78.0 -6.43 54.46 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.741 1.216 . . . . 0.0 114.188 171.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.96 18.8 57.36 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.048 1.309 . . . . 0.0 114.189 -178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -129.37 157.53 41.66 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.207 1.403 . . . . 0.0 112.69 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.9 m -73.23 138.9 45.85 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.492 1.517 . . . . 0.0 112.377 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.904 0 C-N-CA 125.434 1.492 . . . . 0.0 113.228 176.747 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 40.3 t -80.72 118.73 73.7 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.387 175.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.81 169.69 20.57 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.014 2.476 . . . . 0.0 111.776 177.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -77.43 39.32 0.26 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.434 1.493 . . . . 0.0 113.41 -176.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -79.32 172.9 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.946 1.698 . . . . 0.0 112.326 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.8 tp -142.38 87.13 2.0 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.007 1.323 . . . . 0.0 108.75 172.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -111.04 134.59 52.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.548 1.539 . . . . 0.0 110.587 -177.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -62.64 153.6 31.78 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.065 0.848 . . . . 0.0 111.987 175.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.1 p -159.26 156.73 29.31 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 176.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -110.04 -26.61 9.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.883 2.073 . . . . 0.0 110.105 168.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -159.54 171.92 18.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.4 1.88 . . . . 0.0 112.287 178.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -61.13 -27.69 68.57 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.199 1.0 . . . . 0.0 113.057 -172.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.6 m -63.33 -17.28 62.4 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.158 1.383 . . . . 0.0 113.94 176.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -81.83 -21.17 37.74 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.038 0.935 . . . . 0.0 112.619 173.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.7 m -90.78 140.86 26.45 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 114.356 -168.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -84.2 145.96 11.09 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.227 2.618 . . . . 0.0 111.912 -169.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.59 -122.37 29.57 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 121.977 -0.452 . . . . 0.0 112.003 177.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.69 5.37 52.05 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.692 1.197 . . . . 0.0 114.079 176.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.6 m -62.3 146.37 51.24 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.198 -0.939 . . . . 0.0 112.421 176.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.8 pt -122.57 154.77 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.612 1.965 . . . . 0.0 109.907 175.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -78.32 129.29 34.84 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.332 -0.855 . . . . 0.0 110.728 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -103.42 168.02 9.43 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.798 1.239 . . . . 0.0 111.79 -178.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.86 -16.9 66.76 Favored Glycine 0 N--CA 1.477 1.422 0 C-N-CA 124.638 1.113 . . . . 0.0 115.244 -171.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -77.15 -6.62 53.63 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.71 1.204 . . . . 0.0 114.14 171.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.07 20.0 54.22 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.862 1.22 . . . . 0.0 114.039 -178.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -133.34 158.75 42.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.205 1.402 . . . . 0.0 112.682 177.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.3 m -74.17 138.28 43.7 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.665 1.586 . . . . 0.0 112.465 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.01 0 C-N-CA 125.291 1.424 . . . . 0.0 113.305 175.999 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.6 t -91.4 116.57 66.71 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.963 172.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.82 152.12 77.76 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.833 2.355 . . . . 0.0 111.363 177.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.56 15.43 1.31 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -169.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.8 pt -79.37 149.55 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.238 1.415 . . . . 0.0 111.87 179.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.6 tp -95.9 94.53 7.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.5 1.12 . . . . 0.0 109.363 177.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -110.31 132.8 53.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.186 1.394 . . . . 0.0 111.153 -177.072 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -63.28 156.18 26.33 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.853 0.751 . . . . 0.0 112.102 174.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.3 p -158.95 152.79 23.27 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 175.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -97.23 -31.34 12.48 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.504 1.922 . . . . 0.0 110.602 169.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -168.19 173.64 7.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.363 2.665 . . . . 0.0 110.518 -175.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.38 -26.63 65.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.294 1.038 . . . . 0.0 113.222 -172.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -61.01 -21.6 63.74 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.458 1.503 . . . . 0.0 114.157 177.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -84.53 -16.96 40.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.016 0.926 . . . . 0.0 112.795 175.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.8 m -91.6 139.94 25.14 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 124.616 1.166 . . . . 0.0 114.054 -169.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -84.73 147.17 10.75 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.653 2.902 . . . . 0.0 112.42 -169.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.51 -121.27 26.07 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 177.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.03 6.37 49.01 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.759 1.224 . . . . 0.0 113.973 175.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.1 m -62.77 146.45 52.47 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.485 1.039 . . . . 0.0 112.169 177.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.65 156.26 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.313 1.845 . . . . 0.0 109.963 171.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.2 t -80.12 127.33 32.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.368 -0.832 . . . . 0.0 110.852 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -97.83 164.63 12.3 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.843 1.257 . . . . 0.0 111.48 -179.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.93 -19.94 63.95 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -169.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -79.87 -6.66 57.83 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 118.468 1.134 . . . . 0.0 113.861 174.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.21 23.5 22.01 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.115 1.341 . . . . 0.0 114.451 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -135.68 156.5 48.74 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.924 1.29 . . . . 0.0 112.832 178.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.6 m -74.04 140.6 45.5 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.775 1.63 . . . . 0.0 112.804 -177.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.031 0 C-N-CA 125.272 1.415 . . . . 0.0 113.398 176.261 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 40.7 t -91.01 117.32 67.82 Favored Pre-proline 0 CA--C 1.547 0.864 0 CA-C-O 118.19 -0.909 . . . . 0.0 109.845 170.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.28 168.43 22.24 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.023 2.482 . . . . 0.0 112.098 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -75.51 31.22 0.1 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 125.839 1.655 . . . . 0.0 113.522 -177.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.3 tt -80.92 156.17 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.396 1.878 . . . . 0.0 111.883 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.9 tp -122.69 85.84 2.48 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.998 1.319 . . . . 0.0 108.135 169.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -109.15 132.7 53.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.535 1.534 . . . . 0.0 110.6 -175.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -72.15 159.36 34.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.158 0.89 . . . . 0.0 111.48 177.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.8 p -161.76 158.05 25.18 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -174.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.56 -29.46 8.75 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.38 1.872 . . . . 0.0 110.475 168.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -159.81 177.52 10.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.552 1.941 . . . . 0.0 111.969 176.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -63.28 -26.7 68.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -169.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.0 p -69.69 -11.76 61.1 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 177.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -81.92 -14.88 55.51 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.088 0.955 . . . . 0.0 112.616 170.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.1 m -99.7 139.97 21.23 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.193 1.397 . . . . 0.0 113.49 -169.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -87.0 151.27 8.34 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.363 2.709 . . . . 0.0 112.375 -169.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.2 -122.57 29.89 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 178.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.62 7.75 45.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.579 1.152 . . . . 0.0 113.884 175.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.1 m -62.37 145.25 54.44 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.107 -0.996 . . . . 0.0 112.16 176.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.7 pt -120.02 155.21 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.467 1.907 . . . . 0.0 110.01 173.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -80.16 123.12 27.63 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.441 -0.787 . . . . 0.0 110.677 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -95.13 169.08 10.35 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.856 1.262 . . . . 0.0 111.783 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.61 67.05 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 124.54 1.067 . . . . 0.0 115.197 -172.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -78.17 -6.08 53.7 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.702 1.201 . . . . 0.0 114.211 171.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.21 15.57 60.46 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.081 1.324 . . . . 0.0 114.296 -178.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -127.28 156.19 42.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.841 1.257 . . . . 0.0 112.984 178.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -72.52 138.7 47.13 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.716 1.606 . . . . 0.0 112.252 -178.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.941 0 C-N-CA 125.085 1.326 . . . . 0.0 113.489 177.45 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.1 t -90.27 117.21 67.86 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.871 172.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.17 152.27 79.96 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.765 2.31 . . . . 0.0 111.539 178.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.42 15.13 1.34 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -169.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.2 pt -79.16 149.17 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.279 1.432 . . . . 0.0 111.753 178.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.6 tp -95.04 92.0 6.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.343 1.057 . . . . 0.0 109.206 175.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -108.73 130.04 55.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.279 1.432 . . . . 0.0 110.635 -178.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -69.85 160.36 31.93 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.479 1.036 . . . . 0.0 112.539 172.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.7 p -158.21 151.96 23.66 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -176.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -88.1 -39.56 14.48 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.168 1.387 . . . . 0.0 111.386 169.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -165.4 179.62 6.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.429 2.291 . . . . 0.0 110.942 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.14 -29.66 69.91 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.509 1.123 . . . . 0.0 113.947 -170.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.7 p -66.91 -17.48 64.92 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.326 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -94.76 -1.73 52.36 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.168 1.387 . . . . 0.0 112.85 176.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.0 m -96.12 141.73 23.56 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.921 1.288 . . . . 0.0 112.936 177.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -83.61 146.5 12.05 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.538 2.826 . . . . 0.0 112.611 -169.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.88 -122.04 28.48 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 177.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.45 6.47 48.91 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.681 1.192 . . . . 0.0 114.007 175.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.7 m -62.47 145.47 54.08 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.373 0.988 . . . . 0.0 112.411 178.065 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.3 pt -114.45 155.57 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.37 1.868 . . . . 0.0 110.008 170.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.1 t -84.9 115.11 22.59 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.511 -0.743 . . . . 0.0 110.432 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -84.23 168.58 15.59 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.045 1.338 . . . . 0.0 111.726 -176.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.31 -17.76 66.56 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 124.503 1.049 . . . . 0.0 115.188 -173.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -78.37 -6.57 55.56 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.76 1.224 . . . . 0.0 114.195 171.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.84 17.33 58.27 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.994 1.283 . . . . 0.0 114.452 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.07 157.26 40.11 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.352 1.461 . . . . 0.0 112.363 177.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.5 m -74.95 139.82 43.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.861 1.664 . . . . 0.0 112.573 -178.035 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.943 0 C-N-CA 125.104 1.335 . . . . 0.0 113.377 177.677 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.0 t -91.38 118.83 68.67 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.401 174.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.78 141.89 55.86 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.65 2.233 . . . . 0.0 110.558 172.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -82.14 30.25 0.4 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.629 1.172 . . . . 0.0 113.91 -169.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt -78.98 150.36 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.621 1.569 . . . . 0.0 111.671 177.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.0 tp -92.67 86.71 5.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.086 0.954 . . . . 0.0 109.164 174.256 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -109.33 128.09 54.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.665 1.586 . . . . 0.0 110.895 -176.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -63.66 154.07 34.11 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.931 0.787 . . . . 0.0 112.354 178.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.9 p -159.46 162.02 35.55 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 175.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -115.49 -23.05 8.99 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.619 1.968 . . . . 0.0 110.703 168.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -161.91 169.75 20.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.681 1.993 . . . . 0.0 112.376 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -63.32 -27.11 69.1 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -169.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.7 p -71.35 -10.59 60.01 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 177.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -79.77 -18.51 50.85 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.208 -0.932 . . . . 0.0 112.108 169.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.3 m -98.91 138.74 20.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.388 1.475 . . . . 0.0 113.616 -169.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -87.53 152.89 7.7 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.755 2.97 . . . . 0.0 112.49 -169.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -120.63 23.48 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 176.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.03 5.38 50.5 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.474 1.11 . . . . 0.0 113.923 175.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.0 m -64.24 143.44 57.89 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.516 1.053 . . . . 0.0 112.166 179.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.0 pt -116.72 157.72 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.522 1.929 . . . . 0.0 109.973 171.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.7 t -81.72 117.96 22.46 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.394 -0.816 . . . . 0.0 110.585 178.073 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -87.74 167.52 13.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.889 1.276 . . . . 0.0 111.682 -177.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.29 -17.48 66.2 Favored Glycine 0 N--CA 1.478 1.456 0 C-N-CA 124.519 1.057 . . . . 0.0 115.25 -172.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -77.23 -8.56 57.79 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 171.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.81 21.38 43.27 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.937 1.256 . . . . 0.0 114.201 -178.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -132.9 156.84 46.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.082 1.353 . . . . 0.0 112.26 177.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.6 m -70.85 142.35 51.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.166 1.386 . . . . 0.0 112.311 -178.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.878 0 C-N-CA 124.787 1.184 . . . . 0.0 113.609 177.315 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 t -90.63 120.04 68.94 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.312 173.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.72 145.66 48.28 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 124.092 3.195 . . . . 0.0 113.292 173.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -89.86 11.85 19.04 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 pp -79.67 167.3 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.629 1.572 . . . . 0.0 112.188 172.068 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.2 tp -108.22 100.09 9.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.91 1.284 . . . . 0.0 109.831 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -113.01 131.7 55.67 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.278 1.431 . . . . 0.0 111.01 -179.296 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -71.76 161.62 30.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.116 0.871 . . . . 0.0 111.273 173.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.9 p -160.13 151.38 19.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -175.042 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.8 ttt180 -88.97 -38.21 14.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.348 1.459 . . . . 0.0 111.293 169.281 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -164.88 178.49 7.12 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.359 2.264 . . . . 0.0 111.028 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -58.88 -30.67 67.92 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.69 1.196 . . . . 0.0 113.429 -173.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -60.67 -21.15 62.5 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.961 1.304 . . . . 0.0 113.833 177.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -97.9 0.2 46.14 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.251 1.42 . . . . 0.0 113.038 179.481 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.5 m -97.47 141.09 22.48 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.042 1.337 . . . . 0.0 113.07 178.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.43 148.13 11.37 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.49 2.793 . . . . 0.0 112.607 -169.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.7 -124.05 34.55 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 179.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.88 7.66 45.25 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.719 1.208 . . . . 0.0 114.052 175.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.2 m -62.35 145.52 53.67 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.15 -0.969 . . . . 0.0 112.517 178.057 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -115.25 154.6 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.363 1.865 . . . . 0.0 110.098 170.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.0 t -84.13 112.72 20.5 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.478 -0.764 . . . . 0.0 110.328 179.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -81.48 168.69 18.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.994 1.317 . . . . 0.0 111.717 -177.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.24 -17.84 66.51 Favored Glycine 0 N--CA 1.478 1.457 0 C-N-CA 124.572 1.082 . . . . 0.0 115.143 -172.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -78.27 -6.36 54.74 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.754 1.222 . . . . 0.0 114.212 171.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.62 16.4 58.53 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.036 1.303 . . . . 0.0 114.379 -178.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -126.51 154.99 43.03 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.919 1.287 . . . . 0.0 113.184 178.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 81.8 m -73.6 137.19 44.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.349 1.46 . . . . 0.0 112.384 -177.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.965 0 C-N-CA 125.048 1.309 . . . . 0.0 113.347 178.037 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.9 t -89.92 118.64 69.09 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.058 171.577 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -62.4 165.18 15.82 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.203 2.602 . . . . 0.0 113.235 177.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.39 21.93 0.59 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.038 1.335 . . . . 0.0 114.527 -171.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.25 168.18 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.082 1.353 . . . . 0.0 112.989 -177.018 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.9 tp -125.59 86.04 2.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.105 1.362 . . . . 0.0 107.885 169.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -106.97 130.19 54.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.34 1.456 . . . . 0.0 110.393 -175.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -71.01 158.44 36.51 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.109 0.868 . . . . 0.0 111.262 177.022 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.5 p -160.97 157.24 26.05 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -107.71 -28.13 9.88 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.715 2.006 . . . . 0.0 110.116 168.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 -160.13 172.46 17.41 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.362 1.865 . . . . 0.0 112.486 179.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -61.2 -27.36 68.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.211 1.004 . . . . 0.0 113.02 -172.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -63.42 -17.34 62.56 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.091 1.357 . . . . 0.0 113.949 177.021 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -82.01 -20.81 37.66 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.161 0.984 . . . . 0.0 112.636 173.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.8 m -92.14 139.54 24.31 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.158 1.383 . . . . 0.0 114.202 -168.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -86.26 151.21 9.32 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.356 2.704 . . . . 0.0 112.229 -170.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.96 -125.48 38.28 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.13 10.45 39.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.574 1.15 . . . . 0.0 113.874 174.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.31 145.56 51.01 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.13 -0.981 . . . . 0.0 112.064 174.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.02 153.61 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.278 1.831 . . . . 0.0 110.062 173.876 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.8 t -78.09 124.39 27.99 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.502 -0.749 . . . . 0.0 110.546 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -98.13 169.36 9.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.774 1.23 . . . . 0.0 111.782 -176.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.55 -17.68 67.0 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 124.58 1.086 . . . . 0.0 115.223 -172.571 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -78.09 -6.35 54.38 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.686 1.194 . . . . 0.0 114.21 171.54 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.41 16.26 59.09 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.063 1.316 . . . . 0.0 114.315 -178.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -128.24 156.12 43.47 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.971 1.309 . . . . 0.0 113.081 178.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.3 m -72.12 136.89 46.67 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.535 1.534 . . . . 0.0 112.075 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.932 0 C-N-CA 125.205 1.383 . . . . 0.0 113.063 177.398 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.0 t -95.69 117.02 66.67 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.342 -0.837 . . . . 0.0 109.761 169.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.64 172.23 16.18 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.124 2.55 . . . . 0.0 112.404 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -72.22 25.5 0.05 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.53 1.932 . . . . 0.0 115.476 -175.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.2 pt -77.69 170.31 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.313 1.845 . . . . 0.0 112.764 -177.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.5 tp -136.86 88.05 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.24 1.416 . . . . 0.0 108.467 169.606 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -108.94 133.68 52.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.529 1.532 . . . . 0.0 110.859 -175.712 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -63.58 154.89 31.24 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.996 0.816 . . . . 0.0 112.248 175.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.8 p -159.38 156.91 29.33 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 176.176 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -107.15 -32.35 7.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.819 2.048 . . . . 0.0 110.141 168.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -158.03 176.64 12.26 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.227 1.811 . . . . 0.0 112.054 176.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -63.09 -26.71 68.96 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.4 p -69.56 -12.29 61.52 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -78.87 -21.58 47.3 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.409 -0.807 . . . . 0.0 112.283 169.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.5 m -94.85 134.17 25.37 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.976 1.31 . . . . 0.0 113.33 -169.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -88.47 160.01 6.64 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.423 2.749 . . . . 0.0 112.131 -170.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.15 -125.04 35.23 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 178.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.45 7.96 45.49 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.355 1.062 . . . . 0.0 113.686 173.425 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -63.78 146.53 53.72 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.162 -0.961 . . . . 0.0 112.371 177.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 pt -123.37 155.82 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.81 2.044 . . . . 0.0 109.616 174.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.4 t -78.69 131.27 36.57 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.19 -0.943 . . . . 0.0 110.776 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.44 168.06 9.33 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.696 1.198 . . . . 0.0 111.86 -178.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.88 -16.65 66.46 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.638 1.113 . . . . 0.0 115.327 -171.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -76.63 -7.07 54.54 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.723 1.209 . . . . 0.0 114.138 170.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.4 20.11 52.91 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.008 1.29 . . . . 0.0 114.09 -178.287 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -133.47 158.06 44.05 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.149 1.38 . . . . 0.0 112.807 178.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -73.6 136.05 43.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.747 1.619 . . . . 0.0 112.319 -178.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.968 0 C-N-CA 125.421 1.486 . . . . 0.0 113.393 176.226 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.1 t -90.86 117.84 68.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.865 170.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.36 167.6 24.74 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.949 2.433 . . . . 0.0 111.849 178.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -76.11 33.24 0.12 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.632 1.573 . . . . 0.0 113.246 -177.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.0 tt -79.89 154.54 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.189 1.796 . . . . 0.0 111.699 178.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.1 tp -120.65 86.06 2.5 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.915 1.286 . . . . 0.0 108.038 169.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -108.14 132.83 53.19 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.293 1.437 . . . . 0.0 110.737 -176.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.58 153.66 31.34 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.937 0.79 . . . . 0.0 111.812 175.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.9 p -159.64 158.27 31.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 176.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -113.8 -22.97 9.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.658 1.983 . . . . 0.0 110.814 168.487 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -161.83 171.24 18.1 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.607 1.963 . . . . 0.0 112.178 177.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -61.97 -27.04 68.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.03 0.932 . . . . 0.0 113.121 -171.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -62.86 -18.12 62.48 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.035 1.334 . . . . 0.0 113.982 176.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -80.78 -20.94 41.51 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.142 0.977 . . . . 0.0 112.564 174.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.8 m -92.71 138.8 23.51 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.04 1.336 . . . . 0.0 114.477 -168.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -87.07 153.29 8.3 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.436 2.757 . . . . 0.0 112.222 -170.366 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -123.63 32.89 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.22 8.89 44.16 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.506 1.122 . . . . 0.0 113.887 174.192 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 80.8 m -62.55 146.8 50.92 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.066 -1.021 . . . . 0.0 112.187 176.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.8 pt -122.3 155.32 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 126.543 1.937 . . . . 0.0 109.824 174.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.0 t -77.68 130.6 37.02 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.203 -0.936 . . . . 0.0 110.763 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.45 167.6 9.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.717 1.207 . . . . 0.0 111.916 -178.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.06 -16.47 66.59 Favored Glycine 0 N--CA 1.477 1.381 0 C-N-CA 124.732 1.158 . . . . 0.0 115.373 -171.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -76.32 -7.01 54.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.696 1.198 . . . . 0.0 114.107 170.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.55 19.32 54.88 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.016 1.294 . . . . 0.0 114.0 -178.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -133.71 158.7 42.62 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.255 1.422 . . . . 0.0 112.695 178.193 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.7 m -73.06 138.78 46.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.565 1.546 . . . . 0.0 112.424 -179.113 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 C-N-CA 125.257 1.408 . . . . 0.0 113.433 176.044 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.2 t -86.72 115.66 63.19 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.016 173.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -67.98 160.47 48.42 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.78 2.32 . . . . 0.0 112.054 178.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.93 16.03 0.17 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -172.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 tp -75.12 144.67 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.895 1.678 . . . . 0.0 111.746 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.5 tp -102.94 88.37 3.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.749 1.22 . . . . 0.0 108.328 169.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -108.63 129.78 55.33 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.256 1.422 . . . . 0.0 110.413 -177.274 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.28 157.75 34.89 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.391 0.996 . . . . 0.0 112.109 172.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -157.22 151.49 25.0 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -174.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -91.13 -35.7 14.41 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.192 1.397 . . . . 0.0 111.505 169.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -164.75 177.35 8.04 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.198 2.199 . . . . 0.0 111.277 179.277 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -59.67 -30.54 68.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.703 1.201 . . . . 0.0 113.467 -173.012 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 m -60.91 -20.69 62.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.909 1.284 . . . . 0.0 113.735 177.335 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -97.21 0.83 48.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.374 1.47 . . . . 0.0 112.988 179.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.7 m -98.98 141.1 22.3 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.074 1.35 . . . . 0.0 113.2 178.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -84.68 149.42 11.25 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.5 2.8 . . . . 0.0 112.589 -169.342 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.34 -124.0 33.77 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.3 10.48 40.58 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.675 1.19 . . . . 0.0 113.745 174.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.2 m -61.51 145.57 51.47 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.099 -1.0 . . . . 0.0 112.52 176.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.1 pt -116.19 154.89 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.448 1.899 . . . . 0.0 110.054 172.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.2 t -83.52 116.43 22.56 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.588 -0.695 . . . . 0.0 110.517 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -87.05 168.72 13.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.041 1.337 . . . . 0.0 111.752 -176.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -17.58 67.11 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 124.602 1.096 . . . . 0.0 115.193 -173.316 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -78.27 -6.34 54.69 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.732 1.213 . . . . 0.0 114.149 171.744 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.08 16.16 59.79 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.028 1.299 . . . . 0.0 114.404 -179.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -126.54 157.78 37.89 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.407 1.483 . . . . 0.0 112.397 177.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.9 m -73.84 140.3 45.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.962 1.705 . . . . 0.0 112.481 -179.532 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.891 0 C-N-CA 125.164 1.364 . . . . 0.0 113.431 177.71 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.586 -0.206 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -163.58 151.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.794 1.638 . . . . 0.0 109.079 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.5 t -94.53 118.19 66.94 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.22 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.19 150.95 54.29 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.59 2.86 . . . . 0.0 113.232 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -77.89 17.92 0.53 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.122 1.369 . . . . 0.0 114.226 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.0 pt -79.12 159.71 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.983 1.713 . . . . 0.0 112.341 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.4 tp -105.56 87.55 2.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.676 1.191 . . . . 0.0 108.935 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -107.95 127.08 53.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.259 1.424 . . . . 0.0 110.704 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -70.59 159.13 34.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.25 0.932 . . . . 0.0 112.744 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.3 p -159.51 153.18 22.8 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -96.25 -30.01 13.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.24 1.816 . . . . 0.0 110.837 169.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.2 ptm85 -169.21 173.23 6.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.327 2.651 . . . . 0.0 110.67 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.81 -26.81 66.06 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.314 1.046 . . . . 0.0 113.252 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 m -62.99 -18.59 63.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.083 1.353 . . . . 0.0 114.049 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -86.47 -10.55 53.95 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.169 0.988 . . . . 0.0 112.923 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.3 m -101.87 136.34 19.54 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.825 1.25 . . . . 0.0 113.265 -171.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -88.73 155.08 6.17 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.428 2.752 . . . . 0.0 112.559 -169.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.72 -123.14 30.99 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.86 5.89 50.2 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.526 1.13 . . . . 0.0 113.883 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.9 m -64.0 144.9 56.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.408 1.004 . . . . 0.0 112.228 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.3 pt -120.06 155.69 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.42 1.888 . . . . 0.0 109.8 171.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.4 t -79.64 126.27 30.69 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.348 -0.845 . . . . 0.0 110.674 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -97.94 168.26 10.4 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.801 1.24 . . . . 0.0 111.756 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.45 -17.62 66.71 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 124.585 1.088 . . . . 0.0 115.218 -171.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -77.49 -7.84 56.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.714 1.206 . . . . 0.0 114.21 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.0 19.06 52.64 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.123 1.344 . . . . 0.0 114.263 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -129.98 156.22 44.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.323 1.449 . . . . 0.0 112.35 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.5 m -73.08 138.29 45.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.009 1.723 . . . . 0.0 112.203 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.26 -170.48 23.87 Favored Glycine 0 N--CA 1.47 0.95 0 C-N-CA 125.042 1.306 . . . . 0.0 113.556 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.537 0 O-C-N 121.253 -1.146 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.5 p -163.91 152.18 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.911 1.684 . . . . 0.0 108.981 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.8 t -90.48 117.33 67.91 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.104 172.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -62.11 160.57 29.73 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.149 2.566 . . . . 0.0 112.721 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -77.36 32.04 0.15 Allowed 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.263 1.425 . . . . 0.0 113.65 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 pp -80.33 174.05 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.353 1.861 . . . . 0.0 112.853 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.8 tp -136.48 86.75 2.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.292 1.437 . . . . 0.0 108.325 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -109.4 133.03 53.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.511 1.524 . . . . 0.0 110.287 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -70.98 160.01 33.68 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.329 0.968 . . . . 0.0 111.221 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.6 p -160.32 152.27 20.18 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -94.42 -34.59 12.69 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.198 1.799 . . . . 0.0 110.433 169.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -166.77 178.06 6.12 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.233 2.613 . . . . 0.0 110.449 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -61.1 -26.9 67.98 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.1 p -69.64 -13.15 62.16 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -82.08 -18.43 43.1 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.018 0.826 . . . . 0.0 112.593 170.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.6 m -91.66 139.9 25.05 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.697 1.199 . . . . 0.0 113.766 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -85.7 150.13 9.97 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.439 2.759 . . . . 0.0 112.437 -169.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.56 -123.52 32.18 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.35 9.83 42.17 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.646 1.178 . . . . 0.0 113.832 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 91.2 m -61.62 145.71 51.29 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.071 -1.018 . . . . 0.0 112.31 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.2 pt -120.43 154.57 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.398 1.879 . . . . 0.0 110.006 174.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.9 t -80.68 123.87 28.54 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.385 -0.822 . . . . 0.0 110.626 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -95.76 169.97 9.64 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.891 1.277 . . . . 0.0 111.734 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.47 -17.88 67.05 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.574 1.083 . . . . 0.0 115.224 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -78.25 -6.09 53.91 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.839 1.256 . . . . 0.0 114.212 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.0 15.75 60.56 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.082 1.325 . . . . 0.0 114.281 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -127.33 156.53 41.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.975 1.31 . . . . 0.0 113.099 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.2 m -74.02 137.3 43.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.753 1.621 . . . . 0.0 112.466 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.95 -168.93 21.7 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.225 1.393 . . . . 0.0 113.366 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 O-C-N 121.348 -1.09 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 112.566 -0.214 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p -163.37 150.45 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.752 1.621 . . . . 0.0 109.264 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.5 t -90.59 116.16 65.79 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.182 173.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.1 154.46 72.45 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.947 2.432 . . . . 0.0 111.735 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -83.25 14.97 3.15 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -169.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.2 pt -79.18 151.73 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.5 1.52 . . . . 0.0 112.279 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.4 tp -89.47 89.38 7.83 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.322 1.049 . . . . 0.0 109.249 174.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -109.71 122.5 47.62 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.704 1.601 . . . . 0.0 109.61 -173.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -73.14 160.09 32.53 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.169 -0.957 . . . . 0.0 112.095 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.5 p -161.78 153.49 18.94 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -96.31 -32.95 12.14 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.993 1.717 . . . . 0.0 110.34 169.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.7 ptt-85 -165.85 177.32 7.24 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 128.417 2.687 . . . . 0.0 110.437 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -59.33 -27.29 65.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.334 1.054 . . . . 0.0 113.496 -172.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.7 m -60.01 -22.4 62.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.094 1.358 . . . . 0.0 114.067 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -88.56 -10.32 49.21 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.196 0.998 . . . . 0.0 113.085 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.2 m -93.79 140.14 22.93 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -84.43 147.47 11.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.548 2.832 . . . . 0.0 112.317 -169.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.88 -122.03 28.44 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.903 -0.498 . . . . 0.0 111.916 177.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.54 6.0 50.09 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.746 1.218 . . . . 0.0 114.03 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.0 m -63.76 149.62 46.38 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.173 -0.954 . . . . 0.0 113.109 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.9 pt -117.4 157.1 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.605 1.962 . . . . 0.0 110.107 169.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.8 t -84.18 119.93 25.59 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.439 -0.788 . . . . 0.0 110.911 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -88.28 168.09 13.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.651 1.18 . . . . 0.0 111.519 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -16.72 66.04 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.587 1.089 . . . . 0.0 115.297 -172.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -78.06 -7.07 56.47 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 172.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.82 16.94 57.45 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.851 1.215 . . . . 0.0 114.225 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -129.88 156.52 44.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.049 1.34 . . . . 0.0 112.763 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.9 m -76.43 144.0 40.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.164 1.386 . . . . 0.0 113.016 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.81 -170.09 27.16 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.158 1.361 . . . . 0.0 113.444 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.531 0 O-C-N 121.25 -1.147 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.2 p -163.43 150.18 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.689 1.596 . . . . 0.0 109.238 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.4 t -92.57 116.03 65.8 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.261 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 147.2 63.78 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.666 2.244 . . . . 0.0 111.101 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -80.92 17.64 1.16 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.869 1.268 . . . . 0.0 114.379 -171.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.9 pt -75.79 152.91 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.532 1.533 . . . . 0.0 112.231 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.2 tp -88.14 87.35 7.29 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.303 1.041 . . . . 0.0 109.506 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -109.56 121.03 44.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.76 1.624 . . . . 0.0 109.527 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -73.56 159.21 33.47 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.208 -0.932 . . . . 0.0 112.289 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.1 p -161.54 156.21 23.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.18 -32.5 9.11 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.572 1.949 . . . . 0.0 109.686 168.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -159.62 177.1 11.24 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.232 2.213 . . . . 0.0 111.295 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -60.67 -26.78 67.34 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.455 1.102 . . . . 0.0 113.496 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.8 m -60.02 -21.16 61.0 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.02 1.328 . . . . 0.0 113.928 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -86.65 -13.84 44.41 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.237 1.015 . . . . 0.0 113.097 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.1 m -92.35 140.13 24.18 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.46 147.48 11.19 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.573 2.848 . . . . 0.0 112.301 -169.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.96 -121.59 27.05 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.76 5.85 50.34 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.697 1.199 . . . . 0.0 113.964 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.1 m -63.77 150.32 44.85 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.108 -0.995 . . . . 0.0 113.134 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.0 155.68 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.636 1.974 . . . . 0.0 109.941 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.6 t -78.8 131.99 36.71 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.18 -0.95 . . . . 0.0 110.642 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -104.25 167.64 9.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.596 1.158 . . . . 0.0 111.765 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.74 -16.89 66.48 Favored Glycine 0 N--CA 1.477 1.403 0 C-N-CA 124.712 1.149 . . . . 0.0 115.362 -170.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -76.83 -8.06 56.63 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 171.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.4 15.98 56.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.09 1.329 . . . . 0.0 114.2 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -130.98 157.44 42.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.03 1.332 . . . . 0.0 112.631 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.9 m -76.02 141.47 42.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.201 1.4 . . . . 0.0 112.89 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.34 -168.34 19.69 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.417 1.484 . . . . 0.0 113.437 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.496 0 O-C-N 121.237 -1.154 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m -147.69 159.22 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.286 1.834 . . . . 0.0 108.701 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.6 t -93.65 116.72 66.85 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.176 173.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.21 150.11 71.2 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.785 2.324 . . . . 0.0 111.591 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -77.29 13.43 1.17 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -171.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 pt -78.21 151.59 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.539 1.536 . . . . 0.0 112.301 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.4 tp -89.3 88.45 7.5 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.384 1.074 . . . . 0.0 109.407 175.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -109.66 121.97 46.42 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.783 1.633 . . . . 0.0 109.562 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -73.6 159.33 33.25 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.131 -0.98 . . . . 0.0 112.312 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.2 p -163.74 161.86 23.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -112.99 -32.29 6.41 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.505 1.922 . . . . 0.0 110.299 168.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -155.33 175.36 13.96 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.141 1.776 . . . . 0.0 111.057 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -61.97 -26.88 68.47 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.165 1.386 . . . . 0.0 113.439 -169.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.2 m -63.36 -18.79 64.04 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.758 1.223 . . . . 0.0 113.499 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -84.67 -13.83 50.32 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.284 1.034 . . . . 0.0 112.901 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.6 m -95.17 141.54 23.38 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.701 1.201 . . . . 0.0 114.18 -169.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -84.39 146.35 10.97 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.585 2.856 . . . . 0.0 112.262 -169.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.84 -122.69 30.53 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.84 5.97 50.34 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.793 1.237 . . . . 0.0 113.986 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.4 m -62.99 149.03 45.91 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.227 -0.921 . . . . 0.0 113.04 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.6 pt -117.86 155.97 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.458 1.903 . . . . 0.0 110.338 170.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 t -82.97 122.71 28.64 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.374 -0.829 . . . . 0.0 111.021 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -93.46 168.13 11.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.7 1.2 . . . . 0.0 111.74 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.7 -17.22 66.8 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.631 1.11 . . . . 0.0 115.294 -171.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -77.7 -7.39 56.42 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 172.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.18 16.99 56.75 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.982 1.277 . . . . 0.0 114.221 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -130.63 157.16 43.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.974 1.309 . . . . 0.0 112.632 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.5 m -76.08 143.51 41.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.185 1.394 . . . . 0.0 112.849 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.86 -167.93 24.02 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.127 1.346 . . . . 0.0 113.422 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 O-C-N 121.326 -1.102 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.787 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p -163.97 151.43 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.818 1.647 . . . . 0.0 109.037 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.4 t -89.41 118.38 69.04 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.209 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -58.8 161.25 15.66 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.472 2.782 . . . . 0.0 113.467 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -78.58 17.91 0.63 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.865 1.266 . . . . 0.0 113.355 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 tp -76.1 148.59 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 126.124 1.77 . . . . 0.0 112.076 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.1 tp -106.2 86.55 2.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.763 1.225 . . . . 0.0 108.101 169.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -107.15 131.63 53.93 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.123 1.369 . . . . 0.0 110.442 -176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -70.56 160.76 31.9 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.059 0.845 . . . . 0.0 111.089 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -160.21 150.76 18.61 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -93.3 -35.67 12.95 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.406 1.882 . . . . 0.0 110.428 169.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -165.04 -179.85 5.96 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.399 2.68 . . . . 0.0 110.198 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -59.72 -26.03 65.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.318 1.047 . . . . 0.0 113.645 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 m -59.46 -22.76 62.01 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.375 1.47 . . . . 0.0 114.176 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -84.47 -17.3 39.57 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.896 0.878 . . . . 0.0 113.004 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.6 m -91.21 138.09 25.94 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -169.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -87.15 151.53 8.15 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.406 2.737 . . . . 0.0 112.441 -169.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.56 -125.07 36.27 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.57 9.36 41.73 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.578 1.151 . . . . 0.0 113.862 174.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.2 m -62.35 146.93 49.91 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.104 -0.997 . . . . 0.0 112.256 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.94 154.53 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.442 1.897 . . . . 0.0 109.823 172.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -78.38 129.86 35.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.336 -0.852 . . . . 0.0 110.525 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -103.29 169.81 8.33 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.644 1.178 . . . . 0.0 111.854 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.52 -17.71 66.96 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.695 1.14 . . . . 0.0 115.297 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -77.28 -6.7 54.12 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.751 1.22 . . . . 0.0 114.131 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.11 15.77 60.34 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.19 1.376 . . . . 0.0 114.201 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -127.95 156.86 42.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.074 1.35 . . . . 0.0 113.098 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.4 m -73.8 136.21 43.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.711 1.605 . . . . 0.0 112.468 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.15 -169.89 20.15 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.332 1.444 . . . . 0.0 113.452 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.53 0 O-C-N 121.169 -1.195 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.6 p -165.06 146.56 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.831 1.652 . . . . 0.0 109.521 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 48.7 t -84.11 117.77 69.55 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.337 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.88 175.58 10.18 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.517 2.811 . . . . 0.0 112.337 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -76.44 35.26 0.14 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.026 1.731 . . . . 0.0 113.635 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.3 pt -80.35 170.82 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.459 1.904 . . . . 0.0 112.185 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.4 tp -143.86 91.03 2.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.969 1.308 . . . . 0.0 109.372 173.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -112.33 136.85 51.27 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.672 1.589 . . . . 0.0 111.041 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -63.94 155.72 29.99 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 118.844 0.747 . . . . 0.0 111.597 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.0 p -159.83 155.15 25.28 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -98.46 -36.19 10.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.443 1.897 . . . . 0.0 110.485 169.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -163.16 175.53 10.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.937 2.495 . . . . 0.0 109.442 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -60.6 -26.4 66.96 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.397 1.479 . . . . 0.0 113.523 -169.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.5 m -62.54 -20.44 64.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.867 1.267 . . . . 0.0 113.781 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -83.07 -14.25 54.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.723 0.809 . . . . 0.0 113.023 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.3 m -99.03 137.38 20.46 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.046 1.338 . . . . 0.0 113.014 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -86.65 150.93 8.79 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.834 2.356 . . . . 0.0 112.015 -170.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.56 -123.3 32.46 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.34 0.495 . . . . 0.0 112.168 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.17 1.83 56.97 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.689 1.196 . . . . 0.0 114.085 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.8 m -64.2 143.42 57.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.375 0.989 . . . . 0.0 112.376 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.6 pt -120.76 155.86 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.34 1.856 . . . . 0.0 110.132 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.0 t -83.1 116.27 22.25 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.505 -0.747 . . . . 0.0 110.886 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -86.88 169.2 12.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.935 1.294 . . . . 0.0 111.777 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.48 -17.26 66.35 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 124.565 1.079 . . . . 0.0 115.21 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -77.64 -6.6 54.39 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.777 1.231 . . . . 0.0 114.2 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.39 20.46 54.58 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.867 1.223 . . . . 0.0 114.17 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -131.93 157.99 42.59 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.003 1.321 . . . . 0.0 112.865 177.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 75.3 m -73.6 136.77 43.96 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.595 1.558 . . . . 0.0 112.514 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.95 -168.51 22.01 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.257 1.408 . . . . 0.0 113.366 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.515 0 O-C-N 121.262 -1.14 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p -163.92 150.28 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.83 1.652 . . . . 0.0 109.095 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.9 t -90.59 117.86 68.28 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.322 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.32 146.06 52.71 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.875 3.05 . . . . 0.0 113.286 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -78.41 10.49 3.07 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -170.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.4 pt -79.45 154.05 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.333 1.453 . . . . 0.0 112.114 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.34 93.6 6.59 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.508 1.123 . . . . 0.0 108.805 171.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -108.22 133.63 52.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.3 1.44 . . . . 0.0 111.196 -175.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -62.24 153.74 29.66 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.946 0.794 . . . . 0.0 112.269 171.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -160.42 167.02 28.23 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -128.02 -9.94 5.39 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.242 1.417 . . . . 0.0 112.922 169.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 ptm85 -167.01 166.16 15.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.085 2.154 . . . . 0.0 111.987 173.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -61.37 -30.47 70.55 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.565 1.146 . . . . 0.0 112.85 -171.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 m -62.72 -19.14 63.63 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.098 1.359 . . . . 0.0 113.617 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -95.57 -2.57 48.15 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.288 1.435 . . . . 0.0 112.904 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.3 m -97.64 140.42 21.97 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.063 1.345 . . . . 0.0 112.947 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -83.39 148.52 12.93 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.422 2.748 . . . . 0.0 112.559 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.28 -123.55 33.3 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.669 -0.573 . . . . 0.0 111.669 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.93 8.61 43.18 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.703 1.201 . . . . 0.0 113.917 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.2 m -62.38 145.71 53.23 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.439 1.018 . . . . 0.0 112.151 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.8 pt -115.32 154.75 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.198 1.799 . . . . 0.0 110.198 172.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.0 t -82.65 123.54 29.35 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.457 -0.777 . . . . 0.0 110.635 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.44 167.07 11.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.737 1.215 . . . . 0.0 111.761 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.23 66.6 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 124.572 1.082 . . . . 0.0 115.269 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -77.7 -6.41 53.83 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 171.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.44 22.64 46.71 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.872 1.225 . . . . 0.0 113.978 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -132.77 156.36 47.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.216 1.406 . . . . 0.0 112.747 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.8 m -73.82 140.67 45.96 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 112.363 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.94 -172.34 24.06 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 125.194 1.378 . . . . 0.0 113.395 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.499 0 O-C-N 121.273 -1.134 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p -163.77 150.71 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.748 1.619 . . . . 0.0 109.146 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.9 t -90.03 114.0 59.24 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 118.177 -0.916 . . . . 0.0 109.985 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.95 160.89 47.94 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.942 2.428 . . . . 0.0 111.872 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -79.62 18.58 0.73 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.082 1.353 . . . . 0.0 114.246 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.4 mt -79.01 138.15 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.709 1.604 . . . . 0.0 109.921 -176.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.5 tp -84.07 84.83 7.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.16 0.984 . . . . 0.0 108.701 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -107.01 123.42 48.17 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.906 1.682 . . . . 0.0 109.484 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -72.22 159.28 34.36 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.075 -1.016 . . . . 0.0 111.982 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.2 p -162.27 158.46 24.31 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -112.37 -26.71 8.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.265 1.826 . . . . 0.0 110.658 168.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.3 175.97 12.73 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.91 2.084 . . . . 0.0 111.37 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -60.91 -27.19 68.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.966 0.907 . . . . 0.0 113.265 -171.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -62.86 -18.06 62.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.178 1.391 . . . . 0.0 113.881 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.7 -14.2 46.13 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.349 1.059 . . . . 0.0 112.881 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.7 m -93.43 141.36 23.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -83.81 146.35 11.74 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.442 2.762 . . . . 0.0 112.129 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.8 -121.8 27.73 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.79 7.33 46.84 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.792 1.237 . . . . 0.0 113.907 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.2 m -63.19 150.88 41.87 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.127 -0.983 . . . . 0.0 113.023 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.2 pt -119.35 154.76 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.542 1.937 . . . . 0.0 110.162 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.9 t -79.1 132.53 36.62 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.145 -0.972 . . . . 0.0 110.849 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -105.26 167.12 9.94 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.624 1.169 . . . . 0.0 111.798 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.03 -16.51 66.58 Favored Glycine 0 N--CA 1.478 1.478 0 C-N-CA 124.649 1.119 . . . . 0.0 115.433 -170.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -76.8 -6.97 54.47 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.21 58.98 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.043 1.306 . . . . 0.0 114.154 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -130.38 157.49 42.45 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.99 1.316 . . . . 0.0 112.741 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.0 m -76.48 141.51 41.27 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.265 1.426 . . . . 0.0 112.729 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -153.31 -169.71 18.7 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.637 1.589 . . . . 0.0 113.375 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.507 0 O-C-N 121.137 -1.213 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 112.549 -0.221 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p -163.61 150.51 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.751 1.621 . . . . 0.0 109.3 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.2 t -92.75 115.94 65.69 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.33 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.68 145.94 59.16 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.691 2.261 . . . . 0.0 110.975 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -80.82 18.06 1.06 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.825 1.25 . . . . 0.0 114.254 -171.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 pt -75.02 153.38 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.591 1.556 . . . . 0.0 112.235 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.7 tp -87.71 86.66 7.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.279 1.032 . . . . 0.0 109.586 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -109.16 120.41 42.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.843 1.657 . . . . 0.0 109.454 -175.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -72.75 159.29 34.04 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.23 -0.919 . . . . 0.0 112.284 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.4 p -162.37 156.22 21.06 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.93 -31.85 9.05 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.546 1.938 . . . . 0.0 109.726 168.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 ptm85 -161.06 174.65 13.42 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.285 2.234 . . . . 0.0 111.428 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -60.97 -26.6 67.67 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.461 1.104 . . . . 0.0 113.93 -169.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 t -66.03 -14.85 62.4 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -86.16 -14.41 44.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.041 0.937 . . . . 0.0 112.836 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -92.74 140.62 23.79 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.41 147.3 11.21 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.619 2.88 . . . . 0.0 112.314 -169.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.01 -121.56 26.92 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.62 5.77 50.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.691 1.196 . . . . 0.0 114.005 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.3 m -63.91 150.34 45.22 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.19 -0.944 . . . . 0.0 113.146 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.2 pt -119.48 155.9 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.704 2.002 . . . . 0.0 109.913 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.5 t -78.97 132.23 36.61 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.986 -1.071 . . . . 0.0 110.68 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -104.35 167.26 9.86 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.645 1.178 . . . . 0.0 111.775 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -16.77 66.41 Favored Glycine 0 N--CA 1.477 1.393 0 C-N-CA 124.713 1.149 . . . . 0.0 115.4 -170.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -76.69 -8.1 56.62 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.5 16.16 55.65 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.133 1.349 . . . . 0.0 114.13 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -131.4 157.23 43.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.918 1.287 . . . . 0.0 112.679 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.7 m -75.82 141.65 42.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.278 1.431 . . . . 0.0 112.808 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.54 -168.06 19.44 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.375 1.464 . . . . 0.0 113.394 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.489 0 O-C-N 121.175 -1.191 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.859 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.1 p -163.8 150.9 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.861 1.664 . . . . 0.0 109.253 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.8 t -87.4 115.91 64.35 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 118.15 -0.929 . . . . 0.0 109.984 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.45 151.34 80.25 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.69 2.26 . . . . 0.0 111.609 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -75.77 12.62 1.01 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -170.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.1 pt -79.35 148.52 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.397 1.479 . . . . 0.0 111.885 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 tp -95.11 93.47 7.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.394 1.078 . . . . 0.0 109.299 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -109.32 130.01 55.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.216 1.406 . . . . 0.0 110.835 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -70.3 158.0 36.7 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.237 0.926 . . . . 0.0 112.749 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.9 p -159.97 162.63 34.41 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.581 1.153 . . . . 0.0 113.705 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -113.49 -19.11 11.79 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.406 1.482 . . . . 0.0 112.474 168.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -167.87 169.0 11.84 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 127.105 2.162 . . . . 0.0 111.881 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -60.8 -30.9 70.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.628 1.171 . . . . 0.0 112.987 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -62.86 -18.51 63.01 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.999 1.32 . . . . 0.0 113.667 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -97.62 -0.44 45.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.409 1.484 . . . . 0.0 112.79 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.9 m -97.54 142.59 24.79 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.065 1.346 . . . . 0.0 113.018 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -83.56 146.36 12.06 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.619 2.88 . . . . 0.0 112.587 -169.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.91 -120.8 24.38 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.73 7.76 45.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.757 1.223 . . . . 0.0 114.007 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.9 m -62.54 146.73 51.06 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.155 -0.966 . . . . 0.0 112.458 177.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.7 pt -116.63 153.49 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.302 1.841 . . . . 0.0 110.195 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -82.32 121.93 27.31 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.481 -0.762 . . . . 0.0 110.43 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -93.89 168.47 10.96 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.852 1.261 . . . . 0.0 111.895 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -17.92 67.5 Favored Glycine 0 N--CA 1.477 1.398 0 C-N-CA 124.683 1.135 . . . . 0.0 115.169 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -77.59 -6.86 55.21 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.669 1.188 . . . . 0.0 114.111 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.64 16.07 58.99 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.076 1.322 . . . . 0.0 114.416 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -126.92 157.5 39.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.475 1.51 . . . . 0.0 112.253 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.3 m -74.7 139.85 43.75 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.049 1.74 . . . . 0.0 112.22 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.43 -170.47 23.13 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.171 1.367 . . . . 0.0 113.465 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.473 0 O-C-N 121.246 -1.149 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 112.41 -0.276 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.18 153.35 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.293 1.837 . . . . 0.0 108.784 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.8 t -85.63 120.5 73.0 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.387 173.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.05 170.72 19.12 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.44 2.76 . . . . 0.0 112.122 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.62 36.64 0.21 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.752 1.621 . . . . 0.0 113.693 -175.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.0 pt -78.4 161.46 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.937 1.695 . . . . 0.0 112.327 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.3 tp -123.21 83.26 2.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 108.567 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -112.1 124.03 51.55 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.98 1.712 . . . . 0.0 109.594 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.5 153.1 36.62 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.344 -0.847 . . . . 0.0 112.819 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -160.38 161.7 33.15 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -113.62 -32.09 6.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.726 2.01 . . . . 0.0 110.349 168.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.05 174.43 15.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.797 1.639 . . . . 0.0 111.354 175.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -62.42 -25.8 68.15 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.322 1.449 . . . . 0.0 113.756 -169.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 p -65.31 -16.26 63.39 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.206 1.402 . . . . 0.0 113.852 174.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -83.34 -14.47 52.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.232 1.013 . . . . 0.0 112.838 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -100.76 138.9 20.19 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.942 1.297 . . . . 0.0 113.448 -169.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.22 147.87 9.0 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.149 2.566 . . . . 0.0 111.988 -169.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.17 -122.71 30.8 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.41 0.528 . . . . 0.0 112.415 175.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.29 -0.37 57.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.747 1.219 . . . . 0.0 114.204 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 79.7 m -64.75 144.68 57.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.374 0.988 . . . . 0.0 112.962 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.8 pt -119.18 156.79 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.676 1.99 . . . . 0.0 110.122 172.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.8 t -83.24 119.12 24.16 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.321 -0.862 . . . . 0.0 111.13 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -89.74 167.34 12.96 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.791 1.236 . . . . 0.0 111.743 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.44 -17.0 65.97 Favored Glycine 0 N--CA 1.477 1.408 0 C-N-CA 124.634 1.111 . . . . 0.0 115.295 -172.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -76.83 -8.93 58.25 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 171.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.58 23.48 36.34 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.821 1.2 . . . . 0.0 114.077 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -136.5 157.57 46.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.97 1.308 . . . . 0.0 112.546 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.6 m -73.62 139.19 45.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.463 1.505 . . . . 0.0 112.681 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.44 -167.82 22.44 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 125.247 1.403 . . . . 0.0 113.33 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.522 0 O-C-N 121.299 -1.118 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.902 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.8 p -164.04 150.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.826 1.65 . . . . 0.0 109.277 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.7 t -89.6 117.42 68.14 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.3 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.99 169.63 21.72 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.143 2.562 . . . . 0.0 112.243 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -73.3 26.82 0.06 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.271 1.829 . . . . 0.0 115.3 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.3 pt -75.03 168.24 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.282 1.833 . . . . 0.0 112.752 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.2 tp -132.5 86.48 2.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.273 1.429 . . . . 0.0 108.603 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.26 131.19 54.95 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.506 1.523 . . . . 0.0 110.647 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.54 153.02 37.0 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.895 0.771 . . . . 0.0 112.128 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -160.69 160.59 31.67 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -117.68 -17.44 9.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.893 1.677 . . . . 0.0 111.339 167.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -163.16 168.69 20.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.928 2.091 . . . . 0.0 112.065 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -62.31 -26.15 68.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.943 0.897 . . . . 0.0 113.134 -171.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -63.49 -18.04 63.38 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.962 1.305 . . . . 0.0 113.964 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -79.3 -22.51 44.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.834 0.854 . . . . 0.0 112.494 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.0 m -93.55 134.14 27.08 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.957 1.303 . . . . 0.0 113.788 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -88.29 159.04 6.86 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.374 2.716 . . . . 0.0 112.14 -171.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.11 -123.68 31.88 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.46 6.7 46.99 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.462 1.105 . . . . 0.0 113.787 174.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.2 m -64.23 145.95 55.13 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.144 -0.972 . . . . 0.0 112.451 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.3 pt -122.59 156.12 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.791 2.036 . . . . 0.0 109.737 173.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -77.61 130.57 37.05 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.191 -0.943 . . . . 0.0 110.781 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -104.09 166.98 10.06 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.814 1.245 . . . . 0.0 111.798 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.73 -16.74 66.24 Favored Glycine 0 N--CA 1.477 1.372 0 C-N-CA 124.665 1.126 . . . . 0.0 115.348 -171.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -76.7 -7.52 55.49 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.718 1.207 . . . . 0.0 114.179 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.9 22.11 43.77 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.93 1.253 . . . . 0.0 114.016 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -135.43 157.61 46.46 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.086 1.355 . . . . 0.0 112.736 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.8 m -72.85 137.86 45.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.602 1.561 . . . . 0.0 112.307 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.01 -169.62 21.08 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.255 1.407 . . . . 0.0 113.494 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.5 0 O-C-N 121.228 -1.16 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -163.82 151.08 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.766 1.626 . . . . 0.0 109.155 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.8 t -89.03 114.1 58.8 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.098 173.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.04 153.49 67.57 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.642 2.228 . . . . 0.0 110.92 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -78.88 25.16 0.28 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.861 1.264 . . . . 0.0 114.148 -171.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.3 mt -79.5 136.17 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.845 1.658 . . . . 0.0 109.381 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.7 tp -89.4 88.62 7.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.385 1.074 . . . . 0.0 109.043 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -108.15 130.52 55.12 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.296 1.439 . . . . 0.0 110.579 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -71.68 159.36 34.53 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.026 0.83 . . . . 0.0 111.411 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.4 p -161.67 157.36 24.38 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -108.75 -25.71 10.68 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.495 1.918 . . . . 0.0 110.511 168.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -161.91 172.98 15.15 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.766 2.026 . . . . 0.0 112.142 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.84 -27.36 68.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.238 1.015 . . . . 0.0 112.97 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 m -62.42 -18.66 62.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.312 1.445 . . . . 0.0 113.952 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.47 -20.15 34.54 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.176 0.99 . . . . 0.0 112.683 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.5 m -90.11 141.63 28.0 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -168.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -84.88 147.6 10.63 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.575 2.85 . . . . 0.0 112.32 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.63 -121.51 26.82 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.41 7.89 45.65 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.681 1.192 . . . . 0.0 113.95 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.4 m -62.54 147.03 50.25 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.07 -1.019 . . . . 0.0 112.339 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.2 pt -120.62 154.11 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.496 1.918 . . . . 0.0 110.09 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -79.07 125.82 29.9 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.341 -0.849 . . . . 0.0 110.616 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -99.06 168.71 9.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.754 1.222 . . . . 0.0 111.89 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.87 -17.43 67.42 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 124.628 1.108 . . . . 0.0 115.241 -172.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -77.35 -6.68 54.19 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.663 1.185 . . . . 0.0 114.116 171.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.95 15.4 59.4 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.157 1.36 . . . . 0.0 114.3 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -128.34 156.65 42.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.914 1.286 . . . . 0.0 113.019 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.8 m -73.23 138.52 45.63 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.536 1.534 . . . . 0.0 112.298 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.44 -167.61 20.33 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.144 1.354 . . . . 0.0 113.398 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.477 0 O-C-N 121.194 -1.18 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.3 p -163.76 152.56 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.856 1.663 . . . . 0.0 109.084 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.94 115.46 63.99 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 118.308 -0.854 . . . . 0.0 109.831 171.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.74 170.32 18.97 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.837 2.358 . . . . 0.0 111.832 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -76.71 33.43 0.14 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.765 1.626 . . . . 0.0 113.785 -174.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -79.72 173.73 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.296 1.839 . . . . 0.0 112.649 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 tp -141.97 88.48 2.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.171 1.389 . . . . 0.0 108.398 169.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -110.23 134.67 52.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.568 1.547 . . . . 0.0 110.04 -177.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -68.35 160.87 28.66 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.476 1.035 . . . . 0.0 110.794 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -157.01 150.9 24.69 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -94.2 -28.87 15.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.282 1.433 . . . . 0.0 111.431 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.0 ptm85 -173.51 174.17 3.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.666 2.787 . . . . 0.0 110.728 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -59.19 -31.04 68.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.508 1.123 . . . . 0.0 113.141 -173.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -63.87 -17.64 63.38 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.943 1.297 . . . . 0.0 113.836 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -92.0 -9.39 43.08 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.132 1.373 . . . . 0.0 112.398 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.8 m -92.18 140.74 24.55 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.008 1.323 . . . . 0.0 113.399 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.92 149.95 12.47 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.374 2.716 . . . . 0.0 112.404 -169.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.88 -122.72 29.59 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.72 10.84 40.65 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.583 1.153 . . . . 0.0 113.706 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -61.27 146.74 46.86 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.119 -0.988 . . . . 0.0 112.579 176.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.4 pt -118.89 152.94 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.417 1.887 . . . . 0.0 110.227 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -82.21 121.39 26.56 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.418 -0.801 . . . . 0.0 110.531 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.06 169.71 10.07 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.928 1.291 . . . . 0.0 111.817 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.99 67.49 Favored Glycine 0 N--CA 1.477 1.396 0 C-N-CA 124.6 1.095 . . . . 0.0 115.14 -172.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -78.33 -5.59 52.61 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.824 1.25 . . . . 0.0 114.197 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.09 13.84 63.48 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.182 1.373 . . . . 0.0 114.409 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -124.85 156.67 37.49 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.064 1.345 . . . . 0.0 113.373 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.5 m -73.97 137.49 43.57 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.87 1.668 . . . . 0.0 112.447 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.76 -169.32 20.58 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.329 1.442 . . . . 0.0 113.267 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.482 0 O-C-N 121.3 -1.117 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.9 m -147.76 158.92 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 126.365 1.866 . . . . 0.0 108.68 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.6 t -96.84 117.73 65.62 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.637 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -53.96 142.87 63.31 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.257 3.305 . . . . 0.0 113.276 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.55 13.57 6.73 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.4 pt -79.13 154.4 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.496 1.518 . . . . 0.0 112.347 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.0 tp -87.82 88.45 7.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.37 1.068 . . . . 0.0 109.299 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -109.3 121.88 46.13 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.82 1.648 . . . . 0.0 109.675 -174.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -73.51 159.66 32.85 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.148 -0.97 . . . . 0.0 112.311 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -162.44 159.49 25.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -175.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -109.98 -29.68 8.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.321 1.848 . . . . 0.0 110.503 168.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -158.98 177.58 10.98 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.542 1.937 . . . . 0.0 111.965 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.21 -27.31 68.89 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -169.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.0 p -69.87 -12.38 61.58 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -83.85 -14.05 52.16 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.029 0.932 . . . . 0.0 112.558 171.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.3 m -96.0 140.53 22.31 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.924 1.29 . . . . 0.0 113.984 -169.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -84.25 147.91 11.57 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.459 2.772 . . . . 0.0 112.206 -169.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.22 -125.1 37.88 Favored Glycine 0 CA--C 1.532 1.102 0 O-C-N 121.84 -0.538 . . . . 0.0 111.911 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.2 6.62 47.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.92 1.288 . . . . 0.0 114.1 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.3 m -62.52 147.5 48.72 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.055 -1.028 . . . . 0.0 112.813 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.7 pt -115.5 156.99 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.507 1.923 . . . . 0.0 110.228 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.3 t -83.5 118.11 23.55 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.47 -0.769 . . . . 0.0 110.797 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.5 mmm-85 -86.85 167.46 14.33 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.635 1.174 . . . . 0.0 111.609 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.66 -16.76 66.12 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 124.601 1.096 . . . . 0.0 115.322 -172.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -77.73 -7.5 56.62 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.687 1.195 . . . . 0.0 114.186 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.23 17.41 55.68 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.885 1.231 . . . . 0.0 114.264 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -130.49 156.29 45.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.85 1.26 . . . . 0.0 112.71 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.9 m -75.26 143.47 43.02 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.133 1.373 . . . . 0.0 112.857 -175.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.57 -170.33 28.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.943 1.259 . . . . 0.0 113.494 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.481 0 O-C-N 121.229 -1.16 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 p -163.52 149.82 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.672 1.589 . . . . 0.0 109.375 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.0 t -91.56 117.42 67.78 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.233 173.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.81 149.66 86.54 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.829 2.353 . . . . 0.0 111.336 176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -81.82 18.24 1.33 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -169.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.6 pt -74.57 150.98 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.412 1.485 . . . . 0.0 111.993 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 tp -94.33 86.39 4.88 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.265 1.026 . . . . 0.0 109.18 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -107.73 124.73 50.46 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.391 1.477 . . . . 0.0 110.699 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -70.89 158.57 36.19 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.18 -0.95 . . . . 0.0 113.106 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.1 p -159.17 154.72 25.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -174.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -100.57 -31.85 11.05 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.259 1.423 . . . . 0.0 110.721 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.72 177.32 9.45 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.083 2.153 . . . . 0.0 111.155 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -60.8 -25.52 66.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -63.39 -19.46 64.69 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.933 1.293 . . . . 0.0 113.993 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.8 -17.67 52.79 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.064 0.946 . . . . 0.0 112.798 173.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.8 m -98.83 137.11 20.5 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.803 1.241 . . . . 0.0 113.837 -169.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -88.76 154.55 6.14 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.752 2.968 . . . . 0.0 112.446 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -121.5 26.55 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.28 5.04 51.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.449 1.1 . . . . 0.0 113.933 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.8 m -64.91 145.4 56.35 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.458 1.026 . . . . 0.0 112.217 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.5 pt -120.42 156.29 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.572 1.949 . . . . 0.0 109.755 171.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.8 t -79.65 125.86 30.18 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.315 -0.866 . . . . 0.0 110.62 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -97.47 168.36 10.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.732 1.213 . . . . 0.0 111.819 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.58 -17.62 67.0 Favored Glycine 0 N--CA 1.476 1.354 0 C-N-CA 124.631 1.11 . . . . 0.0 115.273 -171.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -77.31 -8.18 57.22 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.673 1.189 . . . . 0.0 114.181 171.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.32 18.51 52.8 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.09 1.329 . . . . 0.0 114.346 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -129.8 156.6 44.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.414 1.486 . . . . 0.0 112.238 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 82.4 m -72.91 139.21 46.66 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.979 1.711 . . . . 0.0 112.376 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.35 -169.13 24.22 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 124.977 1.275 . . . . 0.0 113.514 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 O-C-N 121.256 -1.144 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -145.5 136.52 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.812 1.645 . . . . 0.0 107.943 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.7 t -79.33 119.9 78.61 Favored Pre-proline 0 CA--C 1.551 0.984 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.217 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.26 173.25 11.69 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.625 2.884 . . . . 0.0 112.845 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -75.32 33.02 0.1 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.262 1.825 . . . . 0.0 114.048 -174.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.8 pt -78.37 168.93 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.027 1.731 . . . . 0.0 112.169 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 tp -137.85 83.44 1.98 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.844 1.257 . . . . 0.0 108.847 170.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -106.75 126.51 52.38 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.484 1.514 . . . . 0.0 110.108 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -70.28 156.67 38.95 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.32 0.964 . . . . 0.0 112.804 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.1 p -160.0 156.98 27.94 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -106.96 -25.44 11.63 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.575 1.95 . . . . 0.0 110.607 168.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -163.11 171.87 15.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.461 1.904 . . . . 0.0 112.143 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -61.32 -27.11 68.25 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 113.058 -172.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -62.7 -18.46 62.51 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.145 1.378 . . . . 0.0 113.856 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -81.16 -22.03 39.28 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.083 0.953 . . . . 0.0 112.417 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.1 m -92.69 135.95 25.69 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.886 1.274 . . . . 0.0 113.244 -169.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.72 148.14 9.67 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.965 2.444 . . . . 0.0 111.918 -170.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.27 -122.73 30.82 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.437 0.542 . . . . 0.0 112.378 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.58 -2.56 58.7 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.81 1.244 . . . . 0.0 114.313 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -65.74 146.3 54.95 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.325 0.966 . . . . 0.0 112.844 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.9 pt -125.1 155.39 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.859 2.064 . . . . 0.0 109.632 174.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.79 131.29 37.54 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.146 -0.971 . . . . 0.0 110.712 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -105.95 168.15 9.32 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.649 1.18 . . . . 0.0 111.79 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.82 -17.11 66.93 Favored Glycine 0 N--CA 1.477 1.394 0 C-N-CA 124.632 1.11 . . . . 0.0 115.255 -171.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -76.52 -7.99 56.27 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.701 1.2 . . . . 0.0 114.095 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.17 17.79 54.97 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.079 1.323 . . . . 0.0 114.266 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -130.77 157.97 41.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.341 1.456 . . . . 0.0 112.306 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.1 m -73.81 135.21 43.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.086 1.754 . . . . 0.0 112.057 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.41 -168.92 18.56 Favored Glycine 0 N--CA 1.471 1.009 0 C-N-CA 125.398 1.475 . . . . 0.0 113.315 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.521 0 O-C-N 121.233 -1.157 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p -163.95 151.8 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.861 1.665 . . . . 0.0 109.024 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.6 t -89.23 117.33 68.12 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.925 171.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -61.6 163.26 18.73 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.194 2.596 . . . . 0.0 113.153 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -76.01 28.29 0.11 Allowed 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.598 1.559 . . . . 0.0 113.871 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.09 174.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.531 1.932 . . . . 0.0 112.939 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.8 tp -138.88 88.05 2.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.391 1.476 . . . . 0.0 108.226 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -109.29 133.07 53.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.503 1.521 . . . . 0.0 110.439 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -69.05 158.9 33.88 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.246 0.93 . . . . 0.0 111.06 176.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.8 p -160.95 157.87 27.14 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -176.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -111.03 -24.38 10.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.619 1.968 . . . . 0.0 110.615 168.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -161.91 173.29 14.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.835 2.054 . . . . 0.0 111.977 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.68 -26.68 67.28 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.232 1.013 . . . . 0.0 113.024 -173.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 m -60.98 -20.16 62.02 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.548 1.539 . . . . 0.0 113.968 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -82.79 -20.78 35.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.247 1.019 . . . . 0.0 112.697 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.8 m -90.87 138.98 25.98 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 124.933 1.293 . . . . 0.0 114.312 -168.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -86.27 151.38 9.32 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.417 2.745 . . . . 0.0 112.301 -170.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.4 -124.03 33.76 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.73 10.51 41.0 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.639 1.176 . . . . 0.0 113.765 173.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 80.6 m -61.8 147.05 47.65 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.157 -0.964 . . . . 0.0 112.082 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.31 153.23 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.42 1.888 . . . . 0.0 110.029 175.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -77.47 130.01 36.45 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.357 -0.839 . . . . 0.0 110.629 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -104.91 168.64 8.92 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.716 1.207 . . . . 0.0 111.866 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -17.18 66.93 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 124.743 1.163 . . . . 0.0 115.247 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -76.95 -6.41 52.43 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.795 1.238 . . . . 0.0 114.109 171.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.22 16.72 58.7 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.125 1.345 . . . . 0.0 114.13 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -129.81 156.65 43.99 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.97 1.308 . . . . 0.0 113.25 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 82.9 m -73.67 134.12 43.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.773 1.629 . . . . 0.0 112.084 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.11 -172.38 19.41 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 125.428 1.489 . . . . 0.0 113.382 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.525 0 O-C-N 121.263 -1.14 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.767 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.0 p -164.96 146.93 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.916 1.687 . . . . 0.0 109.553 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.2 t -83.78 117.99 70.17 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.161 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.42 172.29 14.49 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.388 2.725 . . . . 0.0 112.245 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.01 34.57 0.13 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.928 1.691 . . . . 0.0 113.914 -175.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.0 pt -79.05 168.22 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.135 1.774 . . . . 0.0 112.112 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.4 tp -136.49 86.41 2.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.961 1.304 . . . . 0.0 108.597 169.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -108.04 134.78 50.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.757 1.623 . . . . 0.0 110.635 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.34 154.95 22.56 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.413 1.006 . . . . 0.0 111.974 171.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.1 p -153.6 151.04 29.28 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.605 1.705 . . . . 0.0 115.605 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -96.51 -25.43 15.65 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.697 1.999 . . . . 0.0 113.246 169.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -174.89 173.69 2.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 128.01 2.524 . . . . 0.0 111.257 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -60.2 -33.43 72.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.329 1.052 . . . . 0.0 112.871 -175.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -64.38 -16.58 62.55 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.942 1.297 . . . . 0.0 113.474 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -93.34 -8.26 42.47 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.635 1.574 . . . . 0.0 112.516 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.8 m -94.71 138.95 22.09 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.534 1.534 . . . . 0.0 112.629 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -84.02 149.79 12.29 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.107 2.538 . . . . 0.0 112.2 -169.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -123.72 33.14 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.297 0.475 . . . . 0.0 111.985 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.59 3.5 55.41 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.603 1.161 . . . . 0.0 114.015 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.6 m -63.61 145.97 54.66 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.159 -0.963 . . . . 0.0 112.683 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.2 pt -119.88 154.77 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.74 2.016 . . . . 0.0 110.039 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.9 t -83.51 123.16 29.46 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.39 -0.819 . . . . 0.0 110.531 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -95.28 169.36 10.13 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.732 1.213 . . . . 0.0 111.796 -176.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.48 -17.92 67.13 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.653 1.121 . . . . 0.0 115.157 -172.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -78.0 -6.43 54.46 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.741 1.216 . . . . 0.0 114.188 171.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.96 18.8 57.36 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.048 1.309 . . . . 0.0 114.189 -178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -129.37 157.53 41.66 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.207 1.403 . . . . 0.0 112.69 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.9 m -73.23 138.9 45.85 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.492 1.517 . . . . 0.0 112.377 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.85 -168.58 20.41 Favored Glycine 0 N--CA 1.47 0.904 0 C-N-CA 125.434 1.492 . . . . 0.0 113.228 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.525 0 O-C-N 121.3 -1.118 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.3 t -145.78 139.0 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 126.044 1.738 . . . . 0.0 107.764 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 40.3 t -80.72 118.73 73.7 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.387 175.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.81 169.69 20.57 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.014 2.476 . . . . 0.0 111.776 177.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -77.43 39.32 0.26 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.434 1.493 . . . . 0.0 113.41 -176.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -79.32 172.9 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.946 1.698 . . . . 0.0 112.326 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.8 tp -142.38 87.13 2.0 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.007 1.323 . . . . 0.0 108.75 172.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -111.04 134.59 52.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.548 1.539 . . . . 0.0 110.587 -177.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -62.64 153.6 31.78 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.065 0.848 . . . . 0.0 111.987 175.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.1 p -159.26 156.73 29.31 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 176.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -110.04 -26.61 9.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.883 2.073 . . . . 0.0 110.105 168.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -159.54 171.92 18.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.4 1.88 . . . . 0.0 112.287 178.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -61.13 -27.69 68.57 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.199 1.0 . . . . 0.0 113.057 -172.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.6 m -63.33 -17.28 62.4 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.158 1.383 . . . . 0.0 113.94 176.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -81.83 -21.17 37.74 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.038 0.935 . . . . 0.0 112.619 173.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.7 m -90.78 140.86 26.45 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 114.356 -168.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -84.2 145.96 11.09 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.227 2.618 . . . . 0.0 111.912 -169.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.59 -122.37 29.57 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 121.977 -0.452 . . . . 0.0 112.003 177.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.69 5.37 52.05 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.692 1.197 . . . . 0.0 114.079 176.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.6 m -62.3 146.37 51.24 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.198 -0.939 . . . . 0.0 112.421 176.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.8 pt -122.57 154.77 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.612 1.965 . . . . 0.0 109.907 175.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -78.32 129.29 34.84 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.332 -0.855 . . . . 0.0 110.728 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -103.42 168.02 9.43 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.798 1.239 . . . . 0.0 111.79 -178.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.86 -16.9 66.76 Favored Glycine 0 N--CA 1.477 1.422 0 C-N-CA 124.638 1.113 . . . . 0.0 115.244 -171.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -77.15 -6.62 53.63 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.71 1.204 . . . . 0.0 114.14 171.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.07 20.0 54.22 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.862 1.22 . . . . 0.0 114.039 -178.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -133.34 158.75 42.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.205 1.402 . . . . 0.0 112.682 177.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.3 m -74.17 138.28 43.7 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.665 1.586 . . . . 0.0 112.465 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.65 -168.29 19.14 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.291 1.424 . . . . 0.0 113.305 175.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.468 0 O-C-N 121.251 -1.147 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.817 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.1 m -147.81 159.58 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 126.281 1.832 . . . . 0.0 108.637 178.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.6 t -91.4 116.57 66.71 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.963 172.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.82 152.12 77.76 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.833 2.355 . . . . 0.0 111.363 177.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.56 15.43 1.31 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -169.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.8 pt -79.37 149.55 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.238 1.415 . . . . 0.0 111.87 179.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.6 tp -95.9 94.53 7.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.5 1.12 . . . . 0.0 109.363 177.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -110.31 132.8 53.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.186 1.394 . . . . 0.0 111.153 -177.072 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -63.28 156.18 26.33 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.853 0.751 . . . . 0.0 112.102 174.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.3 p -158.95 152.79 23.27 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 175.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -97.23 -31.34 12.48 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.504 1.922 . . . . 0.0 110.602 169.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -168.19 173.64 7.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.363 2.665 . . . . 0.0 110.518 -175.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.38 -26.63 65.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.294 1.038 . . . . 0.0 113.222 -172.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -61.01 -21.6 63.74 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.458 1.503 . . . . 0.0 114.157 177.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -84.53 -16.96 40.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.016 0.926 . . . . 0.0 112.795 175.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.8 m -91.6 139.94 25.14 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 124.616 1.166 . . . . 0.0 114.054 -169.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -84.73 147.17 10.75 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.653 2.902 . . . . 0.0 112.42 -169.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.51 -121.27 26.07 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 177.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.03 6.37 49.01 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.759 1.224 . . . . 0.0 113.973 175.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.1 m -62.77 146.45 52.47 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.485 1.039 . . . . 0.0 112.169 177.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.65 156.26 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.313 1.845 . . . . 0.0 109.963 171.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.2 t -80.12 127.33 32.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.368 -0.832 . . . . 0.0 110.852 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -97.83 164.63 12.3 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.843 1.257 . . . . 0.0 111.48 -179.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.93 -19.94 63.95 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -169.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -79.87 -6.66 57.83 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 118.468 1.134 . . . . 0.0 113.861 174.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.21 23.5 22.01 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.115 1.341 . . . . 0.0 114.451 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -135.68 156.5 48.74 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.924 1.29 . . . . 0.0 112.832 178.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.6 m -74.04 140.6 45.5 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.775 1.63 . . . . 0.0 112.804 -177.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.36 -171.46 24.28 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 125.272 1.415 . . . . 0.0 113.398 176.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.522 0 O-C-N 121.3 -1.118 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.7 m -148.1 161.49 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.388 1.875 . . . . 0.0 108.56 178.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 40.7 t -91.01 117.32 67.82 Favored Pre-proline 0 CA--C 1.547 0.864 0 CA-C-O 118.19 -0.909 . . . . 0.0 109.845 170.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.28 168.43 22.24 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.023 2.482 . . . . 0.0 112.098 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -75.51 31.22 0.1 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 125.839 1.655 . . . . 0.0 113.522 -177.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.3 tt -80.92 156.17 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.396 1.878 . . . . 0.0 111.883 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.9 tp -122.69 85.84 2.48 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.998 1.319 . . . . 0.0 108.135 169.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -109.15 132.7 53.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.535 1.534 . . . . 0.0 110.6 -175.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -72.15 159.36 34.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.158 0.89 . . . . 0.0 111.48 177.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.8 p -161.76 158.05 25.18 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -174.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.56 -29.46 8.75 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.38 1.872 . . . . 0.0 110.475 168.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -159.81 177.52 10.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.552 1.941 . . . . 0.0 111.969 176.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -63.28 -26.7 68.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -169.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.0 p -69.69 -11.76 61.1 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 177.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -81.92 -14.88 55.51 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.088 0.955 . . . . 0.0 112.616 170.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.1 m -99.7 139.97 21.23 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.193 1.397 . . . . 0.0 113.49 -169.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -87.0 151.27 8.34 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.363 2.709 . . . . 0.0 112.375 -169.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.2 -122.57 29.89 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 178.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.62 7.75 45.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.579 1.152 . . . . 0.0 113.884 175.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.1 m -62.37 145.25 54.44 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.107 -0.996 . . . . 0.0 112.16 176.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.7 pt -120.02 155.21 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.467 1.907 . . . . 0.0 110.01 173.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -80.16 123.12 27.63 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.441 -0.787 . . . . 0.0 110.677 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -95.13 169.08 10.35 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.856 1.262 . . . . 0.0 111.783 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.61 67.05 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 124.54 1.067 . . . . 0.0 115.197 -172.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -78.17 -6.08 53.7 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.702 1.201 . . . . 0.0 114.211 171.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.21 15.57 60.46 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.081 1.324 . . . . 0.0 114.296 -178.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -127.28 156.19 42.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.841 1.257 . . . . 0.0 112.984 178.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -72.52 138.7 47.13 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.716 1.606 . . . . 0.0 112.252 -178.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.97 -169.16 23.85 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.085 1.326 . . . . 0.0 113.489 177.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.535 0 O-C-N 121.321 -1.105 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m -148.1 159.56 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 126.263 1.825 . . . . 0.0 108.543 178.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.1 t -90.27 117.21 67.86 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.871 172.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.17 152.27 79.96 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.765 2.31 . . . . 0.0 111.539 178.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.42 15.13 1.34 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -169.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.2 pt -79.16 149.17 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.279 1.432 . . . . 0.0 111.753 178.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.6 tp -95.04 92.0 6.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.343 1.057 . . . . 0.0 109.206 175.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -108.73 130.04 55.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.279 1.432 . . . . 0.0 110.635 -178.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -69.85 160.36 31.93 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.479 1.036 . . . . 0.0 112.539 172.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.7 p -158.21 151.96 23.66 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -176.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -88.1 -39.56 14.48 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.168 1.387 . . . . 0.0 111.386 169.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -165.4 179.62 6.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.429 2.291 . . . . 0.0 110.942 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.14 -29.66 69.91 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.509 1.123 . . . . 0.0 113.947 -170.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.7 p -66.91 -17.48 64.92 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.326 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -94.76 -1.73 52.36 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.168 1.387 . . . . 0.0 112.85 176.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.0 m -96.12 141.73 23.56 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.921 1.288 . . . . 0.0 112.936 177.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -83.61 146.5 12.05 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.538 2.826 . . . . 0.0 112.611 -169.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.88 -122.04 28.48 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 177.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.45 6.47 48.91 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.681 1.192 . . . . 0.0 114.007 175.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.7 m -62.47 145.47 54.08 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.373 0.988 . . . . 0.0 112.411 178.065 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.3 pt -114.45 155.57 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.37 1.868 . . . . 0.0 110.008 170.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.1 t -84.9 115.11 22.59 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.511 -0.743 . . . . 0.0 110.432 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -84.23 168.58 15.59 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.045 1.338 . . . . 0.0 111.726 -176.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.31 -17.76 66.56 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 124.503 1.049 . . . . 0.0 115.188 -173.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -78.37 -6.57 55.56 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.76 1.224 . . . . 0.0 114.195 171.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.84 17.33 58.27 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.994 1.283 . . . . 0.0 114.452 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.07 157.26 40.11 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.352 1.461 . . . . 0.0 112.363 177.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.5 m -74.95 139.82 43.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.861 1.664 . . . . 0.0 112.573 -178.035 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.89 -168.82 24.34 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.104 1.335 . . . . 0.0 113.377 177.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.433 0 O-C-N 121.276 -1.132 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.756 0 N-CA-C 112.555 -0.218 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p -163.58 149.85 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.706 1.603 . . . . 0.0 109.305 -178.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.0 t -91.38 118.83 68.67 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.401 174.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.78 141.89 55.86 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.65 2.233 . . . . 0.0 110.558 172.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -82.14 30.25 0.4 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.629 1.172 . . . . 0.0 113.91 -169.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt -78.98 150.36 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.621 1.569 . . . . 0.0 111.671 177.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.0 tp -92.67 86.71 5.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.086 0.954 . . . . 0.0 109.164 174.256 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -109.33 128.09 54.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.665 1.586 . . . . 0.0 110.895 -176.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -63.66 154.07 34.11 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.931 0.787 . . . . 0.0 112.354 178.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.9 p -159.46 162.02 35.55 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 175.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -115.49 -23.05 8.99 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.619 1.968 . . . . 0.0 110.703 168.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -161.91 169.75 20.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.681 1.993 . . . . 0.0 112.376 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -63.32 -27.11 69.1 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -169.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.7 p -71.35 -10.59 60.01 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 177.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -79.77 -18.51 50.85 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.208 -0.932 . . . . 0.0 112.108 169.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.3 m -98.91 138.74 20.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.388 1.475 . . . . 0.0 113.616 -169.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -87.53 152.89 7.7 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.755 2.97 . . . . 0.0 112.49 -169.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -120.63 23.48 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 176.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.03 5.38 50.5 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.474 1.11 . . . . 0.0 113.923 175.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.0 m -64.24 143.44 57.89 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.516 1.053 . . . . 0.0 112.166 179.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.0 pt -116.72 157.72 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.522 1.929 . . . . 0.0 109.973 171.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.7 t -81.72 117.96 22.46 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.394 -0.816 . . . . 0.0 110.585 178.073 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -87.74 167.52 13.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.889 1.276 . . . . 0.0 111.682 -177.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.29 -17.48 66.2 Favored Glycine 0 N--CA 1.478 1.456 0 C-N-CA 124.519 1.057 . . . . 0.0 115.25 -172.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -77.23 -8.56 57.79 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 171.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.81 21.38 43.27 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.937 1.256 . . . . 0.0 114.201 -178.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -132.9 156.84 46.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.082 1.353 . . . . 0.0 112.26 177.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.6 m -70.85 142.35 51.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.166 1.386 . . . . 0.0 112.311 -178.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.23 -167.81 28.46 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.787 1.184 . . . . 0.0 113.609 177.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.537 0 O-C-N 121.315 -1.109 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.843 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 p -163.75 149.17 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.777 1.631 . . . . 0.0 109.143 -179.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 t -90.63 120.04 68.94 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.312 173.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.72 145.66 48.28 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 124.092 3.195 . . . . 0.0 113.292 173.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -89.86 11.85 19.04 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 pp -79.67 167.3 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.629 1.572 . . . . 0.0 112.188 172.068 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.2 tp -108.22 100.09 9.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.91 1.284 . . . . 0.0 109.831 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -113.01 131.7 55.67 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.278 1.431 . . . . 0.0 111.01 -179.296 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -71.76 161.62 30.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.116 0.871 . . . . 0.0 111.273 173.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.9 p -160.13 151.38 19.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -175.042 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.8 ttt180 -88.97 -38.21 14.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.348 1.459 . . . . 0.0 111.293 169.281 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -164.88 178.49 7.12 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.359 2.264 . . . . 0.0 111.028 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -58.88 -30.67 67.92 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.69 1.196 . . . . 0.0 113.429 -173.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -60.67 -21.15 62.5 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.961 1.304 . . . . 0.0 113.833 177.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -97.9 0.2 46.14 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.251 1.42 . . . . 0.0 113.038 179.481 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.5 m -97.47 141.09 22.48 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.042 1.337 . . . . 0.0 113.07 178.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.43 148.13 11.37 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.49 2.793 . . . . 0.0 112.607 -169.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.7 -124.05 34.55 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 179.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.88 7.66 45.25 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.719 1.208 . . . . 0.0 114.052 175.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.2 m -62.35 145.52 53.67 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.15 -0.969 . . . . 0.0 112.517 178.057 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -115.25 154.6 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.363 1.865 . . . . 0.0 110.098 170.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.0 t -84.13 112.72 20.5 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.478 -0.764 . . . . 0.0 110.328 179.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -81.48 168.69 18.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.994 1.317 . . . . 0.0 111.717 -177.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.24 -17.84 66.51 Favored Glycine 0 N--CA 1.478 1.457 0 C-N-CA 124.572 1.082 . . . . 0.0 115.143 -172.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -78.27 -6.36 54.74 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.754 1.222 . . . . 0.0 114.212 171.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.62 16.4 58.53 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.036 1.303 . . . . 0.0 114.379 -178.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -126.51 154.99 43.03 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.919 1.287 . . . . 0.0 113.184 178.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 81.8 m -73.6 137.19 44.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.349 1.46 . . . . 0.0 112.384 -177.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.49 -167.42 21.91 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.048 1.309 . . . . 0.0 113.347 178.037 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.449 0 O-C-N 121.224 -1.162 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m -148.38 159.6 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.372 1.869 . . . . 0.0 108.448 178.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.9 t -89.92 118.64 69.09 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.058 171.577 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -62.4 165.18 15.82 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.203 2.602 . . . . 0.0 113.235 177.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.39 21.93 0.59 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.038 1.335 . . . . 0.0 114.527 -171.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.25 168.18 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.082 1.353 . . . . 0.0 112.989 -177.018 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.9 tp -125.59 86.04 2.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.105 1.362 . . . . 0.0 107.885 169.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -106.97 130.19 54.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.34 1.456 . . . . 0.0 110.393 -175.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -71.01 158.44 36.51 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.109 0.868 . . . . 0.0 111.262 177.022 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.5 p -160.97 157.24 26.05 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -107.71 -28.13 9.88 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.715 2.006 . . . . 0.0 110.116 168.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 -160.13 172.46 17.41 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.362 1.865 . . . . 0.0 112.486 179.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -61.2 -27.36 68.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.211 1.004 . . . . 0.0 113.02 -172.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -63.42 -17.34 62.56 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.091 1.357 . . . . 0.0 113.949 177.021 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -82.01 -20.81 37.66 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.161 0.984 . . . . 0.0 112.636 173.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.8 m -92.14 139.54 24.31 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.158 1.383 . . . . 0.0 114.202 -168.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -86.26 151.21 9.32 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.356 2.704 . . . . 0.0 112.229 -170.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.96 -125.48 38.28 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.13 10.45 39.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.574 1.15 . . . . 0.0 113.874 174.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.31 145.56 51.01 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.13 -0.981 . . . . 0.0 112.064 174.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.02 153.61 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.278 1.831 . . . . 0.0 110.062 173.876 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.8 t -78.09 124.39 27.99 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.502 -0.749 . . . . 0.0 110.546 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -98.13 169.36 9.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.774 1.23 . . . . 0.0 111.782 -176.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.55 -17.68 67.0 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 124.58 1.086 . . . . 0.0 115.223 -172.571 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -78.09 -6.35 54.38 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.686 1.194 . . . . 0.0 114.21 171.54 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.41 16.26 59.09 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.063 1.316 . . . . 0.0 114.315 -178.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -128.24 156.12 43.47 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.971 1.309 . . . . 0.0 113.081 178.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.3 m -72.12 136.89 46.67 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.535 1.534 . . . . 0.0 112.075 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.33 -169.46 21.14 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.205 1.383 . . . . 0.0 113.063 177.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.555 0 O-C-N 121.4 -1.059 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.788 0 N-CA-C 112.432 -0.267 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.1 m -148.0 163.26 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 126.393 1.877 . . . . 0.0 108.732 179.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.0 t -95.69 117.02 66.67 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.342 -0.837 . . . . 0.0 109.761 169.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.64 172.23 16.18 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.124 2.55 . . . . 0.0 112.404 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -72.22 25.5 0.05 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.53 1.932 . . . . 0.0 115.476 -175.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.2 pt -77.69 170.31 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.313 1.845 . . . . 0.0 112.764 -177.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.5 tp -136.86 88.05 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.24 1.416 . . . . 0.0 108.467 169.606 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -108.94 133.68 52.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.529 1.532 . . . . 0.0 110.859 -175.712 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -63.58 154.89 31.24 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.996 0.816 . . . . 0.0 112.248 175.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.8 p -159.38 156.91 29.33 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 176.176 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -107.15 -32.35 7.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.819 2.048 . . . . 0.0 110.141 168.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -158.03 176.64 12.26 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.227 1.811 . . . . 0.0 112.054 176.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -63.09 -26.71 68.96 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.4 p -69.56 -12.29 61.52 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -78.87 -21.58 47.3 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.409 -0.807 . . . . 0.0 112.283 169.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.5 m -94.85 134.17 25.37 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.976 1.31 . . . . 0.0 113.33 -169.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -88.47 160.01 6.64 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.423 2.749 . . . . 0.0 112.131 -170.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.15 -125.04 35.23 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 178.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.45 7.96 45.49 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.355 1.062 . . . . 0.0 113.686 173.425 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -63.78 146.53 53.72 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.162 -0.961 . . . . 0.0 112.371 177.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 pt -123.37 155.82 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.81 2.044 . . . . 0.0 109.616 174.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.4 t -78.69 131.27 36.57 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.19 -0.943 . . . . 0.0 110.776 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.44 168.06 9.33 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.696 1.198 . . . . 0.0 111.86 -178.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.88 -16.65 66.46 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.638 1.113 . . . . 0.0 115.327 -171.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -76.63 -7.07 54.54 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.723 1.209 . . . . 0.0 114.138 170.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.4 20.11 52.91 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.008 1.29 . . . . 0.0 114.09 -178.287 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -133.47 158.06 44.05 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.149 1.38 . . . . 0.0 112.807 178.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -73.6 136.05 43.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.747 1.619 . . . . 0.0 112.319 -178.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.53 -172.09 20.69 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.421 1.486 . . . . 0.0 113.393 176.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 O-C-N 121.22 -1.165 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.792 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.5 m -148.32 161.32 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.306 1.842 . . . . 0.0 108.584 178.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.1 t -90.86 117.84 68.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.865 170.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.36 167.6 24.74 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.949 2.433 . . . . 0.0 111.849 178.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -76.11 33.24 0.12 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.632 1.573 . . . . 0.0 113.246 -177.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.0 tt -79.89 154.54 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.189 1.796 . . . . 0.0 111.699 178.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.1 tp -120.65 86.06 2.5 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.915 1.286 . . . . 0.0 108.038 169.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -108.14 132.83 53.19 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.293 1.437 . . . . 0.0 110.737 -176.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.58 153.66 31.34 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.937 0.79 . . . . 0.0 111.812 175.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.9 p -159.64 158.27 31.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 176.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -113.8 -22.97 9.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.658 1.983 . . . . 0.0 110.814 168.487 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -161.83 171.24 18.1 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.607 1.963 . . . . 0.0 112.178 177.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -61.97 -27.04 68.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.03 0.932 . . . . 0.0 113.121 -171.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -62.86 -18.12 62.48 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.035 1.334 . . . . 0.0 113.982 176.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -80.78 -20.94 41.51 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.142 0.977 . . . . 0.0 112.564 174.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.8 m -92.71 138.8 23.51 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.04 1.336 . . . . 0.0 114.477 -168.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -87.07 153.29 8.3 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.436 2.757 . . . . 0.0 112.222 -170.366 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -123.63 32.89 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.22 8.89 44.16 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.506 1.122 . . . . 0.0 113.887 174.192 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 80.8 m -62.55 146.8 50.92 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.066 -1.021 . . . . 0.0 112.187 176.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.8 pt -122.3 155.32 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 126.543 1.937 . . . . 0.0 109.824 174.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.0 t -77.68 130.6 37.02 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.203 -0.936 . . . . 0.0 110.763 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.45 167.6 9.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.717 1.207 . . . . 0.0 111.916 -178.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.06 -16.47 66.59 Favored Glycine 0 N--CA 1.477 1.381 0 C-N-CA 124.732 1.158 . . . . 0.0 115.373 -171.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -76.32 -7.01 54.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.696 1.198 . . . . 0.0 114.107 170.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.55 19.32 54.88 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.016 1.294 . . . . 0.0 114.0 -178.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -133.71 158.7 42.62 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.255 1.422 . . . . 0.0 112.695 178.193 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.7 m -73.06 138.78 46.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.565 1.546 . . . . 0.0 112.424 -179.113 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.94 -170.3 21.12 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.257 1.408 . . . . 0.0 113.433 176.044 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.516 0 O-C-N 121.257 -1.143 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.736 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -163.51 150.37 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.718 1.607 . . . . 0.0 109.164 -179.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.2 t -86.72 115.66 63.19 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.016 173.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -67.98 160.47 48.42 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.78 2.32 . . . . 0.0 112.054 178.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.93 16.03 0.17 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -172.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 tp -75.12 144.67 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.895 1.678 . . . . 0.0 111.746 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.5 tp -102.94 88.37 3.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.749 1.22 . . . . 0.0 108.328 169.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -108.63 129.78 55.33 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.256 1.422 . . . . 0.0 110.413 -177.274 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.28 157.75 34.89 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.391 0.996 . . . . 0.0 112.109 172.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -157.22 151.49 25.0 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -174.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -91.13 -35.7 14.41 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.192 1.397 . . . . 0.0 111.505 169.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -164.75 177.35 8.04 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.198 2.199 . . . . 0.0 111.277 179.277 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -59.67 -30.54 68.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.703 1.201 . . . . 0.0 113.467 -173.012 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 m -60.91 -20.69 62.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.909 1.284 . . . . 0.0 113.735 177.335 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -97.21 0.83 48.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.374 1.47 . . . . 0.0 112.988 179.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.7 m -98.98 141.1 22.3 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.074 1.35 . . . . 0.0 113.2 178.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -84.68 149.42 11.25 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.5 2.8 . . . . 0.0 112.589 -169.342 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.34 -124.0 33.77 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.3 10.48 40.58 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.675 1.19 . . . . 0.0 113.745 174.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.2 m -61.51 145.57 51.47 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.099 -1.0 . . . . 0.0 112.52 176.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.1 pt -116.19 154.89 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.448 1.899 . . . . 0.0 110.054 172.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.2 t -83.52 116.43 22.56 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.588 -0.695 . . . . 0.0 110.517 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -87.05 168.72 13.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.041 1.337 . . . . 0.0 111.752 -176.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -17.58 67.11 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 124.602 1.096 . . . . 0.0 115.193 -173.316 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -78.27 -6.34 54.69 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.732 1.213 . . . . 0.0 114.149 171.744 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.08 16.16 59.79 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.028 1.299 . . . . 0.0 114.404 -179.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -126.54 157.78 37.89 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.407 1.483 . . . . 0.0 112.397 177.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.9 m -73.84 140.3 45.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.962 1.705 . . . . 0.0 112.481 -179.532 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.53 -167.33 23.83 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.164 1.364 . . . . 0.0 113.431 177.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.49 0 O-C-N 121.265 -1.138 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.5 t -94.53 118.19 66.94 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.22 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.19 150.95 54.29 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.59 2.86 . . . . 0.0 113.232 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -77.89 17.92 0.53 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.122 1.369 . . . . 0.0 114.226 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.0 pt -79.12 159.71 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.983 1.713 . . . . 0.0 112.341 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.4 tp -105.56 87.55 2.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.676 1.191 . . . . 0.0 108.935 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -107.95 127.08 53.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.259 1.424 . . . . 0.0 110.704 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -70.59 159.13 34.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.25 0.932 . . . . 0.0 112.744 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.3 p -159.51 153.18 22.8 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -96.25 -30.01 13.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.24 1.816 . . . . 0.0 110.837 169.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.2 ptm85 -169.21 173.23 6.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.327 2.651 . . . . 0.0 110.67 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.81 -26.81 66.06 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.314 1.046 . . . . 0.0 113.252 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 m -62.99 -18.59 63.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.083 1.353 . . . . 0.0 114.049 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -86.47 -10.55 53.95 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.169 0.988 . . . . 0.0 112.923 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.3 m -101.87 136.34 19.54 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.825 1.25 . . . . 0.0 113.265 -171.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -88.73 155.08 6.17 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.428 2.752 . . . . 0.0 112.559 -169.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.72 -123.14 30.99 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.86 5.89 50.2 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.526 1.13 . . . . 0.0 113.883 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.9 m -64.0 144.9 56.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.408 1.004 . . . . 0.0 112.228 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.3 pt -120.06 155.69 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.42 1.888 . . . . 0.0 109.8 171.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.4 t -79.64 126.27 30.69 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.348 -0.845 . . . . 0.0 110.674 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -97.94 168.26 10.4 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.801 1.24 . . . . 0.0 111.756 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.45 -17.62 66.71 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 124.585 1.088 . . . . 0.0 115.218 -171.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -77.49 -7.84 56.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.714 1.206 . . . . 0.0 114.21 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.0 19.06 52.64 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.123 1.344 . . . . 0.0 114.263 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -129.98 156.22 44.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.323 1.449 . . . . 0.0 112.35 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.5 m -73.08 138.29 45.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.009 1.723 . . . . 0.0 112.203 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.95 0 C-N-CA 125.042 1.306 . . . . 0.0 113.556 177.305 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.8 t -90.48 117.33 67.91 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.104 172.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -62.11 160.57 29.73 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.149 2.566 . . . . 0.0 112.721 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -77.36 32.04 0.15 Allowed 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.263 1.425 . . . . 0.0 113.65 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 pp -80.33 174.05 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.353 1.861 . . . . 0.0 112.853 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.8 tp -136.48 86.75 2.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.292 1.437 . . . . 0.0 108.325 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -109.4 133.03 53.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.511 1.524 . . . . 0.0 110.287 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -70.98 160.01 33.68 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.329 0.968 . . . . 0.0 111.221 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.6 p -160.32 152.27 20.18 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -94.42 -34.59 12.69 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.198 1.799 . . . . 0.0 110.433 169.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -166.77 178.06 6.12 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.233 2.613 . . . . 0.0 110.449 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -61.1 -26.9 67.98 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.1 p -69.64 -13.15 62.16 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -82.08 -18.43 43.1 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.018 0.826 . . . . 0.0 112.593 170.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.6 m -91.66 139.9 25.05 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.697 1.199 . . . . 0.0 113.766 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -85.7 150.13 9.97 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.439 2.759 . . . . 0.0 112.437 -169.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.56 -123.52 32.18 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.35 9.83 42.17 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.646 1.178 . . . . 0.0 113.832 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 91.2 m -61.62 145.71 51.29 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.071 -1.018 . . . . 0.0 112.31 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.2 pt -120.43 154.57 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.398 1.879 . . . . 0.0 110.006 174.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.9 t -80.68 123.87 28.54 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.385 -0.822 . . . . 0.0 110.626 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -95.76 169.97 9.64 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.891 1.277 . . . . 0.0 111.734 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.47 -17.88 67.05 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.574 1.083 . . . . 0.0 115.224 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -78.25 -6.09 53.91 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.839 1.256 . . . . 0.0 114.212 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.0 15.75 60.56 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.082 1.325 . . . . 0.0 114.281 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -127.33 156.53 41.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.975 1.31 . . . . 0.0 113.099 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.2 m -74.02 137.3 43.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.753 1.621 . . . . 0.0 112.466 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 C-N-CA 125.225 1.393 . . . . 0.0 113.366 177.162 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.5 t -90.59 116.16 65.79 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.182 173.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.1 154.46 72.45 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.947 2.432 . . . . 0.0 111.735 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -83.25 14.97 3.15 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -169.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.2 pt -79.18 151.73 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.5 1.52 . . . . 0.0 112.279 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.4 tp -89.47 89.38 7.83 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.322 1.049 . . . . 0.0 109.249 174.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -109.71 122.5 47.62 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.704 1.601 . . . . 0.0 109.61 -173.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -73.14 160.09 32.53 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.169 -0.957 . . . . 0.0 112.095 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.5 p -161.78 153.49 18.94 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -96.31 -32.95 12.14 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.993 1.717 . . . . 0.0 110.34 169.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.7 ptt-85 -165.85 177.32 7.24 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 128.417 2.687 . . . . 0.0 110.437 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -59.33 -27.29 65.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.334 1.054 . . . . 0.0 113.496 -172.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.7 m -60.01 -22.4 62.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.094 1.358 . . . . 0.0 114.067 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -88.56 -10.32 49.21 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.196 0.998 . . . . 0.0 113.085 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.2 m -93.79 140.14 22.93 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -84.43 147.47 11.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.548 2.832 . . . . 0.0 112.317 -169.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.88 -122.03 28.44 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.903 -0.498 . . . . 0.0 111.916 177.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.54 6.0 50.09 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.746 1.218 . . . . 0.0 114.03 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.0 m -63.76 149.62 46.38 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.173 -0.954 . . . . 0.0 113.109 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.9 pt -117.4 157.1 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.605 1.962 . . . . 0.0 110.107 169.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.8 t -84.18 119.93 25.59 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.439 -0.788 . . . . 0.0 110.911 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -88.28 168.09 13.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.651 1.18 . . . . 0.0 111.519 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -16.72 66.04 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.587 1.089 . . . . 0.0 115.297 -172.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -78.06 -7.07 56.47 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 172.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.82 16.94 57.45 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.851 1.215 . . . . 0.0 114.225 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -129.88 156.52 44.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.049 1.34 . . . . 0.0 112.763 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.9 m -76.43 144.0 40.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.164 1.386 . . . . 0.0 113.016 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.917 0 C-N-CA 125.158 1.361 . . . . 0.0 113.444 177.06 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.4 t -92.57 116.03 65.8 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.261 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 147.2 63.78 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.666 2.244 . . . . 0.0 111.101 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -80.92 17.64 1.16 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.869 1.268 . . . . 0.0 114.379 -171.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.9 pt -75.79 152.91 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.532 1.533 . . . . 0.0 112.231 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.2 tp -88.14 87.35 7.29 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.303 1.041 . . . . 0.0 109.506 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -109.56 121.03 44.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.76 1.624 . . . . 0.0 109.527 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -73.56 159.21 33.47 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.208 -0.932 . . . . 0.0 112.289 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.1 p -161.54 156.21 23.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.18 -32.5 9.11 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.572 1.949 . . . . 0.0 109.686 168.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -159.62 177.1 11.24 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.232 2.213 . . . . 0.0 111.295 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -60.67 -26.78 67.34 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.455 1.102 . . . . 0.0 113.496 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.8 m -60.02 -21.16 61.0 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.02 1.328 . . . . 0.0 113.928 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -86.65 -13.84 44.41 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.237 1.015 . . . . 0.0 113.097 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.1 m -92.35 140.13 24.18 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.46 147.48 11.19 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.573 2.848 . . . . 0.0 112.301 -169.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.96 -121.59 27.05 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.76 5.85 50.34 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.697 1.199 . . . . 0.0 113.964 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.1 m -63.77 150.32 44.85 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.108 -0.995 . . . . 0.0 113.134 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.0 155.68 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.636 1.974 . . . . 0.0 109.941 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.6 t -78.8 131.99 36.71 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.18 -0.95 . . . . 0.0 110.642 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -104.25 167.64 9.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.596 1.158 . . . . 0.0 111.765 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.74 -16.89 66.48 Favored Glycine 0 N--CA 1.477 1.403 0 C-N-CA 124.712 1.149 . . . . 0.0 115.362 -170.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -76.83 -8.06 56.63 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 171.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.4 15.98 56.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.09 1.329 . . . . 0.0 114.2 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -130.98 157.44 42.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.03 1.332 . . . . 0.0 112.631 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.9 m -76.02 141.47 42.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.201 1.4 . . . . 0.0 112.89 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.994 0 C-N-CA 125.417 1.484 . . . . 0.0 113.437 176.357 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.6 t -93.65 116.72 66.85 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.176 173.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.21 150.11 71.2 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.785 2.324 . . . . 0.0 111.591 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -77.29 13.43 1.17 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -171.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 pt -78.21 151.59 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.539 1.536 . . . . 0.0 112.301 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.4 tp -89.3 88.45 7.5 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.384 1.074 . . . . 0.0 109.407 175.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -109.66 121.97 46.42 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.783 1.633 . . . . 0.0 109.562 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -73.6 159.33 33.25 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.131 -0.98 . . . . 0.0 112.312 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.2 p -163.74 161.86 23.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -112.99 -32.29 6.41 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.505 1.922 . . . . 0.0 110.299 168.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.429 ' HG3' ' H ' ' A' ' 13' ' ' ASP . 1.1 tpm_? -155.33 175.36 13.96 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.141 1.776 . . . . 0.0 111.057 175.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.429 ' H ' ' HG3' ' A' ' 12' ' ' ARG . 22.5 m-20 -61.97 -26.88 68.47 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.165 1.386 . . . . 0.0 113.439 -169.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.2 m -63.36 -18.79 64.04 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.758 1.223 . . . . 0.0 113.499 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -84.67 -13.83 50.32 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.284 1.034 . . . . 0.0 112.901 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.6 m -95.17 141.54 23.38 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.701 1.201 . . . . 0.0 114.18 -169.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -84.39 146.35 10.97 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.585 2.856 . . . . 0.0 112.262 -169.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.84 -122.69 30.53 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.84 5.97 50.34 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.793 1.237 . . . . 0.0 113.986 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.4 m -62.99 149.03 45.91 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.227 -0.921 . . . . 0.0 113.04 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.6 pt -117.86 155.97 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.458 1.903 . . . . 0.0 110.338 170.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 t -82.97 122.71 28.64 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.374 -0.829 . . . . 0.0 111.021 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -93.46 168.13 11.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.7 1.2 . . . . 0.0 111.74 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.7 -17.22 66.8 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.631 1.11 . . . . 0.0 115.294 -171.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -77.7 -7.39 56.42 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 172.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.18 16.99 56.75 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.982 1.277 . . . . 0.0 114.221 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -130.63 157.16 43.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.974 1.309 . . . . 0.0 112.632 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.5 m -76.08 143.51 41.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.185 1.394 . . . . 0.0 112.849 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.998 0 C-N-CA 125.127 1.346 . . . . 0.0 113.422 177.908 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.4 t -89.41 118.38 69.04 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.209 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -58.8 161.25 15.66 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.472 2.782 . . . . 0.0 113.467 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -78.58 17.91 0.63 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.865 1.266 . . . . 0.0 113.355 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 tp -76.1 148.59 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 126.124 1.77 . . . . 0.0 112.076 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.1 tp -106.2 86.55 2.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.763 1.225 . . . . 0.0 108.101 169.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -107.15 131.63 53.93 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.123 1.369 . . . . 0.0 110.442 -176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -70.56 160.76 31.9 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.059 0.845 . . . . 0.0 111.089 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -160.21 150.76 18.61 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -93.3 -35.67 12.95 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.406 1.882 . . . . 0.0 110.428 169.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -165.04 -179.85 5.96 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.399 2.68 . . . . 0.0 110.198 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -59.72 -26.03 65.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.318 1.047 . . . . 0.0 113.645 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 m -59.46 -22.76 62.01 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.375 1.47 . . . . 0.0 114.176 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -84.47 -17.3 39.57 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.896 0.878 . . . . 0.0 113.004 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.6 m -91.21 138.09 25.94 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -169.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -87.15 151.53 8.15 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.406 2.737 . . . . 0.0 112.441 -169.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.56 -125.07 36.27 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.57 9.36 41.73 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.578 1.151 . . . . 0.0 113.862 174.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.2 m -62.35 146.93 49.91 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.104 -0.997 . . . . 0.0 112.256 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.94 154.53 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.442 1.897 . . . . 0.0 109.823 172.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -78.38 129.86 35.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.336 -0.852 . . . . 0.0 110.525 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -103.29 169.81 8.33 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.644 1.178 . . . . 0.0 111.854 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.52 -17.71 66.96 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.695 1.14 . . . . 0.0 115.297 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -77.28 -6.7 54.12 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.751 1.22 . . . . 0.0 114.131 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.11 15.77 60.34 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.19 1.376 . . . . 0.0 114.201 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -127.95 156.86 42.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.074 1.35 . . . . 0.0 113.098 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.4 m -73.8 136.21 43.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.711 1.605 . . . . 0.0 112.468 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.96 0 C-N-CA 125.332 1.444 . . . . 0.0 113.452 176.785 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 48.7 t -84.11 117.77 69.55 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.337 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.88 175.58 10.18 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.517 2.811 . . . . 0.0 112.337 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -76.44 35.26 0.14 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.026 1.731 . . . . 0.0 113.635 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.3 pt -80.35 170.82 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.459 1.904 . . . . 0.0 112.185 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.4 tp -143.86 91.03 2.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.969 1.308 . . . . 0.0 109.372 173.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -112.33 136.85 51.27 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.672 1.589 . . . . 0.0 111.041 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -63.94 155.72 29.99 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 118.844 0.747 . . . . 0.0 111.597 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.0 p -159.83 155.15 25.28 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -98.46 -36.19 10.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.443 1.897 . . . . 0.0 110.485 169.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.431 ' HG3' ' H ' ' A' ' 13' ' ' ASP . 1.5 tpm_? -163.16 175.53 10.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.937 2.495 . . . . 0.0 109.442 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 12' ' ' ARG . 24.3 m-20 -60.6 -26.4 66.96 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.397 1.479 . . . . 0.0 113.523 -169.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.5 m -62.54 -20.44 64.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.867 1.267 . . . . 0.0 113.781 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -83.07 -14.25 54.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.723 0.809 . . . . 0.0 113.023 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.3 m -99.03 137.38 20.46 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.046 1.338 . . . . 0.0 113.014 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -86.65 150.93 8.79 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.834 2.356 . . . . 0.0 112.015 -170.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.56 -123.3 32.46 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.34 0.495 . . . . 0.0 112.168 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.17 1.83 56.97 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.689 1.196 . . . . 0.0 114.085 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.8 m -64.2 143.42 57.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.375 0.989 . . . . 0.0 112.376 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.6 pt -120.76 155.86 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.34 1.856 . . . . 0.0 110.132 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.0 t -83.1 116.27 22.25 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.505 -0.747 . . . . 0.0 110.886 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -86.88 169.2 12.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.935 1.294 . . . . 0.0 111.777 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.48 -17.26 66.35 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 124.565 1.079 . . . . 0.0 115.21 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -77.64 -6.6 54.39 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.777 1.231 . . . . 0.0 114.2 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.39 20.46 54.58 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.867 1.223 . . . . 0.0 114.17 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -131.93 157.99 42.59 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.003 1.321 . . . . 0.0 112.865 177.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 75.3 m -73.6 136.77 43.96 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.595 1.558 . . . . 0.0 112.514 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.933 0 C-N-CA 125.257 1.408 . . . . 0.0 113.366 177.816 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.9 t -90.59 117.86 68.28 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.322 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.32 146.06 52.71 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.875 3.05 . . . . 0.0 113.286 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -78.41 10.49 3.07 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -170.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.4 pt -79.45 154.05 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.333 1.453 . . . . 0.0 112.114 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.34 93.6 6.59 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.508 1.123 . . . . 0.0 108.805 171.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -108.22 133.63 52.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.3 1.44 . . . . 0.0 111.196 -175.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -62.24 153.74 29.66 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.946 0.794 . . . . 0.0 112.269 171.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -160.42 167.02 28.23 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -128.02 -9.94 5.39 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.242 1.417 . . . . 0.0 112.922 169.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 ptm85 -167.01 166.16 15.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.085 2.154 . . . . 0.0 111.987 173.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -61.37 -30.47 70.55 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.565 1.146 . . . . 0.0 112.85 -171.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 m -62.72 -19.14 63.63 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.098 1.359 . . . . 0.0 113.617 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -95.57 -2.57 48.15 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.288 1.435 . . . . 0.0 112.904 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.3 m -97.64 140.42 21.97 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.063 1.345 . . . . 0.0 112.947 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -83.39 148.52 12.93 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.422 2.748 . . . . 0.0 112.559 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.28 -123.55 33.3 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.669 -0.573 . . . . 0.0 111.669 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.93 8.61 43.18 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.703 1.201 . . . . 0.0 113.917 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.2 m -62.38 145.71 53.23 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.439 1.018 . . . . 0.0 112.151 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.8 pt -115.32 154.75 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.198 1.799 . . . . 0.0 110.198 172.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.0 t -82.65 123.54 29.35 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.457 -0.777 . . . . 0.0 110.635 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.44 167.07 11.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.737 1.215 . . . . 0.0 111.761 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.23 66.6 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 124.572 1.082 . . . . 0.0 115.269 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -77.7 -6.41 53.83 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 171.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.44 22.64 46.71 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.872 1.225 . . . . 0.0 113.978 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -132.77 156.36 47.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.216 1.406 . . . . 0.0 112.747 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.8 m -73.82 140.67 45.96 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 112.363 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.015 0 C-N-CA 125.194 1.378 . . . . 0.0 113.395 176.766 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.9 t -90.03 114.0 59.24 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 118.177 -0.916 . . . . 0.0 109.985 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.95 160.89 47.94 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.942 2.428 . . . . 0.0 111.872 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -79.62 18.58 0.73 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.082 1.353 . . . . 0.0 114.246 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.4 mt -79.01 138.15 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.709 1.604 . . . . 0.0 109.921 -176.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.5 tp -84.07 84.83 7.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.16 0.984 . . . . 0.0 108.701 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -107.01 123.42 48.17 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.906 1.682 . . . . 0.0 109.484 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -72.22 159.28 34.36 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.075 -1.016 . . . . 0.0 111.982 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.2 p -162.27 158.46 24.31 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -112.37 -26.71 8.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.265 1.826 . . . . 0.0 110.658 168.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.3 175.97 12.73 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.91 2.084 . . . . 0.0 111.37 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -60.91 -27.19 68.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.966 0.907 . . . . 0.0 113.265 -171.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -62.86 -18.06 62.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.178 1.391 . . . . 0.0 113.881 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.7 -14.2 46.13 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.349 1.059 . . . . 0.0 112.881 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.7 m -93.43 141.36 23.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -83.81 146.35 11.74 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.442 2.762 . . . . 0.0 112.129 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.8 -121.8 27.73 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.79 7.33 46.84 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.792 1.237 . . . . 0.0 113.907 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.2 m -63.19 150.88 41.87 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.127 -0.983 . . . . 0.0 113.023 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.2 pt -119.35 154.76 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.542 1.937 . . . . 0.0 110.162 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.9 t -79.1 132.53 36.62 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.145 -0.972 . . . . 0.0 110.849 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -105.26 167.12 9.94 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.624 1.169 . . . . 0.0 111.798 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.03 -16.51 66.58 Favored Glycine 0 N--CA 1.478 1.478 0 C-N-CA 124.649 1.119 . . . . 0.0 115.433 -170.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -76.8 -6.97 54.47 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.21 58.98 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.043 1.306 . . . . 0.0 114.154 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -130.38 157.49 42.45 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.99 1.316 . . . . 0.0 112.741 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.0 m -76.48 141.51 41.27 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.265 1.426 . . . . 0.0 112.729 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.922 0 C-N-CA 125.637 1.589 . . . . 0.0 113.375 176.071 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.2 t -92.75 115.94 65.69 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.33 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.68 145.94 59.16 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.691 2.261 . . . . 0.0 110.975 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -80.82 18.06 1.06 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.825 1.25 . . . . 0.0 114.254 -171.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 pt -75.02 153.38 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.591 1.556 . . . . 0.0 112.235 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.7 tp -87.71 86.66 7.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.279 1.032 . . . . 0.0 109.586 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -109.16 120.41 42.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.843 1.657 . . . . 0.0 109.454 -175.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -72.75 159.29 34.04 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.23 -0.919 . . . . 0.0 112.284 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.4 p -162.37 156.22 21.06 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.93 -31.85 9.05 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.546 1.938 . . . . 0.0 109.726 168.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 ptm85 -161.06 174.65 13.42 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.285 2.234 . . . . 0.0 111.428 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -60.97 -26.6 67.67 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.461 1.104 . . . . 0.0 113.93 -169.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 t -66.03 -14.85 62.4 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -86.16 -14.41 44.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.041 0.937 . . . . 0.0 112.836 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -92.74 140.62 23.79 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.41 147.3 11.21 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.619 2.88 . . . . 0.0 112.314 -169.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.01 -121.56 26.92 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.62 5.77 50.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.691 1.196 . . . . 0.0 114.005 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.3 m -63.91 150.34 45.22 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.19 -0.944 . . . . 0.0 113.146 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.2 pt -119.48 155.9 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.704 2.002 . . . . 0.0 109.913 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.5 t -78.97 132.23 36.61 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.986 -1.071 . . . . 0.0 110.68 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -104.35 167.26 9.86 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.645 1.178 . . . . 0.0 111.775 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -16.77 66.41 Favored Glycine 0 N--CA 1.477 1.393 0 C-N-CA 124.713 1.149 . . . . 0.0 115.4 -170.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -76.69 -8.1 56.62 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.5 16.16 55.65 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.133 1.349 . . . . 0.0 114.13 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -131.4 157.23 43.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.918 1.287 . . . . 0.0 112.679 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.7 m -75.82 141.65 42.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.278 1.431 . . . . 0.0 112.808 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.938 0 C-N-CA 125.375 1.464 . . . . 0.0 113.394 176.317 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.8 t -87.4 115.91 64.35 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 118.15 -0.929 . . . . 0.0 109.984 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.45 151.34 80.25 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.69 2.26 . . . . 0.0 111.609 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -75.77 12.62 1.01 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -170.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.1 pt -79.35 148.52 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.397 1.479 . . . . 0.0 111.885 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 tp -95.11 93.47 7.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.394 1.078 . . . . 0.0 109.299 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -109.32 130.01 55.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.216 1.406 . . . . 0.0 110.835 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -70.3 158.0 36.7 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.237 0.926 . . . . 0.0 112.749 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.9 p -159.97 162.63 34.41 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.581 1.153 . . . . 0.0 113.705 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -113.49 -19.11 11.79 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.406 1.482 . . . . 0.0 112.474 168.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -167.87 169.0 11.84 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 127.105 2.162 . . . . 0.0 111.881 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -60.8 -30.9 70.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.628 1.171 . . . . 0.0 112.987 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -62.86 -18.51 63.01 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.999 1.32 . . . . 0.0 113.667 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -97.62 -0.44 45.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.409 1.484 . . . . 0.0 112.79 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.9 m -97.54 142.59 24.79 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.065 1.346 . . . . 0.0 113.018 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -83.56 146.36 12.06 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.619 2.88 . . . . 0.0 112.587 -169.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.91 -120.8 24.38 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.73 7.76 45.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.757 1.223 . . . . 0.0 114.007 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.9 m -62.54 146.73 51.06 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.155 -0.966 . . . . 0.0 112.458 177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.7 pt -116.63 153.49 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.302 1.841 . . . . 0.0 110.195 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -82.32 121.93 27.31 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.481 -0.762 . . . . 0.0 110.43 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -93.89 168.47 10.96 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.852 1.261 . . . . 0.0 111.895 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -17.92 67.5 Favored Glycine 0 N--CA 1.477 1.398 0 C-N-CA 124.683 1.135 . . . . 0.0 115.169 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -77.59 -6.86 55.21 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.669 1.188 . . . . 0.0 114.111 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.64 16.07 58.99 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.076 1.322 . . . . 0.0 114.416 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -126.92 157.5 39.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.475 1.51 . . . . 0.0 112.253 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.3 m -74.7 139.85 43.75 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.049 1.74 . . . . 0.0 112.22 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.926 0 C-N-CA 125.171 1.367 . . . . 0.0 113.465 177.31 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.8 t -85.63 120.5 73.0 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.387 173.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.05 170.72 19.12 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.44 2.76 . . . . 0.0 112.122 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.62 36.64 0.21 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.752 1.621 . . . . 0.0 113.693 -175.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.0 pt -78.4 161.46 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.937 1.695 . . . . 0.0 112.327 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.3 tp -123.21 83.26 2.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 108.567 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -112.1 124.03 51.55 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.98 1.712 . . . . 0.0 109.594 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.5 153.1 36.62 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.344 -0.847 . . . . 0.0 112.819 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -160.38 161.7 33.15 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -113.62 -32.09 6.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.726 2.01 . . . . 0.0 110.349 168.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -155.05 174.43 15.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.797 1.639 . . . . 0.0 111.354 175.102 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.411 ' H ' ' HG3' ' A' ' 12' ' ' ARG . 25.6 m-20 -62.42 -25.8 68.15 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.322 1.449 . . . . 0.0 113.756 -169.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 p -65.31 -16.26 63.39 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.206 1.402 . . . . 0.0 113.852 174.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -83.34 -14.47 52.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.232 1.013 . . . . 0.0 112.838 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -100.76 138.9 20.19 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.942 1.297 . . . . 0.0 113.448 -169.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.22 147.87 9.0 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.149 2.566 . . . . 0.0 111.988 -169.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.17 -122.71 30.8 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.41 0.528 . . . . 0.0 112.415 175.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.29 -0.37 57.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.747 1.219 . . . . 0.0 114.204 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 79.7 m -64.75 144.68 57.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.374 0.988 . . . . 0.0 112.962 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.8 pt -119.18 156.79 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.676 1.99 . . . . 0.0 110.122 172.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.8 t -83.24 119.12 24.16 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.321 -0.862 . . . . 0.0 111.13 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -89.74 167.34 12.96 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.791 1.236 . . . . 0.0 111.743 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.44 -17.0 65.97 Favored Glycine 0 N--CA 1.477 1.408 0 C-N-CA 124.634 1.111 . . . . 0.0 115.295 -172.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -76.83 -8.93 58.25 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 171.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.58 23.48 36.34 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.821 1.2 . . . . 0.0 114.077 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -136.5 157.57 46.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.97 1.308 . . . . 0.0 112.546 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.6 m -73.62 139.19 45.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.463 1.505 . . . . 0.0 112.681 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.986 0 C-N-CA 125.247 1.403 . . . . 0.0 113.33 178.705 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.7 t -89.6 117.42 68.14 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.3 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.99 169.63 21.72 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.143 2.562 . . . . 0.0 112.243 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -73.3 26.82 0.06 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.271 1.829 . . . . 0.0 115.3 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.3 pt -75.03 168.24 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.282 1.833 . . . . 0.0 112.752 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.2 tp -132.5 86.48 2.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.273 1.429 . . . . 0.0 108.603 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.26 131.19 54.95 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.506 1.523 . . . . 0.0 110.647 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.54 153.02 37.0 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.895 0.771 . . . . 0.0 112.128 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -160.69 160.59 31.67 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -117.68 -17.44 9.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.893 1.677 . . . . 0.0 111.339 167.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -163.16 168.69 20.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.928 2.091 . . . . 0.0 112.065 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -62.31 -26.15 68.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.943 0.897 . . . . 0.0 113.134 -171.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -63.49 -18.04 63.38 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.962 1.305 . . . . 0.0 113.964 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -79.3 -22.51 44.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.834 0.854 . . . . 0.0 112.494 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.0 m -93.55 134.14 27.08 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.957 1.303 . . . . 0.0 113.788 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -88.29 159.04 6.86 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.374 2.716 . . . . 0.0 112.14 -171.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.11 -123.68 31.88 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.46 6.7 46.99 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.462 1.105 . . . . 0.0 113.787 174.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.2 m -64.23 145.95 55.13 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.144 -0.972 . . . . 0.0 112.451 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.3 pt -122.59 156.12 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.791 2.036 . . . . 0.0 109.737 173.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -77.61 130.57 37.05 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.191 -0.943 . . . . 0.0 110.781 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -104.09 166.98 10.06 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.814 1.245 . . . . 0.0 111.798 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.73 -16.74 66.24 Favored Glycine 0 N--CA 1.477 1.372 0 C-N-CA 124.665 1.126 . . . . 0.0 115.348 -171.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -76.7 -7.52 55.49 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.718 1.207 . . . . 0.0 114.179 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.9 22.11 43.77 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.93 1.253 . . . . 0.0 114.016 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -135.43 157.61 46.46 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.086 1.355 . . . . 0.0 112.736 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.8 m -72.85 137.86 45.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.602 1.561 . . . . 0.0 112.307 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.914 0 C-N-CA 125.255 1.407 . . . . 0.0 113.494 176.383 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.8 t -89.03 114.1 58.8 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.098 173.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.04 153.49 67.57 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.642 2.228 . . . . 0.0 110.92 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -78.88 25.16 0.28 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.861 1.264 . . . . 0.0 114.148 -171.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.3 mt -79.5 136.17 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.845 1.658 . . . . 0.0 109.381 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.7 tp -89.4 88.62 7.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.385 1.074 . . . . 0.0 109.043 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -108.15 130.52 55.12 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.296 1.439 . . . . 0.0 110.579 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -71.68 159.36 34.53 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.026 0.83 . . . . 0.0 111.411 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.4 p -161.67 157.36 24.38 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -108.75 -25.71 10.68 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.495 1.918 . . . . 0.0 110.511 168.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -161.91 172.98 15.15 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.766 2.026 . . . . 0.0 112.142 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.84 -27.36 68.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.238 1.015 . . . . 0.0 112.97 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 m -62.42 -18.66 62.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.312 1.445 . . . . 0.0 113.952 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.47 -20.15 34.54 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.176 0.99 . . . . 0.0 112.683 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.5 m -90.11 141.63 28.0 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -168.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -84.88 147.6 10.63 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.575 2.85 . . . . 0.0 112.32 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.63 -121.51 26.82 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.41 7.89 45.65 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.681 1.192 . . . . 0.0 113.95 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.4 m -62.54 147.03 50.25 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.07 -1.019 . . . . 0.0 112.339 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.2 pt -120.62 154.11 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.496 1.918 . . . . 0.0 110.09 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -79.07 125.82 29.9 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.341 -0.849 . . . . 0.0 110.616 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -99.06 168.71 9.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.754 1.222 . . . . 0.0 111.89 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.87 -17.43 67.42 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 124.628 1.108 . . . . 0.0 115.241 -172.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -77.35 -6.68 54.19 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.663 1.185 . . . . 0.0 114.116 171.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.95 15.4 59.4 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.157 1.36 . . . . 0.0 114.3 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -128.34 156.65 42.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.914 1.286 . . . . 0.0 113.019 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.8 m -73.23 138.52 45.63 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.536 1.534 . . . . 0.0 112.298 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.952 0 C-N-CA 125.144 1.354 . . . . 0.0 113.398 177.376 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.94 115.46 63.99 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 118.308 -0.854 . . . . 0.0 109.831 171.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.74 170.32 18.97 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.837 2.358 . . . . 0.0 111.832 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -76.71 33.43 0.14 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.765 1.626 . . . . 0.0 113.785 -174.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -79.72 173.73 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.296 1.839 . . . . 0.0 112.649 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 tp -141.97 88.48 2.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.171 1.389 . . . . 0.0 108.398 169.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -110.23 134.67 52.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.568 1.547 . . . . 0.0 110.04 -177.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -68.35 160.87 28.66 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.476 1.035 . . . . 0.0 110.794 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -157.01 150.9 24.69 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -94.2 -28.87 15.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.282 1.433 . . . . 0.0 111.431 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.0 ptm85 -173.51 174.17 3.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.666 2.787 . . . . 0.0 110.728 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -59.19 -31.04 68.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.508 1.123 . . . . 0.0 113.141 -173.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -63.87 -17.64 63.38 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.943 1.297 . . . . 0.0 113.836 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -92.0 -9.39 43.08 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.132 1.373 . . . . 0.0 112.398 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.8 m -92.18 140.74 24.55 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.008 1.323 . . . . 0.0 113.399 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.92 149.95 12.47 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.374 2.716 . . . . 0.0 112.404 -169.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.88 -122.72 29.59 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.72 10.84 40.65 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.583 1.153 . . . . 0.0 113.706 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -61.27 146.74 46.86 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.119 -0.988 . . . . 0.0 112.579 176.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.4 pt -118.89 152.94 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.417 1.887 . . . . 0.0 110.227 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -82.21 121.39 26.56 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.418 -0.801 . . . . 0.0 110.531 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.06 169.71 10.07 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.928 1.291 . . . . 0.0 111.817 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.99 67.49 Favored Glycine 0 N--CA 1.477 1.396 0 C-N-CA 124.6 1.095 . . . . 0.0 115.14 -172.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -78.33 -5.59 52.61 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.824 1.25 . . . . 0.0 114.197 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.09 13.84 63.48 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.182 1.373 . . . . 0.0 114.409 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -124.85 156.67 37.49 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.064 1.345 . . . . 0.0 113.373 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.5 m -73.97 137.49 43.57 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.87 1.668 . . . . 0.0 112.447 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.909 0 C-N-CA 125.329 1.442 . . . . 0.0 113.267 176.996 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.6 t -96.84 117.73 65.62 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.637 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -53.96 142.87 63.31 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.257 3.305 . . . . 0.0 113.276 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.55 13.57 6.73 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.4 pt -79.13 154.4 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.496 1.518 . . . . 0.0 112.347 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.0 tp -87.82 88.45 7.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.37 1.068 . . . . 0.0 109.299 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -109.3 121.88 46.13 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.82 1.648 . . . . 0.0 109.675 -174.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -73.51 159.66 32.85 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.148 -0.97 . . . . 0.0 112.311 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -162.44 159.49 25.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -175.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -109.98 -29.68 8.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.321 1.848 . . . . 0.0 110.503 168.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -158.98 177.58 10.98 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.542 1.937 . . . . 0.0 111.965 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.21 -27.31 68.89 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -169.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.0 p -69.87 -12.38 61.58 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -83.85 -14.05 52.16 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.029 0.932 . . . . 0.0 112.558 171.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.3 m -96.0 140.53 22.31 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.924 1.29 . . . . 0.0 113.984 -169.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -84.25 147.91 11.57 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.459 2.772 . . . . 0.0 112.206 -169.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.22 -125.1 37.88 Favored Glycine 0 CA--C 1.532 1.102 0 O-C-N 121.84 -0.538 . . . . 0.0 111.911 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.2 6.62 47.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.92 1.288 . . . . 0.0 114.1 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.3 m -62.52 147.5 48.72 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.055 -1.028 . . . . 0.0 112.813 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.7 pt -115.5 156.99 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.507 1.923 . . . . 0.0 110.228 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.3 t -83.5 118.11 23.55 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.47 -0.769 . . . . 0.0 110.797 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.5 mmm-85 -86.85 167.46 14.33 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.635 1.174 . . . . 0.0 111.609 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.66 -16.76 66.12 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 124.601 1.096 . . . . 0.0 115.322 -172.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -77.73 -7.5 56.62 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.687 1.195 . . . . 0.0 114.186 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.23 17.41 55.68 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.885 1.231 . . . . 0.0 114.264 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -130.49 156.29 45.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.85 1.26 . . . . 0.0 112.71 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.9 m -75.26 143.47 43.02 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.133 1.373 . . . . 0.0 112.857 -175.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.95 0 C-N-CA 124.943 1.259 . . . . 0.0 113.494 177.493 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.0 t -91.56 117.42 67.78 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.233 173.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.81 149.66 86.54 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.829 2.353 . . . . 0.0 111.336 176.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -81.82 18.24 1.33 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -169.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.6 pt -74.57 150.98 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.412 1.485 . . . . 0.0 111.993 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 tp -94.33 86.39 4.88 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.265 1.026 . . . . 0.0 109.18 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -107.73 124.73 50.46 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.391 1.477 . . . . 0.0 110.699 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -70.89 158.57 36.19 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.18 -0.95 . . . . 0.0 113.106 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.1 p -159.17 154.72 25.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -174.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -100.57 -31.85 11.05 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.259 1.423 . . . . 0.0 110.721 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.72 177.32 9.45 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.083 2.153 . . . . 0.0 111.155 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -60.8 -25.52 66.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -63.39 -19.46 64.69 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.933 1.293 . . . . 0.0 113.993 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.8 -17.67 52.79 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.064 0.946 . . . . 0.0 112.798 173.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.8 m -98.83 137.11 20.5 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.803 1.241 . . . . 0.0 113.837 -169.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -88.76 154.55 6.14 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.752 2.968 . . . . 0.0 112.446 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -121.5 26.55 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.28 5.04 51.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.449 1.1 . . . . 0.0 113.933 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.8 m -64.91 145.4 56.35 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.458 1.026 . . . . 0.0 112.217 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.5 pt -120.42 156.29 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.572 1.949 . . . . 0.0 109.755 171.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.8 t -79.65 125.86 30.18 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.315 -0.866 . . . . 0.0 110.62 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -97.47 168.36 10.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.732 1.213 . . . . 0.0 111.819 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.58 -17.62 67.0 Favored Glycine 0 N--CA 1.476 1.354 0 C-N-CA 124.631 1.11 . . . . 0.0 115.273 -171.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -77.31 -8.18 57.22 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.673 1.189 . . . . 0.0 114.181 171.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.32 18.51 52.8 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.09 1.329 . . . . 0.0 114.346 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -129.8 156.6 44.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.414 1.486 . . . . 0.0 112.238 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 82.4 m -72.91 139.21 46.66 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.979 1.711 . . . . 0.0 112.376 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 C-N-CA 124.977 1.275 . . . . 0.0 113.514 177.321 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.7 t -79.33 119.9 78.61 Favored Pre-proline 0 CA--C 1.551 0.984 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.217 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.26 173.25 11.69 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.625 2.884 . . . . 0.0 112.845 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -75.32 33.02 0.1 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.262 1.825 . . . . 0.0 114.048 -174.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.8 pt -78.37 168.93 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.027 1.731 . . . . 0.0 112.169 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 tp -137.85 83.44 1.98 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.844 1.257 . . . . 0.0 108.847 170.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -106.75 126.51 52.38 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.484 1.514 . . . . 0.0 110.108 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -70.28 156.67 38.95 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.32 0.964 . . . . 0.0 112.804 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.1 p -160.0 156.98 27.94 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -106.96 -25.44 11.63 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.575 1.95 . . . . 0.0 110.607 168.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -163.11 171.87 15.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.461 1.904 . . . . 0.0 112.143 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -61.32 -27.11 68.25 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 113.058 -172.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -62.7 -18.46 62.51 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.145 1.378 . . . . 0.0 113.856 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -81.16 -22.03 39.28 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.083 0.953 . . . . 0.0 112.417 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.1 m -92.69 135.95 25.69 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.886 1.274 . . . . 0.0 113.244 -169.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.72 148.14 9.67 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.965 2.444 . . . . 0.0 111.918 -170.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.27 -122.73 30.82 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.437 0.542 . . . . 0.0 112.378 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.58 -2.56 58.7 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.81 1.244 . . . . 0.0 114.313 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -65.74 146.3 54.95 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.325 0.966 . . . . 0.0 112.844 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.9 pt -125.1 155.39 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.859 2.064 . . . . 0.0 109.632 174.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.79 131.29 37.54 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.146 -0.971 . . . . 0.0 110.712 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -105.95 168.15 9.32 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.649 1.18 . . . . 0.0 111.79 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.82 -17.11 66.93 Favored Glycine 0 N--CA 1.477 1.394 0 C-N-CA 124.632 1.11 . . . . 0.0 115.255 -171.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -76.52 -7.99 56.27 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.701 1.2 . . . . 0.0 114.095 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.17 17.79 54.97 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.079 1.323 . . . . 0.0 114.266 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -130.77 157.97 41.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.341 1.456 . . . . 0.0 112.306 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.1 m -73.81 135.21 43.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.086 1.754 . . . . 0.0 112.057 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.009 0 C-N-CA 125.398 1.475 . . . . 0.0 113.315 177.82 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.6 t -89.23 117.33 68.12 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.925 171.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -61.6 163.26 18.73 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.194 2.596 . . . . 0.0 113.153 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -76.01 28.29 0.11 Allowed 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.598 1.559 . . . . 0.0 113.871 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.09 174.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.531 1.932 . . . . 0.0 112.939 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.8 tp -138.88 88.05 2.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.391 1.476 . . . . 0.0 108.226 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -109.29 133.07 53.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.503 1.521 . . . . 0.0 110.439 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -69.05 158.9 33.88 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.246 0.93 . . . . 0.0 111.06 176.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.8 p -160.95 157.87 27.14 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -176.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -111.03 -24.38 10.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.619 1.968 . . . . 0.0 110.615 168.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -161.91 173.29 14.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.835 2.054 . . . . 0.0 111.977 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.68 -26.68 67.28 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.232 1.013 . . . . 0.0 113.024 -173.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 m -60.98 -20.16 62.02 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.548 1.539 . . . . 0.0 113.968 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -82.79 -20.78 35.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.247 1.019 . . . . 0.0 112.697 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.8 m -90.87 138.98 25.98 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 124.933 1.293 . . . . 0.0 114.312 -168.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -86.27 151.38 9.32 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.417 2.745 . . . . 0.0 112.301 -170.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.4 -124.03 33.76 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.73 10.51 41.0 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.639 1.176 . . . . 0.0 113.765 173.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 80.6 m -61.8 147.05 47.65 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.157 -0.964 . . . . 0.0 112.082 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.31 153.23 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.42 1.888 . . . . 0.0 110.029 175.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -77.47 130.01 36.45 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.357 -0.839 . . . . 0.0 110.629 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -104.91 168.64 8.92 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.716 1.207 . . . . 0.0 111.866 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -17.18 66.93 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 124.743 1.163 . . . . 0.0 115.247 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -76.95 -6.41 52.43 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.795 1.238 . . . . 0.0 114.109 171.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.22 16.72 58.7 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.125 1.345 . . . . 0.0 114.13 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -129.81 156.65 43.99 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.97 1.308 . . . . 0.0 113.25 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 82.9 m -73.67 134.12 43.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.773 1.629 . . . . 0.0 112.084 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.008 0 C-N-CA 125.428 1.489 . . . . 0.0 113.382 176.628 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.2 t -83.78 117.99 70.17 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.161 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.42 172.29 14.49 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.388 2.725 . . . . 0.0 112.245 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.01 34.57 0.13 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.928 1.691 . . . . 0.0 113.914 -175.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.0 pt -79.05 168.22 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.135 1.774 . . . . 0.0 112.112 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.4 tp -136.49 86.41 2.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.961 1.304 . . . . 0.0 108.597 169.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -108.04 134.78 50.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.757 1.623 . . . . 0.0 110.635 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.34 154.95 22.56 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.413 1.006 . . . . 0.0 111.974 171.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.1 p -153.6 151.04 29.28 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.605 1.705 . . . . 0.0 115.605 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -96.51 -25.43 15.65 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.697 1.999 . . . . 0.0 113.246 169.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -174.89 173.69 2.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 128.01 2.524 . . . . 0.0 111.257 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -60.2 -33.43 72.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.329 1.052 . . . . 0.0 112.871 -175.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -64.38 -16.58 62.55 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.942 1.297 . . . . 0.0 113.474 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -93.34 -8.26 42.47 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.635 1.574 . . . . 0.0 112.516 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.8 m -94.71 138.95 22.09 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.534 1.534 . . . . 0.0 112.629 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -84.02 149.79 12.29 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.107 2.538 . . . . 0.0 112.2 -169.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -123.72 33.14 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.297 0.475 . . . . 0.0 111.985 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.59 3.5 55.41 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.603 1.161 . . . . 0.0 114.015 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.6 m -63.61 145.97 54.66 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.159 -0.963 . . . . 0.0 112.683 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.2 pt -119.88 154.77 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.74 2.016 . . . . 0.0 110.039 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.9 t -83.51 123.16 29.46 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.39 -0.819 . . . . 0.0 110.531 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -95.28 169.36 10.13 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.732 1.213 . . . . 0.0 111.796 -176.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.48 -17.92 67.13 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.653 1.121 . . . . 0.0 115.157 -172.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -78.0 -6.43 54.46 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.741 1.216 . . . . 0.0 114.188 171.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.96 18.8 57.36 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.048 1.309 . . . . 0.0 114.189 -178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -129.37 157.53 41.66 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.207 1.403 . . . . 0.0 112.69 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.9 m -73.23 138.9 45.85 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.492 1.517 . . . . 0.0 112.377 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.904 0 C-N-CA 125.434 1.492 . . . . 0.0 113.228 176.747 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 40.3 t -80.72 118.73 73.7 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.387 175.271 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.81 169.69 20.57 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.014 2.476 . . . . 0.0 111.776 177.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -77.43 39.32 0.26 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.434 1.493 . . . . 0.0 113.41 -176.524 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -79.32 172.9 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.946 1.698 . . . . 0.0 112.326 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.8 tp -142.38 87.13 2.0 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.007 1.323 . . . . 0.0 108.75 172.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -111.04 134.59 52.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.548 1.539 . . . . 0.0 110.587 -177.418 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -62.64 153.6 31.78 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.065 0.848 . . . . 0.0 111.987 175.064 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.1 p -159.26 156.73 29.31 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 176.793 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -110.04 -26.61 9.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.883 2.073 . . . . 0.0 110.105 168.381 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -159.54 171.92 18.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.4 1.88 . . . . 0.0 112.287 178.354 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -61.13 -27.69 68.57 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.199 1.0 . . . . 0.0 113.057 -172.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.6 m -63.33 -17.28 62.4 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.158 1.383 . . . . 0.0 113.94 176.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -81.83 -21.17 37.74 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.038 0.935 . . . . 0.0 112.619 173.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.7 m -90.78 140.86 26.45 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 114.356 -168.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -84.2 145.96 11.09 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.227 2.618 . . . . 0.0 111.912 -169.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.59 -122.37 29.57 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 121.977 -0.452 . . . . 0.0 112.003 177.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.69 5.37 52.05 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.692 1.197 . . . . 0.0 114.079 176.417 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.6 m -62.3 146.37 51.24 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.198 -0.939 . . . . 0.0 112.421 176.356 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.8 pt -122.57 154.77 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.612 1.965 . . . . 0.0 109.907 175.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -78.32 129.29 34.84 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.332 -0.855 . . . . 0.0 110.728 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -103.42 168.02 9.43 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.798 1.239 . . . . 0.0 111.79 -178.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.86 -16.9 66.76 Favored Glycine 0 N--CA 1.477 1.422 0 C-N-CA 124.638 1.113 . . . . 0.0 115.244 -171.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -77.15 -6.62 53.63 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.71 1.204 . . . . 0.0 114.14 171.381 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.07 20.0 54.22 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.862 1.22 . . . . 0.0 114.039 -178.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -133.34 158.75 42.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.205 1.402 . . . . 0.0 112.682 177.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.3 m -74.17 138.28 43.7 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.665 1.586 . . . . 0.0 112.465 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.01 0 C-N-CA 125.291 1.424 . . . . 0.0 113.305 175.999 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.6 t -91.4 116.57 66.71 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.963 172.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.82 152.12 77.76 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.833 2.355 . . . . 0.0 111.363 177.044 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.56 15.43 1.31 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -169.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.8 pt -79.37 149.55 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.238 1.415 . . . . 0.0 111.87 179.055 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.6 tp -95.9 94.53 7.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.5 1.12 . . . . 0.0 109.363 177.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -110.31 132.8 53.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.186 1.394 . . . . 0.0 111.153 -177.072 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -63.28 156.18 26.33 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.853 0.751 . . . . 0.0 112.102 174.529 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.3 p -158.95 152.79 23.27 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 175.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -97.23 -31.34 12.48 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.504 1.922 . . . . 0.0 110.602 169.253 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -168.19 173.64 7.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.363 2.665 . . . . 0.0 110.518 -175.061 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.38 -26.63 65.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.294 1.038 . . . . 0.0 113.222 -172.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -61.01 -21.6 63.74 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.458 1.503 . . . . 0.0 114.157 177.213 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -84.53 -16.96 40.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.016 0.926 . . . . 0.0 112.795 175.263 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.8 m -91.6 139.94 25.14 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 124.616 1.166 . . . . 0.0 114.054 -169.696 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -84.73 147.17 10.75 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.653 2.902 . . . . 0.0 112.42 -169.67 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.51 -121.27 26.07 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 177.096 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.03 6.37 49.01 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.759 1.224 . . . . 0.0 113.973 175.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.1 m -62.77 146.45 52.47 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.485 1.039 . . . . 0.0 112.169 177.325 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.65 156.26 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.313 1.845 . . . . 0.0 109.963 171.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.2 t -80.12 127.33 32.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.368 -0.832 . . . . 0.0 110.852 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -97.83 164.63 12.3 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.843 1.257 . . . . 0.0 111.48 -179.533 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.93 -19.94 63.95 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -169.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -79.87 -6.66 57.83 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 118.468 1.134 . . . . 0.0 113.861 174.318 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.21 23.5 22.01 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.115 1.341 . . . . 0.0 114.451 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -135.68 156.5 48.74 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.924 1.29 . . . . 0.0 112.832 178.243 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.6 m -74.04 140.6 45.5 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.775 1.63 . . . . 0.0 112.804 -177.346 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.031 0 C-N-CA 125.272 1.415 . . . . 0.0 113.398 176.261 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 40.7 t -91.01 117.32 67.82 Favored Pre-proline 0 CA--C 1.547 0.864 0 CA-C-O 118.19 -0.909 . . . . 0.0 109.845 170.524 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.28 168.43 22.24 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.023 2.482 . . . . 0.0 112.098 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -75.51 31.22 0.1 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 125.839 1.655 . . . . 0.0 113.522 -177.555 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.3 tt -80.92 156.17 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.396 1.878 . . . . 0.0 111.883 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.9 tp -122.69 85.84 2.48 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.998 1.319 . . . . 0.0 108.135 169.166 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -109.15 132.7 53.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.535 1.534 . . . . 0.0 110.6 -175.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -72.15 159.36 34.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.158 0.89 . . . . 0.0 111.48 177.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.8 p -161.76 158.05 25.18 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -174.298 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.56 -29.46 8.75 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.38 1.872 . . . . 0.0 110.475 168.675 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -159.81 177.52 10.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.552 1.941 . . . . 0.0 111.969 176.36 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -63.28 -26.7 68.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -169.407 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.0 p -69.69 -11.76 61.1 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 177.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -81.92 -14.88 55.51 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.088 0.955 . . . . 0.0 112.616 170.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.1 m -99.7 139.97 21.23 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.193 1.397 . . . . 0.0 113.49 -169.786 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -87.0 151.27 8.34 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.363 2.709 . . . . 0.0 112.375 -169.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.2 -122.57 29.89 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 178.247 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.62 7.75 45.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.579 1.152 . . . . 0.0 113.884 175.061 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.1 m -62.37 145.25 54.44 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.107 -0.996 . . . . 0.0 112.16 176.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.7 pt -120.02 155.21 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.467 1.907 . . . . 0.0 110.01 173.372 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -80.16 123.12 27.63 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.441 -0.787 . . . . 0.0 110.677 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -95.13 169.08 10.35 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.856 1.262 . . . . 0.0 111.783 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.61 67.05 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 124.54 1.067 . . . . 0.0 115.197 -172.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -78.17 -6.08 53.7 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.702 1.201 . . . . 0.0 114.211 171.5 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.21 15.57 60.46 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.081 1.324 . . . . 0.0 114.296 -178.583 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -127.28 156.19 42.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.841 1.257 . . . . 0.0 112.984 178.566 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -72.52 138.7 47.13 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.716 1.606 . . . . 0.0 112.252 -178.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.941 0 C-N-CA 125.085 1.326 . . . . 0.0 113.489 177.45 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.1 t -90.27 117.21 67.86 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.871 172.421 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.17 152.27 79.96 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.765 2.31 . . . . 0.0 111.539 178.026 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.42 15.13 1.34 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -169.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.2 pt -79.16 149.17 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.279 1.432 . . . . 0.0 111.753 178.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.6 tp -95.04 92.0 6.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.343 1.057 . . . . 0.0 109.206 175.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -108.73 130.04 55.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.279 1.432 . . . . 0.0 110.635 -178.117 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -69.85 160.36 31.93 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.479 1.036 . . . . 0.0 112.539 172.573 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.7 p -158.21 151.96 23.66 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -176.01 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -88.1 -39.56 14.48 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.168 1.387 . . . . 0.0 111.386 169.379 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -165.4 179.62 6.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.429 2.291 . . . . 0.0 110.942 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.14 -29.66 69.91 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.509 1.123 . . . . 0.0 113.947 -170.336 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.7 p -66.91 -17.48 64.92 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.326 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -94.76 -1.73 52.36 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.168 1.387 . . . . 0.0 112.85 176.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.0 m -96.12 141.73 23.56 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.921 1.288 . . . . 0.0 112.936 177.344 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -83.61 146.5 12.05 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.538 2.826 . . . . 0.0 112.611 -169.289 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.88 -122.04 28.48 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 177.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.45 6.47 48.91 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.681 1.192 . . . . 0.0 114.007 175.692 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.7 m -62.47 145.47 54.08 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.373 0.988 . . . . 0.0 112.411 178.065 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.3 pt -114.45 155.57 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.37 1.868 . . . . 0.0 110.008 170.353 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.1 t -84.9 115.11 22.59 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.511 -0.743 . . . . 0.0 110.432 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -84.23 168.58 15.59 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.045 1.338 . . . . 0.0 111.726 -176.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.31 -17.76 66.56 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 124.503 1.049 . . . . 0.0 115.188 -173.095 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -78.37 -6.57 55.56 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.76 1.224 . . . . 0.0 114.195 171.754 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.84 17.33 58.27 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.994 1.283 . . . . 0.0 114.452 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.07 157.26 40.11 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.352 1.461 . . . . 0.0 112.363 177.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.5 m -74.95 139.82 43.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.861 1.664 . . . . 0.0 112.573 -178.035 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.943 0 C-N-CA 125.104 1.335 . . . . 0.0 113.377 177.677 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.0 t -91.38 118.83 68.67 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.401 174.538 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.78 141.89 55.86 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.65 2.233 . . . . 0.0 110.558 172.605 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -82.14 30.25 0.4 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.629 1.172 . . . . 0.0 113.91 -169.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt -78.98 150.36 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.621 1.569 . . . . 0.0 111.671 177.419 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.0 tp -92.67 86.71 5.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.086 0.954 . . . . 0.0 109.164 174.256 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -109.33 128.09 54.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.665 1.586 . . . . 0.0 110.895 -176.339 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -63.66 154.07 34.11 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.931 0.787 . . . . 0.0 112.354 178.002 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.9 p -159.46 162.02 35.55 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 175.622 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -115.49 -23.05 8.99 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.619 1.968 . . . . 0.0 110.703 168.213 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -161.91 169.75 20.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.681 1.993 . . . . 0.0 112.376 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -63.32 -27.11 69.1 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -169.401 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.7 p -71.35 -10.59 60.01 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 177.187 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -79.77 -18.51 50.85 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.208 -0.932 . . . . 0.0 112.108 169.468 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.3 m -98.91 138.74 20.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.388 1.475 . . . . 0.0 113.616 -169.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -87.53 152.89 7.7 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.755 2.97 . . . . 0.0 112.49 -169.599 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -120.63 23.48 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 176.384 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.03 5.38 50.5 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.474 1.11 . . . . 0.0 113.923 175.531 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.0 m -64.24 143.44 57.89 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.516 1.053 . . . . 0.0 112.166 179.007 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.0 pt -116.72 157.72 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.522 1.929 . . . . 0.0 109.973 171.777 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.7 t -81.72 117.96 22.46 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.394 -0.816 . . . . 0.0 110.585 178.073 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -87.74 167.52 13.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.889 1.276 . . . . 0.0 111.682 -177.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.29 -17.48 66.2 Favored Glycine 0 N--CA 1.478 1.456 0 C-N-CA 124.519 1.057 . . . . 0.0 115.25 -172.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -77.23 -8.56 57.79 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 171.592 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.81 21.38 43.27 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.937 1.256 . . . . 0.0 114.201 -178.229 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -132.9 156.84 46.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.082 1.353 . . . . 0.0 112.26 177.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.6 m -70.85 142.35 51.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.166 1.386 . . . . 0.0 112.311 -178.598 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.878 0 C-N-CA 124.787 1.184 . . . . 0.0 113.609 177.315 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 t -90.63 120.04 68.94 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.312 173.875 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.72 145.66 48.28 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 124.092 3.195 . . . . 0.0 113.292 173.107 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -89.86 11.85 19.04 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 pp -79.67 167.3 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.629 1.572 . . . . 0.0 112.188 172.068 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.2 tp -108.22 100.09 9.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.91 1.284 . . . . 0.0 109.831 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -113.01 131.7 55.67 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.278 1.431 . . . . 0.0 111.01 -179.296 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -71.76 161.62 30.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.116 0.871 . . . . 0.0 111.273 173.393 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.9 p -160.13 151.38 19.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -175.042 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.8 ttt180 -88.97 -38.21 14.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.348 1.459 . . . . 0.0 111.293 169.281 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -164.88 178.49 7.12 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.359 2.264 . . . . 0.0 111.028 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -58.88 -30.67 67.92 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.69 1.196 . . . . 0.0 113.429 -173.317 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -60.67 -21.15 62.5 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.961 1.304 . . . . 0.0 113.833 177.255 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -97.9 0.2 46.14 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.251 1.42 . . . . 0.0 113.038 179.481 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.5 m -97.47 141.09 22.48 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.042 1.337 . . . . 0.0 113.07 178.223 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.43 148.13 11.37 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.49 2.793 . . . . 0.0 112.607 -169.397 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.7 -124.05 34.55 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 179.008 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.88 7.66 45.25 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.719 1.208 . . . . 0.0 114.052 175.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.2 m -62.35 145.52 53.67 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.15 -0.969 . . . . 0.0 112.517 178.057 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -115.25 154.6 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.363 1.865 . . . . 0.0 110.098 170.862 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.0 t -84.13 112.72 20.5 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.478 -0.764 . . . . 0.0 110.328 179.317 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -81.48 168.69 18.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.994 1.317 . . . . 0.0 111.717 -177.4 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.24 -17.84 66.51 Favored Glycine 0 N--CA 1.478 1.457 0 C-N-CA 124.572 1.082 . . . . 0.0 115.143 -172.829 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -78.27 -6.36 54.74 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.754 1.222 . . . . 0.0 114.212 171.533 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.62 16.4 58.53 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.036 1.303 . . . . 0.0 114.379 -178.603 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -126.51 154.99 43.03 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.919 1.287 . . . . 0.0 113.184 178.975 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 81.8 m -73.6 137.19 44.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.349 1.46 . . . . 0.0 112.384 -177.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.965 0 C-N-CA 125.048 1.309 . . . . 0.0 113.347 178.037 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.9 t -89.92 118.64 69.09 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.058 171.577 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -62.4 165.18 15.82 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.203 2.602 . . . . 0.0 113.235 177.153 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.39 21.93 0.59 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.038 1.335 . . . . 0.0 114.527 -171.477 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.25 168.18 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.082 1.353 . . . . 0.0 112.989 -177.018 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.9 tp -125.59 86.04 2.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.105 1.362 . . . . 0.0 107.885 169.0 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -106.97 130.19 54.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.34 1.456 . . . . 0.0 110.393 -175.693 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -71.01 158.44 36.51 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.109 0.868 . . . . 0.0 111.262 177.022 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.5 p -160.97 157.24 26.05 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.521 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -107.71 -28.13 9.88 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.715 2.006 . . . . 0.0 110.116 168.488 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 -160.13 172.46 17.41 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.362 1.865 . . . . 0.0 112.486 179.643 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -61.2 -27.36 68.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.211 1.004 . . . . 0.0 113.02 -172.669 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -63.42 -17.34 62.56 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.091 1.357 . . . . 0.0 113.949 177.021 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -82.01 -20.81 37.66 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.161 0.984 . . . . 0.0 112.636 173.508 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.8 m -92.14 139.54 24.31 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.158 1.383 . . . . 0.0 114.202 -168.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -86.26 151.21 9.32 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.356 2.704 . . . . 0.0 112.229 -170.182 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.96 -125.48 38.28 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.13 10.45 39.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.574 1.15 . . . . 0.0 113.874 174.076 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.31 145.56 51.01 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.13 -0.981 . . . . 0.0 112.064 174.565 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.02 153.61 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.278 1.831 . . . . 0.0 110.062 173.876 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.8 t -78.09 124.39 27.99 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.502 -0.749 . . . . 0.0 110.546 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -98.13 169.36 9.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.774 1.23 . . . . 0.0 111.782 -176.429 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.55 -17.68 67.0 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 124.58 1.086 . . . . 0.0 115.223 -172.571 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -78.09 -6.35 54.38 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.686 1.194 . . . . 0.0 114.21 171.54 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.41 16.26 59.09 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.063 1.316 . . . . 0.0 114.315 -178.424 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -128.24 156.12 43.47 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.971 1.309 . . . . 0.0 113.081 178.752 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.3 m -72.12 136.89 46.67 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.535 1.534 . . . . 0.0 112.075 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.932 0 C-N-CA 125.205 1.383 . . . . 0.0 113.063 177.398 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.0 t -95.69 117.02 66.67 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.342 -0.837 . . . . 0.0 109.761 169.796 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.64 172.23 16.18 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.124 2.55 . . . . 0.0 112.404 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -72.22 25.5 0.05 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.53 1.932 . . . . 0.0 115.476 -175.444 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.2 pt -77.69 170.31 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.313 1.845 . . . . 0.0 112.764 -177.537 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.5 tp -136.86 88.05 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.24 1.416 . . . . 0.0 108.467 169.606 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -108.94 133.68 52.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.529 1.532 . . . . 0.0 110.859 -175.712 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -63.58 154.89 31.24 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.996 0.816 . . . . 0.0 112.248 175.722 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.8 p -159.38 156.91 29.33 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 176.176 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -107.15 -32.35 7.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.819 2.048 . . . . 0.0 110.141 168.659 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -158.03 176.64 12.26 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.227 1.811 . . . . 0.0 112.054 176.868 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -63.09 -26.71 68.96 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.498 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.4 p -69.56 -12.29 61.52 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -78.87 -21.58 47.3 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.409 -0.807 . . . . 0.0 112.283 169.87 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.5 m -94.85 134.17 25.37 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.976 1.31 . . . . 0.0 113.33 -169.647 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -88.47 160.01 6.64 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.423 2.749 . . . . 0.0 112.131 -170.932 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.15 -125.04 35.23 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 178.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.45 7.96 45.49 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.355 1.062 . . . . 0.0 113.686 173.425 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -63.78 146.53 53.72 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.162 -0.961 . . . . 0.0 112.371 177.618 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 pt -123.37 155.82 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.81 2.044 . . . . 0.0 109.616 174.035 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.4 t -78.69 131.27 36.57 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.19 -0.943 . . . . 0.0 110.776 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.44 168.06 9.33 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.696 1.198 . . . . 0.0 111.86 -178.753 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.88 -16.65 66.46 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.638 1.113 . . . . 0.0 115.327 -171.508 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -76.63 -7.07 54.54 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.723 1.209 . . . . 0.0 114.138 170.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.4 20.11 52.91 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.008 1.29 . . . . 0.0 114.09 -178.287 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -133.47 158.06 44.05 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.149 1.38 . . . . 0.0 112.807 178.669 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -73.6 136.05 43.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.747 1.619 . . . . 0.0 112.319 -178.919 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.968 0 C-N-CA 125.421 1.486 . . . . 0.0 113.393 176.226 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.1 t -90.86 117.84 68.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.865 170.609 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.36 167.6 24.74 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.949 2.433 . . . . 0.0 111.849 178.118 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -76.11 33.24 0.12 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.632 1.573 . . . . 0.0 113.246 -177.883 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.0 tt -79.89 154.54 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.189 1.796 . . . . 0.0 111.699 178.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.1 tp -120.65 86.06 2.5 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.915 1.286 . . . . 0.0 108.038 169.322 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -108.14 132.83 53.19 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.293 1.437 . . . . 0.0 110.737 -176.026 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.58 153.66 31.34 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.937 0.79 . . . . 0.0 111.812 175.502 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.9 p -159.64 158.27 31.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 176.452 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -113.8 -22.97 9.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.658 1.983 . . . . 0.0 110.814 168.487 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -161.83 171.24 18.1 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.607 1.963 . . . . 0.0 112.178 177.784 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -61.97 -27.04 68.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.03 0.932 . . . . 0.0 113.121 -171.485 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -62.86 -18.12 62.48 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.035 1.334 . . . . 0.0 113.982 176.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -80.78 -20.94 41.51 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.142 0.977 . . . . 0.0 112.564 174.068 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.8 m -92.71 138.8 23.51 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.04 1.336 . . . . 0.0 114.477 -168.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -87.07 153.29 8.3 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.436 2.757 . . . . 0.0 112.222 -170.366 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -123.63 32.89 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.22 8.89 44.16 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.506 1.122 . . . . 0.0 113.887 174.192 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 80.8 m -62.55 146.8 50.92 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.066 -1.021 . . . . 0.0 112.187 176.454 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.8 pt -122.3 155.32 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 126.543 1.937 . . . . 0.0 109.824 174.178 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.0 t -77.68 130.6 37.02 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.203 -0.936 . . . . 0.0 110.763 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.45 167.6 9.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.717 1.207 . . . . 0.0 111.916 -178.617 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.06 -16.47 66.59 Favored Glycine 0 N--CA 1.477 1.381 0 C-N-CA 124.732 1.158 . . . . 0.0 115.373 -171.703 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -76.32 -7.01 54.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.696 1.198 . . . . 0.0 114.107 170.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.55 19.32 54.88 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.016 1.294 . . . . 0.0 114.0 -178.316 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -133.71 158.7 42.62 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.255 1.422 . . . . 0.0 112.695 178.193 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.7 m -73.06 138.78 46.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.565 1.546 . . . . 0.0 112.424 -179.113 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 C-N-CA 125.257 1.408 . . . . 0.0 113.433 176.044 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.2 t -86.72 115.66 63.19 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.016 173.507 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -67.98 160.47 48.42 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.78 2.32 . . . . 0.0 112.054 178.905 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.93 16.03 0.17 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -172.559 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 tp -75.12 144.67 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.895 1.678 . . . . 0.0 111.746 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.5 tp -102.94 88.37 3.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.749 1.22 . . . . 0.0 108.328 169.801 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -108.63 129.78 55.33 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.256 1.422 . . . . 0.0 110.413 -177.274 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.28 157.75 34.89 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.391 0.996 . . . . 0.0 112.109 172.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -157.22 151.49 25.0 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -174.672 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -91.13 -35.7 14.41 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.192 1.397 . . . . 0.0 111.505 169.3 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -164.75 177.35 8.04 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.198 2.199 . . . . 0.0 111.277 179.277 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -59.67 -30.54 68.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.703 1.201 . . . . 0.0 113.467 -173.012 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 m -60.91 -20.69 62.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.909 1.284 . . . . 0.0 113.735 177.335 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -97.21 0.83 48.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.374 1.47 . . . . 0.0 112.988 179.752 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.7 m -98.98 141.1 22.3 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.074 1.35 . . . . 0.0 113.2 178.895 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -84.68 149.42 11.25 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.5 2.8 . . . . 0.0 112.589 -169.342 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.34 -124.0 33.77 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.784 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.3 10.48 40.58 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.675 1.19 . . . . 0.0 113.745 174.231 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.2 m -61.51 145.57 51.47 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.099 -1.0 . . . . 0.0 112.52 176.661 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.1 pt -116.19 154.89 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.448 1.899 . . . . 0.0 110.054 172.268 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.2 t -83.52 116.43 22.56 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.588 -0.695 . . . . 0.0 110.517 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -87.05 168.72 13.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.041 1.337 . . . . 0.0 111.752 -176.502 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -17.58 67.11 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 124.602 1.096 . . . . 0.0 115.193 -173.316 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -78.27 -6.34 54.69 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.732 1.213 . . . . 0.0 114.149 171.744 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.08 16.16 59.79 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.028 1.299 . . . . 0.0 114.404 -179.033 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -126.54 157.78 37.89 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.407 1.483 . . . . 0.0 112.397 177.743 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.9 m -73.84 140.3 45.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.962 1.705 . . . . 0.0 112.481 -179.532 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.891 0 C-N-CA 125.164 1.364 . . . . 0.0 113.431 177.71 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.586 -0.206 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -163.58 151.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.794 1.638 . . . . 0.0 109.079 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.5 t -94.53 118.19 66.94 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.22 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.19 150.95 54.29 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.59 2.86 . . . . 0.0 113.232 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -77.89 17.92 0.53 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.122 1.369 . . . . 0.0 114.226 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.0 pt -79.12 159.71 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.983 1.713 . . . . 0.0 112.341 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.4 tp -105.56 87.55 2.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.676 1.191 . . . . 0.0 108.935 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -107.95 127.08 53.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.259 1.424 . . . . 0.0 110.704 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -70.59 159.13 34.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.25 0.932 . . . . 0.0 112.744 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.3 p -159.51 153.18 22.8 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -96.25 -30.01 13.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.24 1.816 . . . . 0.0 110.837 169.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.2 ptm85 -169.21 173.23 6.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.327 2.651 . . . . 0.0 110.67 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.81 -26.81 66.06 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.314 1.046 . . . . 0.0 113.252 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 m -62.99 -18.59 63.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.083 1.353 . . . . 0.0 114.049 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -86.47 -10.55 53.95 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.169 0.988 . . . . 0.0 112.923 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.3 m -101.87 136.34 19.54 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.825 1.25 . . . . 0.0 113.265 -171.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -88.73 155.08 6.17 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.428 2.752 . . . . 0.0 112.559 -169.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.72 -123.14 30.99 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.86 5.89 50.2 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.526 1.13 . . . . 0.0 113.883 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.9 m -64.0 144.9 56.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.408 1.004 . . . . 0.0 112.228 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.3 pt -120.06 155.69 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.42 1.888 . . . . 0.0 109.8 171.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.4 t -79.64 126.27 30.69 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.348 -0.845 . . . . 0.0 110.674 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -97.94 168.26 10.4 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.801 1.24 . . . . 0.0 111.756 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.45 -17.62 66.71 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 124.585 1.088 . . . . 0.0 115.218 -171.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -77.49 -7.84 56.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.714 1.206 . . . . 0.0 114.21 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.0 19.06 52.64 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.123 1.344 . . . . 0.0 114.263 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -129.98 156.22 44.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.323 1.449 . . . . 0.0 112.35 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.5 m -73.08 138.29 45.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.009 1.723 . . . . 0.0 112.203 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.26 -170.48 23.87 Favored Glycine 0 N--CA 1.47 0.95 0 C-N-CA 125.042 1.306 . . . . 0.0 113.556 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.537 0 O-C-N 121.253 -1.146 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.5 p -163.91 152.18 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.911 1.684 . . . . 0.0 108.981 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.8 t -90.48 117.33 67.91 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.104 172.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -62.11 160.57 29.73 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.149 2.566 . . . . 0.0 112.721 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -77.36 32.04 0.15 Allowed 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.263 1.425 . . . . 0.0 113.65 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 pp -80.33 174.05 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.353 1.861 . . . . 0.0 112.853 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.8 tp -136.48 86.75 2.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.292 1.437 . . . . 0.0 108.325 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -109.4 133.03 53.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.511 1.524 . . . . 0.0 110.287 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -70.98 160.01 33.68 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.329 0.968 . . . . 0.0 111.221 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.6 p -160.32 152.27 20.18 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -94.42 -34.59 12.69 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.198 1.799 . . . . 0.0 110.433 169.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -166.77 178.06 6.12 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.233 2.613 . . . . 0.0 110.449 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -61.1 -26.9 67.98 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.1 p -69.64 -13.15 62.16 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -82.08 -18.43 43.1 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.018 0.826 . . . . 0.0 112.593 170.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.6 m -91.66 139.9 25.05 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.697 1.199 . . . . 0.0 113.766 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -85.7 150.13 9.97 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.439 2.759 . . . . 0.0 112.437 -169.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.56 -123.52 32.18 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.35 9.83 42.17 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.646 1.178 . . . . 0.0 113.832 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 91.2 m -61.62 145.71 51.29 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.071 -1.018 . . . . 0.0 112.31 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.2 pt -120.43 154.57 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.398 1.879 . . . . 0.0 110.006 174.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.9 t -80.68 123.87 28.54 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.385 -0.822 . . . . 0.0 110.626 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -95.76 169.97 9.64 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.891 1.277 . . . . 0.0 111.734 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.47 -17.88 67.05 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.574 1.083 . . . . 0.0 115.224 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -78.25 -6.09 53.91 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.839 1.256 . . . . 0.0 114.212 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.0 15.75 60.56 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.082 1.325 . . . . 0.0 114.281 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -127.33 156.53 41.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.975 1.31 . . . . 0.0 113.099 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.2 m -74.02 137.3 43.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.753 1.621 . . . . 0.0 112.466 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.95 -168.93 21.7 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.225 1.393 . . . . 0.0 113.366 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 O-C-N 121.348 -1.09 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 112.566 -0.214 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p -163.37 150.45 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.752 1.621 . . . . 0.0 109.264 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.5 t -90.59 116.16 65.79 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.182 173.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.1 154.46 72.45 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.947 2.432 . . . . 0.0 111.735 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -83.25 14.97 3.15 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -169.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.2 pt -79.18 151.73 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.5 1.52 . . . . 0.0 112.279 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.4 tp -89.47 89.38 7.83 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.322 1.049 . . . . 0.0 109.249 174.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -109.71 122.5 47.62 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.704 1.601 . . . . 0.0 109.61 -173.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -73.14 160.09 32.53 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.169 -0.957 . . . . 0.0 112.095 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.5 p -161.78 153.49 18.94 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -96.31 -32.95 12.14 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.993 1.717 . . . . 0.0 110.34 169.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.7 ptt-85 -165.85 177.32 7.24 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 128.417 2.687 . . . . 0.0 110.437 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -59.33 -27.29 65.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.334 1.054 . . . . 0.0 113.496 -172.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.7 m -60.01 -22.4 62.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.094 1.358 . . . . 0.0 114.067 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -88.56 -10.32 49.21 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.196 0.998 . . . . 0.0 113.085 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.2 m -93.79 140.14 22.93 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -84.43 147.47 11.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.548 2.832 . . . . 0.0 112.317 -169.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.88 -122.03 28.44 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.903 -0.498 . . . . 0.0 111.916 177.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.54 6.0 50.09 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.746 1.218 . . . . 0.0 114.03 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.0 m -63.76 149.62 46.38 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.173 -0.954 . . . . 0.0 113.109 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.9 pt -117.4 157.1 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.605 1.962 . . . . 0.0 110.107 169.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.8 t -84.18 119.93 25.59 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.439 -0.788 . . . . 0.0 110.911 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -88.28 168.09 13.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.651 1.18 . . . . 0.0 111.519 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -16.72 66.04 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.587 1.089 . . . . 0.0 115.297 -172.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -78.06 -7.07 56.47 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 172.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.82 16.94 57.45 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.851 1.215 . . . . 0.0 114.225 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -129.88 156.52 44.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.049 1.34 . . . . 0.0 112.763 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.9 m -76.43 144.0 40.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.164 1.386 . . . . 0.0 113.016 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.81 -170.09 27.16 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.158 1.361 . . . . 0.0 113.444 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.531 0 O-C-N 121.25 -1.147 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.2 p -163.43 150.18 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.689 1.596 . . . . 0.0 109.238 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.4 t -92.57 116.03 65.8 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.261 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 147.2 63.78 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.666 2.244 . . . . 0.0 111.101 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -80.92 17.64 1.16 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.869 1.268 . . . . 0.0 114.379 -171.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.9 pt -75.79 152.91 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.532 1.533 . . . . 0.0 112.231 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.2 tp -88.14 87.35 7.29 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.303 1.041 . . . . 0.0 109.506 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -109.56 121.03 44.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.76 1.624 . . . . 0.0 109.527 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -73.56 159.21 33.47 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.208 -0.932 . . . . 0.0 112.289 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.1 p -161.54 156.21 23.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.18 -32.5 9.11 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.572 1.949 . . . . 0.0 109.686 168.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -159.62 177.1 11.24 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.232 2.213 . . . . 0.0 111.295 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -60.67 -26.78 67.34 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.455 1.102 . . . . 0.0 113.496 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.8 m -60.02 -21.16 61.0 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.02 1.328 . . . . 0.0 113.928 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -86.65 -13.84 44.41 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.237 1.015 . . . . 0.0 113.097 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.1 m -92.35 140.13 24.18 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.46 147.48 11.19 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.573 2.848 . . . . 0.0 112.301 -169.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.96 -121.59 27.05 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.76 5.85 50.34 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.697 1.199 . . . . 0.0 113.964 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.1 m -63.77 150.32 44.85 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.108 -0.995 . . . . 0.0 113.134 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.0 155.68 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.636 1.974 . . . . 0.0 109.941 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.6 t -78.8 131.99 36.71 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.18 -0.95 . . . . 0.0 110.642 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -104.25 167.64 9.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.596 1.158 . . . . 0.0 111.765 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.74 -16.89 66.48 Favored Glycine 0 N--CA 1.477 1.403 0 C-N-CA 124.712 1.149 . . . . 0.0 115.362 -170.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -76.83 -8.06 56.63 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 171.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.4 15.98 56.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.09 1.329 . . . . 0.0 114.2 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -130.98 157.44 42.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.03 1.332 . . . . 0.0 112.631 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.9 m -76.02 141.47 42.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.201 1.4 . . . . 0.0 112.89 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.34 -168.34 19.69 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.417 1.484 . . . . 0.0 113.437 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.496 0 O-C-N 121.237 -1.154 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m -147.69 159.22 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.286 1.834 . . . . 0.0 108.701 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.6 t -93.65 116.72 66.85 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.176 173.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.21 150.11 71.2 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.785 2.324 . . . . 0.0 111.591 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -77.29 13.43 1.17 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -171.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 pt -78.21 151.59 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.539 1.536 . . . . 0.0 112.301 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.4 tp -89.3 88.45 7.5 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.384 1.074 . . . . 0.0 109.407 175.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -109.66 121.97 46.42 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.783 1.633 . . . . 0.0 109.562 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -73.6 159.33 33.25 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.131 -0.98 . . . . 0.0 112.312 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.2 p -163.74 161.86 23.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -112.99 -32.29 6.41 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.505 1.922 . . . . 0.0 110.299 168.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.429 ' HG3' ' H ' ' A' ' 13' ' ' ASP . 1.1 tpm_? -155.33 175.36 13.96 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.141 1.776 . . . . 0.0 111.057 175.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.429 ' H ' ' HG3' ' A' ' 12' ' ' ARG . 22.5 m-20 -61.97 -26.88 68.47 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.165 1.386 . . . . 0.0 113.439 -169.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.2 m -63.36 -18.79 64.04 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.758 1.223 . . . . 0.0 113.499 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -84.67 -13.83 50.32 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.284 1.034 . . . . 0.0 112.901 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.6 m -95.17 141.54 23.38 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.701 1.201 . . . . 0.0 114.18 -169.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -84.39 146.35 10.97 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.585 2.856 . . . . 0.0 112.262 -169.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.84 -122.69 30.53 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.84 5.97 50.34 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.793 1.237 . . . . 0.0 113.986 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.4 m -62.99 149.03 45.91 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.227 -0.921 . . . . 0.0 113.04 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.6 pt -117.86 155.97 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.458 1.903 . . . . 0.0 110.338 170.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 t -82.97 122.71 28.64 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.374 -0.829 . . . . 0.0 111.021 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -93.46 168.13 11.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.7 1.2 . . . . 0.0 111.74 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.7 -17.22 66.8 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.631 1.11 . . . . 0.0 115.294 -171.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -77.7 -7.39 56.42 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 172.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.18 16.99 56.75 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.982 1.277 . . . . 0.0 114.221 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -130.63 157.16 43.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.974 1.309 . . . . 0.0 112.632 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.5 m -76.08 143.51 41.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.185 1.394 . . . . 0.0 112.849 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.86 -167.93 24.02 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.127 1.346 . . . . 0.0 113.422 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 O-C-N 121.326 -1.102 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.787 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p -163.97 151.43 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.818 1.647 . . . . 0.0 109.037 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.4 t -89.41 118.38 69.04 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.209 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -58.8 161.25 15.66 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.472 2.782 . . . . 0.0 113.467 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -78.58 17.91 0.63 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.865 1.266 . . . . 0.0 113.355 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 tp -76.1 148.59 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 126.124 1.77 . . . . 0.0 112.076 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.1 tp -106.2 86.55 2.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.763 1.225 . . . . 0.0 108.101 169.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -107.15 131.63 53.93 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.123 1.369 . . . . 0.0 110.442 -176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -70.56 160.76 31.9 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.059 0.845 . . . . 0.0 111.089 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -160.21 150.76 18.61 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -93.3 -35.67 12.95 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.406 1.882 . . . . 0.0 110.428 169.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -165.04 -179.85 5.96 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.399 2.68 . . . . 0.0 110.198 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -59.72 -26.03 65.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.318 1.047 . . . . 0.0 113.645 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 m -59.46 -22.76 62.01 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.375 1.47 . . . . 0.0 114.176 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -84.47 -17.3 39.57 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.896 0.878 . . . . 0.0 113.004 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.6 m -91.21 138.09 25.94 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -169.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -87.15 151.53 8.15 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.406 2.737 . . . . 0.0 112.441 -169.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.56 -125.07 36.27 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.57 9.36 41.73 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.578 1.151 . . . . 0.0 113.862 174.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.2 m -62.35 146.93 49.91 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.104 -0.997 . . . . 0.0 112.256 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.94 154.53 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.442 1.897 . . . . 0.0 109.823 172.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -78.38 129.86 35.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.336 -0.852 . . . . 0.0 110.525 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -103.29 169.81 8.33 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.644 1.178 . . . . 0.0 111.854 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.52 -17.71 66.96 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.695 1.14 . . . . 0.0 115.297 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -77.28 -6.7 54.12 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.751 1.22 . . . . 0.0 114.131 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.11 15.77 60.34 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.19 1.376 . . . . 0.0 114.201 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -127.95 156.86 42.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.074 1.35 . . . . 0.0 113.098 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.4 m -73.8 136.21 43.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.711 1.605 . . . . 0.0 112.468 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.15 -169.89 20.15 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.332 1.444 . . . . 0.0 113.452 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.53 0 O-C-N 121.169 -1.195 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.6 p -165.06 146.56 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.831 1.652 . . . . 0.0 109.521 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 48.7 t -84.11 117.77 69.55 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.337 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.88 175.58 10.18 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.517 2.811 . . . . 0.0 112.337 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -76.44 35.26 0.14 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.026 1.731 . . . . 0.0 113.635 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.3 pt -80.35 170.82 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.459 1.904 . . . . 0.0 112.185 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.4 tp -143.86 91.03 2.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.969 1.308 . . . . 0.0 109.372 173.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -112.33 136.85 51.27 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.672 1.589 . . . . 0.0 111.041 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -63.94 155.72 29.99 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 118.844 0.747 . . . . 0.0 111.597 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.0 p -159.83 155.15 25.28 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -98.46 -36.19 10.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.443 1.897 . . . . 0.0 110.485 169.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.431 ' HG3' ' H ' ' A' ' 13' ' ' ASP . 1.5 tpm_? -163.16 175.53 10.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.937 2.495 . . . . 0.0 109.442 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 12' ' ' ARG . 24.3 m-20 -60.6 -26.4 66.96 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.397 1.479 . . . . 0.0 113.523 -169.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.5 m -62.54 -20.44 64.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.867 1.267 . . . . 0.0 113.781 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -83.07 -14.25 54.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.723 0.809 . . . . 0.0 113.023 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.3 m -99.03 137.38 20.46 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.046 1.338 . . . . 0.0 113.014 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -86.65 150.93 8.79 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.834 2.356 . . . . 0.0 112.015 -170.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.56 -123.3 32.46 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.34 0.495 . . . . 0.0 112.168 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.17 1.83 56.97 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.689 1.196 . . . . 0.0 114.085 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.8 m -64.2 143.42 57.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.375 0.989 . . . . 0.0 112.376 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.6 pt -120.76 155.86 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.34 1.856 . . . . 0.0 110.132 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.0 t -83.1 116.27 22.25 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.505 -0.747 . . . . 0.0 110.886 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -86.88 169.2 12.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.935 1.294 . . . . 0.0 111.777 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.48 -17.26 66.35 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 124.565 1.079 . . . . 0.0 115.21 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -77.64 -6.6 54.39 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.777 1.231 . . . . 0.0 114.2 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.39 20.46 54.58 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.867 1.223 . . . . 0.0 114.17 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -131.93 157.99 42.59 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.003 1.321 . . . . 0.0 112.865 177.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 75.3 m -73.6 136.77 43.96 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.595 1.558 . . . . 0.0 112.514 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.95 -168.51 22.01 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.257 1.408 . . . . 0.0 113.366 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.515 0 O-C-N 121.262 -1.14 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p -163.92 150.28 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.83 1.652 . . . . 0.0 109.095 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.9 t -90.59 117.86 68.28 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.322 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.32 146.06 52.71 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.875 3.05 . . . . 0.0 113.286 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -78.41 10.49 3.07 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -170.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.4 pt -79.45 154.05 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.333 1.453 . . . . 0.0 112.114 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.34 93.6 6.59 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.508 1.123 . . . . 0.0 108.805 171.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -108.22 133.63 52.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.3 1.44 . . . . 0.0 111.196 -175.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -62.24 153.74 29.66 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.946 0.794 . . . . 0.0 112.269 171.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -160.42 167.02 28.23 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -128.02 -9.94 5.39 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.242 1.417 . . . . 0.0 112.922 169.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 ptm85 -167.01 166.16 15.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.085 2.154 . . . . 0.0 111.987 173.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -61.37 -30.47 70.55 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.565 1.146 . . . . 0.0 112.85 -171.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 m -62.72 -19.14 63.63 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.098 1.359 . . . . 0.0 113.617 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -95.57 -2.57 48.15 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.288 1.435 . . . . 0.0 112.904 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.3 m -97.64 140.42 21.97 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.063 1.345 . . . . 0.0 112.947 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -83.39 148.52 12.93 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.422 2.748 . . . . 0.0 112.559 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.28 -123.55 33.3 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.669 -0.573 . . . . 0.0 111.669 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.93 8.61 43.18 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.703 1.201 . . . . 0.0 113.917 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.2 m -62.38 145.71 53.23 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.439 1.018 . . . . 0.0 112.151 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.8 pt -115.32 154.75 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.198 1.799 . . . . 0.0 110.198 172.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.0 t -82.65 123.54 29.35 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.457 -0.777 . . . . 0.0 110.635 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.44 167.07 11.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.737 1.215 . . . . 0.0 111.761 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.23 66.6 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 124.572 1.082 . . . . 0.0 115.269 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -77.7 -6.41 53.83 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 171.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.44 22.64 46.71 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.872 1.225 . . . . 0.0 113.978 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -132.77 156.36 47.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.216 1.406 . . . . 0.0 112.747 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.8 m -73.82 140.67 45.96 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 112.363 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.94 -172.34 24.06 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 125.194 1.378 . . . . 0.0 113.395 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.499 0 O-C-N 121.273 -1.134 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p -163.77 150.71 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.748 1.619 . . . . 0.0 109.146 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.9 t -90.03 114.0 59.24 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 118.177 -0.916 . . . . 0.0 109.985 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.95 160.89 47.94 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.942 2.428 . . . . 0.0 111.872 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -79.62 18.58 0.73 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.082 1.353 . . . . 0.0 114.246 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.4 mt -79.01 138.15 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.709 1.604 . . . . 0.0 109.921 -176.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.5 tp -84.07 84.83 7.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.16 0.984 . . . . 0.0 108.701 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -107.01 123.42 48.17 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.906 1.682 . . . . 0.0 109.484 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -72.22 159.28 34.36 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.075 -1.016 . . . . 0.0 111.982 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.2 p -162.27 158.46 24.31 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -112.37 -26.71 8.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.265 1.826 . . . . 0.0 110.658 168.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.3 175.97 12.73 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.91 2.084 . . . . 0.0 111.37 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -60.91 -27.19 68.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.966 0.907 . . . . 0.0 113.265 -171.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -62.86 -18.06 62.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.178 1.391 . . . . 0.0 113.881 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.7 -14.2 46.13 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.349 1.059 . . . . 0.0 112.881 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.7 m -93.43 141.36 23.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -83.81 146.35 11.74 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.442 2.762 . . . . 0.0 112.129 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.8 -121.8 27.73 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.79 7.33 46.84 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.792 1.237 . . . . 0.0 113.907 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.2 m -63.19 150.88 41.87 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.127 -0.983 . . . . 0.0 113.023 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.2 pt -119.35 154.76 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.542 1.937 . . . . 0.0 110.162 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.9 t -79.1 132.53 36.62 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.145 -0.972 . . . . 0.0 110.849 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -105.26 167.12 9.94 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.624 1.169 . . . . 0.0 111.798 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.03 -16.51 66.58 Favored Glycine 0 N--CA 1.478 1.478 0 C-N-CA 124.649 1.119 . . . . 0.0 115.433 -170.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -76.8 -6.97 54.47 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.21 58.98 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.043 1.306 . . . . 0.0 114.154 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -130.38 157.49 42.45 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.99 1.316 . . . . 0.0 112.741 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.0 m -76.48 141.51 41.27 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.265 1.426 . . . . 0.0 112.729 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -153.31 -169.71 18.7 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.637 1.589 . . . . 0.0 113.375 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.507 0 O-C-N 121.137 -1.213 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 112.549 -0.221 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p -163.61 150.51 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.751 1.621 . . . . 0.0 109.3 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.2 t -92.75 115.94 65.69 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.33 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.68 145.94 59.16 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.691 2.261 . . . . 0.0 110.975 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -80.82 18.06 1.06 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.825 1.25 . . . . 0.0 114.254 -171.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 pt -75.02 153.38 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.591 1.556 . . . . 0.0 112.235 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.7 tp -87.71 86.66 7.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.279 1.032 . . . . 0.0 109.586 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -109.16 120.41 42.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.843 1.657 . . . . 0.0 109.454 -175.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -72.75 159.29 34.04 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.23 -0.919 . . . . 0.0 112.284 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.4 p -162.37 156.22 21.06 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.93 -31.85 9.05 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.546 1.938 . . . . 0.0 109.726 168.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 ptm85 -161.06 174.65 13.42 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.285 2.234 . . . . 0.0 111.428 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -60.97 -26.6 67.67 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.461 1.104 . . . . 0.0 113.93 -169.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 t -66.03 -14.85 62.4 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -86.16 -14.41 44.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.041 0.937 . . . . 0.0 112.836 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -92.74 140.62 23.79 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.41 147.3 11.21 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.619 2.88 . . . . 0.0 112.314 -169.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.01 -121.56 26.92 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.62 5.77 50.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.691 1.196 . . . . 0.0 114.005 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.3 m -63.91 150.34 45.22 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.19 -0.944 . . . . 0.0 113.146 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.2 pt -119.48 155.9 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.704 2.002 . . . . 0.0 109.913 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.5 t -78.97 132.23 36.61 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.986 -1.071 . . . . 0.0 110.68 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -104.35 167.26 9.86 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.645 1.178 . . . . 0.0 111.775 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -16.77 66.41 Favored Glycine 0 N--CA 1.477 1.393 0 C-N-CA 124.713 1.149 . . . . 0.0 115.4 -170.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -76.69 -8.1 56.62 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.5 16.16 55.65 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.133 1.349 . . . . 0.0 114.13 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -131.4 157.23 43.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.918 1.287 . . . . 0.0 112.679 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.7 m -75.82 141.65 42.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.278 1.431 . . . . 0.0 112.808 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.54 -168.06 19.44 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.375 1.464 . . . . 0.0 113.394 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.489 0 O-C-N 121.175 -1.191 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.859 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.1 p -163.8 150.9 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.861 1.664 . . . . 0.0 109.253 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.8 t -87.4 115.91 64.35 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 118.15 -0.929 . . . . 0.0 109.984 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.45 151.34 80.25 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.69 2.26 . . . . 0.0 111.609 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -75.77 12.62 1.01 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -170.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.1 pt -79.35 148.52 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.397 1.479 . . . . 0.0 111.885 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 tp -95.11 93.47 7.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.394 1.078 . . . . 0.0 109.299 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -109.32 130.01 55.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.216 1.406 . . . . 0.0 110.835 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -70.3 158.0 36.7 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.237 0.926 . . . . 0.0 112.749 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.9 p -159.97 162.63 34.41 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.581 1.153 . . . . 0.0 113.705 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -113.49 -19.11 11.79 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.406 1.482 . . . . 0.0 112.474 168.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -167.87 169.0 11.84 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 127.105 2.162 . . . . 0.0 111.881 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -60.8 -30.9 70.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.628 1.171 . . . . 0.0 112.987 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -62.86 -18.51 63.01 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.999 1.32 . . . . 0.0 113.667 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -97.62 -0.44 45.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.409 1.484 . . . . 0.0 112.79 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.9 m -97.54 142.59 24.79 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.065 1.346 . . . . 0.0 113.018 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -83.56 146.36 12.06 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.619 2.88 . . . . 0.0 112.587 -169.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.91 -120.8 24.38 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.73 7.76 45.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.757 1.223 . . . . 0.0 114.007 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.9 m -62.54 146.73 51.06 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.155 -0.966 . . . . 0.0 112.458 177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.7 pt -116.63 153.49 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.302 1.841 . . . . 0.0 110.195 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -82.32 121.93 27.31 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.481 -0.762 . . . . 0.0 110.43 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -93.89 168.47 10.96 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.852 1.261 . . . . 0.0 111.895 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -17.92 67.5 Favored Glycine 0 N--CA 1.477 1.398 0 C-N-CA 124.683 1.135 . . . . 0.0 115.169 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -77.59 -6.86 55.21 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.669 1.188 . . . . 0.0 114.111 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.64 16.07 58.99 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.076 1.322 . . . . 0.0 114.416 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -126.92 157.5 39.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.475 1.51 . . . . 0.0 112.253 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.3 m -74.7 139.85 43.75 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.049 1.74 . . . . 0.0 112.22 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.43 -170.47 23.13 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.171 1.367 . . . . 0.0 113.465 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.473 0 O-C-N 121.246 -1.149 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 112.41 -0.276 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.18 153.35 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.293 1.837 . . . . 0.0 108.784 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.8 t -85.63 120.5 73.0 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.387 173.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.05 170.72 19.12 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.44 2.76 . . . . 0.0 112.122 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.62 36.64 0.21 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.752 1.621 . . . . 0.0 113.693 -175.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.0 pt -78.4 161.46 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.937 1.695 . . . . 0.0 112.327 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.3 tp -123.21 83.26 2.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 108.567 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -112.1 124.03 51.55 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.98 1.712 . . . . 0.0 109.594 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.5 153.1 36.62 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.344 -0.847 . . . . 0.0 112.819 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -160.38 161.7 33.15 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -113.62 -32.09 6.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.726 2.01 . . . . 0.0 110.349 168.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -155.05 174.43 15.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.797 1.639 . . . . 0.0 111.354 175.102 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.411 ' H ' ' HG3' ' A' ' 12' ' ' ARG . 25.6 m-20 -62.42 -25.8 68.15 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.322 1.449 . . . . 0.0 113.756 -169.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 p -65.31 -16.26 63.39 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.206 1.402 . . . . 0.0 113.852 174.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -83.34 -14.47 52.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.232 1.013 . . . . 0.0 112.838 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -100.76 138.9 20.19 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.942 1.297 . . . . 0.0 113.448 -169.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.22 147.87 9.0 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.149 2.566 . . . . 0.0 111.988 -169.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.17 -122.71 30.8 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.41 0.528 . . . . 0.0 112.415 175.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.29 -0.37 57.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.747 1.219 . . . . 0.0 114.204 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 79.7 m -64.75 144.68 57.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.374 0.988 . . . . 0.0 112.962 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.8 pt -119.18 156.79 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.676 1.99 . . . . 0.0 110.122 172.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.8 t -83.24 119.12 24.16 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.321 -0.862 . . . . 0.0 111.13 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -89.74 167.34 12.96 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.791 1.236 . . . . 0.0 111.743 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.44 -17.0 65.97 Favored Glycine 0 N--CA 1.477 1.408 0 C-N-CA 124.634 1.111 . . . . 0.0 115.295 -172.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -76.83 -8.93 58.25 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 171.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.58 23.48 36.34 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.821 1.2 . . . . 0.0 114.077 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -136.5 157.57 46.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.97 1.308 . . . . 0.0 112.546 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.6 m -73.62 139.19 45.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.463 1.505 . . . . 0.0 112.681 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.44 -167.82 22.44 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 125.247 1.403 . . . . 0.0 113.33 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.522 0 O-C-N 121.299 -1.118 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.902 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.8 p -164.04 150.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.826 1.65 . . . . 0.0 109.277 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.7 t -89.6 117.42 68.14 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.3 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.99 169.63 21.72 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.143 2.562 . . . . 0.0 112.243 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -73.3 26.82 0.06 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.271 1.829 . . . . 0.0 115.3 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.3 pt -75.03 168.24 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.282 1.833 . . . . 0.0 112.752 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.2 tp -132.5 86.48 2.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.273 1.429 . . . . 0.0 108.603 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.26 131.19 54.95 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.506 1.523 . . . . 0.0 110.647 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.54 153.02 37.0 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.895 0.771 . . . . 0.0 112.128 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -160.69 160.59 31.67 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -117.68 -17.44 9.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.893 1.677 . . . . 0.0 111.339 167.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -163.16 168.69 20.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.928 2.091 . . . . 0.0 112.065 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -62.31 -26.15 68.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.943 0.897 . . . . 0.0 113.134 -171.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -63.49 -18.04 63.38 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.962 1.305 . . . . 0.0 113.964 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -79.3 -22.51 44.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.834 0.854 . . . . 0.0 112.494 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.0 m -93.55 134.14 27.08 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.957 1.303 . . . . 0.0 113.788 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -88.29 159.04 6.86 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.374 2.716 . . . . 0.0 112.14 -171.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.11 -123.68 31.88 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.46 6.7 46.99 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.462 1.105 . . . . 0.0 113.787 174.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.2 m -64.23 145.95 55.13 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.144 -0.972 . . . . 0.0 112.451 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.3 pt -122.59 156.12 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.791 2.036 . . . . 0.0 109.737 173.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -77.61 130.57 37.05 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.191 -0.943 . . . . 0.0 110.781 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -104.09 166.98 10.06 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.814 1.245 . . . . 0.0 111.798 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.73 -16.74 66.24 Favored Glycine 0 N--CA 1.477 1.372 0 C-N-CA 124.665 1.126 . . . . 0.0 115.348 -171.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -76.7 -7.52 55.49 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.718 1.207 . . . . 0.0 114.179 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.9 22.11 43.77 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.93 1.253 . . . . 0.0 114.016 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -135.43 157.61 46.46 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.086 1.355 . . . . 0.0 112.736 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.8 m -72.85 137.86 45.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.602 1.561 . . . . 0.0 112.307 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.01 -169.62 21.08 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.255 1.407 . . . . 0.0 113.494 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.5 0 O-C-N 121.228 -1.16 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -163.82 151.08 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.766 1.626 . . . . 0.0 109.155 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.8 t -89.03 114.1 58.8 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.098 173.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.04 153.49 67.57 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.642 2.228 . . . . 0.0 110.92 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -78.88 25.16 0.28 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.861 1.264 . . . . 0.0 114.148 -171.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.3 mt -79.5 136.17 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.845 1.658 . . . . 0.0 109.381 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.7 tp -89.4 88.62 7.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.385 1.074 . . . . 0.0 109.043 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -108.15 130.52 55.12 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.296 1.439 . . . . 0.0 110.579 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -71.68 159.36 34.53 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.026 0.83 . . . . 0.0 111.411 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.4 p -161.67 157.36 24.38 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -108.75 -25.71 10.68 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.495 1.918 . . . . 0.0 110.511 168.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -161.91 172.98 15.15 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.766 2.026 . . . . 0.0 112.142 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.84 -27.36 68.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.238 1.015 . . . . 0.0 112.97 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 m -62.42 -18.66 62.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.312 1.445 . . . . 0.0 113.952 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.47 -20.15 34.54 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.176 0.99 . . . . 0.0 112.683 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.5 m -90.11 141.63 28.0 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -168.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -84.88 147.6 10.63 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.575 2.85 . . . . 0.0 112.32 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.63 -121.51 26.82 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.41 7.89 45.65 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.681 1.192 . . . . 0.0 113.95 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.4 m -62.54 147.03 50.25 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.07 -1.019 . . . . 0.0 112.339 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.2 pt -120.62 154.11 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.496 1.918 . . . . 0.0 110.09 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -79.07 125.82 29.9 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.341 -0.849 . . . . 0.0 110.616 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -99.06 168.71 9.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.754 1.222 . . . . 0.0 111.89 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.87 -17.43 67.42 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 124.628 1.108 . . . . 0.0 115.241 -172.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -77.35 -6.68 54.19 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.663 1.185 . . . . 0.0 114.116 171.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.95 15.4 59.4 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.157 1.36 . . . . 0.0 114.3 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -128.34 156.65 42.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.914 1.286 . . . . 0.0 113.019 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.8 m -73.23 138.52 45.63 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.536 1.534 . . . . 0.0 112.298 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.44 -167.61 20.33 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.144 1.354 . . . . 0.0 113.398 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.477 0 O-C-N 121.194 -1.18 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.3 p -163.76 152.56 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.856 1.663 . . . . 0.0 109.084 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.94 115.46 63.99 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 118.308 -0.854 . . . . 0.0 109.831 171.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.74 170.32 18.97 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.837 2.358 . . . . 0.0 111.832 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -76.71 33.43 0.14 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.765 1.626 . . . . 0.0 113.785 -174.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -79.72 173.73 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.296 1.839 . . . . 0.0 112.649 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 tp -141.97 88.48 2.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.171 1.389 . . . . 0.0 108.398 169.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -110.23 134.67 52.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.568 1.547 . . . . 0.0 110.04 -177.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -68.35 160.87 28.66 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.476 1.035 . . . . 0.0 110.794 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -157.01 150.9 24.69 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -94.2 -28.87 15.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.282 1.433 . . . . 0.0 111.431 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.0 ptm85 -173.51 174.17 3.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.666 2.787 . . . . 0.0 110.728 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -59.19 -31.04 68.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.508 1.123 . . . . 0.0 113.141 -173.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -63.87 -17.64 63.38 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.943 1.297 . . . . 0.0 113.836 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -92.0 -9.39 43.08 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.132 1.373 . . . . 0.0 112.398 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.8 m -92.18 140.74 24.55 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.008 1.323 . . . . 0.0 113.399 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.92 149.95 12.47 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.374 2.716 . . . . 0.0 112.404 -169.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.88 -122.72 29.59 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.72 10.84 40.65 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.583 1.153 . . . . 0.0 113.706 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -61.27 146.74 46.86 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.119 -0.988 . . . . 0.0 112.579 176.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.4 pt -118.89 152.94 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.417 1.887 . . . . 0.0 110.227 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -82.21 121.39 26.56 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.418 -0.801 . . . . 0.0 110.531 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.06 169.71 10.07 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.928 1.291 . . . . 0.0 111.817 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.99 67.49 Favored Glycine 0 N--CA 1.477 1.396 0 C-N-CA 124.6 1.095 . . . . 0.0 115.14 -172.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -78.33 -5.59 52.61 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.824 1.25 . . . . 0.0 114.197 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.09 13.84 63.48 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.182 1.373 . . . . 0.0 114.409 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -124.85 156.67 37.49 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.064 1.345 . . . . 0.0 113.373 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.5 m -73.97 137.49 43.57 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.87 1.668 . . . . 0.0 112.447 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.76 -169.32 20.58 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.329 1.442 . . . . 0.0 113.267 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.482 0 O-C-N 121.3 -1.117 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.9 m -147.76 158.92 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 126.365 1.866 . . . . 0.0 108.68 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.6 t -96.84 117.73 65.62 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.637 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -53.96 142.87 63.31 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.257 3.305 . . . . 0.0 113.276 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.55 13.57 6.73 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.4 pt -79.13 154.4 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.496 1.518 . . . . 0.0 112.347 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.0 tp -87.82 88.45 7.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.37 1.068 . . . . 0.0 109.299 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -109.3 121.88 46.13 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.82 1.648 . . . . 0.0 109.675 -174.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -73.51 159.66 32.85 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.148 -0.97 . . . . 0.0 112.311 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -162.44 159.49 25.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -175.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -109.98 -29.68 8.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.321 1.848 . . . . 0.0 110.503 168.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -158.98 177.58 10.98 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.542 1.937 . . . . 0.0 111.965 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.21 -27.31 68.89 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -169.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.0 p -69.87 -12.38 61.58 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -83.85 -14.05 52.16 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.029 0.932 . . . . 0.0 112.558 171.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.3 m -96.0 140.53 22.31 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.924 1.29 . . . . 0.0 113.984 -169.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -84.25 147.91 11.57 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.459 2.772 . . . . 0.0 112.206 -169.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.22 -125.1 37.88 Favored Glycine 0 CA--C 1.532 1.102 0 O-C-N 121.84 -0.538 . . . . 0.0 111.911 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.2 6.62 47.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.92 1.288 . . . . 0.0 114.1 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.3 m -62.52 147.5 48.72 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.055 -1.028 . . . . 0.0 112.813 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.7 pt -115.5 156.99 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.507 1.923 . . . . 0.0 110.228 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.3 t -83.5 118.11 23.55 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.47 -0.769 . . . . 0.0 110.797 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.5 mmm-85 -86.85 167.46 14.33 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.635 1.174 . . . . 0.0 111.609 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.66 -16.76 66.12 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 124.601 1.096 . . . . 0.0 115.322 -172.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -77.73 -7.5 56.62 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.687 1.195 . . . . 0.0 114.186 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.23 17.41 55.68 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.885 1.231 . . . . 0.0 114.264 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -130.49 156.29 45.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.85 1.26 . . . . 0.0 112.71 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.9 m -75.26 143.47 43.02 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.133 1.373 . . . . 0.0 112.857 -175.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.57 -170.33 28.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.943 1.259 . . . . 0.0 113.494 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.481 0 O-C-N 121.229 -1.16 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 p -163.52 149.82 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.672 1.589 . . . . 0.0 109.375 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.0 t -91.56 117.42 67.78 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.233 173.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.81 149.66 86.54 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.829 2.353 . . . . 0.0 111.336 176.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -81.82 18.24 1.33 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -169.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.6 pt -74.57 150.98 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.412 1.485 . . . . 0.0 111.993 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 tp -94.33 86.39 4.88 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.265 1.026 . . . . 0.0 109.18 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -107.73 124.73 50.46 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.391 1.477 . . . . 0.0 110.699 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -70.89 158.57 36.19 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.18 -0.95 . . . . 0.0 113.106 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.1 p -159.17 154.72 25.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -174.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -100.57 -31.85 11.05 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.259 1.423 . . . . 0.0 110.721 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.72 177.32 9.45 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.083 2.153 . . . . 0.0 111.155 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -60.8 -25.52 66.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -63.39 -19.46 64.69 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.933 1.293 . . . . 0.0 113.993 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.8 -17.67 52.79 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.064 0.946 . . . . 0.0 112.798 173.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.8 m -98.83 137.11 20.5 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.803 1.241 . . . . 0.0 113.837 -169.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -88.76 154.55 6.14 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.752 2.968 . . . . 0.0 112.446 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -121.5 26.55 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.28 5.04 51.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.449 1.1 . . . . 0.0 113.933 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.8 m -64.91 145.4 56.35 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.458 1.026 . . . . 0.0 112.217 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.5 pt -120.42 156.29 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.572 1.949 . . . . 0.0 109.755 171.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.8 t -79.65 125.86 30.18 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.315 -0.866 . . . . 0.0 110.62 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -97.47 168.36 10.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.732 1.213 . . . . 0.0 111.819 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.58 -17.62 67.0 Favored Glycine 0 N--CA 1.476 1.354 0 C-N-CA 124.631 1.11 . . . . 0.0 115.273 -171.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -77.31 -8.18 57.22 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.673 1.189 . . . . 0.0 114.181 171.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.32 18.51 52.8 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.09 1.329 . . . . 0.0 114.346 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -129.8 156.6 44.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.414 1.486 . . . . 0.0 112.238 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 82.4 m -72.91 139.21 46.66 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.979 1.711 . . . . 0.0 112.376 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.35 -169.13 24.22 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 124.977 1.275 . . . . 0.0 113.514 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 O-C-N 121.256 -1.144 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -145.5 136.52 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.812 1.645 . . . . 0.0 107.943 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.7 t -79.33 119.9 78.61 Favored Pre-proline 0 CA--C 1.551 0.984 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.217 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.26 173.25 11.69 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.625 2.884 . . . . 0.0 112.845 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -75.32 33.02 0.1 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.262 1.825 . . . . 0.0 114.048 -174.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.8 pt -78.37 168.93 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.027 1.731 . . . . 0.0 112.169 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 tp -137.85 83.44 1.98 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.844 1.257 . . . . 0.0 108.847 170.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -106.75 126.51 52.38 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.484 1.514 . . . . 0.0 110.108 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -70.28 156.67 38.95 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.32 0.964 . . . . 0.0 112.804 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.1 p -160.0 156.98 27.94 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -106.96 -25.44 11.63 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.575 1.95 . . . . 0.0 110.607 168.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -163.11 171.87 15.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.461 1.904 . . . . 0.0 112.143 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -61.32 -27.11 68.25 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 113.058 -172.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -62.7 -18.46 62.51 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.145 1.378 . . . . 0.0 113.856 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -81.16 -22.03 39.28 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.083 0.953 . . . . 0.0 112.417 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.1 m -92.69 135.95 25.69 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.886 1.274 . . . . 0.0 113.244 -169.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.72 148.14 9.67 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.965 2.444 . . . . 0.0 111.918 -170.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.27 -122.73 30.82 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.437 0.542 . . . . 0.0 112.378 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.58 -2.56 58.7 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.81 1.244 . . . . 0.0 114.313 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -65.74 146.3 54.95 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.325 0.966 . . . . 0.0 112.844 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.9 pt -125.1 155.39 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.859 2.064 . . . . 0.0 109.632 174.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.79 131.29 37.54 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.146 -0.971 . . . . 0.0 110.712 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -105.95 168.15 9.32 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.649 1.18 . . . . 0.0 111.79 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.82 -17.11 66.93 Favored Glycine 0 N--CA 1.477 1.394 0 C-N-CA 124.632 1.11 . . . . 0.0 115.255 -171.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -76.52 -7.99 56.27 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.701 1.2 . . . . 0.0 114.095 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.17 17.79 54.97 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.079 1.323 . . . . 0.0 114.266 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -130.77 157.97 41.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.341 1.456 . . . . 0.0 112.306 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.1 m -73.81 135.21 43.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.086 1.754 . . . . 0.0 112.057 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.41 -168.92 18.56 Favored Glycine 0 N--CA 1.471 1.009 0 C-N-CA 125.398 1.475 . . . . 0.0 113.315 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.521 0 O-C-N 121.233 -1.157 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p -163.95 151.8 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.861 1.665 . . . . 0.0 109.024 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.6 t -89.23 117.33 68.12 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.925 171.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -61.6 163.26 18.73 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.194 2.596 . . . . 0.0 113.153 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -76.01 28.29 0.11 Allowed 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.598 1.559 . . . . 0.0 113.871 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.09 174.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.531 1.932 . . . . 0.0 112.939 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.8 tp -138.88 88.05 2.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.391 1.476 . . . . 0.0 108.226 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -109.29 133.07 53.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.503 1.521 . . . . 0.0 110.439 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -69.05 158.9 33.88 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.246 0.93 . . . . 0.0 111.06 176.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.8 p -160.95 157.87 27.14 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -176.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -111.03 -24.38 10.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.619 1.968 . . . . 0.0 110.615 168.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -161.91 173.29 14.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.835 2.054 . . . . 0.0 111.977 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.68 -26.68 67.28 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.232 1.013 . . . . 0.0 113.024 -173.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 m -60.98 -20.16 62.02 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.548 1.539 . . . . 0.0 113.968 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -82.79 -20.78 35.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.247 1.019 . . . . 0.0 112.697 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.8 m -90.87 138.98 25.98 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 124.933 1.293 . . . . 0.0 114.312 -168.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -86.27 151.38 9.32 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.417 2.745 . . . . 0.0 112.301 -170.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.4 -124.03 33.76 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.73 10.51 41.0 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.639 1.176 . . . . 0.0 113.765 173.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 80.6 m -61.8 147.05 47.65 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.157 -0.964 . . . . 0.0 112.082 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.31 153.23 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.42 1.888 . . . . 0.0 110.029 175.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -77.47 130.01 36.45 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.357 -0.839 . . . . 0.0 110.629 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -104.91 168.64 8.92 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.716 1.207 . . . . 0.0 111.866 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -17.18 66.93 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 124.743 1.163 . . . . 0.0 115.247 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -76.95 -6.41 52.43 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.795 1.238 . . . . 0.0 114.109 171.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.22 16.72 58.7 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.125 1.345 . . . . 0.0 114.13 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -129.81 156.65 43.99 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.97 1.308 . . . . 0.0 113.25 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 82.9 m -73.67 134.12 43.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.773 1.629 . . . . 0.0 112.084 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.11 -172.38 19.41 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 125.428 1.489 . . . . 0.0 113.382 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.525 0 O-C-N 121.263 -1.14 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.767 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.0 p -164.96 146.93 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.916 1.687 . . . . 0.0 109.553 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.2 t -83.78 117.99 70.17 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.161 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.42 172.29 14.49 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.388 2.725 . . . . 0.0 112.245 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.01 34.57 0.13 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.928 1.691 . . . . 0.0 113.914 -175.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.0 pt -79.05 168.22 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.135 1.774 . . . . 0.0 112.112 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.4 tp -136.49 86.41 2.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.961 1.304 . . . . 0.0 108.597 169.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -108.04 134.78 50.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.757 1.623 . . . . 0.0 110.635 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.34 154.95 22.56 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.413 1.006 . . . . 0.0 111.974 171.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.1 p -153.6 151.04 29.28 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.605 1.705 . . . . 0.0 115.605 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -96.51 -25.43 15.65 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.697 1.999 . . . . 0.0 113.246 169.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -174.89 173.69 2.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 128.01 2.524 . . . . 0.0 111.257 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -60.2 -33.43 72.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.329 1.052 . . . . 0.0 112.871 -175.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -64.38 -16.58 62.55 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.942 1.297 . . . . 0.0 113.474 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -93.34 -8.26 42.47 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.635 1.574 . . . . 0.0 112.516 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.8 m -94.71 138.95 22.09 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.534 1.534 . . . . 0.0 112.629 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -84.02 149.79 12.29 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.107 2.538 . . . . 0.0 112.2 -169.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -123.72 33.14 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.297 0.475 . . . . 0.0 111.985 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.59 3.5 55.41 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.603 1.161 . . . . 0.0 114.015 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.6 m -63.61 145.97 54.66 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.159 -0.963 . . . . 0.0 112.683 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.2 pt -119.88 154.77 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.74 2.016 . . . . 0.0 110.039 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.9 t -83.51 123.16 29.46 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.39 -0.819 . . . . 0.0 110.531 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -95.28 169.36 10.13 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.732 1.213 . . . . 0.0 111.796 -176.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.48 -17.92 67.13 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.653 1.121 . . . . 0.0 115.157 -172.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -78.0 -6.43 54.46 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.741 1.216 . . . . 0.0 114.188 171.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.96 18.8 57.36 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.048 1.309 . . . . 0.0 114.189 -178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -129.37 157.53 41.66 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.207 1.403 . . . . 0.0 112.69 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.9 m -73.23 138.9 45.85 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.492 1.517 . . . . 0.0 112.377 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.85 -168.58 20.41 Favored Glycine 0 N--CA 1.47 0.904 0 C-N-CA 125.434 1.492 . . . . 0.0 113.228 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.525 0 O-C-N 121.3 -1.118 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.3 t -145.78 139.0 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 126.044 1.738 . . . . 0.0 107.764 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 40.3 t -80.72 118.73 73.7 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.387 175.271 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.81 169.69 20.57 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.014 2.476 . . . . 0.0 111.776 177.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -77.43 39.32 0.26 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.434 1.493 . . . . 0.0 113.41 -176.524 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -79.32 172.9 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.946 1.698 . . . . 0.0 112.326 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.8 tp -142.38 87.13 2.0 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.007 1.323 . . . . 0.0 108.75 172.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -111.04 134.59 52.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.548 1.539 . . . . 0.0 110.587 -177.418 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -62.64 153.6 31.78 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.065 0.848 . . . . 0.0 111.987 175.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.1 p -159.26 156.73 29.31 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 176.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -110.04 -26.61 9.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.883 2.073 . . . . 0.0 110.105 168.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -159.54 171.92 18.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.4 1.88 . . . . 0.0 112.287 178.354 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -61.13 -27.69 68.57 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.199 1.0 . . . . 0.0 113.057 -172.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.6 m -63.33 -17.28 62.4 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.158 1.383 . . . . 0.0 113.94 176.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -81.83 -21.17 37.74 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.038 0.935 . . . . 0.0 112.619 173.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.7 m -90.78 140.86 26.45 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 114.356 -168.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -84.2 145.96 11.09 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.227 2.618 . . . . 0.0 111.912 -169.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.59 -122.37 29.57 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 121.977 -0.452 . . . . 0.0 112.003 177.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.69 5.37 52.05 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.692 1.197 . . . . 0.0 114.079 176.417 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.6 m -62.3 146.37 51.24 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.198 -0.939 . . . . 0.0 112.421 176.356 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.8 pt -122.57 154.77 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.612 1.965 . . . . 0.0 109.907 175.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -78.32 129.29 34.84 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.332 -0.855 . . . . 0.0 110.728 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -103.42 168.02 9.43 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.798 1.239 . . . . 0.0 111.79 -178.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.86 -16.9 66.76 Favored Glycine 0 N--CA 1.477 1.422 0 C-N-CA 124.638 1.113 . . . . 0.0 115.244 -171.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -77.15 -6.62 53.63 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.71 1.204 . . . . 0.0 114.14 171.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.07 20.0 54.22 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.862 1.22 . . . . 0.0 114.039 -178.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -133.34 158.75 42.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.205 1.402 . . . . 0.0 112.682 177.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.3 m -74.17 138.28 43.7 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.665 1.586 . . . . 0.0 112.465 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.65 -168.29 19.14 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.291 1.424 . . . . 0.0 113.305 175.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.468 0 O-C-N 121.251 -1.147 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.817 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.1 m -147.81 159.58 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 126.281 1.832 . . . . 0.0 108.637 178.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.6 t -91.4 116.57 66.71 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.963 172.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.82 152.12 77.76 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.833 2.355 . . . . 0.0 111.363 177.044 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.56 15.43 1.31 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -169.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.8 pt -79.37 149.55 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.238 1.415 . . . . 0.0 111.87 179.055 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.6 tp -95.9 94.53 7.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.5 1.12 . . . . 0.0 109.363 177.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -110.31 132.8 53.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.186 1.394 . . . . 0.0 111.153 -177.072 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -63.28 156.18 26.33 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.853 0.751 . . . . 0.0 112.102 174.529 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.3 p -158.95 152.79 23.27 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 175.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -97.23 -31.34 12.48 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.504 1.922 . . . . 0.0 110.602 169.253 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -168.19 173.64 7.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.363 2.665 . . . . 0.0 110.518 -175.061 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.38 -26.63 65.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.294 1.038 . . . . 0.0 113.222 -172.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -61.01 -21.6 63.74 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.458 1.503 . . . . 0.0 114.157 177.213 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -84.53 -16.96 40.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.016 0.926 . . . . 0.0 112.795 175.263 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.8 m -91.6 139.94 25.14 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 124.616 1.166 . . . . 0.0 114.054 -169.696 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -84.73 147.17 10.75 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.653 2.902 . . . . 0.0 112.42 -169.67 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.51 -121.27 26.07 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 177.096 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.03 6.37 49.01 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.759 1.224 . . . . 0.0 113.973 175.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.1 m -62.77 146.45 52.47 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.485 1.039 . . . . 0.0 112.169 177.325 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.65 156.26 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.313 1.845 . . . . 0.0 109.963 171.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.2 t -80.12 127.33 32.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.368 -0.832 . . . . 0.0 110.852 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -97.83 164.63 12.3 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.843 1.257 . . . . 0.0 111.48 -179.533 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.93 -19.94 63.95 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -169.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -79.87 -6.66 57.83 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 118.468 1.134 . . . . 0.0 113.861 174.318 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.21 23.5 22.01 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.115 1.341 . . . . 0.0 114.451 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -135.68 156.5 48.74 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.924 1.29 . . . . 0.0 112.832 178.243 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.6 m -74.04 140.6 45.5 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.775 1.63 . . . . 0.0 112.804 -177.346 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.36 -171.46 24.28 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 125.272 1.415 . . . . 0.0 113.398 176.261 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.522 0 O-C-N 121.3 -1.118 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.7 m -148.1 161.49 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.388 1.875 . . . . 0.0 108.56 178.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 40.7 t -91.01 117.32 67.82 Favored Pre-proline 0 CA--C 1.547 0.864 0 CA-C-O 118.19 -0.909 . . . . 0.0 109.845 170.524 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.28 168.43 22.24 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.023 2.482 . . . . 0.0 112.098 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -75.51 31.22 0.1 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 125.839 1.655 . . . . 0.0 113.522 -177.555 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.3 tt -80.92 156.17 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.396 1.878 . . . . 0.0 111.883 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.9 tp -122.69 85.84 2.48 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.998 1.319 . . . . 0.0 108.135 169.166 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -109.15 132.7 53.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.535 1.534 . . . . 0.0 110.6 -175.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -72.15 159.36 34.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.158 0.89 . . . . 0.0 111.48 177.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.8 p -161.76 158.05 25.18 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -174.298 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.56 -29.46 8.75 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.38 1.872 . . . . 0.0 110.475 168.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -159.81 177.52 10.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.552 1.941 . . . . 0.0 111.969 176.36 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -63.28 -26.7 68.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -169.407 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.0 p -69.69 -11.76 61.1 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 177.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -81.92 -14.88 55.51 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.088 0.955 . . . . 0.0 112.616 170.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.1 m -99.7 139.97 21.23 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.193 1.397 . . . . 0.0 113.49 -169.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -87.0 151.27 8.34 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.363 2.709 . . . . 0.0 112.375 -169.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.2 -122.57 29.89 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 178.247 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.62 7.75 45.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.579 1.152 . . . . 0.0 113.884 175.061 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.1 m -62.37 145.25 54.44 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.107 -0.996 . . . . 0.0 112.16 176.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.7 pt -120.02 155.21 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.467 1.907 . . . . 0.0 110.01 173.372 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -80.16 123.12 27.63 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.441 -0.787 . . . . 0.0 110.677 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -95.13 169.08 10.35 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.856 1.262 . . . . 0.0 111.783 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.61 67.05 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 124.54 1.067 . . . . 0.0 115.197 -172.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -78.17 -6.08 53.7 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.702 1.201 . . . . 0.0 114.211 171.5 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.21 15.57 60.46 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.081 1.324 . . . . 0.0 114.296 -178.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -127.28 156.19 42.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.841 1.257 . . . . 0.0 112.984 178.566 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -72.52 138.7 47.13 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.716 1.606 . . . . 0.0 112.252 -178.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.97 -169.16 23.85 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.085 1.326 . . . . 0.0 113.489 177.45 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.535 0 O-C-N 121.321 -1.105 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m -148.1 159.56 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 126.263 1.825 . . . . 0.0 108.543 178.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.1 t -90.27 117.21 67.86 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.871 172.421 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.17 152.27 79.96 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.765 2.31 . . . . 0.0 111.539 178.026 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.42 15.13 1.34 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -169.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.2 pt -79.16 149.17 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.279 1.432 . . . . 0.0 111.753 178.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.6 tp -95.04 92.0 6.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.343 1.057 . . . . 0.0 109.206 175.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -108.73 130.04 55.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.279 1.432 . . . . 0.0 110.635 -178.117 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -69.85 160.36 31.93 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.479 1.036 . . . . 0.0 112.539 172.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.7 p -158.21 151.96 23.66 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -176.01 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -88.1 -39.56 14.48 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.168 1.387 . . . . 0.0 111.386 169.379 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -165.4 179.62 6.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.429 2.291 . . . . 0.0 110.942 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.14 -29.66 69.91 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.509 1.123 . . . . 0.0 113.947 -170.336 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.7 p -66.91 -17.48 64.92 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.326 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -94.76 -1.73 52.36 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.168 1.387 . . . . 0.0 112.85 176.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.0 m -96.12 141.73 23.56 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.921 1.288 . . . . 0.0 112.936 177.344 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -83.61 146.5 12.05 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.538 2.826 . . . . 0.0 112.611 -169.289 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.88 -122.04 28.48 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 177.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.45 6.47 48.91 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.681 1.192 . . . . 0.0 114.007 175.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.7 m -62.47 145.47 54.08 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.373 0.988 . . . . 0.0 112.411 178.065 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.3 pt -114.45 155.57 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.37 1.868 . . . . 0.0 110.008 170.353 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.1 t -84.9 115.11 22.59 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.511 -0.743 . . . . 0.0 110.432 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -84.23 168.58 15.59 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.045 1.338 . . . . 0.0 111.726 -176.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.31 -17.76 66.56 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 124.503 1.049 . . . . 0.0 115.188 -173.095 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -78.37 -6.57 55.56 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.76 1.224 . . . . 0.0 114.195 171.754 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.84 17.33 58.27 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.994 1.283 . . . . 0.0 114.452 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.07 157.26 40.11 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.352 1.461 . . . . 0.0 112.363 177.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.5 m -74.95 139.82 43.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.861 1.664 . . . . 0.0 112.573 -178.035 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.89 -168.82 24.34 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.104 1.335 . . . . 0.0 113.377 177.677 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.433 0 O-C-N 121.276 -1.132 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.756 0 N-CA-C 112.555 -0.218 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p -163.58 149.85 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.706 1.603 . . . . 0.0 109.305 -178.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.0 t -91.38 118.83 68.67 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.401 174.538 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.78 141.89 55.86 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.65 2.233 . . . . 0.0 110.558 172.605 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -82.14 30.25 0.4 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.629 1.172 . . . . 0.0 113.91 -169.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt -78.98 150.36 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.621 1.569 . . . . 0.0 111.671 177.419 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.0 tp -92.67 86.71 5.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.086 0.954 . . . . 0.0 109.164 174.256 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -109.33 128.09 54.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.665 1.586 . . . . 0.0 110.895 -176.339 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -63.66 154.07 34.11 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.931 0.787 . . . . 0.0 112.354 178.002 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.9 p -159.46 162.02 35.55 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 175.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -115.49 -23.05 8.99 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.619 1.968 . . . . 0.0 110.703 168.213 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -161.91 169.75 20.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.681 1.993 . . . . 0.0 112.376 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -63.32 -27.11 69.1 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -169.401 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.7 p -71.35 -10.59 60.01 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 177.187 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -79.77 -18.51 50.85 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.208 -0.932 . . . . 0.0 112.108 169.468 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.3 m -98.91 138.74 20.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.388 1.475 . . . . 0.0 113.616 -169.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -87.53 152.89 7.7 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.755 2.97 . . . . 0.0 112.49 -169.599 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -120.63 23.48 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 176.384 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.03 5.38 50.5 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.474 1.11 . . . . 0.0 113.923 175.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.0 m -64.24 143.44 57.89 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.516 1.053 . . . . 0.0 112.166 179.007 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.0 pt -116.72 157.72 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.522 1.929 . . . . 0.0 109.973 171.777 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.7 t -81.72 117.96 22.46 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.394 -0.816 . . . . 0.0 110.585 178.073 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -87.74 167.52 13.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.889 1.276 . . . . 0.0 111.682 -177.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.29 -17.48 66.2 Favored Glycine 0 N--CA 1.478 1.456 0 C-N-CA 124.519 1.057 . . . . 0.0 115.25 -172.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -77.23 -8.56 57.79 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 171.592 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.81 21.38 43.27 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.937 1.256 . . . . 0.0 114.201 -178.229 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -132.9 156.84 46.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.082 1.353 . . . . 0.0 112.26 177.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.6 m -70.85 142.35 51.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.166 1.386 . . . . 0.0 112.311 -178.598 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.23 -167.81 28.46 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.787 1.184 . . . . 0.0 113.609 177.315 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.537 0 O-C-N 121.315 -1.109 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.843 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 p -163.75 149.17 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.777 1.631 . . . . 0.0 109.143 -179.174 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 t -90.63 120.04 68.94 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.312 173.875 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.72 145.66 48.28 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 124.092 3.195 . . . . 0.0 113.292 173.107 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -89.86 11.85 19.04 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 pp -79.67 167.3 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.629 1.572 . . . . 0.0 112.188 172.068 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.2 tp -108.22 100.09 9.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.91 1.284 . . . . 0.0 109.831 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -113.01 131.7 55.67 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.278 1.431 . . . . 0.0 111.01 -179.296 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -71.76 161.62 30.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.116 0.871 . . . . 0.0 111.273 173.393 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.9 p -160.13 151.38 19.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -175.042 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.8 ttt180 -88.97 -38.21 14.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.348 1.459 . . . . 0.0 111.293 169.281 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -164.88 178.49 7.12 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.359 2.264 . . . . 0.0 111.028 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -58.88 -30.67 67.92 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.69 1.196 . . . . 0.0 113.429 -173.317 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -60.67 -21.15 62.5 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.961 1.304 . . . . 0.0 113.833 177.255 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -97.9 0.2 46.14 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.251 1.42 . . . . 0.0 113.038 179.481 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.5 m -97.47 141.09 22.48 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.042 1.337 . . . . 0.0 113.07 178.223 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.43 148.13 11.37 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.49 2.793 . . . . 0.0 112.607 -169.397 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.7 -124.05 34.55 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 179.008 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.88 7.66 45.25 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.719 1.208 . . . . 0.0 114.052 175.24 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.2 m -62.35 145.52 53.67 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.15 -0.969 . . . . 0.0 112.517 178.057 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -115.25 154.6 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.363 1.865 . . . . 0.0 110.098 170.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.0 t -84.13 112.72 20.5 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.478 -0.764 . . . . 0.0 110.328 179.317 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -81.48 168.69 18.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.994 1.317 . . . . 0.0 111.717 -177.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.24 -17.84 66.51 Favored Glycine 0 N--CA 1.478 1.457 0 C-N-CA 124.572 1.082 . . . . 0.0 115.143 -172.829 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -78.27 -6.36 54.74 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.754 1.222 . . . . 0.0 114.212 171.533 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.62 16.4 58.53 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.036 1.303 . . . . 0.0 114.379 -178.603 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -126.51 154.99 43.03 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.919 1.287 . . . . 0.0 113.184 178.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 81.8 m -73.6 137.19 44.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.349 1.46 . . . . 0.0 112.384 -177.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.49 -167.42 21.91 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.048 1.309 . . . . 0.0 113.347 178.037 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.449 0 O-C-N 121.224 -1.162 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m -148.38 159.6 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.372 1.869 . . . . 0.0 108.448 178.701 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.9 t -89.92 118.64 69.09 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.058 171.577 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -62.4 165.18 15.82 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.203 2.602 . . . . 0.0 113.235 177.153 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.39 21.93 0.59 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.038 1.335 . . . . 0.0 114.527 -171.477 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.25 168.18 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.082 1.353 . . . . 0.0 112.989 -177.018 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.9 tp -125.59 86.04 2.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.105 1.362 . . . . 0.0 107.885 169.0 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -106.97 130.19 54.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.34 1.456 . . . . 0.0 110.393 -175.693 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -71.01 158.44 36.51 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.109 0.868 . . . . 0.0 111.262 177.022 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.5 p -160.97 157.24 26.05 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.521 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -107.71 -28.13 9.88 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.715 2.006 . . . . 0.0 110.116 168.488 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 -160.13 172.46 17.41 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.362 1.865 . . . . 0.0 112.486 179.643 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -61.2 -27.36 68.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.211 1.004 . . . . 0.0 113.02 -172.669 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -63.42 -17.34 62.56 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.091 1.357 . . . . 0.0 113.949 177.021 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -82.01 -20.81 37.66 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.161 0.984 . . . . 0.0 112.636 173.508 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.8 m -92.14 139.54 24.31 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.158 1.383 . . . . 0.0 114.202 -168.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -86.26 151.21 9.32 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.356 2.704 . . . . 0.0 112.229 -170.182 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.96 -125.48 38.28 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.13 10.45 39.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.574 1.15 . . . . 0.0 113.874 174.076 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.31 145.56 51.01 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.13 -0.981 . . . . 0.0 112.064 174.565 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.02 153.61 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.278 1.831 . . . . 0.0 110.062 173.876 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.8 t -78.09 124.39 27.99 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.502 -0.749 . . . . 0.0 110.546 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -98.13 169.36 9.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.774 1.23 . . . . 0.0 111.782 -176.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.55 -17.68 67.0 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 124.58 1.086 . . . . 0.0 115.223 -172.571 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -78.09 -6.35 54.38 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.686 1.194 . . . . 0.0 114.21 171.54 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.41 16.26 59.09 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.063 1.316 . . . . 0.0 114.315 -178.424 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -128.24 156.12 43.47 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.971 1.309 . . . . 0.0 113.081 178.752 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.3 m -72.12 136.89 46.67 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.535 1.534 . . . . 0.0 112.075 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.33 -169.46 21.14 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.205 1.383 . . . . 0.0 113.063 177.398 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.555 0 O-C-N 121.4 -1.059 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.788 0 N-CA-C 112.432 -0.267 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.1 m -148.0 163.26 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 126.393 1.877 . . . . 0.0 108.732 179.013 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.0 t -95.69 117.02 66.67 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.342 -0.837 . . . . 0.0 109.761 169.796 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.64 172.23 16.18 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.124 2.55 . . . . 0.0 112.404 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -72.22 25.5 0.05 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.53 1.932 . . . . 0.0 115.476 -175.444 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.2 pt -77.69 170.31 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.313 1.845 . . . . 0.0 112.764 -177.537 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.5 tp -136.86 88.05 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.24 1.416 . . . . 0.0 108.467 169.606 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -108.94 133.68 52.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.529 1.532 . . . . 0.0 110.859 -175.712 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -63.58 154.89 31.24 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.996 0.816 . . . . 0.0 112.248 175.722 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.8 p -159.38 156.91 29.33 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 176.176 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -107.15 -32.35 7.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.819 2.048 . . . . 0.0 110.141 168.659 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -158.03 176.64 12.26 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.227 1.811 . . . . 0.0 112.054 176.868 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -63.09 -26.71 68.96 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.498 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.4 p -69.56 -12.29 61.52 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -78.87 -21.58 47.3 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.409 -0.807 . . . . 0.0 112.283 169.87 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.5 m -94.85 134.17 25.37 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.976 1.31 . . . . 0.0 113.33 -169.647 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -88.47 160.01 6.64 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.423 2.749 . . . . 0.0 112.131 -170.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.15 -125.04 35.23 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 178.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.45 7.96 45.49 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.355 1.062 . . . . 0.0 113.686 173.425 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -63.78 146.53 53.72 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.162 -0.961 . . . . 0.0 112.371 177.618 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 pt -123.37 155.82 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.81 2.044 . . . . 0.0 109.616 174.035 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.4 t -78.69 131.27 36.57 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.19 -0.943 . . . . 0.0 110.776 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.44 168.06 9.33 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.696 1.198 . . . . 0.0 111.86 -178.753 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.88 -16.65 66.46 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.638 1.113 . . . . 0.0 115.327 -171.508 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -76.63 -7.07 54.54 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.723 1.209 . . . . 0.0 114.138 170.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.4 20.11 52.91 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.008 1.29 . . . . 0.0 114.09 -178.287 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -133.47 158.06 44.05 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.149 1.38 . . . . 0.0 112.807 178.669 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -73.6 136.05 43.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.747 1.619 . . . . 0.0 112.319 -178.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.53 -172.09 20.69 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.421 1.486 . . . . 0.0 113.393 176.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 O-C-N 121.22 -1.165 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.792 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.5 m -148.32 161.32 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.306 1.842 . . . . 0.0 108.584 178.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.1 t -90.86 117.84 68.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.865 170.609 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.36 167.6 24.74 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.949 2.433 . . . . 0.0 111.849 178.118 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -76.11 33.24 0.12 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.632 1.573 . . . . 0.0 113.246 -177.883 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.0 tt -79.89 154.54 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.189 1.796 . . . . 0.0 111.699 178.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.1 tp -120.65 86.06 2.5 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.915 1.286 . . . . 0.0 108.038 169.322 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -108.14 132.83 53.19 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.293 1.437 . . . . 0.0 110.737 -176.026 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.58 153.66 31.34 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.937 0.79 . . . . 0.0 111.812 175.502 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.9 p -159.64 158.27 31.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 176.452 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -113.8 -22.97 9.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.658 1.983 . . . . 0.0 110.814 168.487 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -161.83 171.24 18.1 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.607 1.963 . . . . 0.0 112.178 177.784 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -61.97 -27.04 68.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.03 0.932 . . . . 0.0 113.121 -171.485 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -62.86 -18.12 62.48 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.035 1.334 . . . . 0.0 113.982 176.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -80.78 -20.94 41.51 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.142 0.977 . . . . 0.0 112.564 174.068 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.8 m -92.71 138.8 23.51 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.04 1.336 . . . . 0.0 114.477 -168.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -87.07 153.29 8.3 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.436 2.757 . . . . 0.0 112.222 -170.366 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -123.63 32.89 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.22 8.89 44.16 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.506 1.122 . . . . 0.0 113.887 174.192 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 80.8 m -62.55 146.8 50.92 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.066 -1.021 . . . . 0.0 112.187 176.454 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.8 pt -122.3 155.32 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 126.543 1.937 . . . . 0.0 109.824 174.178 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.0 t -77.68 130.6 37.02 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.203 -0.936 . . . . 0.0 110.763 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.45 167.6 9.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.717 1.207 . . . . 0.0 111.916 -178.617 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.06 -16.47 66.59 Favored Glycine 0 N--CA 1.477 1.381 0 C-N-CA 124.732 1.158 . . . . 0.0 115.373 -171.703 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -76.32 -7.01 54.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.696 1.198 . . . . 0.0 114.107 170.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.55 19.32 54.88 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.016 1.294 . . . . 0.0 114.0 -178.316 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -133.71 158.7 42.62 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.255 1.422 . . . . 0.0 112.695 178.193 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.7 m -73.06 138.78 46.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.565 1.546 . . . . 0.0 112.424 -179.113 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.94 -170.3 21.12 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.257 1.408 . . . . 0.0 113.433 176.044 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.516 0 O-C-N 121.257 -1.143 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.736 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -163.51 150.37 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.718 1.607 . . . . 0.0 109.164 -179.103 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.2 t -86.72 115.66 63.19 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.016 173.507 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -67.98 160.47 48.42 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.78 2.32 . . . . 0.0 112.054 178.905 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.93 16.03 0.17 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -172.559 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 tp -75.12 144.67 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.895 1.678 . . . . 0.0 111.746 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.5 tp -102.94 88.37 3.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.749 1.22 . . . . 0.0 108.328 169.801 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -108.63 129.78 55.33 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.256 1.422 . . . . 0.0 110.413 -177.274 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.28 157.75 34.89 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.391 0.996 . . . . 0.0 112.109 172.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -157.22 151.49 25.0 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -174.672 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -91.13 -35.7 14.41 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.192 1.397 . . . . 0.0 111.505 169.3 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -164.75 177.35 8.04 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.198 2.199 . . . . 0.0 111.277 179.277 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -59.67 -30.54 68.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.703 1.201 . . . . 0.0 113.467 -173.012 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 m -60.91 -20.69 62.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.909 1.284 . . . . 0.0 113.735 177.335 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -97.21 0.83 48.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.374 1.47 . . . . 0.0 112.988 179.752 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.7 m -98.98 141.1 22.3 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.074 1.35 . . . . 0.0 113.2 178.895 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -84.68 149.42 11.25 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.5 2.8 . . . . 0.0 112.589 -169.342 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.34 -124.0 33.77 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.784 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.3 10.48 40.58 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.675 1.19 . . . . 0.0 113.745 174.231 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.2 m -61.51 145.57 51.47 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.099 -1.0 . . . . 0.0 112.52 176.661 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.1 pt -116.19 154.89 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.448 1.899 . . . . 0.0 110.054 172.268 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.2 t -83.52 116.43 22.56 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.588 -0.695 . . . . 0.0 110.517 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -87.05 168.72 13.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.041 1.337 . . . . 0.0 111.752 -176.502 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -17.58 67.11 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 124.602 1.096 . . . . 0.0 115.193 -173.316 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -78.27 -6.34 54.69 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.732 1.213 . . . . 0.0 114.149 171.744 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.08 16.16 59.79 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.028 1.299 . . . . 0.0 114.404 -179.033 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -126.54 157.78 37.89 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.407 1.483 . . . . 0.0 112.397 177.743 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.9 m -73.84 140.3 45.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.962 1.705 . . . . 0.0 112.481 -179.532 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.53 -167.33 23.83 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.164 1.364 . . . . 0.0 113.431 177.71 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.49 0 O-C-N 121.265 -1.138 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.5 t -94.53 118.19 66.94 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.22 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.19 150.95 54.29 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.59 2.86 . . . . 0.0 113.232 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -77.89 17.92 0.53 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.122 1.369 . . . . 0.0 114.226 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.0 pt -79.12 159.71 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.983 1.713 . . . . 0.0 112.341 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.4 tp -105.56 87.55 2.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.676 1.191 . . . . 0.0 108.935 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -107.95 127.08 53.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.259 1.424 . . . . 0.0 110.704 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -70.59 159.13 34.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.25 0.932 . . . . 0.0 112.744 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.3 p -159.51 153.18 22.8 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -96.25 -30.01 13.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.24 1.816 . . . . 0.0 110.837 169.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.2 ptm85 -169.21 173.23 6.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.327 2.651 . . . . 0.0 110.67 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.81 -26.81 66.06 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.314 1.046 . . . . 0.0 113.252 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 m -62.99 -18.59 63.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.083 1.353 . . . . 0.0 114.049 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -86.47 -10.55 53.95 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.169 0.988 . . . . 0.0 112.923 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.3 m -101.87 136.34 19.54 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.825 1.25 . . . . 0.0 113.265 -171.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -88.73 155.08 6.17 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.428 2.752 . . . . 0.0 112.559 -169.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.72 -123.14 30.99 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.86 5.89 50.2 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.526 1.13 . . . . 0.0 113.883 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.9 m -64.0 144.9 56.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.408 1.004 . . . . 0.0 112.228 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.3 pt -120.06 155.69 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.42 1.888 . . . . 0.0 109.8 171.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.4 t -79.64 126.27 30.69 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.348 -0.845 . . . . 0.0 110.674 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -97.94 168.26 10.4 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.801 1.24 . . . . 0.0 111.756 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.45 -17.62 66.71 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 124.585 1.088 . . . . 0.0 115.218 -171.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -77.49 -7.84 56.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.714 1.206 . . . . 0.0 114.21 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.0 19.06 52.64 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.123 1.344 . . . . 0.0 114.263 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -129.98 156.22 44.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.323 1.449 . . . . 0.0 112.35 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.5 m -73.08 138.29 45.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.009 1.723 . . . . 0.0 112.203 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.95 0 C-N-CA 125.042 1.306 . . . . 0.0 113.556 177.305 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.8 t -90.48 117.33 67.91 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.104 172.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -62.11 160.57 29.73 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.149 2.566 . . . . 0.0 112.721 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -77.36 32.04 0.15 Allowed 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.263 1.425 . . . . 0.0 113.65 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 pp -80.33 174.05 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.353 1.861 . . . . 0.0 112.853 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.8 tp -136.48 86.75 2.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.292 1.437 . . . . 0.0 108.325 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -109.4 133.03 53.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.511 1.524 . . . . 0.0 110.287 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -70.98 160.01 33.68 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.329 0.968 . . . . 0.0 111.221 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.6 p -160.32 152.27 20.18 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -94.42 -34.59 12.69 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.198 1.799 . . . . 0.0 110.433 169.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -166.77 178.06 6.12 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.233 2.613 . . . . 0.0 110.449 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -61.1 -26.9 67.98 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.1 p -69.64 -13.15 62.16 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -82.08 -18.43 43.1 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.018 0.826 . . . . 0.0 112.593 170.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.6 m -91.66 139.9 25.05 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.697 1.199 . . . . 0.0 113.766 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -85.7 150.13 9.97 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.439 2.759 . . . . 0.0 112.437 -169.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.56 -123.52 32.18 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.35 9.83 42.17 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.646 1.178 . . . . 0.0 113.832 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 91.2 m -61.62 145.71 51.29 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.071 -1.018 . . . . 0.0 112.31 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.2 pt -120.43 154.57 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.398 1.879 . . . . 0.0 110.006 174.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.9 t -80.68 123.87 28.54 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.385 -0.822 . . . . 0.0 110.626 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -95.76 169.97 9.64 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.891 1.277 . . . . 0.0 111.734 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.47 -17.88 67.05 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.574 1.083 . . . . 0.0 115.224 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -78.25 -6.09 53.91 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.839 1.256 . . . . 0.0 114.212 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.0 15.75 60.56 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.082 1.325 . . . . 0.0 114.281 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -127.33 156.53 41.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.975 1.31 . . . . 0.0 113.099 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.2 m -74.02 137.3 43.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.753 1.621 . . . . 0.0 112.466 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 C-N-CA 125.225 1.393 . . . . 0.0 113.366 177.162 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.5 t -90.59 116.16 65.79 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.182 173.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.1 154.46 72.45 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.947 2.432 . . . . 0.0 111.735 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -83.25 14.97 3.15 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -169.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.2 pt -79.18 151.73 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.5 1.52 . . . . 0.0 112.279 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.4 tp -89.47 89.38 7.83 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.322 1.049 . . . . 0.0 109.249 174.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -109.71 122.5 47.62 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.704 1.601 . . . . 0.0 109.61 -173.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -73.14 160.09 32.53 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.169 -0.957 . . . . 0.0 112.095 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.5 p -161.78 153.49 18.94 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -96.31 -32.95 12.14 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.993 1.717 . . . . 0.0 110.34 169.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.7 ptt-85 -165.85 177.32 7.24 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 128.417 2.687 . . . . 0.0 110.437 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -59.33 -27.29 65.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.334 1.054 . . . . 0.0 113.496 -172.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.7 m -60.01 -22.4 62.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.094 1.358 . . . . 0.0 114.067 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -88.56 -10.32 49.21 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.196 0.998 . . . . 0.0 113.085 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.2 m -93.79 140.14 22.93 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -84.43 147.47 11.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.548 2.832 . . . . 0.0 112.317 -169.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.88 -122.03 28.44 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.903 -0.498 . . . . 0.0 111.916 177.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.54 6.0 50.09 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.746 1.218 . . . . 0.0 114.03 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.0 m -63.76 149.62 46.38 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.173 -0.954 . . . . 0.0 113.109 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.9 pt -117.4 157.1 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.605 1.962 . . . . 0.0 110.107 169.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.8 t -84.18 119.93 25.59 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.439 -0.788 . . . . 0.0 110.911 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -88.28 168.09 13.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.651 1.18 . . . . 0.0 111.519 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -16.72 66.04 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.587 1.089 . . . . 0.0 115.297 -172.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -78.06 -7.07 56.47 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 172.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.82 16.94 57.45 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.851 1.215 . . . . 0.0 114.225 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -129.88 156.52 44.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.049 1.34 . . . . 0.0 112.763 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.9 m -76.43 144.0 40.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.164 1.386 . . . . 0.0 113.016 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.917 0 C-N-CA 125.158 1.361 . . . . 0.0 113.444 177.06 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.4 t -92.57 116.03 65.8 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.261 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 147.2 63.78 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.666 2.244 . . . . 0.0 111.101 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -80.92 17.64 1.16 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.869 1.268 . . . . 0.0 114.379 -171.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.9 pt -75.79 152.91 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.532 1.533 . . . . 0.0 112.231 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.2 tp -88.14 87.35 7.29 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.303 1.041 . . . . 0.0 109.506 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -109.56 121.03 44.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.76 1.624 . . . . 0.0 109.527 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -73.56 159.21 33.47 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.208 -0.932 . . . . 0.0 112.289 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.1 p -161.54 156.21 23.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.18 -32.5 9.11 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.572 1.949 . . . . 0.0 109.686 168.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -159.62 177.1 11.24 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.232 2.213 . . . . 0.0 111.295 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -60.67 -26.78 67.34 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.455 1.102 . . . . 0.0 113.496 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.8 m -60.02 -21.16 61.0 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.02 1.328 . . . . 0.0 113.928 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -86.65 -13.84 44.41 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.237 1.015 . . . . 0.0 113.097 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.1 m -92.35 140.13 24.18 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.46 147.48 11.19 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.573 2.848 . . . . 0.0 112.301 -169.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.96 -121.59 27.05 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.76 5.85 50.34 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.697 1.199 . . . . 0.0 113.964 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.1 m -63.77 150.32 44.85 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.108 -0.995 . . . . 0.0 113.134 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.0 155.68 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.636 1.974 . . . . 0.0 109.941 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.6 t -78.8 131.99 36.71 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.18 -0.95 . . . . 0.0 110.642 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -104.25 167.64 9.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.596 1.158 . . . . 0.0 111.765 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.74 -16.89 66.48 Favored Glycine 0 N--CA 1.477 1.403 0 C-N-CA 124.712 1.149 . . . . 0.0 115.362 -170.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -76.83 -8.06 56.63 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 171.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.4 15.98 56.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.09 1.329 . . . . 0.0 114.2 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -130.98 157.44 42.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.03 1.332 . . . . 0.0 112.631 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.9 m -76.02 141.47 42.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.201 1.4 . . . . 0.0 112.89 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.994 0 C-N-CA 125.417 1.484 . . . . 0.0 113.437 176.357 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.6 t -93.65 116.72 66.85 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.176 173.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.21 150.11 71.2 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.785 2.324 . . . . 0.0 111.591 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -77.29 13.43 1.17 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -171.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 pt -78.21 151.59 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.539 1.536 . . . . 0.0 112.301 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.4 tp -89.3 88.45 7.5 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.384 1.074 . . . . 0.0 109.407 175.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -109.66 121.97 46.42 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.783 1.633 . . . . 0.0 109.562 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -73.6 159.33 33.25 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.131 -0.98 . . . . 0.0 112.312 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.2 p -163.74 161.86 23.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -112.99 -32.29 6.41 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.505 1.922 . . . . 0.0 110.299 168.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.429 ' HG3' ' H ' ' A' ' 13' ' ' ASP . 1.1 tpm_? -155.33 175.36 13.96 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.141 1.776 . . . . 0.0 111.057 175.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.429 ' H ' ' HG3' ' A' ' 12' ' ' ARG . 22.5 m-20 -61.97 -26.88 68.47 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.165 1.386 . . . . 0.0 113.439 -169.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.2 m -63.36 -18.79 64.04 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.758 1.223 . . . . 0.0 113.499 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -84.67 -13.83 50.32 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.284 1.034 . . . . 0.0 112.901 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.6 m -95.17 141.54 23.38 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.701 1.201 . . . . 0.0 114.18 -169.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -84.39 146.35 10.97 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.585 2.856 . . . . 0.0 112.262 -169.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.84 -122.69 30.53 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.84 5.97 50.34 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.793 1.237 . . . . 0.0 113.986 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.4 m -62.99 149.03 45.91 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.227 -0.921 . . . . 0.0 113.04 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.6 pt -117.86 155.97 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.458 1.903 . . . . 0.0 110.338 170.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 t -82.97 122.71 28.64 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.374 -0.829 . . . . 0.0 111.021 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -93.46 168.13 11.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.7 1.2 . . . . 0.0 111.74 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.7 -17.22 66.8 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.631 1.11 . . . . 0.0 115.294 -171.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -77.7 -7.39 56.42 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 172.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.18 16.99 56.75 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.982 1.277 . . . . 0.0 114.221 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -130.63 157.16 43.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.974 1.309 . . . . 0.0 112.632 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.5 m -76.08 143.51 41.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.185 1.394 . . . . 0.0 112.849 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.998 0 C-N-CA 125.127 1.346 . . . . 0.0 113.422 177.908 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.4 t -89.41 118.38 69.04 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.209 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -58.8 161.25 15.66 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.472 2.782 . . . . 0.0 113.467 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -78.58 17.91 0.63 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.865 1.266 . . . . 0.0 113.355 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 tp -76.1 148.59 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 126.124 1.77 . . . . 0.0 112.076 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.1 tp -106.2 86.55 2.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.763 1.225 . . . . 0.0 108.101 169.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -107.15 131.63 53.93 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.123 1.369 . . . . 0.0 110.442 -176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -70.56 160.76 31.9 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.059 0.845 . . . . 0.0 111.089 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -160.21 150.76 18.61 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -93.3 -35.67 12.95 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.406 1.882 . . . . 0.0 110.428 169.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -165.04 -179.85 5.96 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.399 2.68 . . . . 0.0 110.198 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -59.72 -26.03 65.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.318 1.047 . . . . 0.0 113.645 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 m -59.46 -22.76 62.01 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.375 1.47 . . . . 0.0 114.176 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -84.47 -17.3 39.57 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.896 0.878 . . . . 0.0 113.004 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.6 m -91.21 138.09 25.94 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -169.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -87.15 151.53 8.15 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.406 2.737 . . . . 0.0 112.441 -169.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.56 -125.07 36.27 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.57 9.36 41.73 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.578 1.151 . . . . 0.0 113.862 174.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.2 m -62.35 146.93 49.91 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.104 -0.997 . . . . 0.0 112.256 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.94 154.53 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.442 1.897 . . . . 0.0 109.823 172.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -78.38 129.86 35.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.336 -0.852 . . . . 0.0 110.525 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -103.29 169.81 8.33 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.644 1.178 . . . . 0.0 111.854 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.52 -17.71 66.96 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.695 1.14 . . . . 0.0 115.297 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -77.28 -6.7 54.12 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.751 1.22 . . . . 0.0 114.131 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.11 15.77 60.34 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.19 1.376 . . . . 0.0 114.201 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -127.95 156.86 42.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.074 1.35 . . . . 0.0 113.098 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.4 m -73.8 136.21 43.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.711 1.605 . . . . 0.0 112.468 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.96 0 C-N-CA 125.332 1.444 . . . . 0.0 113.452 176.785 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 48.7 t -84.11 117.77 69.55 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.337 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.88 175.58 10.18 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.517 2.811 . . . . 0.0 112.337 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -76.44 35.26 0.14 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.026 1.731 . . . . 0.0 113.635 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.3 pt -80.35 170.82 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.459 1.904 . . . . 0.0 112.185 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.4 tp -143.86 91.03 2.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.969 1.308 . . . . 0.0 109.372 173.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -112.33 136.85 51.27 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.672 1.589 . . . . 0.0 111.041 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -63.94 155.72 29.99 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 118.844 0.747 . . . . 0.0 111.597 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.0 p -159.83 155.15 25.28 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -98.46 -36.19 10.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.443 1.897 . . . . 0.0 110.485 169.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.431 ' HG3' ' H ' ' A' ' 13' ' ' ASP . 1.5 tpm_? -163.16 175.53 10.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.937 2.495 . . . . 0.0 109.442 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 12' ' ' ARG . 24.3 m-20 -60.6 -26.4 66.96 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.397 1.479 . . . . 0.0 113.523 -169.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.5 m -62.54 -20.44 64.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.867 1.267 . . . . 0.0 113.781 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -83.07 -14.25 54.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.723 0.809 . . . . 0.0 113.023 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.3 m -99.03 137.38 20.46 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.046 1.338 . . . . 0.0 113.014 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -86.65 150.93 8.79 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.834 2.356 . . . . 0.0 112.015 -170.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.56 -123.3 32.46 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.34 0.495 . . . . 0.0 112.168 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.17 1.83 56.97 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.689 1.196 . . . . 0.0 114.085 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.8 m -64.2 143.42 57.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.375 0.989 . . . . 0.0 112.376 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.6 pt -120.76 155.86 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.34 1.856 . . . . 0.0 110.132 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.0 t -83.1 116.27 22.25 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.505 -0.747 . . . . 0.0 110.886 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -86.88 169.2 12.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.935 1.294 . . . . 0.0 111.777 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.48 -17.26 66.35 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 124.565 1.079 . . . . 0.0 115.21 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -77.64 -6.6 54.39 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.777 1.231 . . . . 0.0 114.2 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.39 20.46 54.58 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.867 1.223 . . . . 0.0 114.17 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -131.93 157.99 42.59 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.003 1.321 . . . . 0.0 112.865 177.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 75.3 m -73.6 136.77 43.96 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.595 1.558 . . . . 0.0 112.514 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.933 0 C-N-CA 125.257 1.408 . . . . 0.0 113.366 177.816 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.9 t -90.59 117.86 68.28 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.322 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.32 146.06 52.71 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.875 3.05 . . . . 0.0 113.286 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -78.41 10.49 3.07 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -170.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.4 pt -79.45 154.05 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.333 1.453 . . . . 0.0 112.114 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.34 93.6 6.59 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.508 1.123 . . . . 0.0 108.805 171.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -108.22 133.63 52.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.3 1.44 . . . . 0.0 111.196 -175.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -62.24 153.74 29.66 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.946 0.794 . . . . 0.0 112.269 171.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -160.42 167.02 28.23 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -128.02 -9.94 5.39 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.242 1.417 . . . . 0.0 112.922 169.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 ptm85 -167.01 166.16 15.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.085 2.154 . . . . 0.0 111.987 173.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -61.37 -30.47 70.55 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.565 1.146 . . . . 0.0 112.85 -171.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 m -62.72 -19.14 63.63 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.098 1.359 . . . . 0.0 113.617 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -95.57 -2.57 48.15 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.288 1.435 . . . . 0.0 112.904 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.3 m -97.64 140.42 21.97 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.063 1.345 . . . . 0.0 112.947 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -83.39 148.52 12.93 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.422 2.748 . . . . 0.0 112.559 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.28 -123.55 33.3 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.669 -0.573 . . . . 0.0 111.669 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.93 8.61 43.18 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.703 1.201 . . . . 0.0 113.917 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.2 m -62.38 145.71 53.23 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.439 1.018 . . . . 0.0 112.151 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.8 pt -115.32 154.75 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.198 1.799 . . . . 0.0 110.198 172.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.0 t -82.65 123.54 29.35 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.457 -0.777 . . . . 0.0 110.635 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.44 167.07 11.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.737 1.215 . . . . 0.0 111.761 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.23 66.6 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 124.572 1.082 . . . . 0.0 115.269 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -77.7 -6.41 53.83 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 171.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.44 22.64 46.71 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.872 1.225 . . . . 0.0 113.978 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -132.77 156.36 47.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.216 1.406 . . . . 0.0 112.747 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.8 m -73.82 140.67 45.96 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 112.363 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.015 0 C-N-CA 125.194 1.378 . . . . 0.0 113.395 176.766 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.9 t -90.03 114.0 59.24 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 118.177 -0.916 . . . . 0.0 109.985 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.95 160.89 47.94 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.942 2.428 . . . . 0.0 111.872 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -79.62 18.58 0.73 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.082 1.353 . . . . 0.0 114.246 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.4 mt -79.01 138.15 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.709 1.604 . . . . 0.0 109.921 -176.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.5 tp -84.07 84.83 7.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.16 0.984 . . . . 0.0 108.701 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -107.01 123.42 48.17 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.906 1.682 . . . . 0.0 109.484 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -72.22 159.28 34.36 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.075 -1.016 . . . . 0.0 111.982 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.2 p -162.27 158.46 24.31 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -112.37 -26.71 8.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.265 1.826 . . . . 0.0 110.658 168.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.3 175.97 12.73 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.91 2.084 . . . . 0.0 111.37 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -60.91 -27.19 68.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.966 0.907 . . . . 0.0 113.265 -171.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -62.86 -18.06 62.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.178 1.391 . . . . 0.0 113.881 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.7 -14.2 46.13 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.349 1.059 . . . . 0.0 112.881 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.7 m -93.43 141.36 23.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -83.81 146.35 11.74 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.442 2.762 . . . . 0.0 112.129 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.8 -121.8 27.73 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.79 7.33 46.84 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.792 1.237 . . . . 0.0 113.907 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.2 m -63.19 150.88 41.87 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.127 -0.983 . . . . 0.0 113.023 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.2 pt -119.35 154.76 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.542 1.937 . . . . 0.0 110.162 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.9 t -79.1 132.53 36.62 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.145 -0.972 . . . . 0.0 110.849 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -105.26 167.12 9.94 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.624 1.169 . . . . 0.0 111.798 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.03 -16.51 66.58 Favored Glycine 0 N--CA 1.478 1.478 0 C-N-CA 124.649 1.119 . . . . 0.0 115.433 -170.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -76.8 -6.97 54.47 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.21 58.98 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.043 1.306 . . . . 0.0 114.154 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -130.38 157.49 42.45 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.99 1.316 . . . . 0.0 112.741 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.0 m -76.48 141.51 41.27 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.265 1.426 . . . . 0.0 112.729 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.922 0 C-N-CA 125.637 1.589 . . . . 0.0 113.375 176.071 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.2 t -92.75 115.94 65.69 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.33 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.68 145.94 59.16 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.691 2.261 . . . . 0.0 110.975 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -80.82 18.06 1.06 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.825 1.25 . . . . 0.0 114.254 -171.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 pt -75.02 153.38 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.591 1.556 . . . . 0.0 112.235 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.7 tp -87.71 86.66 7.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.279 1.032 . . . . 0.0 109.586 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -109.16 120.41 42.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.843 1.657 . . . . 0.0 109.454 -175.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -72.75 159.29 34.04 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.23 -0.919 . . . . 0.0 112.284 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.4 p -162.37 156.22 21.06 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.93 -31.85 9.05 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.546 1.938 . . . . 0.0 109.726 168.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 ptm85 -161.06 174.65 13.42 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.285 2.234 . . . . 0.0 111.428 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -60.97 -26.6 67.67 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.461 1.104 . . . . 0.0 113.93 -169.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 t -66.03 -14.85 62.4 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -86.16 -14.41 44.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.041 0.937 . . . . 0.0 112.836 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -92.74 140.62 23.79 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.41 147.3 11.21 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.619 2.88 . . . . 0.0 112.314 -169.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.01 -121.56 26.92 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.62 5.77 50.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.691 1.196 . . . . 0.0 114.005 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.3 m -63.91 150.34 45.22 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.19 -0.944 . . . . 0.0 113.146 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.2 pt -119.48 155.9 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.704 2.002 . . . . 0.0 109.913 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.5 t -78.97 132.23 36.61 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.986 -1.071 . . . . 0.0 110.68 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -104.35 167.26 9.86 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.645 1.178 . . . . 0.0 111.775 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -16.77 66.41 Favored Glycine 0 N--CA 1.477 1.393 0 C-N-CA 124.713 1.149 . . . . 0.0 115.4 -170.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -76.69 -8.1 56.62 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.5 16.16 55.65 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.133 1.349 . . . . 0.0 114.13 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -131.4 157.23 43.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.918 1.287 . . . . 0.0 112.679 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.7 m -75.82 141.65 42.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.278 1.431 . . . . 0.0 112.808 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.938 0 C-N-CA 125.375 1.464 . . . . 0.0 113.394 176.317 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.8 t -87.4 115.91 64.35 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 118.15 -0.929 . . . . 0.0 109.984 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.45 151.34 80.25 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.69 2.26 . . . . 0.0 111.609 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -75.77 12.62 1.01 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -170.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.1 pt -79.35 148.52 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.397 1.479 . . . . 0.0 111.885 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 tp -95.11 93.47 7.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.394 1.078 . . . . 0.0 109.299 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -109.32 130.01 55.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.216 1.406 . . . . 0.0 110.835 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -70.3 158.0 36.7 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.237 0.926 . . . . 0.0 112.749 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.9 p -159.97 162.63 34.41 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.581 1.153 . . . . 0.0 113.705 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -113.49 -19.11 11.79 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.406 1.482 . . . . 0.0 112.474 168.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -167.87 169.0 11.84 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 127.105 2.162 . . . . 0.0 111.881 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -60.8 -30.9 70.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.628 1.171 . . . . 0.0 112.987 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -62.86 -18.51 63.01 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.999 1.32 . . . . 0.0 113.667 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -97.62 -0.44 45.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.409 1.484 . . . . 0.0 112.79 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.9 m -97.54 142.59 24.79 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.065 1.346 . . . . 0.0 113.018 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -83.56 146.36 12.06 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.619 2.88 . . . . 0.0 112.587 -169.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.91 -120.8 24.38 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.73 7.76 45.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.757 1.223 . . . . 0.0 114.007 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.9 m -62.54 146.73 51.06 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.155 -0.966 . . . . 0.0 112.458 177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.7 pt -116.63 153.49 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.302 1.841 . . . . 0.0 110.195 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -82.32 121.93 27.31 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.481 -0.762 . . . . 0.0 110.43 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -93.89 168.47 10.96 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.852 1.261 . . . . 0.0 111.895 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -17.92 67.5 Favored Glycine 0 N--CA 1.477 1.398 0 C-N-CA 124.683 1.135 . . . . 0.0 115.169 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -77.59 -6.86 55.21 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.669 1.188 . . . . 0.0 114.111 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.64 16.07 58.99 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.076 1.322 . . . . 0.0 114.416 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -126.92 157.5 39.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.475 1.51 . . . . 0.0 112.253 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.3 m -74.7 139.85 43.75 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.049 1.74 . . . . 0.0 112.22 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.926 0 C-N-CA 125.171 1.367 . . . . 0.0 113.465 177.31 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.8 t -85.63 120.5 73.0 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.387 173.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.05 170.72 19.12 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.44 2.76 . . . . 0.0 112.122 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.62 36.64 0.21 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.752 1.621 . . . . 0.0 113.693 -175.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.0 pt -78.4 161.46 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.937 1.695 . . . . 0.0 112.327 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.3 tp -123.21 83.26 2.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 108.567 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -112.1 124.03 51.55 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.98 1.712 . . . . 0.0 109.594 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.5 153.1 36.62 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.344 -0.847 . . . . 0.0 112.819 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -160.38 161.7 33.15 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -113.62 -32.09 6.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.726 2.01 . . . . 0.0 110.349 168.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -155.05 174.43 15.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.797 1.639 . . . . 0.0 111.354 175.102 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.411 ' H ' ' HG3' ' A' ' 12' ' ' ARG . 25.6 m-20 -62.42 -25.8 68.15 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.322 1.449 . . . . 0.0 113.756 -169.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 p -65.31 -16.26 63.39 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.206 1.402 . . . . 0.0 113.852 174.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -83.34 -14.47 52.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.232 1.013 . . . . 0.0 112.838 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -100.76 138.9 20.19 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.942 1.297 . . . . 0.0 113.448 -169.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.22 147.87 9.0 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.149 2.566 . . . . 0.0 111.988 -169.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.17 -122.71 30.8 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.41 0.528 . . . . 0.0 112.415 175.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.29 -0.37 57.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.747 1.219 . . . . 0.0 114.204 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 79.7 m -64.75 144.68 57.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.374 0.988 . . . . 0.0 112.962 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.8 pt -119.18 156.79 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.676 1.99 . . . . 0.0 110.122 172.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.8 t -83.24 119.12 24.16 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.321 -0.862 . . . . 0.0 111.13 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -89.74 167.34 12.96 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.791 1.236 . . . . 0.0 111.743 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.44 -17.0 65.97 Favored Glycine 0 N--CA 1.477 1.408 0 C-N-CA 124.634 1.111 . . . . 0.0 115.295 -172.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -76.83 -8.93 58.25 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 171.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.58 23.48 36.34 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.821 1.2 . . . . 0.0 114.077 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -136.5 157.57 46.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.97 1.308 . . . . 0.0 112.546 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.6 m -73.62 139.19 45.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.463 1.505 . . . . 0.0 112.681 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.986 0 C-N-CA 125.247 1.403 . . . . 0.0 113.33 178.705 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.7 t -89.6 117.42 68.14 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.3 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.99 169.63 21.72 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.143 2.562 . . . . 0.0 112.243 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -73.3 26.82 0.06 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.271 1.829 . . . . 0.0 115.3 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.3 pt -75.03 168.24 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.282 1.833 . . . . 0.0 112.752 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.2 tp -132.5 86.48 2.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.273 1.429 . . . . 0.0 108.603 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.26 131.19 54.95 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.506 1.523 . . . . 0.0 110.647 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.54 153.02 37.0 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.895 0.771 . . . . 0.0 112.128 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -160.69 160.59 31.67 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -117.68 -17.44 9.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.893 1.677 . . . . 0.0 111.339 167.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -163.16 168.69 20.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.928 2.091 . . . . 0.0 112.065 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -62.31 -26.15 68.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.943 0.897 . . . . 0.0 113.134 -171.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -63.49 -18.04 63.38 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.962 1.305 . . . . 0.0 113.964 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -79.3 -22.51 44.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.834 0.854 . . . . 0.0 112.494 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.0 m -93.55 134.14 27.08 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.957 1.303 . . . . 0.0 113.788 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -88.29 159.04 6.86 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.374 2.716 . . . . 0.0 112.14 -171.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.11 -123.68 31.88 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.46 6.7 46.99 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.462 1.105 . . . . 0.0 113.787 174.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.2 m -64.23 145.95 55.13 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.144 -0.972 . . . . 0.0 112.451 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.3 pt -122.59 156.12 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.791 2.036 . . . . 0.0 109.737 173.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -77.61 130.57 37.05 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.191 -0.943 . . . . 0.0 110.781 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -104.09 166.98 10.06 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.814 1.245 . . . . 0.0 111.798 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.73 -16.74 66.24 Favored Glycine 0 N--CA 1.477 1.372 0 C-N-CA 124.665 1.126 . . . . 0.0 115.348 -171.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -76.7 -7.52 55.49 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.718 1.207 . . . . 0.0 114.179 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.9 22.11 43.77 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.93 1.253 . . . . 0.0 114.016 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -135.43 157.61 46.46 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.086 1.355 . . . . 0.0 112.736 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.8 m -72.85 137.86 45.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.602 1.561 . . . . 0.0 112.307 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.914 0 C-N-CA 125.255 1.407 . . . . 0.0 113.494 176.383 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.8 t -89.03 114.1 58.8 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.098 173.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.04 153.49 67.57 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.642 2.228 . . . . 0.0 110.92 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -78.88 25.16 0.28 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.861 1.264 . . . . 0.0 114.148 -171.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.3 mt -79.5 136.17 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.845 1.658 . . . . 0.0 109.381 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.7 tp -89.4 88.62 7.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.385 1.074 . . . . 0.0 109.043 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -108.15 130.52 55.12 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.296 1.439 . . . . 0.0 110.579 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -71.68 159.36 34.53 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.026 0.83 . . . . 0.0 111.411 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.4 p -161.67 157.36 24.38 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -108.75 -25.71 10.68 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.495 1.918 . . . . 0.0 110.511 168.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -161.91 172.98 15.15 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.766 2.026 . . . . 0.0 112.142 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.84 -27.36 68.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.238 1.015 . . . . 0.0 112.97 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 m -62.42 -18.66 62.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.312 1.445 . . . . 0.0 113.952 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.47 -20.15 34.54 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.176 0.99 . . . . 0.0 112.683 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.5 m -90.11 141.63 28.0 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -168.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -84.88 147.6 10.63 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.575 2.85 . . . . 0.0 112.32 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.63 -121.51 26.82 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.41 7.89 45.65 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.681 1.192 . . . . 0.0 113.95 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.4 m -62.54 147.03 50.25 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.07 -1.019 . . . . 0.0 112.339 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.2 pt -120.62 154.11 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.496 1.918 . . . . 0.0 110.09 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -79.07 125.82 29.9 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.341 -0.849 . . . . 0.0 110.616 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -99.06 168.71 9.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.754 1.222 . . . . 0.0 111.89 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.87 -17.43 67.42 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 124.628 1.108 . . . . 0.0 115.241 -172.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -77.35 -6.68 54.19 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.663 1.185 . . . . 0.0 114.116 171.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.95 15.4 59.4 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.157 1.36 . . . . 0.0 114.3 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -128.34 156.65 42.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.914 1.286 . . . . 0.0 113.019 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.8 m -73.23 138.52 45.63 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.536 1.534 . . . . 0.0 112.298 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.952 0 C-N-CA 125.144 1.354 . . . . 0.0 113.398 177.376 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.94 115.46 63.99 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 118.308 -0.854 . . . . 0.0 109.831 171.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.74 170.32 18.97 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.837 2.358 . . . . 0.0 111.832 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -76.71 33.43 0.14 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.765 1.626 . . . . 0.0 113.785 -174.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -79.72 173.73 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.296 1.839 . . . . 0.0 112.649 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 tp -141.97 88.48 2.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.171 1.389 . . . . 0.0 108.398 169.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -110.23 134.67 52.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.568 1.547 . . . . 0.0 110.04 -177.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -68.35 160.87 28.66 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.476 1.035 . . . . 0.0 110.794 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -157.01 150.9 24.69 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -94.2 -28.87 15.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.282 1.433 . . . . 0.0 111.431 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.0 ptm85 -173.51 174.17 3.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.666 2.787 . . . . 0.0 110.728 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -59.19 -31.04 68.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.508 1.123 . . . . 0.0 113.141 -173.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -63.87 -17.64 63.38 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.943 1.297 . . . . 0.0 113.836 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -92.0 -9.39 43.08 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.132 1.373 . . . . 0.0 112.398 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.8 m -92.18 140.74 24.55 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.008 1.323 . . . . 0.0 113.399 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.92 149.95 12.47 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.374 2.716 . . . . 0.0 112.404 -169.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.88 -122.72 29.59 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.72 10.84 40.65 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.583 1.153 . . . . 0.0 113.706 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -61.27 146.74 46.86 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.119 -0.988 . . . . 0.0 112.579 176.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.4 pt -118.89 152.94 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.417 1.887 . . . . 0.0 110.227 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -82.21 121.39 26.56 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.418 -0.801 . . . . 0.0 110.531 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.06 169.71 10.07 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.928 1.291 . . . . 0.0 111.817 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.99 67.49 Favored Glycine 0 N--CA 1.477 1.396 0 C-N-CA 124.6 1.095 . . . . 0.0 115.14 -172.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -78.33 -5.59 52.61 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.824 1.25 . . . . 0.0 114.197 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.09 13.84 63.48 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.182 1.373 . . . . 0.0 114.409 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -124.85 156.67 37.49 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.064 1.345 . . . . 0.0 113.373 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.5 m -73.97 137.49 43.57 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.87 1.668 . . . . 0.0 112.447 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.909 0 C-N-CA 125.329 1.442 . . . . 0.0 113.267 176.996 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.6 t -96.84 117.73 65.62 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.637 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -53.96 142.87 63.31 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.257 3.305 . . . . 0.0 113.276 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.55 13.57 6.73 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.4 pt -79.13 154.4 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.496 1.518 . . . . 0.0 112.347 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.0 tp -87.82 88.45 7.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.37 1.068 . . . . 0.0 109.299 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -109.3 121.88 46.13 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.82 1.648 . . . . 0.0 109.675 -174.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -73.51 159.66 32.85 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.148 -0.97 . . . . 0.0 112.311 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -162.44 159.49 25.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -175.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -109.98 -29.68 8.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.321 1.848 . . . . 0.0 110.503 168.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -158.98 177.58 10.98 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.542 1.937 . . . . 0.0 111.965 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.21 -27.31 68.89 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -169.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.0 p -69.87 -12.38 61.58 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -83.85 -14.05 52.16 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.029 0.932 . . . . 0.0 112.558 171.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.3 m -96.0 140.53 22.31 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.924 1.29 . . . . 0.0 113.984 -169.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -84.25 147.91 11.57 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.459 2.772 . . . . 0.0 112.206 -169.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.22 -125.1 37.88 Favored Glycine 0 CA--C 1.532 1.102 0 O-C-N 121.84 -0.538 . . . . 0.0 111.911 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.2 6.62 47.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.92 1.288 . . . . 0.0 114.1 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.3 m -62.52 147.5 48.72 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.055 -1.028 . . . . 0.0 112.813 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.7 pt -115.5 156.99 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.507 1.923 . . . . 0.0 110.228 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.3 t -83.5 118.11 23.55 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.47 -0.769 . . . . 0.0 110.797 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.5 mmm-85 -86.85 167.46 14.33 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.635 1.174 . . . . 0.0 111.609 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.66 -16.76 66.12 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 124.601 1.096 . . . . 0.0 115.322 -172.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -77.73 -7.5 56.62 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.687 1.195 . . . . 0.0 114.186 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.23 17.41 55.68 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.885 1.231 . . . . 0.0 114.264 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -130.49 156.29 45.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.85 1.26 . . . . 0.0 112.71 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.9 m -75.26 143.47 43.02 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.133 1.373 . . . . 0.0 112.857 -175.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.95 0 C-N-CA 124.943 1.259 . . . . 0.0 113.494 177.493 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.0 t -91.56 117.42 67.78 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.233 173.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.81 149.66 86.54 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.829 2.353 . . . . 0.0 111.336 176.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -81.82 18.24 1.33 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -169.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.6 pt -74.57 150.98 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.412 1.485 . . . . 0.0 111.993 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 tp -94.33 86.39 4.88 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.265 1.026 . . . . 0.0 109.18 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -107.73 124.73 50.46 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.391 1.477 . . . . 0.0 110.699 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -70.89 158.57 36.19 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.18 -0.95 . . . . 0.0 113.106 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.1 p -159.17 154.72 25.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -174.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -100.57 -31.85 11.05 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.259 1.423 . . . . 0.0 110.721 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.72 177.32 9.45 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.083 2.153 . . . . 0.0 111.155 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -60.8 -25.52 66.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -63.39 -19.46 64.69 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.933 1.293 . . . . 0.0 113.993 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.8 -17.67 52.79 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.064 0.946 . . . . 0.0 112.798 173.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.8 m -98.83 137.11 20.5 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.803 1.241 . . . . 0.0 113.837 -169.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -88.76 154.55 6.14 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.752 2.968 . . . . 0.0 112.446 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -121.5 26.55 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.28 5.04 51.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.449 1.1 . . . . 0.0 113.933 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.8 m -64.91 145.4 56.35 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.458 1.026 . . . . 0.0 112.217 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.5 pt -120.42 156.29 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.572 1.949 . . . . 0.0 109.755 171.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.8 t -79.65 125.86 30.18 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.315 -0.866 . . . . 0.0 110.62 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -97.47 168.36 10.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.732 1.213 . . . . 0.0 111.819 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.58 -17.62 67.0 Favored Glycine 0 N--CA 1.476 1.354 0 C-N-CA 124.631 1.11 . . . . 0.0 115.273 -171.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -77.31 -8.18 57.22 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.673 1.189 . . . . 0.0 114.181 171.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.32 18.51 52.8 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.09 1.329 . . . . 0.0 114.346 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -129.8 156.6 44.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.414 1.486 . . . . 0.0 112.238 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 82.4 m -72.91 139.21 46.66 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.979 1.711 . . . . 0.0 112.376 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 C-N-CA 124.977 1.275 . . . . 0.0 113.514 177.321 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.7 t -79.33 119.9 78.61 Favored Pre-proline 0 CA--C 1.551 0.984 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.217 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.26 173.25 11.69 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.625 2.884 . . . . 0.0 112.845 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -75.32 33.02 0.1 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.262 1.825 . . . . 0.0 114.048 -174.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.8 pt -78.37 168.93 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.027 1.731 . . . . 0.0 112.169 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 tp -137.85 83.44 1.98 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.844 1.257 . . . . 0.0 108.847 170.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -106.75 126.51 52.38 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.484 1.514 . . . . 0.0 110.108 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -70.28 156.67 38.95 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.32 0.964 . . . . 0.0 112.804 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.1 p -160.0 156.98 27.94 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -106.96 -25.44 11.63 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.575 1.95 . . . . 0.0 110.607 168.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -163.11 171.87 15.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.461 1.904 . . . . 0.0 112.143 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -61.32 -27.11 68.25 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 113.058 -172.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -62.7 -18.46 62.51 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.145 1.378 . . . . 0.0 113.856 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -81.16 -22.03 39.28 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.083 0.953 . . . . 0.0 112.417 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.1 m -92.69 135.95 25.69 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.886 1.274 . . . . 0.0 113.244 -169.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.72 148.14 9.67 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.965 2.444 . . . . 0.0 111.918 -170.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.27 -122.73 30.82 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.437 0.542 . . . . 0.0 112.378 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.58 -2.56 58.7 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.81 1.244 . . . . 0.0 114.313 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -65.74 146.3 54.95 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.325 0.966 . . . . 0.0 112.844 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.9 pt -125.1 155.39 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.859 2.064 . . . . 0.0 109.632 174.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.79 131.29 37.54 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.146 -0.971 . . . . 0.0 110.712 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -105.95 168.15 9.32 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.649 1.18 . . . . 0.0 111.79 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.82 -17.11 66.93 Favored Glycine 0 N--CA 1.477 1.394 0 C-N-CA 124.632 1.11 . . . . 0.0 115.255 -171.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -76.52 -7.99 56.27 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.701 1.2 . . . . 0.0 114.095 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.17 17.79 54.97 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.079 1.323 . . . . 0.0 114.266 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -130.77 157.97 41.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.341 1.456 . . . . 0.0 112.306 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.1 m -73.81 135.21 43.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.086 1.754 . . . . 0.0 112.057 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.009 0 C-N-CA 125.398 1.475 . . . . 0.0 113.315 177.82 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.6 t -89.23 117.33 68.12 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.925 171.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -61.6 163.26 18.73 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.194 2.596 . . . . 0.0 113.153 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -76.01 28.29 0.11 Allowed 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.598 1.559 . . . . 0.0 113.871 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.09 174.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.531 1.932 . . . . 0.0 112.939 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.8 tp -138.88 88.05 2.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.391 1.476 . . . . 0.0 108.226 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -109.29 133.07 53.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.503 1.521 . . . . 0.0 110.439 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -69.05 158.9 33.88 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.246 0.93 . . . . 0.0 111.06 176.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.8 p -160.95 157.87 27.14 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -176.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -111.03 -24.38 10.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.619 1.968 . . . . 0.0 110.615 168.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -161.91 173.29 14.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.835 2.054 . . . . 0.0 111.977 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.68 -26.68 67.28 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.232 1.013 . . . . 0.0 113.024 -173.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 m -60.98 -20.16 62.02 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.548 1.539 . . . . 0.0 113.968 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -82.79 -20.78 35.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.247 1.019 . . . . 0.0 112.697 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.8 m -90.87 138.98 25.98 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 124.933 1.293 . . . . 0.0 114.312 -168.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -86.27 151.38 9.32 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.417 2.745 . . . . 0.0 112.301 -170.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.4 -124.03 33.76 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.73 10.51 41.0 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.639 1.176 . . . . 0.0 113.765 173.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 80.6 m -61.8 147.05 47.65 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.157 -0.964 . . . . 0.0 112.082 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.31 153.23 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.42 1.888 . . . . 0.0 110.029 175.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -77.47 130.01 36.45 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.357 -0.839 . . . . 0.0 110.629 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -104.91 168.64 8.92 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.716 1.207 . . . . 0.0 111.866 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -17.18 66.93 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 124.743 1.163 . . . . 0.0 115.247 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -76.95 -6.41 52.43 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.795 1.238 . . . . 0.0 114.109 171.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.22 16.72 58.7 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.125 1.345 . . . . 0.0 114.13 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -129.81 156.65 43.99 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.97 1.308 . . . . 0.0 113.25 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 82.9 m -73.67 134.12 43.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.773 1.629 . . . . 0.0 112.084 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.008 0 C-N-CA 125.428 1.489 . . . . 0.0 113.382 176.628 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.2 t -83.78 117.99 70.17 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.161 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.42 172.29 14.49 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.388 2.725 . . . . 0.0 112.245 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.01 34.57 0.13 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.928 1.691 . . . . 0.0 113.914 -175.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.0 pt -79.05 168.22 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.135 1.774 . . . . 0.0 112.112 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.4 tp -136.49 86.41 2.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.961 1.304 . . . . 0.0 108.597 169.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -108.04 134.78 50.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.757 1.623 . . . . 0.0 110.635 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.34 154.95 22.56 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.413 1.006 . . . . 0.0 111.974 171.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.1 p -153.6 151.04 29.28 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.605 1.705 . . . . 0.0 115.605 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -96.51 -25.43 15.65 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.697 1.999 . . . . 0.0 113.246 169.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -174.89 173.69 2.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 128.01 2.524 . . . . 0.0 111.257 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -60.2 -33.43 72.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.329 1.052 . . . . 0.0 112.871 -175.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -64.38 -16.58 62.55 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.942 1.297 . . . . 0.0 113.474 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -93.34 -8.26 42.47 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.635 1.574 . . . . 0.0 112.516 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.8 m -94.71 138.95 22.09 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.534 1.534 . . . . 0.0 112.629 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -84.02 149.79 12.29 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.107 2.538 . . . . 0.0 112.2 -169.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -123.72 33.14 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.297 0.475 . . . . 0.0 111.985 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.59 3.5 55.41 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.603 1.161 . . . . 0.0 114.015 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.6 m -63.61 145.97 54.66 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.159 -0.963 . . . . 0.0 112.683 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.2 pt -119.88 154.77 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.74 2.016 . . . . 0.0 110.039 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.9 t -83.51 123.16 29.46 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.39 -0.819 . . . . 0.0 110.531 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -95.28 169.36 10.13 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.732 1.213 . . . . 0.0 111.796 -176.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.48 -17.92 67.13 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.653 1.121 . . . . 0.0 115.157 -172.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -78.0 -6.43 54.46 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.741 1.216 . . . . 0.0 114.188 171.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.96 18.8 57.36 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.048 1.309 . . . . 0.0 114.189 -178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -129.37 157.53 41.66 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.207 1.403 . . . . 0.0 112.69 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.9 m -73.23 138.9 45.85 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.492 1.517 . . . . 0.0 112.377 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.904 0 C-N-CA 125.434 1.492 . . . . 0.0 113.228 176.747 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 40.3 t -80.72 118.73 73.7 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.387 175.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.81 169.69 20.57 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.014 2.476 . . . . 0.0 111.776 177.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -77.43 39.32 0.26 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.434 1.493 . . . . 0.0 113.41 -176.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -79.32 172.9 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.946 1.698 . . . . 0.0 112.326 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.8 tp -142.38 87.13 2.0 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.007 1.323 . . . . 0.0 108.75 172.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -111.04 134.59 52.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.548 1.539 . . . . 0.0 110.587 -177.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -62.64 153.6 31.78 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.065 0.848 . . . . 0.0 111.987 175.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.1 p -159.26 156.73 29.31 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 176.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -110.04 -26.61 9.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.883 2.073 . . . . 0.0 110.105 168.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -159.54 171.92 18.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.4 1.88 . . . . 0.0 112.287 178.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -61.13 -27.69 68.57 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.199 1.0 . . . . 0.0 113.057 -172.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.6 m -63.33 -17.28 62.4 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.158 1.383 . . . . 0.0 113.94 176.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -81.83 -21.17 37.74 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.038 0.935 . . . . 0.0 112.619 173.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.7 m -90.78 140.86 26.45 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 114.356 -168.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -84.2 145.96 11.09 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.227 2.618 . . . . 0.0 111.912 -169.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.59 -122.37 29.57 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 121.977 -0.452 . . . . 0.0 112.003 177.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.69 5.37 52.05 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.692 1.197 . . . . 0.0 114.079 176.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.6 m -62.3 146.37 51.24 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.198 -0.939 . . . . 0.0 112.421 176.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.8 pt -122.57 154.77 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.612 1.965 . . . . 0.0 109.907 175.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -78.32 129.29 34.84 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.332 -0.855 . . . . 0.0 110.728 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -103.42 168.02 9.43 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.798 1.239 . . . . 0.0 111.79 -178.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.86 -16.9 66.76 Favored Glycine 0 N--CA 1.477 1.422 0 C-N-CA 124.638 1.113 . . . . 0.0 115.244 -171.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -77.15 -6.62 53.63 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.71 1.204 . . . . 0.0 114.14 171.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.07 20.0 54.22 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.862 1.22 . . . . 0.0 114.039 -178.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -133.34 158.75 42.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.205 1.402 . . . . 0.0 112.682 177.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.3 m -74.17 138.28 43.7 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.665 1.586 . . . . 0.0 112.465 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.01 0 C-N-CA 125.291 1.424 . . . . 0.0 113.305 175.999 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.6 t -91.4 116.57 66.71 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.963 172.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.82 152.12 77.76 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.833 2.355 . . . . 0.0 111.363 177.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.56 15.43 1.31 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -169.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.8 pt -79.37 149.55 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.238 1.415 . . . . 0.0 111.87 179.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.6 tp -95.9 94.53 7.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.5 1.12 . . . . 0.0 109.363 177.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -110.31 132.8 53.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.186 1.394 . . . . 0.0 111.153 -177.072 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -63.28 156.18 26.33 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.853 0.751 . . . . 0.0 112.102 174.529 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.3 p -158.95 152.79 23.27 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 175.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -97.23 -31.34 12.48 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.504 1.922 . . . . 0.0 110.602 169.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -168.19 173.64 7.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.363 2.665 . . . . 0.0 110.518 -175.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.38 -26.63 65.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.294 1.038 . . . . 0.0 113.222 -172.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -61.01 -21.6 63.74 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.458 1.503 . . . . 0.0 114.157 177.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -84.53 -16.96 40.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.016 0.926 . . . . 0.0 112.795 175.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.8 m -91.6 139.94 25.14 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 124.616 1.166 . . . . 0.0 114.054 -169.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -84.73 147.17 10.75 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.653 2.902 . . . . 0.0 112.42 -169.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.51 -121.27 26.07 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 177.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.03 6.37 49.01 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.759 1.224 . . . . 0.0 113.973 175.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.1 m -62.77 146.45 52.47 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.485 1.039 . . . . 0.0 112.169 177.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.65 156.26 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.313 1.845 . . . . 0.0 109.963 171.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.2 t -80.12 127.33 32.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.368 -0.832 . . . . 0.0 110.852 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -97.83 164.63 12.3 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.843 1.257 . . . . 0.0 111.48 -179.533 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.93 -19.94 63.95 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -169.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -79.87 -6.66 57.83 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 118.468 1.134 . . . . 0.0 113.861 174.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.21 23.5 22.01 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.115 1.341 . . . . 0.0 114.451 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -135.68 156.5 48.74 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.924 1.29 . . . . 0.0 112.832 178.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.6 m -74.04 140.6 45.5 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.775 1.63 . . . . 0.0 112.804 -177.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.031 0 C-N-CA 125.272 1.415 . . . . 0.0 113.398 176.261 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 40.7 t -91.01 117.32 67.82 Favored Pre-proline 0 CA--C 1.547 0.864 0 CA-C-O 118.19 -0.909 . . . . 0.0 109.845 170.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.28 168.43 22.24 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.023 2.482 . . . . 0.0 112.098 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -75.51 31.22 0.1 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 125.839 1.655 . . . . 0.0 113.522 -177.555 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.3 tt -80.92 156.17 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.396 1.878 . . . . 0.0 111.883 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.9 tp -122.69 85.84 2.48 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.998 1.319 . . . . 0.0 108.135 169.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -109.15 132.7 53.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.535 1.534 . . . . 0.0 110.6 -175.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -72.15 159.36 34.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.158 0.89 . . . . 0.0 111.48 177.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.8 p -161.76 158.05 25.18 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -174.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.56 -29.46 8.75 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.38 1.872 . . . . 0.0 110.475 168.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -159.81 177.52 10.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.552 1.941 . . . . 0.0 111.969 176.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -63.28 -26.7 68.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -169.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.0 p -69.69 -11.76 61.1 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 177.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -81.92 -14.88 55.51 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.088 0.955 . . . . 0.0 112.616 170.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.1 m -99.7 139.97 21.23 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.193 1.397 . . . . 0.0 113.49 -169.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -87.0 151.27 8.34 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.363 2.709 . . . . 0.0 112.375 -169.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.2 -122.57 29.89 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 178.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.62 7.75 45.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.579 1.152 . . . . 0.0 113.884 175.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.1 m -62.37 145.25 54.44 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.107 -0.996 . . . . 0.0 112.16 176.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.7 pt -120.02 155.21 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.467 1.907 . . . . 0.0 110.01 173.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -80.16 123.12 27.63 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.441 -0.787 . . . . 0.0 110.677 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -95.13 169.08 10.35 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.856 1.262 . . . . 0.0 111.783 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.61 67.05 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 124.54 1.067 . . . . 0.0 115.197 -172.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -78.17 -6.08 53.7 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.702 1.201 . . . . 0.0 114.211 171.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.21 15.57 60.46 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.081 1.324 . . . . 0.0 114.296 -178.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -127.28 156.19 42.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.841 1.257 . . . . 0.0 112.984 178.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -72.52 138.7 47.13 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.716 1.606 . . . . 0.0 112.252 -178.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.941 0 C-N-CA 125.085 1.326 . . . . 0.0 113.489 177.45 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.1 t -90.27 117.21 67.86 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.871 172.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.17 152.27 79.96 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.765 2.31 . . . . 0.0 111.539 178.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.42 15.13 1.34 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -169.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.2 pt -79.16 149.17 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.279 1.432 . . . . 0.0 111.753 178.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.6 tp -95.04 92.0 6.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.343 1.057 . . . . 0.0 109.206 175.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -108.73 130.04 55.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.279 1.432 . . . . 0.0 110.635 -178.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -69.85 160.36 31.93 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.479 1.036 . . . . 0.0 112.539 172.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.7 p -158.21 151.96 23.66 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -176.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -88.1 -39.56 14.48 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.168 1.387 . . . . 0.0 111.386 169.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -165.4 179.62 6.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.429 2.291 . . . . 0.0 110.942 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.14 -29.66 69.91 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.509 1.123 . . . . 0.0 113.947 -170.336 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.7 p -66.91 -17.48 64.92 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.326 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -94.76 -1.73 52.36 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.168 1.387 . . . . 0.0 112.85 176.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.0 m -96.12 141.73 23.56 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.921 1.288 . . . . 0.0 112.936 177.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -83.61 146.5 12.05 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.538 2.826 . . . . 0.0 112.611 -169.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.88 -122.04 28.48 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 177.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.45 6.47 48.91 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.681 1.192 . . . . 0.0 114.007 175.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.7 m -62.47 145.47 54.08 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.373 0.988 . . . . 0.0 112.411 178.065 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.3 pt -114.45 155.57 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.37 1.868 . . . . 0.0 110.008 170.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.1 t -84.9 115.11 22.59 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.511 -0.743 . . . . 0.0 110.432 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -84.23 168.58 15.59 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.045 1.338 . . . . 0.0 111.726 -176.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.31 -17.76 66.56 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 124.503 1.049 . . . . 0.0 115.188 -173.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -78.37 -6.57 55.56 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.76 1.224 . . . . 0.0 114.195 171.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.84 17.33 58.27 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.994 1.283 . . . . 0.0 114.452 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.07 157.26 40.11 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.352 1.461 . . . . 0.0 112.363 177.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.5 m -74.95 139.82 43.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.861 1.664 . . . . 0.0 112.573 -178.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.943 0 C-N-CA 125.104 1.335 . . . . 0.0 113.377 177.677 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.0 t -91.38 118.83 68.67 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.401 174.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.78 141.89 55.86 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.65 2.233 . . . . 0.0 110.558 172.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -82.14 30.25 0.4 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.629 1.172 . . . . 0.0 113.91 -169.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt -78.98 150.36 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.621 1.569 . . . . 0.0 111.671 177.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.0 tp -92.67 86.71 5.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.086 0.954 . . . . 0.0 109.164 174.256 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -109.33 128.09 54.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.665 1.586 . . . . 0.0 110.895 -176.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -63.66 154.07 34.11 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.931 0.787 . . . . 0.0 112.354 178.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.9 p -159.46 162.02 35.55 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 175.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -115.49 -23.05 8.99 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.619 1.968 . . . . 0.0 110.703 168.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -161.91 169.75 20.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.681 1.993 . . . . 0.0 112.376 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -63.32 -27.11 69.1 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -169.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.7 p -71.35 -10.59 60.01 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 177.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -79.77 -18.51 50.85 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.208 -0.932 . . . . 0.0 112.108 169.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.3 m -98.91 138.74 20.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.388 1.475 . . . . 0.0 113.616 -169.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -87.53 152.89 7.7 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.755 2.97 . . . . 0.0 112.49 -169.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -120.63 23.48 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 176.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.03 5.38 50.5 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.474 1.11 . . . . 0.0 113.923 175.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.0 m -64.24 143.44 57.89 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.516 1.053 . . . . 0.0 112.166 179.007 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.0 pt -116.72 157.72 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.522 1.929 . . . . 0.0 109.973 171.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.7 t -81.72 117.96 22.46 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.394 -0.816 . . . . 0.0 110.585 178.073 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -87.74 167.52 13.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.889 1.276 . . . . 0.0 111.682 -177.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.29 -17.48 66.2 Favored Glycine 0 N--CA 1.478 1.456 0 C-N-CA 124.519 1.057 . . . . 0.0 115.25 -172.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -77.23 -8.56 57.79 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 171.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.81 21.38 43.27 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.937 1.256 . . . . 0.0 114.201 -178.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -132.9 156.84 46.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.082 1.353 . . . . 0.0 112.26 177.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.6 m -70.85 142.35 51.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.166 1.386 . . . . 0.0 112.311 -178.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.878 0 C-N-CA 124.787 1.184 . . . . 0.0 113.609 177.315 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 t -90.63 120.04 68.94 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.312 173.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.72 145.66 48.28 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 124.092 3.195 . . . . 0.0 113.292 173.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -89.86 11.85 19.04 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 pp -79.67 167.3 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.629 1.572 . . . . 0.0 112.188 172.068 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.2 tp -108.22 100.09 9.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.91 1.284 . . . . 0.0 109.831 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -113.01 131.7 55.67 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.278 1.431 . . . . 0.0 111.01 -179.296 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -71.76 161.62 30.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.116 0.871 . . . . 0.0 111.273 173.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.9 p -160.13 151.38 19.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -175.042 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.8 ttt180 -88.97 -38.21 14.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.348 1.459 . . . . 0.0 111.293 169.281 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -164.88 178.49 7.12 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.359 2.264 . . . . 0.0 111.028 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -58.88 -30.67 67.92 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.69 1.196 . . . . 0.0 113.429 -173.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -60.67 -21.15 62.5 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.961 1.304 . . . . 0.0 113.833 177.255 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -97.9 0.2 46.14 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.251 1.42 . . . . 0.0 113.038 179.481 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.5 m -97.47 141.09 22.48 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.042 1.337 . . . . 0.0 113.07 178.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.43 148.13 11.37 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.49 2.793 . . . . 0.0 112.607 -169.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.7 -124.05 34.55 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 179.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.88 7.66 45.25 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.719 1.208 . . . . 0.0 114.052 175.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.2 m -62.35 145.52 53.67 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.15 -0.969 . . . . 0.0 112.517 178.057 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -115.25 154.6 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.363 1.865 . . . . 0.0 110.098 170.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.0 t -84.13 112.72 20.5 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.478 -0.764 . . . . 0.0 110.328 179.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -81.48 168.69 18.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.994 1.317 . . . . 0.0 111.717 -177.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.24 -17.84 66.51 Favored Glycine 0 N--CA 1.478 1.457 0 C-N-CA 124.572 1.082 . . . . 0.0 115.143 -172.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -78.27 -6.36 54.74 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.754 1.222 . . . . 0.0 114.212 171.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.62 16.4 58.53 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.036 1.303 . . . . 0.0 114.379 -178.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -126.51 154.99 43.03 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.919 1.287 . . . . 0.0 113.184 178.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 81.8 m -73.6 137.19 44.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.349 1.46 . . . . 0.0 112.384 -177.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.965 0 C-N-CA 125.048 1.309 . . . . 0.0 113.347 178.037 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.9 t -89.92 118.64 69.09 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.058 171.577 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -62.4 165.18 15.82 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.203 2.602 . . . . 0.0 113.235 177.153 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.39 21.93 0.59 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.038 1.335 . . . . 0.0 114.527 -171.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.25 168.18 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.082 1.353 . . . . 0.0 112.989 -177.018 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.9 tp -125.59 86.04 2.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.105 1.362 . . . . 0.0 107.885 169.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -106.97 130.19 54.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.34 1.456 . . . . 0.0 110.393 -175.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -71.01 158.44 36.51 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.109 0.868 . . . . 0.0 111.262 177.022 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.5 p -160.97 157.24 26.05 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -107.71 -28.13 9.88 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.715 2.006 . . . . 0.0 110.116 168.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 -160.13 172.46 17.41 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.362 1.865 . . . . 0.0 112.486 179.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -61.2 -27.36 68.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.211 1.004 . . . . 0.0 113.02 -172.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -63.42 -17.34 62.56 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.091 1.357 . . . . 0.0 113.949 177.021 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -82.01 -20.81 37.66 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.161 0.984 . . . . 0.0 112.636 173.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.8 m -92.14 139.54 24.31 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.158 1.383 . . . . 0.0 114.202 -168.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -86.26 151.21 9.32 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.356 2.704 . . . . 0.0 112.229 -170.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.96 -125.48 38.28 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.13 10.45 39.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.574 1.15 . . . . 0.0 113.874 174.076 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.31 145.56 51.01 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.13 -0.981 . . . . 0.0 112.064 174.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.02 153.61 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.278 1.831 . . . . 0.0 110.062 173.876 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.8 t -78.09 124.39 27.99 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.502 -0.749 . . . . 0.0 110.546 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -98.13 169.36 9.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.774 1.23 . . . . 0.0 111.782 -176.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.55 -17.68 67.0 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 124.58 1.086 . . . . 0.0 115.223 -172.571 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -78.09 -6.35 54.38 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.686 1.194 . . . . 0.0 114.21 171.54 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.41 16.26 59.09 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.063 1.316 . . . . 0.0 114.315 -178.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -128.24 156.12 43.47 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.971 1.309 . . . . 0.0 113.081 178.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.3 m -72.12 136.89 46.67 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.535 1.534 . . . . 0.0 112.075 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.932 0 C-N-CA 125.205 1.383 . . . . 0.0 113.063 177.398 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.0 t -95.69 117.02 66.67 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.342 -0.837 . . . . 0.0 109.761 169.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.64 172.23 16.18 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.124 2.55 . . . . 0.0 112.404 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -72.22 25.5 0.05 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.53 1.932 . . . . 0.0 115.476 -175.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.2 pt -77.69 170.31 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.313 1.845 . . . . 0.0 112.764 -177.537 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.5 tp -136.86 88.05 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.24 1.416 . . . . 0.0 108.467 169.606 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -108.94 133.68 52.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.529 1.532 . . . . 0.0 110.859 -175.712 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -63.58 154.89 31.24 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.996 0.816 . . . . 0.0 112.248 175.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.8 p -159.38 156.91 29.33 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 176.176 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -107.15 -32.35 7.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.819 2.048 . . . . 0.0 110.141 168.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -158.03 176.64 12.26 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.227 1.811 . . . . 0.0 112.054 176.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -63.09 -26.71 68.96 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.4 p -69.56 -12.29 61.52 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -78.87 -21.58 47.3 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.409 -0.807 . . . . 0.0 112.283 169.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.5 m -94.85 134.17 25.37 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.976 1.31 . . . . 0.0 113.33 -169.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -88.47 160.01 6.64 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.423 2.749 . . . . 0.0 112.131 -170.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.15 -125.04 35.23 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 178.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.45 7.96 45.49 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.355 1.062 . . . . 0.0 113.686 173.425 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -63.78 146.53 53.72 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.162 -0.961 . . . . 0.0 112.371 177.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 pt -123.37 155.82 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.81 2.044 . . . . 0.0 109.616 174.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.4 t -78.69 131.27 36.57 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.19 -0.943 . . . . 0.0 110.776 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.44 168.06 9.33 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.696 1.198 . . . . 0.0 111.86 -178.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.88 -16.65 66.46 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.638 1.113 . . . . 0.0 115.327 -171.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -76.63 -7.07 54.54 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.723 1.209 . . . . 0.0 114.138 170.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.4 20.11 52.91 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.008 1.29 . . . . 0.0 114.09 -178.287 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -133.47 158.06 44.05 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.149 1.38 . . . . 0.0 112.807 178.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -73.6 136.05 43.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.747 1.619 . . . . 0.0 112.319 -178.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.968 0 C-N-CA 125.421 1.486 . . . . 0.0 113.393 176.226 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.1 t -90.86 117.84 68.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.865 170.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.36 167.6 24.74 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.949 2.433 . . . . 0.0 111.849 178.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -76.11 33.24 0.12 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.632 1.573 . . . . 0.0 113.246 -177.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.0 tt -79.89 154.54 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.189 1.796 . . . . 0.0 111.699 178.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.1 tp -120.65 86.06 2.5 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.915 1.286 . . . . 0.0 108.038 169.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -108.14 132.83 53.19 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.293 1.437 . . . . 0.0 110.737 -176.026 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.58 153.66 31.34 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.937 0.79 . . . . 0.0 111.812 175.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.9 p -159.64 158.27 31.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 176.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -113.8 -22.97 9.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.658 1.983 . . . . 0.0 110.814 168.487 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -161.83 171.24 18.1 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.607 1.963 . . . . 0.0 112.178 177.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -61.97 -27.04 68.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.03 0.932 . . . . 0.0 113.121 -171.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -62.86 -18.12 62.48 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.035 1.334 . . . . 0.0 113.982 176.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -80.78 -20.94 41.51 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.142 0.977 . . . . 0.0 112.564 174.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.8 m -92.71 138.8 23.51 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.04 1.336 . . . . 0.0 114.477 -168.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -87.07 153.29 8.3 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.436 2.757 . . . . 0.0 112.222 -170.366 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -123.63 32.89 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.22 8.89 44.16 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.506 1.122 . . . . 0.0 113.887 174.192 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 80.8 m -62.55 146.8 50.92 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.066 -1.021 . . . . 0.0 112.187 176.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.8 pt -122.3 155.32 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 126.543 1.937 . . . . 0.0 109.824 174.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.0 t -77.68 130.6 37.02 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.203 -0.936 . . . . 0.0 110.763 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.45 167.6 9.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.717 1.207 . . . . 0.0 111.916 -178.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.06 -16.47 66.59 Favored Glycine 0 N--CA 1.477 1.381 0 C-N-CA 124.732 1.158 . . . . 0.0 115.373 -171.703 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -76.32 -7.01 54.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.696 1.198 . . . . 0.0 114.107 170.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.55 19.32 54.88 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.016 1.294 . . . . 0.0 114.0 -178.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -133.71 158.7 42.62 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.255 1.422 . . . . 0.0 112.695 178.193 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.7 m -73.06 138.78 46.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.565 1.546 . . . . 0.0 112.424 -179.113 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 C-N-CA 125.257 1.408 . . . . 0.0 113.433 176.044 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.2 t -86.72 115.66 63.19 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.016 173.507 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -67.98 160.47 48.42 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.78 2.32 . . . . 0.0 112.054 178.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.93 16.03 0.17 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -172.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 tp -75.12 144.67 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.895 1.678 . . . . 0.0 111.746 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.5 tp -102.94 88.37 3.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.749 1.22 . . . . 0.0 108.328 169.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -108.63 129.78 55.33 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.256 1.422 . . . . 0.0 110.413 -177.274 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.28 157.75 34.89 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.391 0.996 . . . . 0.0 112.109 172.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -157.22 151.49 25.0 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -174.672 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -91.13 -35.7 14.41 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.192 1.397 . . . . 0.0 111.505 169.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -164.75 177.35 8.04 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.198 2.199 . . . . 0.0 111.277 179.277 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -59.67 -30.54 68.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.703 1.201 . . . . 0.0 113.467 -173.012 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 m -60.91 -20.69 62.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.909 1.284 . . . . 0.0 113.735 177.335 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -97.21 0.83 48.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.374 1.47 . . . . 0.0 112.988 179.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.7 m -98.98 141.1 22.3 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.074 1.35 . . . . 0.0 113.2 178.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -84.68 149.42 11.25 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.5 2.8 . . . . 0.0 112.589 -169.342 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.34 -124.0 33.77 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.3 10.48 40.58 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.675 1.19 . . . . 0.0 113.745 174.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.2 m -61.51 145.57 51.47 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.099 -1.0 . . . . 0.0 112.52 176.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.1 pt -116.19 154.89 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.448 1.899 . . . . 0.0 110.054 172.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.2 t -83.52 116.43 22.56 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.588 -0.695 . . . . 0.0 110.517 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -87.05 168.72 13.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.041 1.337 . . . . 0.0 111.752 -176.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -17.58 67.11 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 124.602 1.096 . . . . 0.0 115.193 -173.316 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -78.27 -6.34 54.69 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.732 1.213 . . . . 0.0 114.149 171.744 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.08 16.16 59.79 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.028 1.299 . . . . 0.0 114.404 -179.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -126.54 157.78 37.89 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.407 1.483 . . . . 0.0 112.397 177.743 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.9 m -73.84 140.3 45.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.962 1.705 . . . . 0.0 112.481 -179.532 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.891 0 C-N-CA 125.164 1.364 . . . . 0.0 113.431 177.71 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.586 -0.206 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -163.58 151.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.794 1.638 . . . . 0.0 109.079 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.5 t -94.53 118.19 66.94 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.22 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.19 150.95 54.29 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.59 2.86 . . . . 0.0 113.232 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -77.89 17.92 0.53 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.122 1.369 . . . . 0.0 114.226 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.0 pt -79.12 159.71 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.983 1.713 . . . . 0.0 112.341 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.4 tp -105.56 87.55 2.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.676 1.191 . . . . 0.0 108.935 170.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -107.95 127.08 53.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.259 1.424 . . . . 0.0 110.704 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -70.59 159.13 34.93 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.25 0.932 . . . . 0.0 112.744 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.3 p -159.51 153.18 22.8 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -96.25 -30.01 13.7 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.24 1.816 . . . . 0.0 110.837 169.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.2 ptm85 -169.21 173.23 6.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.327 2.651 . . . . 0.0 110.67 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.81 -26.81 66.06 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.314 1.046 . . . . 0.0 113.252 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.5 m -62.99 -18.59 63.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.083 1.353 . . . . 0.0 114.049 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -86.47 -10.55 53.95 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.169 0.988 . . . . 0.0 112.923 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.3 m -101.87 136.34 19.54 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.825 1.25 . . . . 0.0 113.265 -171.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -88.73 155.08 6.17 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.428 2.752 . . . . 0.0 112.559 -169.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.72 -123.14 30.99 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.86 5.89 50.2 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.526 1.13 . . . . 0.0 113.883 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.9 m -64.0 144.9 56.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.408 1.004 . . . . 0.0 112.228 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.3 pt -120.06 155.69 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.42 1.888 . . . . 0.0 109.8 171.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.4 t -79.64 126.27 30.69 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.348 -0.845 . . . . 0.0 110.674 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -97.94 168.26 10.4 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.801 1.24 . . . . 0.0 111.756 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.45 -17.62 66.71 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 124.585 1.088 . . . . 0.0 115.218 -171.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -77.49 -7.84 56.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.714 1.206 . . . . 0.0 114.21 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.0 19.06 52.64 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.123 1.344 . . . . 0.0 114.263 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -129.98 156.22 44.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.323 1.449 . . . . 0.0 112.35 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.5 m -73.08 138.29 45.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.009 1.723 . . . . 0.0 112.203 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.26 -170.48 23.87 Favored Glycine 0 N--CA 1.47 0.95 0 C-N-CA 125.042 1.306 . . . . 0.0 113.556 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.537 0 O-C-N 121.253 -1.146 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.5 p -163.91 152.18 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.911 1.684 . . . . 0.0 108.981 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.8 t -90.48 117.33 67.91 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.104 172.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -62.11 160.57 29.73 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.149 2.566 . . . . 0.0 112.721 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -77.36 32.04 0.15 Allowed 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.263 1.425 . . . . 0.0 113.65 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 pp -80.33 174.05 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.353 1.861 . . . . 0.0 112.853 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.8 tp -136.48 86.75 2.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.292 1.437 . . . . 0.0 108.325 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -109.4 133.03 53.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.511 1.524 . . . . 0.0 110.287 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -70.98 160.01 33.68 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.329 0.968 . . . . 0.0 111.221 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.6 p -160.32 152.27 20.18 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -94.42 -34.59 12.69 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.198 1.799 . . . . 0.0 110.433 169.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -166.77 178.06 6.12 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.233 2.613 . . . . 0.0 110.449 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -61.1 -26.9 67.98 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -169.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.1 p -69.64 -13.15 62.16 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -82.08 -18.43 43.1 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.018 0.826 . . . . 0.0 112.593 170.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.6 m -91.66 139.9 25.05 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.697 1.199 . . . . 0.0 113.766 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -85.7 150.13 9.97 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.439 2.759 . . . . 0.0 112.437 -169.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.56 -123.52 32.18 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.35 9.83 42.17 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.646 1.178 . . . . 0.0 113.832 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 91.2 m -61.62 145.71 51.29 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.071 -1.018 . . . . 0.0 112.31 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.2 pt -120.43 154.57 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.398 1.879 . . . . 0.0 110.006 174.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.9 t -80.68 123.87 28.54 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.385 -0.822 . . . . 0.0 110.626 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -95.76 169.97 9.64 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.891 1.277 . . . . 0.0 111.734 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.47 -17.88 67.05 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.574 1.083 . . . . 0.0 115.224 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -78.25 -6.09 53.91 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.839 1.256 . . . . 0.0 114.212 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.0 15.75 60.56 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.082 1.325 . . . . 0.0 114.281 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -127.33 156.53 41.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.975 1.31 . . . . 0.0 113.099 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.2 m -74.02 137.3 43.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.753 1.621 . . . . 0.0 112.466 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.95 -168.93 21.7 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.225 1.393 . . . . 0.0 113.366 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 O-C-N 121.348 -1.09 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 112.566 -0.214 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p -163.37 150.45 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.752 1.621 . . . . 0.0 109.264 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.5 t -90.59 116.16 65.79 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.182 173.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.1 154.46 72.45 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.947 2.432 . . . . 0.0 111.735 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -83.25 14.97 3.15 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -169.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.2 pt -79.18 151.73 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.5 1.52 . . . . 0.0 112.279 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.4 tp -89.47 89.38 7.83 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.322 1.049 . . . . 0.0 109.249 174.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -109.71 122.5 47.62 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.704 1.601 . . . . 0.0 109.61 -173.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -73.14 160.09 32.53 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.169 -0.957 . . . . 0.0 112.095 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.5 p -161.78 153.49 18.94 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -96.31 -32.95 12.14 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.993 1.717 . . . . 0.0 110.34 169.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.7 ptt-85 -165.85 177.32 7.24 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 128.417 2.687 . . . . 0.0 110.437 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -59.33 -27.29 65.77 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.334 1.054 . . . . 0.0 113.496 -172.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.7 m -60.01 -22.4 62.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.094 1.358 . . . . 0.0 114.067 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -88.56 -10.32 49.21 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.196 0.998 . . . . 0.0 113.085 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.2 m -93.79 140.14 22.93 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -84.43 147.47 11.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.548 2.832 . . . . 0.0 112.317 -169.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.88 -122.03 28.44 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.903 -0.498 . . . . 0.0 111.916 177.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.54 6.0 50.09 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.746 1.218 . . . . 0.0 114.03 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.0 m -63.76 149.62 46.38 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.173 -0.954 . . . . 0.0 113.109 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.9 pt -117.4 157.1 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.605 1.962 . . . . 0.0 110.107 169.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.8 t -84.18 119.93 25.59 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.439 -0.788 . . . . 0.0 110.911 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -88.28 168.09 13.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.651 1.18 . . . . 0.0 111.519 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -16.72 66.04 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.587 1.089 . . . . 0.0 115.297 -172.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -78.06 -7.07 56.47 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 172.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.82 16.94 57.45 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.851 1.215 . . . . 0.0 114.225 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -129.88 156.52 44.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.049 1.34 . . . . 0.0 112.763 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.9 m -76.43 144.0 40.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.164 1.386 . . . . 0.0 113.016 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.81 -170.09 27.16 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.158 1.361 . . . . 0.0 113.444 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.531 0 O-C-N 121.25 -1.147 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.2 p -163.43 150.18 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.689 1.596 . . . . 0.0 109.238 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.4 t -92.57 116.03 65.8 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.261 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 147.2 63.78 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.666 2.244 . . . . 0.0 111.101 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -80.92 17.64 1.16 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.869 1.268 . . . . 0.0 114.379 -171.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.9 pt -75.79 152.91 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.532 1.533 . . . . 0.0 112.231 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.2 tp -88.14 87.35 7.29 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.303 1.041 . . . . 0.0 109.506 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -109.56 121.03 44.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.76 1.624 . . . . 0.0 109.527 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -73.56 159.21 33.47 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.208 -0.932 . . . . 0.0 112.289 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.1 p -161.54 156.21 23.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.18 -32.5 9.11 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.572 1.949 . . . . 0.0 109.686 168.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -159.62 177.1 11.24 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.232 2.213 . . . . 0.0 111.295 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -60.67 -26.78 67.34 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.455 1.102 . . . . 0.0 113.496 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.8 m -60.02 -21.16 61.0 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.02 1.328 . . . . 0.0 113.928 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -86.65 -13.84 44.41 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.237 1.015 . . . . 0.0 113.097 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.1 m -92.35 140.13 24.18 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -169.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.46 147.48 11.19 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.573 2.848 . . . . 0.0 112.301 -169.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.96 -121.59 27.05 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.76 5.85 50.34 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.697 1.199 . . . . 0.0 113.964 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.1 m -63.77 150.32 44.85 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.108 -0.995 . . . . 0.0 113.134 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.0 155.68 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.636 1.974 . . . . 0.0 109.941 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.6 t -78.8 131.99 36.71 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.18 -0.95 . . . . 0.0 110.642 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -104.25 167.64 9.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.596 1.158 . . . . 0.0 111.765 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.74 -16.89 66.48 Favored Glycine 0 N--CA 1.477 1.403 0 C-N-CA 124.712 1.149 . . . . 0.0 115.362 -170.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -76.83 -8.06 56.63 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 171.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.4 15.98 56.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.09 1.329 . . . . 0.0 114.2 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -130.98 157.44 42.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.03 1.332 . . . . 0.0 112.631 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.9 m -76.02 141.47 42.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.201 1.4 . . . . 0.0 112.89 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.34 -168.34 19.69 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.417 1.484 . . . . 0.0 113.437 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.496 0 O-C-N 121.237 -1.154 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m -147.69 159.22 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.286 1.834 . . . . 0.0 108.701 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.6 t -93.65 116.72 66.85 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.176 173.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.21 150.11 71.2 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.785 2.324 . . . . 0.0 111.591 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -77.29 13.43 1.17 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -171.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 pt -78.21 151.59 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.539 1.536 . . . . 0.0 112.301 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.4 tp -89.3 88.45 7.5 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.384 1.074 . . . . 0.0 109.407 175.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -109.66 121.97 46.42 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.783 1.633 . . . . 0.0 109.562 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -73.6 159.33 33.25 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.131 -0.98 . . . . 0.0 112.312 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.2 p -163.74 161.86 23.65 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -112.99 -32.29 6.41 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.505 1.922 . . . . 0.0 110.299 168.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.429 ' HG3' ' H ' ' A' ' 13' ' ' ASP . 1.1 tpm_? -155.33 175.36 13.96 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.141 1.776 . . . . 0.0 111.057 175.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.429 ' H ' ' HG3' ' A' ' 12' ' ' ARG . 22.5 m-20 -61.97 -26.88 68.47 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.165 1.386 . . . . 0.0 113.439 -169.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.2 m -63.36 -18.79 64.04 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.758 1.223 . . . . 0.0 113.499 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -84.67 -13.83 50.32 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.284 1.034 . . . . 0.0 112.901 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.6 m -95.17 141.54 23.38 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.701 1.201 . . . . 0.0 114.18 -169.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -84.39 146.35 10.97 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.585 2.856 . . . . 0.0 112.262 -169.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.84 -122.69 30.53 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.84 5.97 50.34 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.793 1.237 . . . . 0.0 113.986 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.4 m -62.99 149.03 45.91 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.227 -0.921 . . . . 0.0 113.04 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.6 pt -117.86 155.97 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.458 1.903 . . . . 0.0 110.338 170.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 t -82.97 122.71 28.64 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.374 -0.829 . . . . 0.0 111.021 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -93.46 168.13 11.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.7 1.2 . . . . 0.0 111.74 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.7 -17.22 66.8 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.631 1.11 . . . . 0.0 115.294 -171.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -77.7 -7.39 56.42 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 172.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.18 16.99 56.75 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.982 1.277 . . . . 0.0 114.221 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -130.63 157.16 43.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.974 1.309 . . . . 0.0 112.632 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.5 m -76.08 143.51 41.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.185 1.394 . . . . 0.0 112.849 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.86 -167.93 24.02 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.127 1.346 . . . . 0.0 113.422 177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 O-C-N 121.326 -1.102 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.787 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p -163.97 151.43 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.818 1.647 . . . . 0.0 109.037 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.4 t -89.41 118.38 69.04 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.209 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -58.8 161.25 15.66 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.472 2.782 . . . . 0.0 113.467 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -78.58 17.91 0.63 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.865 1.266 . . . . 0.0 113.355 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 tp -76.1 148.59 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 126.124 1.77 . . . . 0.0 112.076 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.1 tp -106.2 86.55 2.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.763 1.225 . . . . 0.0 108.101 169.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -107.15 131.63 53.93 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.123 1.369 . . . . 0.0 110.442 -176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -70.56 160.76 31.9 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.059 0.845 . . . . 0.0 111.089 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -160.21 150.76 18.61 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -93.3 -35.67 12.95 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.406 1.882 . . . . 0.0 110.428 169.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -165.04 -179.85 5.96 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.399 2.68 . . . . 0.0 110.198 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -59.72 -26.03 65.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.318 1.047 . . . . 0.0 113.645 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 m -59.46 -22.76 62.01 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.375 1.47 . . . . 0.0 114.176 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -84.47 -17.3 39.57 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.896 0.878 . . . . 0.0 113.004 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.6 m -91.21 138.09 25.94 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -169.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -87.15 151.53 8.15 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.406 2.737 . . . . 0.0 112.441 -169.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.56 -125.07 36.27 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.57 9.36 41.73 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.578 1.151 . . . . 0.0 113.862 174.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.2 m -62.35 146.93 49.91 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.104 -0.997 . . . . 0.0 112.256 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.94 154.53 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.442 1.897 . . . . 0.0 109.823 172.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -78.38 129.86 35.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.336 -0.852 . . . . 0.0 110.525 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -103.29 169.81 8.33 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.644 1.178 . . . . 0.0 111.854 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.52 -17.71 66.96 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.695 1.14 . . . . 0.0 115.297 -171.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -77.28 -6.7 54.12 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.751 1.22 . . . . 0.0 114.131 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.11 15.77 60.34 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.19 1.376 . . . . 0.0 114.201 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -127.95 156.86 42.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.074 1.35 . . . . 0.0 113.098 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.4 m -73.8 136.21 43.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.711 1.605 . . . . 0.0 112.468 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.15 -169.89 20.15 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.332 1.444 . . . . 0.0 113.452 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.53 0 O-C-N 121.169 -1.195 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.6 p -165.06 146.56 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.831 1.652 . . . . 0.0 109.521 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 48.7 t -84.11 117.77 69.55 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.337 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.88 175.58 10.18 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.517 2.811 . . . . 0.0 112.337 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -76.44 35.26 0.14 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.026 1.731 . . . . 0.0 113.635 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.3 pt -80.35 170.82 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.459 1.904 . . . . 0.0 112.185 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.4 tp -143.86 91.03 2.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.969 1.308 . . . . 0.0 109.372 173.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -112.33 136.85 51.27 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.672 1.589 . . . . 0.0 111.041 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -63.94 155.72 29.99 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 118.844 0.747 . . . . 0.0 111.597 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.0 p -159.83 155.15 25.28 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -98.46 -36.19 10.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.443 1.897 . . . . 0.0 110.485 169.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.431 ' HG3' ' H ' ' A' ' 13' ' ' ASP . 1.5 tpm_? -163.16 175.53 10.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.937 2.495 . . . . 0.0 109.442 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 12' ' ' ARG . 24.3 m-20 -60.6 -26.4 66.96 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.397 1.479 . . . . 0.0 113.523 -169.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.5 m -62.54 -20.44 64.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.867 1.267 . . . . 0.0 113.781 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -83.07 -14.25 54.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.723 0.809 . . . . 0.0 113.023 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.3 m -99.03 137.38 20.46 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.046 1.338 . . . . 0.0 113.014 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -86.65 150.93 8.79 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.834 2.356 . . . . 0.0 112.015 -170.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.56 -123.3 32.46 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.34 0.495 . . . . 0.0 112.168 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.17 1.83 56.97 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.689 1.196 . . . . 0.0 114.085 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.8 m -64.2 143.42 57.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.375 0.989 . . . . 0.0 112.376 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.6 pt -120.76 155.86 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.34 1.856 . . . . 0.0 110.132 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.0 t -83.1 116.27 22.25 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.505 -0.747 . . . . 0.0 110.886 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -86.88 169.2 12.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.935 1.294 . . . . 0.0 111.777 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.48 -17.26 66.35 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 124.565 1.079 . . . . 0.0 115.21 -172.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -77.64 -6.6 54.39 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.777 1.231 . . . . 0.0 114.2 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.39 20.46 54.58 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.867 1.223 . . . . 0.0 114.17 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -131.93 157.99 42.59 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.003 1.321 . . . . 0.0 112.865 177.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 75.3 m -73.6 136.77 43.96 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.595 1.558 . . . . 0.0 112.514 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.95 -168.51 22.01 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.257 1.408 . . . . 0.0 113.366 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.515 0 O-C-N 121.262 -1.14 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p -163.92 150.28 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.83 1.652 . . . . 0.0 109.095 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.9 t -90.59 117.86 68.28 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.322 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.32 146.06 52.71 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.875 3.05 . . . . 0.0 113.286 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -78.41 10.49 3.07 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -170.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.4 pt -79.45 154.05 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.333 1.453 . . . . 0.0 112.114 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.34 93.6 6.59 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.508 1.123 . . . . 0.0 108.805 171.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -108.22 133.63 52.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.3 1.44 . . . . 0.0 111.196 -175.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -62.24 153.74 29.66 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.946 0.794 . . . . 0.0 112.269 171.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -160.42 167.02 28.23 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -128.02 -9.94 5.39 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.242 1.417 . . . . 0.0 112.922 169.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 ptm85 -167.01 166.16 15.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.085 2.154 . . . . 0.0 111.987 173.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -61.37 -30.47 70.55 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.565 1.146 . . . . 0.0 112.85 -171.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 m -62.72 -19.14 63.63 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.098 1.359 . . . . 0.0 113.617 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -95.57 -2.57 48.15 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.288 1.435 . . . . 0.0 112.904 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.3 m -97.64 140.42 21.97 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.063 1.345 . . . . 0.0 112.947 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -83.39 148.52 12.93 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.422 2.748 . . . . 0.0 112.559 -169.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.28 -123.55 33.3 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.669 -0.573 . . . . 0.0 111.669 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.93 8.61 43.18 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.703 1.201 . . . . 0.0 113.917 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.2 m -62.38 145.71 53.23 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.439 1.018 . . . . 0.0 112.151 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.8 pt -115.32 154.75 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.198 1.799 . . . . 0.0 110.198 172.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.0 t -82.65 123.54 29.35 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.457 -0.777 . . . . 0.0 110.635 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.44 167.07 11.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.737 1.215 . . . . 0.0 111.761 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.23 66.6 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 124.572 1.082 . . . . 0.0 115.269 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -77.7 -6.41 53.83 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 171.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.44 22.64 46.71 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.872 1.225 . . . . 0.0 113.978 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -132.77 156.36 47.23 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.216 1.406 . . . . 0.0 112.747 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.8 m -73.82 140.67 45.96 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 112.363 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.94 -172.34 24.06 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 125.194 1.378 . . . . 0.0 113.395 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.499 0 O-C-N 121.273 -1.134 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p -163.77 150.71 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.748 1.619 . . . . 0.0 109.146 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.9 t -90.03 114.0 59.24 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 118.177 -0.916 . . . . 0.0 109.985 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.95 160.89 47.94 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.942 2.428 . . . . 0.0 111.872 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -79.62 18.58 0.73 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.082 1.353 . . . . 0.0 114.246 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.4 mt -79.01 138.15 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.709 1.604 . . . . 0.0 109.921 -176.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.5 tp -84.07 84.83 7.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.16 0.984 . . . . 0.0 108.701 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -107.01 123.42 48.17 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.906 1.682 . . . . 0.0 109.484 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -72.22 159.28 34.36 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.075 -1.016 . . . . 0.0 111.982 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.2 p -162.27 158.46 24.31 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -112.37 -26.71 8.6 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.265 1.826 . . . . 0.0 110.658 168.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.3 175.97 12.73 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.91 2.084 . . . . 0.0 111.37 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -60.91 -27.19 68.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.966 0.907 . . . . 0.0 113.265 -171.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -62.86 -18.06 62.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.178 1.391 . . . . 0.0 113.881 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.7 -14.2 46.13 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.349 1.059 . . . . 0.0 112.881 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.7 m -93.43 141.36 23.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -83.81 146.35 11.74 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.442 2.762 . . . . 0.0 112.129 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.8 -121.8 27.73 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.79 7.33 46.84 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.792 1.237 . . . . 0.0 113.907 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.2 m -63.19 150.88 41.87 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.127 -0.983 . . . . 0.0 113.023 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.2 pt -119.35 154.76 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.542 1.937 . . . . 0.0 110.162 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.9 t -79.1 132.53 36.62 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.145 -0.972 . . . . 0.0 110.849 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -105.26 167.12 9.94 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.624 1.169 . . . . 0.0 111.798 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.03 -16.51 66.58 Favored Glycine 0 N--CA 1.478 1.478 0 C-N-CA 124.649 1.119 . . . . 0.0 115.433 -170.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -76.8 -6.97 54.47 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.21 58.98 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.043 1.306 . . . . 0.0 114.154 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -130.38 157.49 42.45 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.99 1.316 . . . . 0.0 112.741 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.0 m -76.48 141.51 41.27 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.265 1.426 . . . . 0.0 112.729 -175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -153.31 -169.71 18.7 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.637 1.589 . . . . 0.0 113.375 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.507 0 O-C-N 121.137 -1.213 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 112.549 -0.221 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p -163.61 150.51 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.751 1.621 . . . . 0.0 109.3 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.2 t -92.75 115.94 65.69 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.33 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.68 145.94 59.16 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.691 2.261 . . . . 0.0 110.975 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -80.82 18.06 1.06 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.825 1.25 . . . . 0.0 114.254 -171.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.7 pt -75.02 153.38 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.591 1.556 . . . . 0.0 112.235 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.7 tp -87.71 86.66 7.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.279 1.032 . . . . 0.0 109.586 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -109.16 120.41 42.45 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.843 1.657 . . . . 0.0 109.454 -175.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -72.75 159.29 34.04 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.23 -0.919 . . . . 0.0 112.284 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.4 p -162.37 156.22 21.06 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -104.93 -31.85 9.05 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.546 1.938 . . . . 0.0 109.726 168.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.3 ptm85 -161.06 174.65 13.42 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.285 2.234 . . . . 0.0 111.428 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -60.97 -26.6 67.67 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.461 1.104 . . . . 0.0 113.93 -169.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 t -66.03 -14.85 62.4 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -86.16 -14.41 44.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.041 0.937 . . . . 0.0 112.836 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.4 m -92.74 140.62 23.79 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.41 147.3 11.21 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.619 2.88 . . . . 0.0 112.314 -169.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.01 -121.56 26.92 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.62 5.77 50.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.691 1.196 . . . . 0.0 114.005 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.3 m -63.91 150.34 45.22 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.19 -0.944 . . . . 0.0 113.146 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.2 pt -119.48 155.9 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.704 2.002 . . . . 0.0 109.913 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.5 t -78.97 132.23 36.61 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.986 -1.071 . . . . 0.0 110.68 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -104.35 167.26 9.86 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.645 1.178 . . . . 0.0 111.775 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -16.77 66.41 Favored Glycine 0 N--CA 1.477 1.393 0 C-N-CA 124.713 1.149 . . . . 0.0 115.4 -170.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -76.69 -8.1 56.62 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.5 16.16 55.65 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.133 1.349 . . . . 0.0 114.13 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -131.4 157.23 43.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.918 1.287 . . . . 0.0 112.679 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.7 m -75.82 141.65 42.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.278 1.431 . . . . 0.0 112.808 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.54 -168.06 19.44 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.375 1.464 . . . . 0.0 113.394 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.489 0 O-C-N 121.175 -1.191 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.859 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.1 p -163.8 150.9 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.861 1.664 . . . . 0.0 109.253 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.8 t -87.4 115.91 64.35 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 118.15 -0.929 . . . . 0.0 109.984 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.45 151.34 80.25 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.69 2.26 . . . . 0.0 111.609 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -75.77 12.62 1.01 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -170.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.1 pt -79.35 148.52 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.397 1.479 . . . . 0.0 111.885 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 tp -95.11 93.47 7.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.394 1.078 . . . . 0.0 109.299 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -109.32 130.01 55.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.216 1.406 . . . . 0.0 110.835 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -70.3 158.0 36.7 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.237 0.926 . . . . 0.0 112.749 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.9 p -159.97 162.63 34.41 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.581 1.153 . . . . 0.0 113.705 -174.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -113.49 -19.11 11.79 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.406 1.482 . . . . 0.0 112.474 168.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -167.87 169.0 11.84 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 127.105 2.162 . . . . 0.0 111.881 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -60.8 -30.9 70.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.628 1.171 . . . . 0.0 112.987 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 m -62.86 -18.51 63.01 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.999 1.32 . . . . 0.0 113.667 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -97.62 -0.44 45.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.409 1.484 . . . . 0.0 112.79 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.9 m -97.54 142.59 24.79 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.065 1.346 . . . . 0.0 113.018 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -83.56 146.36 12.06 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.619 2.88 . . . . 0.0 112.587 -169.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.91 -120.8 24.38 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.73 7.76 45.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.757 1.223 . . . . 0.0 114.007 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.9 m -62.54 146.73 51.06 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.155 -0.966 . . . . 0.0 112.458 177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.7 pt -116.63 153.49 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.302 1.841 . . . . 0.0 110.195 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -82.32 121.93 27.31 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.481 -0.762 . . . . 0.0 110.43 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -93.89 168.47 10.96 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.852 1.261 . . . . 0.0 111.895 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -17.92 67.5 Favored Glycine 0 N--CA 1.477 1.398 0 C-N-CA 124.683 1.135 . . . . 0.0 115.169 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -77.59 -6.86 55.21 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.669 1.188 . . . . 0.0 114.111 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.64 16.07 58.99 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.076 1.322 . . . . 0.0 114.416 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -126.92 157.5 39.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.475 1.51 . . . . 0.0 112.253 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.3 m -74.7 139.85 43.75 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.049 1.74 . . . . 0.0 112.22 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.43 -170.47 23.13 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 125.171 1.367 . . . . 0.0 113.465 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.473 0 O-C-N 121.246 -1.149 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 112.41 -0.276 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.18 153.35 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.293 1.837 . . . . 0.0 108.784 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.8 t -85.63 120.5 73.0 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.387 173.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.05 170.72 19.12 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.44 2.76 . . . . 0.0 112.122 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.62 36.64 0.21 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.752 1.621 . . . . 0.0 113.693 -175.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.0 pt -78.4 161.46 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.937 1.695 . . . . 0.0 112.327 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.3 tp -123.21 83.26 2.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.076 1.35 . . . . 0.0 108.567 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -112.1 124.03 51.55 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.98 1.712 . . . . 0.0 109.594 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.5 153.1 36.62 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.344 -0.847 . . . . 0.0 112.819 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -160.38 161.7 33.15 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -113.62 -32.09 6.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.726 2.01 . . . . 0.0 110.349 168.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -155.05 174.43 15.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.797 1.639 . . . . 0.0 111.354 175.102 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.411 ' H ' ' HG3' ' A' ' 12' ' ' ARG . 25.6 m-20 -62.42 -25.8 68.15 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.322 1.449 . . . . 0.0 113.756 -169.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 p -65.31 -16.26 63.39 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.206 1.402 . . . . 0.0 113.852 174.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -83.34 -14.47 52.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.232 1.013 . . . . 0.0 112.838 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -100.76 138.9 20.19 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.942 1.297 . . . . 0.0 113.448 -169.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.22 147.87 9.0 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.149 2.566 . . . . 0.0 111.988 -169.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.17 -122.71 30.8 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.41 0.528 . . . . 0.0 112.415 175.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.29 -0.37 57.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.747 1.219 . . . . 0.0 114.204 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 79.7 m -64.75 144.68 57.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.374 0.988 . . . . 0.0 112.962 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.8 pt -119.18 156.79 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.676 1.99 . . . . 0.0 110.122 172.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.8 t -83.24 119.12 24.16 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.321 -0.862 . . . . 0.0 111.13 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -89.74 167.34 12.96 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.791 1.236 . . . . 0.0 111.743 -177.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.44 -17.0 65.97 Favored Glycine 0 N--CA 1.477 1.408 0 C-N-CA 124.634 1.111 . . . . 0.0 115.295 -172.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -76.83 -8.93 58.25 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 171.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.58 23.48 36.34 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.821 1.2 . . . . 0.0 114.077 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -136.5 157.57 46.48 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.97 1.308 . . . . 0.0 112.546 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.6 m -73.62 139.19 45.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.463 1.505 . . . . 0.0 112.681 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.44 -167.82 22.44 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 125.247 1.403 . . . . 0.0 113.33 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.522 0 O-C-N 121.299 -1.118 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.902 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.8 p -164.04 150.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.826 1.65 . . . . 0.0 109.277 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.7 t -89.6 117.42 68.14 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.3 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.99 169.63 21.72 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.143 2.562 . . . . 0.0 112.243 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -73.3 26.82 0.06 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.271 1.829 . . . . 0.0 115.3 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.3 pt -75.03 168.24 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.282 1.833 . . . . 0.0 112.752 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.2 tp -132.5 86.48 2.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.273 1.429 . . . . 0.0 108.603 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.26 131.19 54.95 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.506 1.523 . . . . 0.0 110.647 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.54 153.02 37.0 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.895 0.771 . . . . 0.0 112.128 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -160.69 160.59 31.67 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -117.68 -17.44 9.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.893 1.677 . . . . 0.0 111.339 167.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -163.16 168.69 20.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.928 2.091 . . . . 0.0 112.065 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -62.31 -26.15 68.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.943 0.897 . . . . 0.0 113.134 -171.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -63.49 -18.04 63.38 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.962 1.305 . . . . 0.0 113.964 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -79.3 -22.51 44.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.834 0.854 . . . . 0.0 112.494 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 68.0 m -93.55 134.14 27.08 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.957 1.303 . . . . 0.0 113.788 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -88.29 159.04 6.86 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.374 2.716 . . . . 0.0 112.14 -171.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.11 -123.68 31.88 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.46 6.7 46.99 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.462 1.105 . . . . 0.0 113.787 174.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.2 m -64.23 145.95 55.13 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.144 -0.972 . . . . 0.0 112.451 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.3 pt -122.59 156.12 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.791 2.036 . . . . 0.0 109.737 173.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -77.61 130.57 37.05 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.191 -0.943 . . . . 0.0 110.781 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -104.09 166.98 10.06 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.814 1.245 . . . . 0.0 111.798 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.73 -16.74 66.24 Favored Glycine 0 N--CA 1.477 1.372 0 C-N-CA 124.665 1.126 . . . . 0.0 115.348 -171.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -76.7 -7.52 55.49 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.718 1.207 . . . . 0.0 114.179 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.9 22.11 43.77 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.93 1.253 . . . . 0.0 114.016 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -135.43 157.61 46.46 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.086 1.355 . . . . 0.0 112.736 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.8 m -72.85 137.86 45.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.602 1.561 . . . . 0.0 112.307 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.01 -169.62 21.08 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.255 1.407 . . . . 0.0 113.494 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.5 0 O-C-N 121.228 -1.16 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -163.82 151.08 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.766 1.626 . . . . 0.0 109.155 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.8 t -89.03 114.1 58.8 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.098 173.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.04 153.49 67.57 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.642 2.228 . . . . 0.0 110.92 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -78.88 25.16 0.28 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.861 1.264 . . . . 0.0 114.148 -171.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.3 mt -79.5 136.17 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.845 1.658 . . . . 0.0 109.381 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.7 tp -89.4 88.62 7.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.385 1.074 . . . . 0.0 109.043 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -108.15 130.52 55.12 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.296 1.439 . . . . 0.0 110.579 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -71.68 159.36 34.53 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.026 0.83 . . . . 0.0 111.411 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.4 p -161.67 157.36 24.38 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -108.75 -25.71 10.68 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.495 1.918 . . . . 0.0 110.511 168.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -161.91 172.98 15.15 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.766 2.026 . . . . 0.0 112.142 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.84 -27.36 68.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.238 1.015 . . . . 0.0 112.97 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 m -62.42 -18.66 62.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.312 1.445 . . . . 0.0 113.952 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.47 -20.15 34.54 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.176 0.99 . . . . 0.0 112.683 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.5 m -90.11 141.63 28.0 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -168.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -84.88 147.6 10.63 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.575 2.85 . . . . 0.0 112.32 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.63 -121.51 26.82 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.41 7.89 45.65 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.681 1.192 . . . . 0.0 113.95 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.4 m -62.54 147.03 50.25 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.07 -1.019 . . . . 0.0 112.339 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.2 pt -120.62 154.11 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.496 1.918 . . . . 0.0 110.09 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -79.07 125.82 29.9 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.341 -0.849 . . . . 0.0 110.616 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -99.06 168.71 9.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.754 1.222 . . . . 0.0 111.89 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.87 -17.43 67.42 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 124.628 1.108 . . . . 0.0 115.241 -172.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -77.35 -6.68 54.19 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.663 1.185 . . . . 0.0 114.116 171.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.95 15.4 59.4 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.157 1.36 . . . . 0.0 114.3 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -128.34 156.65 42.74 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.914 1.286 . . . . 0.0 113.019 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.8 m -73.23 138.52 45.63 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.536 1.534 . . . . 0.0 112.298 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.44 -167.61 20.33 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.144 1.354 . . . . 0.0 113.398 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.477 0 O-C-N 121.194 -1.18 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.3 p -163.76 152.56 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.856 1.663 . . . . 0.0 109.084 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.94 115.46 63.99 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 118.308 -0.854 . . . . 0.0 109.831 171.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.74 170.32 18.97 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.837 2.358 . . . . 0.0 111.832 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -76.71 33.43 0.14 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.765 1.626 . . . . 0.0 113.785 -174.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -79.72 173.73 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.296 1.839 . . . . 0.0 112.649 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 tp -141.97 88.48 2.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.171 1.389 . . . . 0.0 108.398 169.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -110.23 134.67 52.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.568 1.547 . . . . 0.0 110.04 -177.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -68.35 160.87 28.66 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.476 1.035 . . . . 0.0 110.794 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -157.01 150.9 24.69 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -175.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -94.2 -28.87 15.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.282 1.433 . . . . 0.0 111.431 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.0 ptm85 -173.51 174.17 3.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.666 2.787 . . . . 0.0 110.728 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -59.19 -31.04 68.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.508 1.123 . . . . 0.0 113.141 -173.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.9 m -63.87 -17.64 63.38 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.943 1.297 . . . . 0.0 113.836 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -92.0 -9.39 43.08 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.132 1.373 . . . . 0.0 112.398 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.8 m -92.18 140.74 24.55 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.008 1.323 . . . . 0.0 113.399 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.92 149.95 12.47 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.374 2.716 . . . . 0.0 112.404 -169.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.88 -122.72 29.59 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.72 10.84 40.65 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.583 1.153 . . . . 0.0 113.706 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.0 m -61.27 146.74 46.86 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.119 -0.988 . . . . 0.0 112.579 176.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.4 pt -118.89 152.94 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.417 1.887 . . . . 0.0 110.227 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -82.21 121.39 26.56 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.418 -0.801 . . . . 0.0 110.531 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -94.06 169.71 10.07 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.928 1.291 . . . . 0.0 111.817 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.99 67.49 Favored Glycine 0 N--CA 1.477 1.396 0 C-N-CA 124.6 1.095 . . . . 0.0 115.14 -172.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -78.33 -5.59 52.61 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.824 1.25 . . . . 0.0 114.197 171.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.09 13.84 63.48 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.182 1.373 . . . . 0.0 114.409 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -124.85 156.67 37.49 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.064 1.345 . . . . 0.0 113.373 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.5 m -73.97 137.49 43.57 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.87 1.668 . . . . 0.0 112.447 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.76 -169.32 20.58 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.329 1.442 . . . . 0.0 113.267 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.482 0 O-C-N 121.3 -1.117 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.9 m -147.76 158.92 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 126.365 1.866 . . . . 0.0 108.68 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.6 t -96.84 117.73 65.62 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.637 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -53.96 142.87 63.31 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.257 3.305 . . . . 0.0 113.276 172.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.55 13.57 6.73 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.4 pt -79.13 154.4 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.496 1.518 . . . . 0.0 112.347 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.0 tp -87.82 88.45 7.66 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.37 1.068 . . . . 0.0 109.299 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -109.3 121.88 46.13 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.82 1.648 . . . . 0.0 109.675 -174.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -73.51 159.66 32.85 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.148 -0.97 . . . . 0.0 112.311 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -162.44 159.49 25.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -175.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -109.98 -29.68 8.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.321 1.848 . . . . 0.0 110.503 168.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -158.98 177.58 10.98 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.542 1.937 . . . . 0.0 111.965 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.21 -27.31 68.89 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -169.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.0 p -69.87 -12.38 61.58 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -83.85 -14.05 52.16 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.029 0.932 . . . . 0.0 112.558 171.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.3 m -96.0 140.53 22.31 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.924 1.29 . . . . 0.0 113.984 -169.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -84.25 147.91 11.57 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.459 2.772 . . . . 0.0 112.206 -169.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.22 -125.1 37.88 Favored Glycine 0 CA--C 1.532 1.102 0 O-C-N 121.84 -0.538 . . . . 0.0 111.911 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.2 6.62 47.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.92 1.288 . . . . 0.0 114.1 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.3 m -62.52 147.5 48.72 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.055 -1.028 . . . . 0.0 112.813 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.7 pt -115.5 156.99 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.507 1.923 . . . . 0.0 110.228 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.3 t -83.5 118.11 23.55 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.47 -0.769 . . . . 0.0 110.797 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.5 mmm-85 -86.85 167.46 14.33 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.635 1.174 . . . . 0.0 111.609 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.66 -16.76 66.12 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 124.601 1.096 . . . . 0.0 115.322 -172.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -77.73 -7.5 56.62 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.687 1.195 . . . . 0.0 114.186 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.23 17.41 55.68 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.885 1.231 . . . . 0.0 114.264 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -130.49 156.29 45.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.85 1.26 . . . . 0.0 112.71 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.9 m -75.26 143.47 43.02 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.133 1.373 . . . . 0.0 112.857 -175.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.57 -170.33 28.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.943 1.259 . . . . 0.0 113.494 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.481 0 O-C-N 121.229 -1.16 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 p -163.52 149.82 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.672 1.589 . . . . 0.0 109.375 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.0 t -91.56 117.42 67.78 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.233 173.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.81 149.66 86.54 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.829 2.353 . . . . 0.0 111.336 176.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -81.82 18.24 1.33 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -169.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.6 pt -74.57 150.98 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.412 1.485 . . . . 0.0 111.993 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 tp -94.33 86.39 4.88 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.265 1.026 . . . . 0.0 109.18 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -107.73 124.73 50.46 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.391 1.477 . . . . 0.0 110.699 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -70.89 158.57 36.19 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.18 -0.95 . . . . 0.0 113.106 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.1 p -159.17 154.72 25.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -174.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -100.57 -31.85 11.05 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.259 1.423 . . . . 0.0 110.721 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.72 177.32 9.45 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.083 2.153 . . . . 0.0 111.155 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -60.8 -25.52 66.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -63.39 -19.46 64.69 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.933 1.293 . . . . 0.0 113.993 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.8 -17.67 52.79 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.064 0.946 . . . . 0.0 112.798 173.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.8 m -98.83 137.11 20.5 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.803 1.241 . . . . 0.0 113.837 -169.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -88.76 154.55 6.14 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.752 2.968 . . . . 0.0 112.446 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -121.5 26.55 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.28 5.04 51.85 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.449 1.1 . . . . 0.0 113.933 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.8 m -64.91 145.4 56.35 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.458 1.026 . . . . 0.0 112.217 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.5 pt -120.42 156.29 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.572 1.949 . . . . 0.0 109.755 171.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.8 t -79.65 125.86 30.18 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.315 -0.866 . . . . 0.0 110.62 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -97.47 168.36 10.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.732 1.213 . . . . 0.0 111.819 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.58 -17.62 67.0 Favored Glycine 0 N--CA 1.476 1.354 0 C-N-CA 124.631 1.11 . . . . 0.0 115.273 -171.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -77.31 -8.18 57.22 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.673 1.189 . . . . 0.0 114.181 171.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.32 18.51 52.8 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.09 1.329 . . . . 0.0 114.346 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -129.8 156.6 44.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.414 1.486 . . . . 0.0 112.238 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 82.4 m -72.91 139.21 46.66 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.979 1.711 . . . . 0.0 112.376 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.35 -169.13 24.22 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 124.977 1.275 . . . . 0.0 113.514 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 O-C-N 121.256 -1.144 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -145.5 136.52 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.812 1.645 . . . . 0.0 107.943 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.7 t -79.33 119.9 78.61 Favored Pre-proline 0 CA--C 1.551 0.984 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.217 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.26 173.25 11.69 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.625 2.884 . . . . 0.0 112.845 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -75.32 33.02 0.1 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.262 1.825 . . . . 0.0 114.048 -174.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.8 pt -78.37 168.93 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.027 1.731 . . . . 0.0 112.169 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 tp -137.85 83.44 1.98 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.844 1.257 . . . . 0.0 108.847 170.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -106.75 126.51 52.38 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.484 1.514 . . . . 0.0 110.108 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -70.28 156.67 38.95 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.32 0.964 . . . . 0.0 112.804 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.1 p -160.0 156.98 27.94 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -106.96 -25.44 11.63 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.575 1.95 . . . . 0.0 110.607 168.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -163.11 171.87 15.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.461 1.904 . . . . 0.0 112.143 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -61.32 -27.11 68.25 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 113.058 -172.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -62.7 -18.46 62.51 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.145 1.378 . . . . 0.0 113.856 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -81.16 -22.03 39.28 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.083 0.953 . . . . 0.0 112.417 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.1 m -92.69 135.95 25.69 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.886 1.274 . . . . 0.0 113.244 -169.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.72 148.14 9.67 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.965 2.444 . . . . 0.0 111.918 -170.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.27 -122.73 30.82 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.437 0.542 . . . . 0.0 112.378 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.58 -2.56 58.7 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.81 1.244 . . . . 0.0 114.313 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.3 m -65.74 146.3 54.95 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.325 0.966 . . . . 0.0 112.844 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.9 pt -125.1 155.39 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.859 2.064 . . . . 0.0 109.632 174.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.79 131.29 37.54 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.146 -0.971 . . . . 0.0 110.712 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -105.95 168.15 9.32 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.649 1.18 . . . . 0.0 111.79 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.82 -17.11 66.93 Favored Glycine 0 N--CA 1.477 1.394 0 C-N-CA 124.632 1.11 . . . . 0.0 115.255 -171.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -76.52 -7.99 56.27 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.701 1.2 . . . . 0.0 114.095 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.17 17.79 54.97 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.079 1.323 . . . . 0.0 114.266 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -130.77 157.97 41.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.341 1.456 . . . . 0.0 112.306 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.1 m -73.81 135.21 43.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.086 1.754 . . . . 0.0 112.057 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.41 -168.92 18.56 Favored Glycine 0 N--CA 1.471 1.009 0 C-N-CA 125.398 1.475 . . . . 0.0 113.315 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.521 0 O-C-N 121.233 -1.157 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p -163.95 151.8 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.861 1.665 . . . . 0.0 109.024 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.6 t -89.23 117.33 68.12 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.925 171.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -61.6 163.26 18.73 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.194 2.596 . . . . 0.0 113.153 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -76.01 28.29 0.11 Allowed 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.598 1.559 . . . . 0.0 113.871 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.09 174.19 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.531 1.932 . . . . 0.0 112.939 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.8 tp -138.88 88.05 2.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.391 1.476 . . . . 0.0 108.226 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -109.29 133.07 53.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.503 1.521 . . . . 0.0 110.439 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -69.05 158.9 33.88 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.246 0.93 . . . . 0.0 111.06 176.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.8 p -160.95 157.87 27.14 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -176.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -111.03 -24.38 10.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.619 1.968 . . . . 0.0 110.615 168.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -161.91 173.29 14.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.835 2.054 . . . . 0.0 111.977 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.68 -26.68 67.28 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.232 1.013 . . . . 0.0 113.024 -173.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 m -60.98 -20.16 62.02 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.548 1.539 . . . . 0.0 113.968 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -82.79 -20.78 35.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.247 1.019 . . . . 0.0 112.697 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.8 m -90.87 138.98 25.98 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 124.933 1.293 . . . . 0.0 114.312 -168.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -86.27 151.38 9.32 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.417 2.745 . . . . 0.0 112.301 -170.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.4 -124.03 33.76 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.73 10.51 41.0 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.639 1.176 . . . . 0.0 113.765 173.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 80.6 m -61.8 147.05 47.65 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.157 -0.964 . . . . 0.0 112.082 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.31 153.23 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.42 1.888 . . . . 0.0 110.029 175.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.1 t -77.47 130.01 36.45 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.357 -0.839 . . . . 0.0 110.629 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -104.91 168.64 8.92 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.716 1.207 . . . . 0.0 111.866 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -17.18 66.93 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 124.743 1.163 . . . . 0.0 115.247 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -76.95 -6.41 52.43 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.795 1.238 . . . . 0.0 114.109 171.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.22 16.72 58.7 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.125 1.345 . . . . 0.0 114.13 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -129.81 156.65 43.99 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.97 1.308 . . . . 0.0 113.25 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 82.9 m -73.67 134.12 43.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.773 1.629 . . . . 0.0 112.084 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.11 -172.38 19.41 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 125.428 1.489 . . . . 0.0 113.382 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.525 0 O-C-N 121.263 -1.14 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.767 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.0 p -164.96 146.93 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.916 1.687 . . . . 0.0 109.553 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.2 t -83.78 117.99 70.17 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.161 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.42 172.29 14.49 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.388 2.725 . . . . 0.0 112.245 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.01 34.57 0.13 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.928 1.691 . . . . 0.0 113.914 -175.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.0 pt -79.05 168.22 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.135 1.774 . . . . 0.0 112.112 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.4 tp -136.49 86.41 2.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.961 1.304 . . . . 0.0 108.597 169.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -108.04 134.78 50.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.757 1.623 . . . . 0.0 110.635 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.34 154.95 22.56 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.413 1.006 . . . . 0.0 111.974 171.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.1 p -153.6 151.04 29.28 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.605 1.705 . . . . 0.0 115.605 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -96.51 -25.43 15.65 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.697 1.999 . . . . 0.0 113.246 169.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -174.89 173.69 2.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 128.01 2.524 . . . . 0.0 111.257 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -60.2 -33.43 72.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.329 1.052 . . . . 0.0 112.871 -175.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -64.38 -16.58 62.55 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.942 1.297 . . . . 0.0 113.474 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -93.34 -8.26 42.47 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.635 1.574 . . . . 0.0 112.516 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 94.8 m -94.71 138.95 22.09 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.534 1.534 . . . . 0.0 112.629 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -84.02 149.79 12.29 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.107 2.538 . . . . 0.0 112.2 -169.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -123.72 33.14 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.297 0.475 . . . . 0.0 111.985 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.59 3.5 55.41 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.603 1.161 . . . . 0.0 114.015 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.6 m -63.61 145.97 54.66 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.159 -0.963 . . . . 0.0 112.683 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.2 pt -119.88 154.77 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.74 2.016 . . . . 0.0 110.039 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.9 t -83.51 123.16 29.46 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.39 -0.819 . . . . 0.0 110.531 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -95.28 169.36 10.13 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.732 1.213 . . . . 0.0 111.796 -176.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.48 -17.92 67.13 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.653 1.121 . . . . 0.0 115.157 -172.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -78.0 -6.43 54.46 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.741 1.216 . . . . 0.0 114.188 171.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.96 18.8 57.36 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.048 1.309 . . . . 0.0 114.189 -178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -129.37 157.53 41.66 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.207 1.403 . . . . 0.0 112.69 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.9 m -73.23 138.9 45.85 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.492 1.517 . . . . 0.0 112.377 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.85 -168.58 20.41 Favored Glycine 0 N--CA 1.47 0.904 0 C-N-CA 125.434 1.492 . . . . 0.0 113.228 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.525 0 O-C-N 121.3 -1.118 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.3 t -145.78 139.0 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 126.044 1.738 . . . . 0.0 107.764 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 40.3 t -80.72 118.73 73.7 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.387 175.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.81 169.69 20.57 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 123.014 2.476 . . . . 0.0 111.776 177.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -77.43 39.32 0.26 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.434 1.493 . . . . 0.0 113.41 -176.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 pp -79.32 172.9 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.946 1.698 . . . . 0.0 112.326 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.8 tp -142.38 87.13 2.0 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.007 1.323 . . . . 0.0 108.75 172.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -111.04 134.59 52.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.548 1.539 . . . . 0.0 110.587 -177.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -62.64 153.6 31.78 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.065 0.848 . . . . 0.0 111.987 175.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.1 p -159.26 156.73 29.31 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 176.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -110.04 -26.61 9.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.883 2.073 . . . . 0.0 110.105 168.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -159.54 171.92 18.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.4 1.88 . . . . 0.0 112.287 178.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -61.13 -27.69 68.57 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.199 1.0 . . . . 0.0 113.057 -172.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.6 m -63.33 -17.28 62.4 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.158 1.383 . . . . 0.0 113.94 176.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -81.83 -21.17 37.74 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.038 0.935 . . . . 0.0 112.619 173.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.7 m -90.78 140.86 26.45 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 114.356 -168.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -84.2 145.96 11.09 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.227 2.618 . . . . 0.0 111.912 -169.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.59 -122.37 29.57 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 121.977 -0.452 . . . . 0.0 112.003 177.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.69 5.37 52.05 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.692 1.197 . . . . 0.0 114.079 176.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 74.6 m -62.3 146.37 51.24 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.198 -0.939 . . . . 0.0 112.421 176.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.8 pt -122.57 154.77 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.612 1.965 . . . . 0.0 109.907 175.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -78.32 129.29 34.84 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.332 -0.855 . . . . 0.0 110.728 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -103.42 168.02 9.43 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.798 1.239 . . . . 0.0 111.79 -178.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.86 -16.9 66.76 Favored Glycine 0 N--CA 1.477 1.422 0 C-N-CA 124.638 1.113 . . . . 0.0 115.244 -171.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -77.15 -6.62 53.63 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.71 1.204 . . . . 0.0 114.14 171.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.07 20.0 54.22 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.862 1.22 . . . . 0.0 114.039 -178.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -133.34 158.75 42.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.205 1.402 . . . . 0.0 112.682 177.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.3 m -74.17 138.28 43.7 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.665 1.586 . . . . 0.0 112.465 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.65 -168.29 19.14 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.291 1.424 . . . . 0.0 113.305 175.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.468 0 O-C-N 121.251 -1.147 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.817 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.1 m -147.81 159.58 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 126.281 1.832 . . . . 0.0 108.637 178.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.6 t -91.4 116.57 66.71 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.963 172.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.82 152.12 77.76 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.833 2.355 . . . . 0.0 111.363 177.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.56 15.43 1.31 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -169.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.8 pt -79.37 149.55 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.238 1.415 . . . . 0.0 111.87 179.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.6 tp -95.9 94.53 7.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.5 1.12 . . . . 0.0 109.363 177.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -110.31 132.8 53.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.186 1.394 . . . . 0.0 111.153 -177.072 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -63.28 156.18 26.33 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.853 0.751 . . . . 0.0 112.102 174.529 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.3 p -158.95 152.79 23.27 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 175.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -97.23 -31.34 12.48 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.504 1.922 . . . . 0.0 110.602 169.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -168.19 173.64 7.72 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.363 2.665 . . . . 0.0 110.518 -175.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.38 -26.63 65.28 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.294 1.038 . . . . 0.0 113.222 -172.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -61.01 -21.6 63.74 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.458 1.503 . . . . 0.0 114.157 177.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -84.53 -16.96 40.49 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.016 0.926 . . . . 0.0 112.795 175.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.8 m -91.6 139.94 25.14 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 124.616 1.166 . . . . 0.0 114.054 -169.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -84.73 147.17 10.75 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.653 2.902 . . . . 0.0 112.42 -169.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.51 -121.27 26.07 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 177.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.03 6.37 49.01 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.759 1.224 . . . . 0.0 113.973 175.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.1 m -62.77 146.45 52.47 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.485 1.039 . . . . 0.0 112.169 177.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.65 156.26 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.313 1.845 . . . . 0.0 109.963 171.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.2 t -80.12 127.33 32.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.368 -0.832 . . . . 0.0 110.852 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -97.83 164.63 12.3 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.843 1.257 . . . . 0.0 111.48 -179.533 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.93 -19.94 63.95 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -169.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -79.87 -6.66 57.83 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 118.468 1.134 . . . . 0.0 113.861 174.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.21 23.5 22.01 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.115 1.341 . . . . 0.0 114.451 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -135.68 156.5 48.74 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.924 1.29 . . . . 0.0 112.832 178.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.6 m -74.04 140.6 45.5 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.775 1.63 . . . . 0.0 112.804 -177.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.36 -171.46 24.28 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 125.272 1.415 . . . . 0.0 113.398 176.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.522 0 O-C-N 121.3 -1.118 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.7 m -148.1 161.49 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.388 1.875 . . . . 0.0 108.56 178.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 40.7 t -91.01 117.32 67.82 Favored Pre-proline 0 CA--C 1.547 0.864 0 CA-C-O 118.19 -0.909 . . . . 0.0 109.845 170.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.28 168.43 22.24 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.023 2.482 . . . . 0.0 112.098 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -75.51 31.22 0.1 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 125.839 1.655 . . . . 0.0 113.522 -177.555 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.3 tt -80.92 156.17 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.396 1.878 . . . . 0.0 111.883 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.9 tp -122.69 85.84 2.48 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.998 1.319 . . . . 0.0 108.135 169.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -109.15 132.7 53.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.535 1.534 . . . . 0.0 110.6 -175.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -72.15 159.36 34.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.158 0.89 . . . . 0.0 111.48 177.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.8 p -161.76 158.05 25.18 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -174.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.56 -29.46 8.75 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.38 1.872 . . . . 0.0 110.475 168.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -159.81 177.52 10.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.552 1.941 . . . . 0.0 111.969 176.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -63.28 -26.7 68.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -169.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.0 p -69.69 -11.76 61.1 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 177.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -81.92 -14.88 55.51 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.088 0.955 . . . . 0.0 112.616 170.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.1 m -99.7 139.97 21.23 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.193 1.397 . . . . 0.0 113.49 -169.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -87.0 151.27 8.34 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.363 2.709 . . . . 0.0 112.375 -169.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.2 -122.57 29.89 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 178.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.62 7.75 45.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.579 1.152 . . . . 0.0 113.884 175.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.1 m -62.37 145.25 54.44 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.107 -0.996 . . . . 0.0 112.16 176.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.7 pt -120.02 155.21 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.467 1.907 . . . . 0.0 110.01 173.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.1 t -80.16 123.12 27.63 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.441 -0.787 . . . . 0.0 110.677 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -95.13 169.08 10.35 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.856 1.262 . . . . 0.0 111.783 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.61 -17.61 67.05 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 124.54 1.067 . . . . 0.0 115.197 -172.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -78.17 -6.08 53.7 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.702 1.201 . . . . 0.0 114.211 171.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.21 15.57 60.46 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.081 1.324 . . . . 0.0 114.296 -178.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -127.28 156.19 42.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.841 1.257 . . . . 0.0 112.984 178.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -72.52 138.7 47.13 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.716 1.606 . . . . 0.0 112.252 -178.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.97 -169.16 23.85 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.085 1.326 . . . . 0.0 113.489 177.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.535 0 O-C-N 121.321 -1.105 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m -148.1 159.56 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 126.263 1.825 . . . . 0.0 108.543 178.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.1 t -90.27 117.21 67.86 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.871 172.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.17 152.27 79.96 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.765 2.31 . . . . 0.0 111.539 178.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.42 15.13 1.34 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -169.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.2 pt -79.16 149.17 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.279 1.432 . . . . 0.0 111.753 178.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.6 tp -95.04 92.0 6.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.343 1.057 . . . . 0.0 109.206 175.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -108.73 130.04 55.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.279 1.432 . . . . 0.0 110.635 -178.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -69.85 160.36 31.93 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.479 1.036 . . . . 0.0 112.539 172.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.7 p -158.21 151.96 23.66 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -176.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.5 ttp85 -88.1 -39.56 14.48 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.168 1.387 . . . . 0.0 111.386 169.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -165.4 179.62 6.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.429 2.291 . . . . 0.0 110.942 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.14 -29.66 69.91 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.509 1.123 . . . . 0.0 113.947 -170.336 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.7 p -66.91 -17.48 64.92 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.326 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -94.76 -1.73 52.36 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.168 1.387 . . . . 0.0 112.85 176.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.0 m -96.12 141.73 23.56 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.921 1.288 . . . . 0.0 112.936 177.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -83.61 146.5 12.05 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.538 2.826 . . . . 0.0 112.611 -169.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.88 -122.04 28.48 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 177.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.45 6.47 48.91 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.681 1.192 . . . . 0.0 114.007 175.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.7 m -62.47 145.47 54.08 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.373 0.988 . . . . 0.0 112.411 178.065 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.3 pt -114.45 155.57 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 126.37 1.868 . . . . 0.0 110.008 170.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.1 t -84.9 115.11 22.59 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.511 -0.743 . . . . 0.0 110.432 179.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -84.23 168.58 15.59 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.045 1.338 . . . . 0.0 111.726 -176.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.31 -17.76 66.56 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 124.503 1.049 . . . . 0.0 115.188 -173.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -78.37 -6.57 55.56 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.76 1.224 . . . . 0.0 114.195 171.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.84 17.33 58.27 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.994 1.283 . . . . 0.0 114.452 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.07 157.26 40.11 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.352 1.461 . . . . 0.0 112.363 177.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 79.5 m -74.95 139.82 43.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.861 1.664 . . . . 0.0 112.573 -178.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.89 -168.82 24.34 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.104 1.335 . . . . 0.0 113.377 177.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.433 0 O-C-N 121.276 -1.132 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.756 0 N-CA-C 112.555 -0.218 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p -163.58 149.85 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.706 1.603 . . . . 0.0 109.305 -178.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.0 t -91.38 118.83 68.67 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.401 174.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.78 141.89 55.86 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.65 2.233 . . . . 0.0 110.558 172.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -82.14 30.25 0.4 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.629 1.172 . . . . 0.0 113.91 -169.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt -78.98 150.36 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.621 1.569 . . . . 0.0 111.671 177.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.0 tp -92.67 86.71 5.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.086 0.954 . . . . 0.0 109.164 174.256 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -109.33 128.09 54.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.665 1.586 . . . . 0.0 110.895 -176.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -63.66 154.07 34.11 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.931 0.787 . . . . 0.0 112.354 178.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.9 p -159.46 162.02 35.55 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 175.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -115.49 -23.05 8.99 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.619 1.968 . . . . 0.0 110.703 168.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -161.91 169.75 20.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.681 1.993 . . . . 0.0 112.376 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -63.32 -27.11 69.1 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -169.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.7 p -71.35 -10.59 60.01 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 177.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -79.77 -18.51 50.85 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.208 -0.932 . . . . 0.0 112.108 169.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.3 m -98.91 138.74 20.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.388 1.475 . . . . 0.0 113.616 -169.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -87.53 152.89 7.7 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.755 2.97 . . . . 0.0 112.49 -169.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -120.63 23.48 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 176.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.03 5.38 50.5 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.474 1.11 . . . . 0.0 113.923 175.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.0 m -64.24 143.44 57.89 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.516 1.053 . . . . 0.0 112.166 179.007 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.0 pt -116.72 157.72 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 126.522 1.929 . . . . 0.0 109.973 171.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.7 t -81.72 117.96 22.46 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.394 -0.816 . . . . 0.0 110.585 178.073 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -87.74 167.52 13.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.889 1.276 . . . . 0.0 111.682 -177.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.29 -17.48 66.2 Favored Glycine 0 N--CA 1.478 1.456 0 C-N-CA 124.519 1.057 . . . . 0.0 115.25 -172.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -77.23 -8.56 57.79 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 171.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.81 21.38 43.27 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.937 1.256 . . . . 0.0 114.201 -178.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -132.9 156.84 46.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.082 1.353 . . . . 0.0 112.26 177.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.6 m -70.85 142.35 51.24 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.166 1.386 . . . . 0.0 112.311 -178.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.23 -167.81 28.46 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.787 1.184 . . . . 0.0 113.609 177.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.537 0 O-C-N 121.315 -1.109 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.843 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 p -163.75 149.17 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.777 1.631 . . . . 0.0 109.143 -179.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 t -90.63 120.04 68.94 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.312 173.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -53.72 145.66 48.28 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 124.092 3.195 . . . . 0.0 113.292 173.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -89.86 11.85 19.04 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 pp -79.67 167.3 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.629 1.572 . . . . 0.0 112.188 172.068 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.2 tp -108.22 100.09 9.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.91 1.284 . . . . 0.0 109.831 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -113.01 131.7 55.67 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.278 1.431 . . . . 0.0 111.01 -179.296 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -71.76 161.62 30.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.116 0.871 . . . . 0.0 111.273 173.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.9 p -160.13 151.38 19.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -175.042 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.8 ttt180 -88.97 -38.21 14.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.348 1.459 . . . . 0.0 111.293 169.281 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -164.88 178.49 7.12 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.359 2.264 . . . . 0.0 111.028 179.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -58.88 -30.67 67.92 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.69 1.196 . . . . 0.0 113.429 -173.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 m -60.67 -21.15 62.5 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.961 1.304 . . . . 0.0 113.833 177.255 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -97.9 0.2 46.14 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.251 1.42 . . . . 0.0 113.038 179.481 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.5 m -97.47 141.09 22.48 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.042 1.337 . . . . 0.0 113.07 178.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.43 148.13 11.37 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.49 2.793 . . . . 0.0 112.607 -169.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.7 -124.05 34.55 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 179.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.88 7.66 45.25 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.719 1.208 . . . . 0.0 114.052 175.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 85.2 m -62.35 145.52 53.67 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.15 -0.969 . . . . 0.0 112.517 178.057 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -115.25 154.6 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.363 1.865 . . . . 0.0 110.098 170.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.0 t -84.13 112.72 20.5 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.478 -0.764 . . . . 0.0 110.328 179.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -81.48 168.69 18.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.994 1.317 . . . . 0.0 111.717 -177.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.24 -17.84 66.51 Favored Glycine 0 N--CA 1.478 1.457 0 C-N-CA 124.572 1.082 . . . . 0.0 115.143 -172.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 p-10 -78.27 -6.36 54.74 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.754 1.222 . . . . 0.0 114.212 171.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.62 16.4 58.53 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.036 1.303 . . . . 0.0 114.379 -178.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -126.51 154.99 43.03 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.919 1.287 . . . . 0.0 113.184 178.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 81.8 m -73.6 137.19 44.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.349 1.46 . . . . 0.0 112.384 -177.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.49 -167.42 21.91 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.048 1.309 . . . . 0.0 113.347 178.037 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.449 0 O-C-N 121.224 -1.162 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m -148.38 159.6 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.372 1.869 . . . . 0.0 108.448 178.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.9 t -89.92 118.64 69.09 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.058 171.577 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -62.4 165.18 15.82 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.203 2.602 . . . . 0.0 113.235 177.153 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.39 21.93 0.59 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.038 1.335 . . . . 0.0 114.527 -171.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.25 168.18 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.082 1.353 . . . . 0.0 112.989 -177.018 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.9 tp -125.59 86.04 2.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.105 1.362 . . . . 0.0 107.885 169.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -106.97 130.19 54.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.34 1.456 . . . . 0.0 110.393 -175.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -71.01 158.44 36.51 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.109 0.868 . . . . 0.0 111.262 177.022 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.5 p -160.97 157.24 26.05 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -174.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -107.71 -28.13 9.88 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.715 2.006 . . . . 0.0 110.116 168.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ptm85 -160.13 172.46 17.41 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.362 1.865 . . . . 0.0 112.486 179.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -61.2 -27.36 68.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.211 1.004 . . . . 0.0 113.02 -172.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -63.42 -17.34 62.56 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.091 1.357 . . . . 0.0 113.949 177.021 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -82.01 -20.81 37.66 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.161 0.984 . . . . 0.0 112.636 173.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.8 m -92.14 139.54 24.31 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.158 1.383 . . . . 0.0 114.202 -168.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -86.26 151.21 9.32 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.356 2.704 . . . . 0.0 112.229 -170.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.96 -125.48 38.28 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.13 10.45 39.36 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.574 1.15 . . . . 0.0 113.874 174.076 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.31 145.56 51.01 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.13 -0.981 . . . . 0.0 112.064 174.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.02 153.61 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.278 1.831 . . . . 0.0 110.062 173.876 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.8 t -78.09 124.39 27.99 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.502 -0.749 . . . . 0.0 110.546 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -98.13 169.36 9.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.774 1.23 . . . . 0.0 111.782 -176.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.55 -17.68 67.0 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 124.58 1.086 . . . . 0.0 115.223 -172.571 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -78.09 -6.35 54.38 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.686 1.194 . . . . 0.0 114.21 171.54 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.41 16.26 59.09 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.063 1.316 . . . . 0.0 114.315 -178.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -128.24 156.12 43.47 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.971 1.309 . . . . 0.0 113.081 178.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.3 m -72.12 136.89 46.67 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.535 1.534 . . . . 0.0 112.075 179.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.33 -169.46 21.14 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.205 1.383 . . . . 0.0 113.063 177.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.555 0 O-C-N 121.4 -1.059 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.788 0 N-CA-C 112.432 -0.267 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.1 m -148.0 163.26 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 126.393 1.877 . . . . 0.0 108.732 179.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.0 t -95.69 117.02 66.67 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.342 -0.837 . . . . 0.0 109.761 169.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.64 172.23 16.18 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.124 2.55 . . . . 0.0 112.404 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -72.22 25.5 0.05 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.53 1.932 . . . . 0.0 115.476 -175.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.2 pt -77.69 170.31 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.313 1.845 . . . . 0.0 112.764 -177.537 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.5 tp -136.86 88.05 2.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.24 1.416 . . . . 0.0 108.467 169.606 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -108.94 133.68 52.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.529 1.532 . . . . 0.0 110.859 -175.712 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -63.58 154.89 31.24 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.996 0.816 . . . . 0.0 112.248 175.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.8 p -159.38 156.91 29.33 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 176.176 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -107.15 -32.35 7.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.819 2.048 . . . . 0.0 110.141 168.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -158.03 176.64 12.26 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.227 1.811 . . . . 0.0 112.054 176.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -63.09 -26.71 68.96 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.4 p -69.56 -12.29 61.52 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -78.87 -21.58 47.3 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.409 -0.807 . . . . 0.0 112.283 169.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.5 m -94.85 134.17 25.37 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.976 1.31 . . . . 0.0 113.33 -169.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -88.47 160.01 6.64 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.423 2.749 . . . . 0.0 112.131 -170.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.15 -125.04 35.23 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 178.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.45 7.96 45.49 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.355 1.062 . . . . 0.0 113.686 173.425 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -63.78 146.53 53.72 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.162 -0.961 . . . . 0.0 112.371 177.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 pt -123.37 155.82 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.81 2.044 . . . . 0.0 109.616 174.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.4 t -78.69 131.27 36.57 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.19 -0.943 . . . . 0.0 110.776 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.44 168.06 9.33 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.696 1.198 . . . . 0.0 111.86 -178.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.88 -16.65 66.46 Favored Glycine 0 N--CA 1.477 1.391 0 C-N-CA 124.638 1.113 . . . . 0.0 115.327 -171.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -76.63 -7.07 54.54 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.723 1.209 . . . . 0.0 114.138 170.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.4 20.11 52.91 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.008 1.29 . . . . 0.0 114.09 -178.287 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -133.47 158.06 44.05 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.149 1.38 . . . . 0.0 112.807 178.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.4 m -73.6 136.05 43.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.747 1.619 . . . . 0.0 112.319 -178.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.53 -172.09 20.69 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.421 1.486 . . . . 0.0 113.393 176.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 O-C-N 121.22 -1.165 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.792 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.5 m -148.32 161.32 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.306 1.842 . . . . 0.0 108.584 178.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.1 t -90.86 117.84 68.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.865 170.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.36 167.6 24.74 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.949 2.433 . . . . 0.0 111.849 178.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -76.11 33.24 0.12 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.632 1.573 . . . . 0.0 113.246 -177.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.0 tt -79.89 154.54 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.189 1.796 . . . . 0.0 111.699 178.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.1 tp -120.65 86.06 2.5 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.915 1.286 . . . . 0.0 108.038 169.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -108.14 132.83 53.19 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.293 1.437 . . . . 0.0 110.737 -176.026 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.58 153.66 31.34 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.937 0.79 . . . . 0.0 111.812 175.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.9 p -159.64 158.27 31.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 176.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -113.8 -22.97 9.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.658 1.983 . . . . 0.0 110.814 168.487 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -161.83 171.24 18.1 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.607 1.963 . . . . 0.0 112.178 177.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -61.97 -27.04 68.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.03 0.932 . . . . 0.0 113.121 -171.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -62.86 -18.12 62.48 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.035 1.334 . . . . 0.0 113.982 176.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -80.78 -20.94 41.51 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.142 0.977 . . . . 0.0 112.564 174.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.8 m -92.71 138.8 23.51 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.04 1.336 . . . . 0.0 114.477 -168.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -87.07 153.29 8.3 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.436 2.757 . . . . 0.0 112.222 -170.366 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.24 -123.63 32.89 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.22 8.89 44.16 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.506 1.122 . . . . 0.0 113.887 174.192 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 80.8 m -62.55 146.8 50.92 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.066 -1.021 . . . . 0.0 112.187 176.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.8 pt -122.3 155.32 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 126.543 1.937 . . . . 0.0 109.824 174.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.0 t -77.68 130.6 37.02 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.203 -0.936 . . . . 0.0 110.763 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.45 167.6 9.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.717 1.207 . . . . 0.0 111.916 -178.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.06 -16.47 66.59 Favored Glycine 0 N--CA 1.477 1.381 0 C-N-CA 124.732 1.158 . . . . 0.0 115.373 -171.703 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -76.32 -7.01 54.04 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.696 1.198 . . . . 0.0 114.107 170.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.55 19.32 54.88 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.016 1.294 . . . . 0.0 114.0 -178.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -133.71 158.7 42.62 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.255 1.422 . . . . 0.0 112.695 178.193 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.7 m -73.06 138.78 46.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.565 1.546 . . . . 0.0 112.424 -179.113 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.94 -170.3 21.12 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.257 1.408 . . . . 0.0 113.433 176.044 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.516 0 O-C-N 121.257 -1.143 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.736 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -163.51 150.37 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.718 1.607 . . . . 0.0 109.164 -179.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.2 t -86.72 115.66 63.19 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.016 173.507 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -67.98 160.47 48.42 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.78 2.32 . . . . 0.0 112.054 178.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.93 16.03 0.17 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -172.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 tp -75.12 144.67 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.895 1.678 . . . . 0.0 111.746 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.5 tp -102.94 88.37 3.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.749 1.22 . . . . 0.0 108.328 169.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -108.63 129.78 55.33 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.256 1.422 . . . . 0.0 110.413 -177.274 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.28 157.75 34.89 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.391 0.996 . . . . 0.0 112.109 172.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -157.22 151.49 25.0 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -174.672 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -91.13 -35.7 14.41 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.192 1.397 . . . . 0.0 111.505 169.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -164.75 177.35 8.04 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 127.198 2.199 . . . . 0.0 111.277 179.277 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -59.67 -30.54 68.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.703 1.201 . . . . 0.0 113.467 -173.012 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 m -60.91 -20.69 62.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.909 1.284 . . . . 0.0 113.735 177.335 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -97.21 0.83 48.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.374 1.47 . . . . 0.0 112.988 179.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 97.7 m -98.98 141.1 22.3 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.074 1.35 . . . . 0.0 113.2 178.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -84.68 149.42 11.25 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.5 2.8 . . . . 0.0 112.589 -169.342 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.34 -124.0 33.77 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.3 10.48 40.58 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.675 1.19 . . . . 0.0 113.745 174.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.2 m -61.51 145.57 51.47 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.099 -1.0 . . . . 0.0 112.52 176.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.1 pt -116.19 154.89 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.448 1.899 . . . . 0.0 110.054 172.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.2 t -83.52 116.43 22.56 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.588 -0.695 . . . . 0.0 110.517 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -87.05 168.72 13.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.041 1.337 . . . . 0.0 111.752 -176.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.65 -17.58 67.11 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 124.602 1.096 . . . . 0.0 115.193 -173.316 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -78.27 -6.34 54.69 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.732 1.213 . . . . 0.0 114.149 171.744 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.08 16.16 59.79 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.028 1.299 . . . . 0.0 114.404 -179.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -126.54 157.78 37.89 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.407 1.483 . . . . 0.0 112.397 177.743 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 80.9 m -73.84 140.3 45.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.962 1.705 . . . . 0.0 112.481 -179.532 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.53 -167.33 23.83 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.164 1.364 . . . . 0.0 113.431 177.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.49 0 O-C-N 121.265 -1.138 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_